{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.14200"}, {"@name": "filename", "#text": "20482_000908688.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL \n\nCENTRO DE BIOTECNOLOGIA \n\nPROGRAMA DE P\u00d3S-GRADUA\u00c7\u00c3O EM BIOLOGIA CELULAR E \n\nMOLECULAR \n\n \n\n \n\n \n\n \n\n Mecanismos de Toxicidade Sist\u00eamica no \n\nEnvenenamento pela Taturana Lonomia obliqua: \n\nAltera\u00e7\u00f5es Fisiopatol\u00f3gicas Renais e Vasculares na \n\nNefrotoxicidade Induzida pelo Veneno   \n\n \n\n \n\n \n\nMarkus Berger \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nPorto Alegre \n\nOutubro de 2013 \n\n \n\n\n\n \n\n \n\nUNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL \n\nCENTRO DE BIOTECNOLOGIA \n\nPROGRAMA DE P\u00d3S-GRADUA\u00c7\u00c3O EM BIOLOGIA CELULAR E MOLECULAR \n\n \n\n \n\nMecanismos de Toxicidade Sist\u00eamica no \n\nEnvenenamento pela Taturana Lonomia obliqua: \n\nAltera\u00e7\u00f5es Fisiopatol\u00f3gicas Renais e Vasculares na \n\nNefrotoxicidade Induzida pelo Veneno   \n\n \n\nMarkus Berger \n\n \n\nOrientador: Dr. Jorge Almeida Guimar\u00e3es \n\nCoorientadora: Dra. Maria Aparecida Ribeiro Vieira \n\n \n\n \n\n \n\nTese submetida ao Programa de P\u00f3s-Gradua\u00e7\u00e3o \n\nem Biologia Celular e Molecular do Centro de \n\nBiotecnologia da Universidade Federal do Rio \n\nGrande do Sul como requisito parcial para \n\nobten\u00e7\u00e3o do grau de Doutor em Ci\u00eancias.  \n\n \n\n\u00c1rea de concentra\u00e7\u00e3o: Biologia Celular e \n\nMolecular \n\n \n\n \n\n \n\n \n\n \n\n \n\nPorto Alegre \n\nOutubro de 2013 \n\n \n\n\n\n \n\n \n\nMecanismos de Toxicidade Sist\u00eamica no Envenenamento pela \n\nTaturana Lonomia obliqua: Altera\u00e7\u00f5es Fisiopatol\u00f3gicas Renais e \n\nVasculares na Nefrotoxicidade Induzida pelo Veneno   \n\n \n\nMarkus Berger \n\n \n\nTese submetida ao Programa de P\u00f3s-gradua\u00e7\u00e3o em Biologia Celular e Molecular \n\n(PPGBCM) do Centro de Biotecnologia \u2013 UFRGS como requisito parcial para a \n\nobten\u00e7\u00e3o do grau de Doutor em Ci\u00eancias. \n\n \n\nBANCA EXAMINADORA \n\n \n\n \n \n\n \n\nProf. Dr. Jorge Almeida Guimar\u00e3es \n\nCentro de Biotecnologia, Instituto de Bioci\u00eancias - \n\nUFRGS \n\nProf. Em\u00e9rito \n\nOrientador \n\n \n\nProfa. Dra. Maria Aparecida Ribeiro Vieira \n\nDepartamento de Fisiologia e Biof\u00edsica, Instituto de \n\nCi\u00eancias Biol\u00f3gicas - UFMG \n\nProf. Associado IV \n\nCoorientadora \n\n \n\nProf. Dr. Jo\u00e3o Batista Calixto \n\nDepartamento de Farmacologia, Centro de Ci\u00eancias \n\nBiol\u00f3gicas - UFSC \n\nProf. Titular \n\nMembro da Comiss\u00e3o Examinadora \n\n \n\nProfa. Dra. Maria Elena de Lima Perez Garcia \n\nDepartamento de Bioqu\u00edmica e Imunologia, \n\nInstituto de Ci\u00eancias Biol\u00f3gicas - UFMG \n\nProf. Associado IV \n\nMembro da Comiss\u00e3o Examinadora \n\n \n\nProf. Dr. Arthur Germano Fett-Neto \n\nDepartamento de Bot\u00e2nica, Instituto de Bioci\u00eancias \n\ne Centro de Biotecnologia - UFRGS \n\nProf. Titular \n\nMembro da Comiss\u00e3o Examinadora \n\n \n\nProf. Dr. Giancarlo Pasquali \n\nDepartamento de Biologia Molecular e \n\nBiotecnologia, Instituto de Bioci\u00eancias e Centro de \n\nBiotecnologia - UFRGS \n\nProf. Associado IV \n\nMembro da Comiss\u00e3o Examinadora \nRevisor e membro suplente \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\"VIVER como si fosse morrer amanh\u00e3- \n\nESTUDAR como si fosse viver sempre\". \n\nSto. Isidoro de Sevilha \n\n \n\n \n\n \n\n \n\nPara minha m\u00e3e \n\n\n\n \n\n \n\nAGRADECIMENTOS \n\n \n\n\"Al\u00e9m dos la\u00e7os que se formam entre um pesquisador e seus contempor\u00e2neos, h\u00e1 os que o ligam \u00e0queles \n\nque, antes dele, tiveram igual interesse pela ci\u00eancia. Ele continua o caminho desbravado pelos seus \n\nantecessores ... \u00c9 como se olhasse para tr\u00e1s e se sentisse preso aos que o precederam, como se fizesse \n\nparte de uma fam\u00edlia ligada n\u00e3o pelo sangue mas pelos liames afetivos do mesmo ideal ...\"  \n\nCannon, W.B. - The way of an Investigator, W.N. Norton &amp; Co. New York, 1945 pag. 83. \n\n \n\n \n\nAgrade\u00e7o aos meus mestres e \u00e0queles que os antecederam e, de forma especial, ao meu \n\norientador, Professor Jorge Almeida Guimar\u00e3es, pelos in\u00fameros ensinamentos, pelas \n\noportunidades de trabalho e pelo exemplo de conduta cient\u00edfica. \u00c9 uma honra ser seu \n\naluno. \n\n\u00c0 minha coorientadora, Dra. Maria Aparecida Ribeiro Vieira, por me receber em seu \n\nlaborat\u00f3rio, pelas conversas e ensinamentos em fisiologia renal. \n\nAos membros da banca examinadora pela disponibilidade e por avaliarem este trabalho. \n\nAos membros da minha comiss\u00e3o de acompanhamento, Dr. Carlos Termignoni e Dra. \n\nMarilene Henning Vainstein. \n\nAo Dr. Marcelo Vidigal Caliari do Departamento de Patologia da UFMG pelos \n\nensinamentos em patologia renal, aux\u00edlio com a imunohistoqu\u00edmica e morfometria. \n\nAo Dr. Almir de Sousa Martins do Departamento de Fisiologia e Biof\u00edsica da UFMG \n\npelo aux\u00edlio na determina\u00e7\u00e3o dos n\u00edveis de express\u00e3o dos componentes do sistema \n\ncalicre\u00edna-cininas e renina-angiotensinas. \n\nAo Dr. David Driemeier do Departamento de Patologia Cl\u00ednica Veterin\u00e1ria da UFRGS \n\npela colabora\u00e7\u00e3o de longa data com as an\u00e1lises histopatol\u00f3gicas. \n\nAo Dr. Walter Orlando Beys da Silva e Dra. Luc\u00e9lia Santi pela amizade e \n\ncompanheirismo ao longo de todos esses anos e, tamb\u00e9m, pela inestim\u00e1vel colabora\u00e7\u00e3o \n\ncom a an\u00e1lise prote\u00f4mica. \n\n\n\n \n\n \n\n\u00c0 K\u00e1tia R.L.M. da Silva do Centro de Informa\u00e7\u00f5es Toxicol\u00f3gicas do Rio Grande do Sul \n\n(CIT-RS) pela amizade e pelo fornecimento das lagartas utilizadas para a extra\u00e7\u00e3o do \n\nveneno.  \n\n\u00c0 Sra. Zelma Regina de Almeida do Departamento de Biof\u00edsica da UFRGS pela \n\ndedica\u00e7\u00e3o e cuidado com os animais de experimenta\u00e7\u00e3o. \n\n\u00c0 Universidade Federal do Rio Grande do Sul (UFRGS) pelo ensino de qualidade. \n\n\u00c0 Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES) pela bolsa \n\nconcedida durante esta etapa. \n\nAos meus familiares, em especial \u00e0 minha m\u00e3e Denise, a quem dedico este trabalho, \n\npelo incentivo aos meus estudos, pela vida e pelo amor incondicional.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\u201c...In practical terms, the discovery of bradykinin had a strong \n\nbearing on the problem of mediation in acute inflammation, in \n\nshock by venoms and toxins, on the mechanism of anaphylaxis, \n\nand opened a new perspective on the therapeutics of circulatory \n\naffections\u201d. \n\n Maur\u00edcio Oscar da Rocha e Silva. Kinin \n\nHormones. With Special Reference to \n\nBradykinin and Related Kinins. Springfield, \n\nIL: Charles C. Thomas, 1970. \n\n\n\n \n\n \n\n\u00cdNDICE \n\nLISTA DE ABREVIATURAS  ................................................................................. 10 \n\nLISTA DE FIGURAS  ............................................................................................... 13 \n\nLISTA DE TABELAS  .............................................................................................. 14 \n\nRESUMO  ................................................................................................................. 15 \n\nABSTRACT  ............................................................................................................. 17 \n\nAPRESENTA\u00c7\u00c3O ................................................................................................... 19 \n\n1.  INTRODU\u00c7\u00c3O  .......................................................................................... 21 \n\n1.1       Os acidentes com animais pe\u00e7onhentos e sua relev\u00e2ncia para a sa\u00fade \n\np\u00fablica  .......................................................................................................... \n\n \n\n22 \n\n1.2  Os acidentes com a taturana Lonomia obliqua  .......................................... 26 \n\n1.2.1  Dados epidemiol\u00f3gicos  ................................................................................. 26 \n\n1.2.2  Aspectos morfol\u00f3gicos da lagarta e do sistema de produ\u00e7\u00e3o de veneno  ...... 29 \n\n1.2.3 A s\u00edndrome hemorr\u00e1gica  ............................................................................... 33 \n\n1.2.4    Composi\u00e7\u00e3o bioqu\u00edmica do veneno ............................................................... 37 \n\n1.3  Insufici\u00eancia renal aguda no envenenamento por animais pe\u00e7onhentos  42 \n\n1.4  O sistema calicre\u00edna-cininas ........................................................................ 45 \n\n2.  OBJETIVOS  ................................................................................................ 48 \n\n3.  RESULTADOS  ............................................................................................ 50 \n\n3.1  Cap\u00edtulo I ...................................................................................................... \n\nArtigo: Lonomia obliqua venom: In vivo effects and molecular aspects associated \n\nwith the hemorrhagic syndrome  \n\n51 \n\n3.2       Cap\u00edtulo II ..................................................................................................... \n\nArtigo: Acute Lonomia obliqua caterpillar envenomation-induced \n\nphysiopathological alterations in rats: Evidence of new toxic venom \n\nactivities and the efficacy of serum therapy to counteract systemic tissue \n\ndamage  \n\n62 \n\n3.3       Cap\u00edtulo III ................................................................................................... \n\nCap\u00edtulo de livro: Acute kidney injury induced by snake and arthropod venoms \n\n78 \n\n3.4       Cap\u00edtulo IV ................................................................................................... \n\nManuscrito: Acute kidney injury induced by experimental Lonomia obliqua \n\nenvenomation \n\n \n\n111 \n\n\n\n \n\n \n\n3.5  Cap\u00edtulo V ..................................................................................................... \n\nManuscrito: Pharmacological blockade of the kinin B1 receptor or kallikrein \n\ninhibition reduces renal damage in a model of Lonomia obliqua \n\nvenom-induced acute kidney injury \n\n165 \n\n \n\n4.  DISCUSS\u00c3O  ................................................................................................   198 \n\nCONCLUS\u00c3O  ......................................................................................................... 207 \n\nREFER\u00caNCIAS  ...................................................................................................... 210 \n\nANEXOS ....................................................................................................... ............ 221 \n\nCurriculum vitae  ....................................................................................................... 239 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n10 \n\n \n\nLISTA DE ABREVIATURAS \n\n \n\n?2AP   ?2-Antiplasmina \n\nArg  Arginina \n\nBK  Bradicinina (do ingl\u00eas, Bradykinin) \n\nDABK  des-Arg\n9\n-BK \n\nDALBK des-Arg\n9\n-Leu\n\n8\n-BK \n\nCIT/RS  Centro de Informa\u00e7\u00f5es Toxicol\u00f3gicas do Rio Grande do Sul \n\nCIT/SC  Centro de Informa\u00e7\u00f5es Toxicol\u00f3gicas de Santa Catarina \n\nCIVD  Coagula\u00e7\u00e3o intravascular disseminada \n\nCTGF  Fator de crescimento do tecido conjuntivo (do ingl\u00eas, connective tissue  \n\n  growth factor ) \n\nDa   Dalton \n\nD-D   D-D\u00edmeros \n\nECA  Enzima conversora de angiotensina \n\nEROs  Esp\u00e9cies reativas de oxig\u00eanio \n\nF1+2   Fragmento 1+2 da ativa\u00e7\u00e3o de protrombina \n\nFg   Fibrinog\u00eanio \n\nHb  Hemoglobina \n\nHO-1  Heme-oxigenase 1 \n\nHOE-140 D-Arg\n0\n-[Hyp\n\n3\n,Thi\n\n5\n, D-Tic\n\n7\n, Oic\n\n8\n]-BK, (Icatibant) \n\nHMWK Cininog\u00eanio de alto peso molecular  (do ingl\u00eas, high molecular weight  \n\n  kininogen) \n\nHpt  Haptoglobina \n\nHpx  Hemopexina \n\nIL-1?  Interleucina-1? \n\nIL-4  Interleucina-4 \n\nIL-8  Interleucina-8 \n\nIL-10  Interleucina-10 \n\nIRA  Insufici\u00eancia renal aguda \n\nkDa  Quilodaltons \n\nLeu  Leucina \n\nLMWH Cininog\u00eanio de baixo peso molecular  (do ingl\u00eas, low molecular weight  \n\n  kininogen) \n\n\n\n11 \n\n \n\nL-NAME Metil\u00e9ster de N\nG\n-nitro-L-arginina (do ingl\u00eas, N\n\nG\n-nitro-L-arginine- \n\n  methyl-ester) \n\nLOPAP  Ativador de protrombina de Lonomia obliqua  (do ingl\u00eas, Lonomia \n\nobliqua Prothrombin Activator Protease) \n\nLOSAC  Ativador de fator X de Lonomia obliqua (do ingl\u00eas, Lonomia obliqua  \n\n  Stuart-factor Activator)  \n\nLPS  Lipopolissacar\u00eddeo \n\nMAPK  Prote\u00edna ativada por mit\u00f3geno  (do ingl\u00eas, mitogen-activated protein  \n\n  kinase) \n\nMb  Mioglobina \n\nMCP-1 Quimiocina envolvida no recrutamento de mon\u00f3citos  (do ingl\u00eas,   \n\n  monocyte chemoattractant protein-1) \n\nMCP-3 Quimiocina envolvida no recrutamento de mon\u00f3citos  (do ingl\u00eas,   \n\n  monocyte chemoattractant protein-3) \n\nMM  Massa molecular \n\nNO  \u00d3xido n\u00edtrico (do ingl\u00eas, nitric oxide) \n\nNOS  \u00d3xido n\u00edtrico sintase (do ingl\u00eas, nitric oxide synthase) \n\nOMS  Organiza\u00e7\u00e3o Mundial da Sa\u00fade \n\nPA   Ativador de plasminog\u00eanio (do ingl\u00eas, plasminogen activator) \n\nPAI-1  Inibidor do ativador de plasminog\u00eanio-1 (do ingl\u00eas, plasminogen   \n\n  activator inhibitor-1) \n\nPC   Prote\u00edna C \n\nPCG  Press\u00e3o no capilar glomerular \n\nPDF   Produto de degrada\u00e7\u00e3o de fibrina \n\nPGI2  Prostaglandina I2 \n\nPK   Precalicre\u00edna (do ingl\u00eas, pre-kallikrein) \n\nPlg   Plasminog\u00eanio \n\nRFG  Ritmo de filtra\u00e7\u00e3o glomerular \n\nSCC  Sistema calicre\u00edna-cininas \n\nTAT   Complexo trombina-antitrombina (do ingl\u00eas, thrombin-antithrombin  \n\n  complex) \n\nTF   Fator tecidual ou tissular (do ingl\u00eas, tissue factor) \n\nTFPI   Inibidor da via do fator tecidual  (do ingl\u00eas, tissue factor pathway   \n\n  inhibitor) \n\n\n\n12 \n\n \n\nTGF-?  Fator de crescimento transformante  (do ingl\u00eas, transforming growth  \n\n  factor - ?) \n\nTNF-?  Fator de necrose tumoral-?  (do ingl\u00eas, tumor necrosis factor-?) \n\nTP   Tempo de Protrombina \n\ntPA  Ativador de plasminog\u00eanio tipo tecidual (do ingl\u00eas, tissue type \n\nplasminogen activator) \n\nTTPa   Tempo de Tromboplastina Parcialmente ativada \n\nTT   Tempo de Trombina  \n\nTXA2   Tromboxana A2 \n\nuPA  Ativador de plasminog\u00eanio tipo uroquinase (do ingl\u00eas, urokinase type \n\nplasminogen activator ) \n\nvWF   Fator de von Willebrand  (do ingl\u00eas, von Willebrand factor) \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n13 \n\n \n\nLISTA DE FIGURAS \n\n \n\nFigura 1.  N\u00fameros de acidentes causados por Lonomia obliqua registrados \n\npelo CIT/RS no per\u00edodo de 1997 a 2012  ........................................ \n\n \n\n27 \n\nFigura 2.  Localidade dos acidentes com Lonomia obliqua no Rio Grande do \n\nSul  ................................................................................................... \n\n \n\n28 \n\nFigura 3.  A lagarta Lonomia obliqua (taturana)  ............................................. 30 \n\nFigura 4.  Ciclo de vida do lepid\u00f3ptero Lonomia obliqua  .............................. 31 \n\nFigura 5.  Ultraestrutura do tegumento de Lonomia obliqua  .......................... 32 \n\nFigura 6.  Sistema envolvido na produ\u00e7\u00e3o e inje\u00e7\u00e3o do veneno de Lonomia \n\nobliqua.............................................................................................. \n\n \n\n33 \n\nFigura 7.  Sinais cl\u00ednicos do envenenamento por Lonomia obliqua ................ 34 \n\nFigura 8.  Hemat\u00faria ......................................................................................... 43 \n\nFigura 9.  Poss\u00edveis mecanismos envolvidos na insufici\u00eancia renal aguda \n\n(IRA) induzida pelo veneno da taturana Lonomia obliqua ............. \n\n \n\n206 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n14 \n\n \n\nLISTA DE TABELAS \n\n \n\nTabela 1.  Compara\u00e7\u00e3o da incid\u00eancia e mortalidade nos acidentes com \n\nserpentes com algumas doen\u00e7as negligenciadas reconhecidas pela \n\nOMS ................................................................................................... \n\n \n\n \n\n23 \n\nTabela 2.  N\u00famero de acidentes com animais pe\u00e7onhentos registrados nos \n\n\u00faltimos 5 anos no Rio Grande do Sul ................................................ \n\n \n\n24 \n\nTabela 3.  Toxinas isoladas do veneno de Lonomia obliqua  ............................. 41 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n15 \n\n \n\nRESUMO \n\n \n\n O envenenamento por animais pe\u00e7onhentos \u00e9 considerado uma doen\u00e7a \n\nocupacional comum e grave, especialmente em \u00e1reas rurais de pa\u00edses tropicais em \n\ndesenvolvimento. Sua import\u00e2ncia para a sa\u00fade p\u00fablica tem sido largamente ignorada \n\npelas autoridades m\u00e9dicas em todo o mundo. Apesar dos soros antivenenos serem \n\nproduzidos por v\u00e1rios laborat\u00f3rios distribu\u00eddos em todos os continentes, o alto n\u00famero \n\nde acidentes, a mortalidade e a morbidade associadas a eles continuam tendo um grande \n\nimpacto sobre a popula\u00e7\u00e3o e os sistemas de sa\u00fade desses pa\u00edses. Especificamente nas \n\nregi\u00f5es do sul do Brasil, os acidentes com lagartas venenosas da esp\u00e9cie Lonomia \n\nobliqua t\u00eam sido um problema crescente, n\u00e3o somente pelas altas taxas de incid\u00eancia, \n\nmas tamb\u00e9m pela severidade das consequ\u00eancias cl\u00ednicas observadas nos casos de \n\nenvenenamento. Frequentemente, as v\u00edtimas envenenadas apresentam uma s\u00edndrome \n\nhemorr\u00e1gica grave, que pode evoluir para insufici\u00eancia renal aguda (IRA), hemorragia \n\nintracraniana e morte. O presente trabalho foi desenvolvido com o objetivo de investigar \n\nos mecanismos fisiopatol\u00f3gicos induzidos pela toxicidade sist\u00eamica do veneno de L. \n\nobliqua, dando aten\u00e7\u00e3o especial \u00e0s altera\u00e7\u00f5es renais e vasculares que s\u00e3o descritas como \n\nas principais causas de morte neste tipo de envenenamento. Os resultados obtidos s\u00e3o \n\naqui apresentados na forma de artigos cient\u00edficos que abordam os seguintes aspectos: (i) \n\no conhecimento atual sobre os componentes moleculares do veneno de L. obliqua e as \n\ncaracter\u00edsticas cl\u00ednicas do envenenamento; (ii) a caracteriza\u00e7\u00e3o das principais altera\u00e7\u00f5es \n\nhistopatol\u00f3gicas, hematol\u00f3gicas, bioqu\u00edmicas e genot\u00f3xicas em diferentes \u00f3rg\u00e3os e a \n\ncapacidade da soroterapia antiveneno em neutralizar os efeitos t\u00f3xicos sist\u00eamicos do \n\nveneno de L. obliqua em um modelo experimental in vivo em ratos; (iii) a \n\nepidemiologia, a fisiopatologia e o manejo terap\u00eautico da IRA induzida por diferentes \n\nvenenos nefrot\u00f3xicos; (iv) os mecanismos envolvidos na IRA induzida pelo \n\nenvenenamento experimental com L. obliqua; e (v) a contribui\u00e7\u00e3o dos componentes do \n\nsistema calicre\u00edna-cininas (SCC) para a instabilidade hemodin\u00e2mica, a inflama\u00e7\u00e3o e o \n\nconsequente comprometimento renal observado no envenenamento experimental com L. \n\nobliqua. Resumidamente, os dados obtidos permitiram-nos indicar que a inje\u00e7\u00e3o \n\nsubcut\u00e2nea do veneno de L. obliqua em ratos induz altera\u00e7\u00f5es hemost\u00e1ticas severas e \n\ndanos em m\u00faltiplos \u00f3rg\u00e3os, principalmente nos pulm\u00f5es, cora\u00e7\u00e3o, rins e ba\u00e7o. H\u00e1 \n\ntamb\u00e9m evid\u00eancias de que o veneno possui atividade cardiot\u00f3xica, miot\u00f3xica e \n\ngenot\u00f3xica. Al\u00e9m disso, o tratamento com soro s\u00f3 \u00e9 eficaz em neutralizar os efeitos \n\n\n\n16 \n\n \n\nfisiopatol\u00f3gicos sist\u00eamicos se for administrado durante a fase inicial de envenenamento. \n\nEm rela\u00e7\u00e3o ao mecanismo da IRA induzida pelo veneno, este parece ser complexo e \n\nmultifatorial envolvendo tr\u00eas aspectos principais: a citotoxicidade tubular derivada da \n\na\u00e7\u00e3o do heme; as altera\u00e7\u00f5es vasculares, incluindo hipotens\u00e3o sist\u00eamica, aumento de \n\npermeabilidade vascular e deposi\u00e7\u00e3o de fibrina nos capilares glomerulares; e a ativa\u00e7\u00e3o \n\ndo SCC renal. Em conjunto, estes mecanismos est\u00e3o diretamente relacionados com as \n\naltera\u00e7\u00f5es funcionais observadas em ratos envenenados, como a hipoperfus\u00e3o renal, \n\ninflama\u00e7\u00e3o, necrose tubular e a perda s\u00fabita das fun\u00e7\u00f5es b\u00e1sicas do rim, incluindo perda \n\nda capacidade de filtra\u00e7\u00e3o e excre\u00e7\u00e3o, concentra\u00e7\u00e3o de urina e manuten\u00e7\u00e3o do equil\u00edbrio \n\nh\u00eddrico. As ativa\u00e7\u00f5es da calicre\u00edna renal e do receptor B1 de bradicinina (B1R) \n\ndesempenham papel fundamental na IRA induzida por L. obliqua, pois tanto o bloqueio \n\nfarmacol\u00f3gico do B1R quanto a inibi\u00e7\u00e3o da calicre\u00edna s\u00e3o capazes de prevenir as \n\naltera\u00e7\u00f5es funcionais e histopatol\u00f3gicas renais observadas nos ratos envenenados. Os \n\nprincipais mecanismos envolvidos nesses efeitos ben\u00e9ficos est\u00e3o associados com uma \n\ndiminui\u00e7\u00e3o da resposta inflamat\u00f3ria renal (redu\u00e7\u00e3o da migra\u00e7\u00e3o de c\u00e9lulas \n\nproinflamat\u00f3rias e dos n\u00edveis de citocinas proinflamat\u00f3rias) e da degenera\u00e7\u00e3o tubular. \n\nPortanto, o conjunto de todos os resultados aqui mostrados permitiram fornecer \n\nevid\u00eancias consistentes que relacionam a ativa\u00e7\u00e3o do SCC e a IRA induzida por L. \n\nobliqua e tamb\u00e9m indicar que a inibi\u00e7\u00e3o de componentes do SCC, principalmente a \n\ninibi\u00e7\u00e3o de calicre\u00edna ou o antagonismo do B1R, podem ser alternativas terap\u00eauticas \n\npara o controle da progress\u00e3o da les\u00e3o renal nos casos de envenenamento.  \n\n \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n17 \n\n \n\nABSTRACT \n\n \n\n The envenomation by venomous animals is considered a common and serious \n\noccupational disease, especially in rural areas of tropical developing countries. Its \n\npublic health relevance has been largely ignored by medical authorities worldwide. \n\nAlthough antivenoms are produced by various laboratories in every continent, the \n\nburden of envenomation cases, causing both morbidity and mortality, still has a major \n\nimpact on the population and on health-care systems. Specifically in regions of southern \n\nBrazil, accidents with the venomous caterpillar Lonomia obliqua have been an emergent \n\nproblem, not only for their high incidence rates, but also by the severity of the clinical \n\nconsequences observed in envenomation cases. Frequently, envenomed victims present \n\na severe hemorrhagic syndrome that can progress to acute kidney injury (AKI), \n\nintracranial hemorrhage and death. Through this work we aimed to investigate the \n\nphysiopathological mechanisms induced by the systemic toxicity of L. obliqua venom, \n\nwith particular attention to renal and vascular disorders that are described as the leading \n\ncause of death in this type of envenomation. Results are presented here as scientific \n\narticles that address the following aspects: (i) the current knowledge about the \n\nmolecular components of L. obliqua venom and the clinical features of envenomation; \n\n(ii) the characterization of the main histopathological, hematological, biochemical and \n\ngenotoxic alterations in different organs and the ability of antivenom serotherapy to \n\ncounteract the systemic toxic effects of L. obliqua venom using an in vivo experimental \n\nmodel in rats; (iii) some aspects of epidemiology, physiopathology and management of \n\nAKI induced by different nephrotoxic venoms; (iv) the mechanisms involved in \n\nexperimental L. obliqua-induced AKI; and (v) the contribution of kallikrein-kinin \n\nsystem (KKS) components to the hemodynamic instability, inflammation and the \n\nconsequent renal functional impairment during L. obliqua experimental envenomation. \n\nIn summary, the data indicate that the subcutaneous injection of L. obliqua venom in \n\nrats induce severe hemostatic abnormalities and multi-organ damage, mainly in the \n\nlungs, heart, kidneys and spleen. There are also evidences of cardiotoxic, myotoxic and \n\ngenotoxic activities in L. obliqua venom. Moreover, treatment with antivenom is only \n\neffective at counteracting the systemic physiopathological effects if it is administered \n\nduring the initial phase of envenomation. Regarding the mechanism of venom-induced \n\nAKI, it seems to be complex and multifactorial involving three main issues: the heme-\n\nderived tubular cytotoxicity; vascular alterations, including systemic hypotension, \n\n\n\n18 \n\n \n\nincrease in vascular permeability and glomerular fibrin deposition; and the activation of \n\nrenal KKS. Acting together these mechanisms are directly related to the functional \n\nalterations observed in envenomed rats such as renal hypoperfusion, inflammation, \n\ntubular necrosis and the sudden loss of basic renal functions, including filtration and \n\nexcretion capacities, urinary concentration and maintenance of body fluid homeostasis. \n\nThe activation of renal kallikrein and the bradykinin receptor B1 (B1R) play a crucial \n\nrole in L. obliqua-induced AKI, because both the pharmacological blockade of B1R or \n\nkallikrein inhibition are able to prevent the renal functional and histopathological \n\nalterations observed in the kidneys of envenomed rats. The main mechanisms \n\nunderlying these beneficial effects are associated with a decrease in renal inflammatory \n\nresponse (reduction of pro-inflammatory cell migration and pro-inflammatory cytokine \n\nlevels) and tubular degeneration. Thus, the set of all findings allowed us to show a \n\nconsistent evidence linking KKS activation with the L. obliqua-induced AKI and \n\nindicate that the inhibition of KKS components, mainly kallikrein inhibition or B1R \n\nantagonism, could be a therapeutic alternative to control the progression of renal injury \n\nin the cases of such envenomation.  \n\n \n\n \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n19 \n\n \n\nAPRESENTA\u00c7\u00c3O \n\n O fasc\u00ednio e o interesse pelos venenos animais \u00e9 milenar. No entanto, somente \n\nno s\u00e9culo XIX a composi\u00e7\u00e3o dos venenos come\u00e7ou a ser melhor compreendida. \n\nImportantes contribui\u00e7\u00f5es nessa \u00e1rea foram feitas por brasileiros como Vital Brasil, um \n\ndos grandes respons\u00e1veis pelo desenvolvimento da toxinologia em nosso pa\u00eds. Desde \n\nent\u00e3o, as pesquisas b\u00e1sicas sobre a bioqu\u00edmica e a farmacologia dos venenos \n\ncontribu\u00edram significativamente para a descoberta de novas subst\u00e2ncias com potencial \n\naplica\u00e7\u00e3o terap\u00eautica e, tamb\u00e9m, para o entendimento da fisiopatologia de in\u00fameras \n\ndoen\u00e7as. Exemplo cl\u00e1ssico \u00e9 a bradicinina, descoberta por pesquisadores brasileiros \n\nquando estudavam o mecanismo de a\u00e7\u00e3o do veneno de Bothrops jararaca (ROCHA E \n\nSILVA et al., 1949). Hoje se sabe que essa descoberta conduziu n\u00e3o s\u00f3 a um novo \n\ncampo de investiga\u00e7\u00e3o cient\u00edfica, mas tamb\u00e9m \u00e0 compreens\u00e3o de diferentes patologias e \n\nao desenvolvimento de uma das classes de anti-hipertensivos mais utilizadas no mundo \n\ninteiro (FERREIRA, 1965; ONDETTI et al., 1971; CUSHMAN et al., 1973).      \n\n Dentro deste contexto e com a inten\u00e7\u00e3o de contribuir para a gera\u00e7\u00e3o de \n\nconhecimento em toxinologia, a presente tese de doutorado versa sobre a fisiopatologia \n\ndos envenenamentos e, em particular, busca caracterizar os mecanismos de toxicidade \n\nsist\u00eamica e aqueles envolvidos na disfun\u00e7\u00e3o renal induzida pelo veneno da taturana \n\nLonomia obliqua em modelos de experimenta\u00e7\u00e3o animal. Os trabalhos aqui \n\napresentados fazem parte do projeto intitulado \"Os Venenos Animais: do Diagn\u00f3stico \n\nao Tratamento, da Estrutura ao Mecanismo de A\u00e7\u00e3o das Toxinas\", e foram \n\ndesenvolvidos na vig\u00eancia de aux\u00edlio concedido pela Coordena\u00e7\u00e3o de Aperfei\u00e7oamento \n\nde Pessoal de N\u00edvel Superior (CAPES) do Minist\u00e9rio da Educa\u00e7\u00e3o \n\n(Toxinologia/Processo 23038.006277/2011-85). Grande parte da etapa experimental foi \n\nrealizada no Laborat\u00f3rio de Bioqu\u00edmica Farmacol\u00f3gica do Centro de Biotecnologia da \n\nUniversidade Federal do Rio Grande do Sul (UFRGS) e no Laborat\u00f3rio de Fisiologia \n\nRenal do Departamento de Fisiologia e Biof\u00edsica da Universidade Federal de Minas \n\nGerais (UFMG). Os experimentos com animais seguiram as atribui\u00e7\u00f5es e compet\u00eancias \n\ndefinidas na Lei 11.794/08 e em resolu\u00e7\u00f5es do Conselho Nacional de Controle em \n\nExperimenta\u00e7\u00e3o Animal (CONCEA). Os protocolos utilizados foram previamente \n\naprovados pela comiss\u00e3o de \u00e9tica no uso de animais em pesquisa de ambas as \n\ninstitui\u00e7\u00f5es onde os experimentos foram realizados. \n\n\n\n20 \n\n \n\n   A tese est\u00e1 dividida em tr\u00eas partes principais: introdu\u00e7\u00e3o, resultados e \n\ndiscuss\u00e3o. A primeira delas \u00e9 destinada a uma breve revis\u00e3o acerca dos conhecimentos \n\nnecess\u00e1rios para o entendimento da segunda parte, onde s\u00e3o apresentados os resultados \n\nobtidos na forma de artigos cient\u00edficos. Dois desses artigos tratam-se de revis\u00e3o da \n\nliteratura cient\u00edfica. Um deles versa sobre aspectos t\u00f3xico-farmacol\u00f3gicos do veneno da \n\ntaturana e o outro sobre os mecanismos da insufici\u00eancia renal aguda induzida por \n\nveneno de animais pe\u00e7onhentos. Outros tr\u00eas artigos, contendo dados experimentais, \n\ntamb\u00e9m fazem parte da se\u00e7\u00e3o de resultados e versam sobre: (i) os mecanismos de \n\ntoxicidade sist\u00eamica no envenenamento por L. obliqua, descri\u00e7\u00e3o de novas atividades e \n\nefeitos do soro antiveneno; (ii) os mecanismos da insufici\u00eancia renal aguda induzida por \n\nL. obliqua; e (iii) a participa\u00e7\u00e3o do sistema calicre\u00edna-cininas na disfun\u00e7\u00e3o renal \n\ninduzida pelo veneno. Por fim, na terceira parte da tese, os resultados obtidos s\u00e3o \n\nmelhor explorados e discutidos. Na proposi\u00e7\u00e3o desta terceira parte, \u00e9 objetivo auxiliar a \n\nintegra\u00e7\u00e3o dos resultados e a gera\u00e7\u00e3o de perspectivas para futuras pesquisas. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n21 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n11..  IINNTTRROODDUU\u00c7\u00c7\u00c3\u00c3OO    \n\n \n\n\n\nIntrodu\u00e7\u00e3o \n\n22 \n\n \n\n1. INTRODU\u00c7\u00c3O \n\n \n\n1.1 Os acidentes com animais pe\u00e7onhentos e sua relev\u00e2ncia para a sa\u00fade p\u00fablica \n\n \n\n O envenenamento por animais pe\u00e7onhentos constitui um importante problema de \n\nsa\u00fade p\u00fablica em muitas regi\u00f5es, particularmente em \u00e1reas tropicais e subtropicais \n\n(GUIMAR\u00c3ES, 2011; GUTI\u00c9RREZ et al., 2006). Considerando somente os acidentes \n\ncom serpentes, estima-se que cerca de 5,4 a 5,5 milh\u00f5es de pessoas s\u00e3o vitimadas por \n\nano no mundo, resultando em 400.000 amputa\u00e7\u00f5es e entre 20.000 e 125.000 mortes \n\n(CHIPPAUX, 1998, KASTURIRATNE et al., 2008; WILLIAMS et al., 2010). \n\nCertamente, esses n\u00fameros s\u00e3o subestimados, pois, al\u00e9m dos problemas de notifica\u00e7\u00e3o, \n\neles n\u00e3o incluem os acidentes com outros animais pe\u00e7onhentos e venenosos. \n\nInteressante notar que, apesar dos acidentes n\u00e3o possu\u00edrem um potencial epid\u00eamico \n\ncomo o de doen\u00e7as infecciosas ou parasit\u00e1rias, as taxas de mortalidade chegam a \n\nsuperar as de algumas mol\u00e9stias tropicais reconhecidas pela Organiza\u00e7\u00e3o Mundial da \n\nSa\u00fade (OMS) como doen\u00e7as negligenciadas (Tabela 1). Em raz\u00e3o disso, a partir de \n\n2009, a OMS incluiu os acidentes com animais pe\u00e7onhentos na lista de doen\u00e7as \n\nnegligenciadas e, desde ent\u00e3o, iniciativas globais de combate ao problema v\u00eam sendo \n\nestimuladas (GUTI\u00c9RREZ et al., 2013).  \n\n A ocorr\u00eancia dos acidentes \u00e9 particularmente grave para os habitantes de \u00e1reas \n\nrurais que s\u00e3o a parte da popula\u00e7\u00e3o mais atingida devido ao seu ambiente espec\u00edfico de \n\ntrabalho, o que lhes proporciona um contato \u00edntimo de m\u00e3os e p\u00e9s, usualmente \n\ndesprotegidos, contra uma gama bastante variada de esp\u00e9cies de animais, inclusive os \n\nvenenosos (MINIST\u00c9RIO DA SA\u00daDE, 1998; GARCIA &amp; DANNI-OLIVEIRA, 2007). \n\nVale ressaltar que a popula\u00e7\u00e3o rural desempenha um exaustivo trabalho agr\u00e1rio, o que \n\nexige sa\u00fade e integridade f\u00edsica. J\u00e1 em 1897, Vital Brazil, atendendo pacientes em \n\nfazendas no interior de S\u00e3o Paulo, impressionava-se com o n\u00famero elevado de pacientes \n\npicados por serpentes venenosas. A partir desta \u00e9poca, buscando desenvolver medica\u00e7\u00e3o \n\neficaz que pudesse ser aplicada a tais pacientes, Vital Brazil e outros pesquisadores \n\nderam in\u00edcio aos estudos b\u00e1sicos sobre a bioqu\u00edmica e a farmacologia dos venenos \n\nanimais, o que acabou gerando o conhecimento cient\u00edfico necess\u00e1rio ao \n\ndesenvolvimento dos soros antivenenos para o tratamento das v\u00edtimas (BARRAVIERA, \n\n1999).\n\n\n\nIntrodu\u00e7\u00e3o \n\n23 \n\n \n\nTabela 1. Compara\u00e7\u00e3o da incid\u00eancia e mortalidade nos acidentes com serpentes \n\ncom algumas doen\u00e7as negligenciadas reconhecidas pela OMS. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFonte: WILLIAMS et al., 2010. Lista completa de doen\u00e7as negligenciadas pode ser \n\nencontrada em: http://www.who.int/neglected_diseases/diseases/en/. \n\n \n\nAtualmente, a utiliza\u00e7\u00e3o dos antivenenos produzidos nos Institutos Butantan \n\n(S\u00e3o Paulo, SP), Vital Brasil (Niter\u00f3i, RJ) e Funda\u00e7\u00e3o Ezequiel Dias (Belo Horizonte, \n\nMG), vem reduzindo significativamente o n\u00famero de \u00f3bitos ocasionados por acidentes \n\ncom animais pe\u00e7onhentos. Desde a implanta\u00e7\u00e3o do Programa Nacional de Controle dos \n\nAcidentes por Animais Pe\u00e7onhentos em 1986, todos os soros produzidos no Brasil s\u00e3o \n\nadquiridos pelo Minist\u00e9rio da Sa\u00fade e distribu\u00eddos \u00e0s secretarias estaduais de sa\u00fade que, \n\npor sua vez, definem os pontos estrat\u00e9gicos para atendimento dos acidentados e \n\nutiliza\u00e7\u00e3o correta e racional dos antivenenos (MINIST\u00c9RIO DA SA\u00daDE, 2005). \n\nTodavia, por falta de um levantamento epidemiol\u00f3gico preciso e problemas de \n\ndistribui\u00e7\u00e3o, nem sempre tais produtos est\u00e3o dispon\u00edveis em localidades distantes onde \n\nmais frequentemente os acidentes ocorrem, sendo, tamb\u00e9m, ainda muito elevados os \n\n\u00edndices de sequelas decorrentes das les\u00f5es geradas por tais envenenamentos (FAN &amp; \n\nCARDOSO, 1995).  \n\n Especificamente no Brasil, o Sistema de Vigil\u00e2ncia Sanit\u00e1ria do Minist\u00e9rio da \n\nSa\u00fade estimou a ocorr\u00eancia de 107.364 acidentes com animais pe\u00e7onhentos (incluindo \n\ncasos de envenenamento por serpentes, aranhas, escorpi\u00f5es, abelhas e lagartas) que \n\nresultaram em 290 mortes somente no ano de 2009 (BOLETIM ELETR\u00d4NICO \n\nEPIDEMIOL\u00d3GICO, 2010). No mesmo ano, o Centro de Informa\u00e7\u00f5es Toxicol\u00f3gicas \n\ndo estado do Rio Grande do Sul (CIT/RS) registrou 5.912 acidentes e 5 \u00f3bitos \n\n Incid\u00eancia N\u00famero de mortes \n\nDoen\u00e7a de Chagas 217.000 14.000 \n\nC\u00f3lera 178.000 4.000 \n\nDengue hemorr\u00e1gica 73.000 19.000 \n\nLeishmaniose 1.691.000 51.000 \n\nEncefalite japonesa 44.000 14.000 \n\nEsquistossomose 5.733.000 15.000 \n\nEnvenenamento por serpentes 420.000-2.682.000 20.000-125.000 \n\nFebre amarela 100-2.100 60-100 \n\n\n\n24 \n\n \n\n(NICOLELLA et al., 2006-2012). No per\u00edodo de 2008\u20132012, um total de 28.895 \n\nacidentes foram notificados no Rio Grande do Sul, sendo 34 % destes acidentes \n\ncausados por aranhas, 20 % por lagartas e 16 % por serpentes (Tabela 2). Armadeiras \n\n(Phoneutria sp.), aranhas-marron (Loxosceles sp.), taturanas (Lonomia sp., Dirphia sp. e \n\nHylesia sp. ) e jararacas (Bothrops sp.) foram os principais animais envolvidos.  \n\n  \n\nTabela 2. N\u00famero de acidentes com animais pe\u00e7onhentos \n\nregistrados nos \u00faltimos 5 anos no Rio Grande do Sul. \n\n \nAno \n\nAnimais \n2008 2009 2010 2011 2012 \n\nAnimais aqu\u00e1ticos 10 12 23 26 21 \n\nAranhas 1.917 1.922 2.196 1.996 1.916 \n\nEscorpi\u00f5es 337 410 403 402 495 \n\nOutros Insetos 299 275 279 279 410 \n\nLagartas 1.375 1.068 1.166 962 866 \n\nSerpentes 977 1.136 977 863 807 \n\nOutros 262 237 284 307 382 \n\nN\u00e3o identificados 596 852 848 652 650 \n\nTOTAL 5.773 5.912 6.176 5.487 5.547 \n\nFonte: Relat\u00f3rio Anual de Atendimento do Centro de Informa\u00e7\u00e3o \n\nToxicol\u00f3gica do Rio Grande do Sul (CIT/RS), Secretaria de Estado da \n\nSa\u00fade do Rio Grande do Sul. Dados dispon\u00edveis em: \n\nhttp://www.cit.rs.gov.br.  \n\n \n\n O registro de acidentes com lagartas come\u00e7ou a aumentar no Rio Grande do Sul \n\na partir de 1989 quando casos de hemorragia sist\u00eamica foram observados em v\u00e1rias \n\nv\u00edtimas que tiveram contato com animais da esp\u00e9cie Lonomia obliqua (Lepidoptera, \n\nSaturniidae). Na mesma \u00e9poca, v\u00e1rios casos semelhantes tamb\u00e9m foram registrados em \n\nSanta Catarina e Paran\u00e1 (DUARTE et al., 1990). Os acidentes foram particularmente \n\npreocupantes entre 1989-1995, per\u00edodo que antecedeu o desenvolvimento do soro \n\nantiveneno espec\u00edfico, quando os n\u00edveis de letalidade chegaram a ser de 3 a 6 vezes \n\nmaiores do que os observados em envenenamentos por serpentes (DIAZ, 2005; \n\nABELLA et al., 2006). O quadro cl\u00ednico resultante do contato com L. obliqua \u00e9 \n\n\n\nIntrodu\u00e7\u00e3o \n\n25 \n\n \n\ncaracterizado por uma s\u00edndrome hemorr\u00e1gica com a presen\u00e7a de equimoses, hemat\u00faria, \n\nsangramento das mucosas e, em casos graves, hemorragia intracraniana e insufici\u00eancia \n\nrenal aguda (PINTO et al., 2010; VEIGA et al., 2009). Nas se\u00e7\u00f5es subsequentes, ser\u00e3o \n\napresentados detalhes da epidemiologia dos acidentes, fisiopatologia do envenenamento \n\ne composi\u00e7\u00e3o do veneno de L. obliqua. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nIntrodu\u00e7\u00e3o \n\n26 \n\n \n\n1.2 Os acidentes com a taturana Lonomia obliqua \n\n \n\n1.2.1  Dados epidemiol\u00f3gicos \n\n  \n\n Os insetos da ordem Lepid\u00f3ptera compreendem as borboletas (animais de \n\nh\u00e1bitos diurnos) e as mariposas (animais de h\u00e1bitos noturnos), existindo no Brasil cerca \n\nde 50.000 esp\u00e9cies diferentes. Em seu desenvolvimento, estes insetos passam pelas \n\nfases de ovo, larva ou lagarta, pupa ou cris\u00e1lida e adulto, ou seja, apresentam evolu\u00e7\u00e3o \n\ncompleta ou holometab\u00f3lica (CARDOSO &amp; HADDAD, 2005).  \n\nQuando na fase larval, s\u00e3o conhecidas popularmente por taturanas, bichos-\n\ncabeludos, lagartas-de-fogo, entre outras denomina\u00e7\u00f5es. Nesta fase, alguns \n\nLepid\u00f3pteros s\u00e3o respons\u00e1veis por envenenamentos em humanos, cujos sintomas mais \n\ncomuns s\u00e3o rea\u00e7\u00f5es cut\u00e2neas, urtic\u00e1ria, dor e sensa\u00e7\u00e3o de queimadura no local de \n\ncontato, podendo ocorrer tamb\u00e9m dist\u00farbios da coagula\u00e7\u00e3o sangu\u00ednea, hemorragias e \n\ninsufici\u00eancia renal aguda (DIAZ, 2005). No Brasil, j\u00e1 na \u00e9poca da coloniza\u00e7\u00e3o, o padre \n\nAnchieta citou, na \u201cCarta de S\u00e3o Vicente\u201d de 1560, o medo dos \u00edndios frente a algumas \n\nlagartas que causavam tais acidentes, produzindo in\u00fameras rea\u00e7\u00f5es e dor intensa ap\u00f3s o \n\ncontato f\u00edsico (ROTBERG, 1971; COSTA, 1994). Esses animais eram chamados de \n\n\u201ctat\u00e1-ran\u00e1\u201d, nome que em Tupi-Guarani significa \u201ccomo fogo\u201d ou \u201csemelhante ao \n\nfogo\u201d; mais tarde este nome originou, na l\u00edngua portuguesa, a palavra \u201ctaturana\u201d. Hoje \n\nse sabe que poucas das esp\u00e9cies encontradas no Brasil s\u00e3o potencialmente perigosas, \n\nsendo que apenas as fam\u00edlias Saturniidae (g\u00eaneros Automeris, Dirphia, Hylesia e \n\nLonomia), Megalopygidae (g\u00eaneros Podalia e Megalopyge) e Arctiidae (especialmente \n\na esp\u00e9cie Premolis semirufa) est\u00e3o envolvidas em acidentes e apresentam, portanto, \n\ninteresse m\u00e9dico e preocupa\u00e7\u00e3o de sa\u00fade p\u00fablica (MINIST\u00c9RIO DA SA\u00daDE, 1998).    \n\nDas diversas esp\u00e9cies existentes no Brasil, apenas duas da fam\u00edlia Saturniidae e \n\npertencentes ao g\u00eanero Lonomia t\u00eam chamado aten\u00e7\u00e3o devido ao grave quadro de \n\ns\u00edndrome hemorr\u00e1gica que causam em v\u00edtimas que entram em contado com suas cerdas \n\nurticantes. O primeiro relato de acidente com essas esp\u00e9cies foi realizado pelo m\u00e9dico \n\nmineiro Zoroastro de Alvarenga em 1912, que descreveu o caso de um agricultor que \n\napresentou saliva sanguinolenta e urina de colora\u00e7\u00e3o marrom escura durante 5 dias ap\u00f3s \n\no contato com uma col\u00f4nia de lagartas (ZANNIN, 2002).  \n\nNo per\u00edodo de 1978 a 1982, um estudo retrospectivo cobrindo as regi\u00f5es do \n\nsudeste do Amap\u00e1 ao oeste da Ilha de Maraj\u00f3 indicou a ocorr\u00eancia de 36 casos de\n\n\n\nIntrodu\u00e7\u00e3o \n\n27 \n\n \n\ns\u00edndrome hemorr\u00e1gica resultantes do contato com taturanas. Neste relato, a mortalidade \n\nfoi de 38% e as lagartas eram da esp\u00e9cie L. achelous (FRAIHA-NETO et al., 1986; \n\n1997). A mesma esp\u00e9cie \u00e9 respons\u00e1vel por acidentes hemorr\u00e1gicos registrados desde \n\n1967 na Venezuela (AROCHA-PI\u00d1ANGO, 1967). H\u00e1, ainda, registros de acidentes \n\ncom este inseto na Guiana Francesa, no Paraguai, no Peru e no Equador (AROCHA-\n\nPI\u00d1ANGO et al., 1992). \n\nA partir de 1989, acidentes semelhantes aos ocorridos no norte do Brasil e na \n\nVenezuela come\u00e7aram a ser registrados tamb\u00e9m nos estados do sul do Brasil. Duarte et \n\nal. (1990) relatou dois casos atendidos em Passo Fundo (RS) em que as v\u00edtimas \n\napresentaram, al\u00e9m dos epis\u00f3dios de sangramentos, insufici\u00eancia renal aguda, \n\ncomplica\u00e7\u00e3o essa at\u00e9 ent\u00e3o desconhecida. Em Santa Catarina e no Rio Grande do Sul, \n\nforam identificadas como respons\u00e1veis pelos acidentes as lagartas da esp\u00e9cie L. obliqua. \n\nNo per\u00edodo de 1997 a 2012, foram registrados pelo CIT/RS um total de 1.836 acidentes \n\ncom a taturana L. obliqua somente no Rio Grande do Sul (Figura 1). Deste total, 12 \n\npacientes evolu\u00edram para o \u00f3bito, resultando numa taxa de letalidade de 0,65% neste \n\nper\u00edodo (NICOLELLA et al., 2006-2012; ABELLA et al., 2006).  \n\n \n\n \n\nFigura 1. N\u00fameros de acidentes causados por Lonomia obliqua registrados pelo CIT/RS no \n\nper\u00edodo de 1997 a 2012. Fonte: NICOLELLA et al., 2006-2012; ABELLA et al., 2006. \n\n \n\n\n\nIntrodu\u00e7\u00e3o \n\n28 \n\n \n\nNo Rio Grande do Sul, v\u00e1rias cidades (Figura 2A) t\u00eam registrado a ocorr\u00eancia \n\nde acidentes ou identifica\u00e7\u00e3o da presen\u00e7a da taturana. O somat\u00f3rio de dados \n\nretrospectivos (per\u00edodo de 1997 a 2005) permitiram demonstrar que 317 munic\u00edpios do \n\nEstado s\u00e3o \u00e1rea de risco para acidentes com Lonomia, o que representa 64 % do total de \n\nmunic\u00edpios. Regi\u00f5es do pampa e litoral s\u00e3o as de menor risco. Os maiores percentuais \n\nde notifica\u00e7\u00f5es foram registrados em Passo Fundo, com 9,7 %, e em Bento Gon\u00e7alves, \n\ncom 5,4 % dos casos (Figura 2B) (ABELLA et al., 2006). \n\n \n\n \n\nFigura 2. Localidade dos acidentes com Lonomia obliqua no Rio Grande do Sul. A. Incid\u00eancia de \n\nacidentes com L. obliqua por 100.000 habitantes, nas respectivas Coordenadorias Regionais de Sa\u00fade. B. \n\nPercentual do n\u00famero de acidentes causados por L. obliqua nas principais cidades do RS (1997-2005). \n\nFonte: ABELLA et al., 2006.  \n\n  \n\n J\u00e1 em Santa Catarina, no per\u00edodo de 1990 a 2001, foram registrados 1.851 \n\nacidentes que resultaram em seis \u00f3bitos (ZANNIN, 2002). No Paran\u00e1, entre 1989 e \n\n2001, aconteceram 252 acidentes com o registro de cinco \u00f3bitos (taxa de letalidade de \n\n1,9%) (GARCIA &amp; DANNI-OLIVEIRA, 2007). \n\n O perfil de sazonalidade dos acidentes com a lagarta L. obliqua \u00e9 semelhante ao \n\ndos acidentes of\u00eddicos. Um n\u00famero maior de casos ocorre no ver\u00e3o, \u00e9poca em que o \n\nanimal est\u00e1 na fase larval, o que coincide com a atividade agr\u00edcola mais intensa e com a \n\n\u00e9poca de f\u00e9rias, per\u00edodo em que as pessoas est\u00e3o mais expostas e mant\u00e9m maior contato \n\ncom o ambiente (DIAZ, 2005). As regi\u00f5es anat\u00f4micas mais frequentemente atingidas no \n\ncontato com Lonomia s\u00e3o os membros superiores (78,1 %), principalmente as m\u00e3os, e \n\nmembros inferiores (13,6 %), na sua maioria tornozelo e p\u00e9. Cabe\u00e7a, tronco, dorso e \n\n\n\nIntrodu\u00e7\u00e3o \n\n29 \n\n \n\nabd\u00f4men representam 8,3 % dos casos. H\u00e1 predomin\u00e2ncia do sexo masculino (68 %) \n\nsobre o feminino (32 %) e os acidentes distribuem-se em todas as faixas et\u00e1rias com um \n\nmaior n\u00famero de casos entre os jovens (at\u00e9 20 anos). Os acidentes na idade adulta s\u00e3o \n\nprincipalmente ocorr\u00eancias ocupacionais (ZANNIN et al., 2003; ABELLA et al., 2006; \n\nGAMBORGI et al., 2006). \n\n \n\n1.2.2  Aspectos morfol\u00f3gicos da lagarta e do sistema de produ\u00e7\u00e3o de veneno \n\n   \n\n A L. obliqua, quando na sua fase larval, possui o corpo com colora\u00e7\u00e3o castanho-\n\nclaro-esverdeado. Apresenta a regi\u00e3o dorsal com uma linha longitudinal cont\u00ednua \n\nmarrom-escura, marginada de preto em toda a sua extens\u00e3o. Outras duas faixas \n\nlongitudinais, com manchas claras e levemente amareladas est\u00e3o dispostas em alguns \n\nsegmentos tor\u00e1cicos. Possuem cerdas esverdeadas em forma de esp\u00edculas ou \u201cespinhos\u201d \n\nramificados e pontiagudos de aspecto arb\u00f3reo simetricamente dispostos ao longo do \n\ndorso (Figura 3A e B). S\u00e3o larvas greg\u00e1rias que mimetizam o tronco de \u00e1rvores \n\nsilvestres e frut\u00edferas tais como ip\u00ea, cedro, goiabeira, pereira, pessegueiro e ameixeira, \n\nonde se agrupam durante o dia e, \u00e0 noite, sobem para as partes mais altas da \u00e1rvore onde \n\nse localizam as folhas mais tenras das quais se alimentam (Figura 3C). Habitam matas, \n\nparques e pomares dom\u00e9sticos (LORINI &amp; CORSEUIL, 2001). Atualmente, acredita-se \n\nque o desequil\u00edbrio ambiental causado pelo desmatamento e pelo cultivo de \n\nmonoculturas for\u00e7aram a adapta\u00e7\u00e3o da L. obliqua aos pomares cultivados pr\u00f3ximos \u00e0s \n\nresid\u00eancias. Al\u00e9m disso, a utiliza\u00e7\u00e3o de agroqu\u00edmicos nas grandes culturas pode ter \n\nexterminado inimigos naturais, desequilibrando o controle natural dessa esp\u00e9cie \n\n(VEIGA et al., 2001).\n\n\n\nIntrodu\u00e7\u00e3o \n\n30 \n\n \n\n \n\nFigura 3. A lagarta Lonomia obliqua (taturana). A e B. A lagarta evidenciando aspectos da \n\nmorfologia externa. C. Col\u00f4nia de lagartas sobre o tronco de uma \u00e1rvore. Fotos: CIT/SC. \n\n \n\n A L. obliqua apresenta um ciclo de vida m\u00e9dio de seis meses, desde a postura, \n\neclos\u00e3o dos ovos, fase larval, fase de pupa e animal adulto, incluindo, obrigatoriamente, \n\no per\u00edodo do ver\u00e3o (Figura 4). Na fase adulta, h\u00e1 um evidente dimorfismo sexual, no \n\nqual a mariposa macho apresenta colora\u00e7\u00e3o amarelada e a f\u00eamea rosa-pardo. Esta fase \n\ntem dura\u00e7\u00e3o de 7 a 10 dias. Ap\u00f3s a c\u00f3pula, a f\u00eamea deposita os ovos nas folhas das \n\nplantas que servir\u00e3o de alimento para as lagartas. Os ovos eclodem em \n\naproximadamente 17 dias. Esta esp\u00e9cie apresenta seis \u00ednstares larvais cujas diferen\u00e7as \n\ns\u00e3o expressas em pequenas modifica\u00e7\u00f5es estruturais que v\u00e3o aumentando em \n\ncomplexidade a cada \u00ednstar. A fase larval tem dura\u00e7\u00e3o m\u00e9dia de 85 dias, sendo que cada \n\n\u00ednstar perdura por aproximadamente duas semanas (LORINI, 1997).  \n\n \n\n\n\nIntrodu\u00e7\u00e3o \n\n31 \n\n \n\n \n\nFigura 4. Ciclo de vida do lepid\u00f3ptero Lonomia obliqua. Fotos: CIT/RS. \n\n \n\nEm um estudo detalhado da morfologia da lagarta L. obliqua foi demonstrado \n\nque n\u00e3o h\u00e1 gl\u00e2ndula produtora de veneno no animal e que o tegumento \u00e9 revestido \n\ninternamente por um epit\u00e9lio secretor composto externamente por in\u00fameras \n\nespecializa\u00e7\u00f5es cuticulares (Figura 5A) (VEIGA et al., 2001). Cada segmento do corpo \n\nda lagarta apresenta um conjunto de cerdas ou esp\u00edculas de formato espinhoso, \n\ndenominado scolus (Figura 5B e C). Nos scolus dorsais, as pontas das cerdas s\u00e3o \n\ndiminutas e, nos scolus subdorsais e subespiraculais, apresentam-se com pontas mais \n\nlongas. As cerdas possuem um poro na extremidade que \u00e9 a abertura de um canal \n\ninterno onde o veneno \u00e9 armazenado (Figura 5D e 6C). Estas cerdas, por serem \n\nconstitu\u00eddas de quitina, s\u00e3o de f\u00e1cil ruptura (Figura 5D), o que acaba facilitando a \n\ninje\u00e7\u00e3o da secre\u00e7\u00e3o venenosa da taturana na pele ou mesmo no tecido subcut\u00e2neo da \n\nv\u00edtima, causando o envenenamento (VEIGA et al., 2001; 2009). \n\n    \n\n\n\nIntrodu\u00e7\u00e3o \n\n32 \n\n \n\n \n\nFigura 5. Ultraestrutura do tegumento de Lonomia obliqua. A. Estruturas \n\nquitinosas que comp\u00f5em a base do tegumento. B. Regi\u00e3o dorsal do tegumento \n\ncom v\u00e1rios scoli contendo as esp\u00edculas. C. Esp\u00edcula \u00edntegra. D. Esp\u00edcula \n\nquebrada na extremidade com canal interno exposto. Fonte: VEIGA et al., 2001. \n\n \n\n O sistema de produ\u00e7\u00e3o do veneno \u00e9 formado por um epit\u00e9lio subjacente ao \n\ntegumento da lagarta que reveste toda a parte interna das cerdas como uma evagina\u00e7\u00e3o \n\ncont\u00ednua do corpo (Figura 6). Em certas regi\u00f5es deste epit\u00e9lio, as c\u00e9lulas expandem-se \n\ne ficam mais cil\u00edndricas do que c\u00fabicas, formando um grupo de c\u00e9lulas especializadas \n\nonde se acumulam produtos de secre\u00e7\u00e3o contendo o veneno (Figura 6A). C\u00e9lulas \n\nirregulares da base dos scolus e mesmo aquelas que revestem o interior das cerdas \n\ntamb\u00e9m possuem atividade secretora intensa (Figura 6B e C). Na regi\u00e3o apical dessas \n\nc\u00e9lulas, os n\u00facleos ficam evidenciados, a concentra\u00e7\u00e3o de ves\u00edculas de secre\u00e7\u00e3o \u00e9 mais \n\nalta e um dep\u00f3sito \u00e9 formado (Figura 6B). Essas ves\u00edculas e produtos de secre\u00e7\u00e3o \n\nacumulam-se e s\u00e3o armazenadas no espa\u00e7o extracelular subcuticular entre a camada \n\nepitelial e a cut\u00edcula (Figura 6B e C). Provavelmente, o veneno \u00e9 liberado pela quebra \n\ndas cerdas durante o contato f\u00edsico, quando a lagarta sente-se pressionada contra a pele, \n\ne os produtos de secre\u00e7\u00e3o contendo as toxinas s\u00e3o drenados atrav\u00e9s do espa\u00e7o \n\nsubcuticular at\u00e9 o canal interno de onde \u00e9 injetado (Figura 6C) (VEIGA et al., 2001; \n\n2009; PINTO et al., 2010). \n\n \n\n \n\n\n\nIntrodu\u00e7\u00e3o \n\n33 \n\n \n\n \n\nFigura 6. Sistema envolvido na produ\u00e7\u00e3o e inje\u00e7\u00e3o do veneno de Lonomia obliqua. A. Se\u00e7\u00e3o \n\nlongitudinal de uma cerda corada com fucsina b\u00e1sica-azul de metileno e visualizada por microscopia \n\n\u00f3ptica. Notar a presen\u00e7a de um epit\u00e9lio tipicamente secretor e c\u00e9lulas especializadas revestindo a parte \n\ninterna da cerda. B. Detalhe do epit\u00e9lio secretor mostrando o ac\u00famulo de ves\u00edculas contendo gr\u00e2nulos \n\ncom produtos de secre\u00e7\u00e3o no espa\u00e7o subcuticular. C. Modelo esquem\u00e1tico da estrutura de produ\u00e7\u00e3o e \n\ninje\u00e7\u00e3o do veneno. As toxinas s\u00e3o produzidas pelas c\u00e9lulas da base e interior das cerdas, direcionadas e \n\narmazenadas no espa\u00e7o subcuticular e drenadas para o canal interno na ponta das cerdas durante o \n\ncontato com a pele. h: hemolinfa, c: cut\u00edcula, ce: c\u00e9lulas especializadas, es: epit\u00e9lio secretor, n: n\u00facleo, \n\ng: gr\u00e2nulos, esc: espa\u00e7o subcuticular, eT: epit\u00e9lio tegumentar, lb: l\u00e2mina basal, art: articula\u00e7\u00e3o da ponta \n\nda cerda, ci: canal interno da ponta da cerda, v: veneno.  Fonte: VEIGA et al., 2001  \n\n \n\n1.2.3  A s\u00edndrome hemorr\u00e1gica \n\n \n\n O contato com as secre\u00e7\u00f5es venenosas de L. obliqua provoca uma rea\u00e7\u00e3o \n\nimediata no local, sendo caracterizada por um ardor intenso (dor caracterizada por \n\nqueima\u00e7\u00e3o), hiperemia, prurido, edema e bolhas sanguinolentas (Figura 7A), \n\nmanifesta\u00e7\u00f5es comumente seguidas por sintomas gerais e inespec\u00edficos do \n\nenvenenamento, que podem surgir mais tardiamente como cefal\u00e9ia holocraniana, mal-\n\n\n\nIntrodu\u00e7\u00e3o \n\n34 \n\n \n\nestar geral, n\u00e1useas e v\u00f4mitos; com menos frequ\u00eancia relata-se dores abdominais, \n\nmialgia, hipotermia e hipotens\u00e3o. O desenvolvimento do quadro hemorr\u00e1gico mais \n\ngrave se segue com dist\u00farbios de coagula\u00e7\u00e3o e sangramentos: gengivorragia (Figura \n\n7D), equimose (Figura 7B e C), epistaxe, sangramento em feridas recentes ou j\u00e1 \n\ncicatrizadas, hemorragias intraarticulares, hemat\u00eamese, melena, hemat\u00faria, sangramento \n\npulmonar e hemorragia cerebral (KELEN et al., 1995; MINIST\u00c9RIO DA SA\u00daDE, \n\n1998). As manifesta\u00e7\u00f5es cl\u00ednicas podem agravar-se com hipotens\u00e3o, choque e \n\ninsufici\u00eancia renal, podendo evoluir para o \u00f3bito. As principais causas de morte j\u00e1 \n\nrelatadas na literatura envolvem complica\u00e7\u00f5es renais e/ou hemorragia intracraniana \n\n(DUARTE et al., 1990, 1996; KOWACS et al., 2006).   \n\n \n\n \n\nFigura 7. Sinais cl\u00ednicos do envenenamento por Lonomia obliqua. A. Hematoma \n\nno dedo da m\u00e3o de um paciente. B e C. Equimoses em diferentes regi\u00f5es do corpo. \n\nD. Gengivorragia. Fotos: CIT/RS e ZANIN et al., 2002. \n\n \n\nOs dados laboratoriais indicam coagulopatia que se caracteriza pelo \n\nprolongamento acentuado do tempo de coagula\u00e7\u00e3o obtido pelos testes espec\u00edficos como \n\ntempo de protrombina (TP), tempo de tromboplastina parcialmente ativada (TTPa) e \n\ntempo de trombina (TT) (AROCHA-PI\u00d1ANGO &amp; GUERRERO, 2003). Verifica-se \n\ntamb\u00e9m queda nos n\u00edveis plasm\u00e1ticos de fibrinog\u00eanio (Fg) e dos fatores V, XIII, \n\nprecalicre\u00edna (PK), plasminog\u00eanio (Plg), prote\u00edna C (PC) e ?2-antiplasmina (?2AP), \n\n\n\nIntrodu\u00e7\u00e3o \n\n35 \n\n \n\nenquanto os n\u00edveis do complexo trombina-antitrombina (TAT), do fragmento 1+2 da \n\nativa\u00e7\u00e3o de protrombina (F1+2) e de D-d\u00edmeros (D-D) encontram-se elevados (ZANNIN \n\net al., 2003). Os n\u00edveis dos fatores X, II, vWF e plaquetas est\u00e3o normais na maioria das \n\nv\u00edtimas de acidentes, excetuando-se a contagem de plaquetas que est\u00e1 \n\nsignificativamente diminu\u00edda em casos graves de envenenamento (GAMBORGI et al., \n\n2006). \n\nO intenso consumo dos fatores de coagula\u00e7\u00e3o observado nos pacientes \n\nenvenenados \u00e9 compat\u00edvel com o quadro cl\u00ednico de coagula\u00e7\u00e3o intravascular \n\ndisseminada (CIVD). De fato, os elevados n\u00edveis de TAT e F1+2 indicam que h\u00e1 gera\u00e7\u00e3o \n\nde trombina intravascular por meio da ativa\u00e7\u00e3o de protrombina. Juntamente com \n\ncomponentes do veneno, a trombina formada seria respons\u00e1vel pelo consumo do \n\nfibrinog\u00eanio circulante e pela ativa\u00e7\u00e3o do sistema de coagula\u00e7\u00e3o sangu\u00ednea, o que \n\ntamb\u00e9m levaria a uma diminui\u00e7\u00e3o de outros fatores como V, XIII, PK e \u00e0 forma\u00e7\u00e3o de \n\nfibrina.  \n\n O sistema fibrinol\u00edtico dos pacientes envenenados tamb\u00e9m parece estar ativado, \n\nj\u00e1 que os n\u00edveis de Plg e ?2AP est\u00e3o reduzidos na maioria dos casos. Al\u00e9m disso, os \n\nn\u00edveis plasm\u00e1ticos de D-D est\u00e3o aumentados, confirmando que h\u00e1 intensa fibrin\u00f3lise \n\ndurante o envenenamento. Provavelmente, componentes do veneno s\u00e3o capazes de \n\nativar direta ou indiretamente o Plg gerando quantidades significativas de plasmina \n\nintravascular. A plasmina assim formada, juntamente com enzimas fibrin(ogen)ol\u00edticas \n\ndo veneno, atuam diretamente sobre a fibrina gerando os D-D. O excesso de plasmina \u00e9 \n\ninibida pela serpina ?2AP, o que explica a redu\u00e7\u00e3o na concentra\u00e7\u00e3o plasm\u00e1tica desse \n\ninibidor. \n\n Estudos in vivo em ratos ou mesmo in vitro em cultura de c\u00e9lulas confirmam as \n\nhip\u00f3teses de ativa\u00e7\u00e3o da coagula\u00e7\u00e3o e fibrin\u00f3lise e os dados indicativos de coagulopatia \n\nde consumo secund\u00e1ria \u00e0 CIVD. Animais envenenados experimentalmente apresentam \n\ntempo de coagula\u00e7\u00e3o prolongado, n\u00edveis baixos de fibrinog\u00eanio circulante e alta \n\natividade do tipo trombina e plasmina no plasma (BERGER et al., 2010a). Al\u00e9m disso, \n\nfibroblastos tratados com veneno apresentam um perfil procoagulante com aumento de \n\nexpress\u00e3o de fator tecidual (FT) e do ativador de plasminog\u00eanio do tipo uroquinase \n\n(uPA) (PINTO et al., 2008). Concomitante ao prolongamento do tempo de coagula\u00e7\u00e3o, \n\nh\u00e1 uma significante diminui\u00e7\u00e3o da fun\u00e7\u00e3o plaquet\u00e1ria em ratos injetados com veneno \n\npor via subcut\u00e2nea. Plaquetas de animais envenenados n\u00e3o agregam quando estimuladas \n\npor ADP, col\u00e1geno ou trombina, o que contribui sobremaneira para o quadro \n\n\n\nIntrodu\u00e7\u00e3o \n\n36 \n\n \n\nhemorr\u00e1gico final. Essa hipoagrega\u00e7\u00e3o plaquet\u00e1ria n\u00e3o est\u00e1 associada com a queda dos \n\nn\u00edveis de fibrinog\u00eanio, mas sim com a gera\u00e7\u00e3o de \u00f3xido n\u00edtrico (NO) intravascular, que \n\n\u00e9 um potente inibidor da agrega\u00e7\u00e3o plaquet\u00e1ria. De fato, foi confirmado que os n\u00edveis de \n\nNO aumentam no plasma, a express\u00e3o da \u00f3xido n\u00edtrico sintase (NOS) aumenta em \n\nfibroblastos e c\u00e9lulas endoteliais envenenadas e as plaquetas de animais envenenados \n\npreviamente tratados com L-NAME (um inibidor da NOS) s\u00e3o capazes de agregar \n\nnormalmente (PINTO et al., 2008; BERGER et al., 2010a; NASCIMENTO-SILVA et \n\nal., 2013).  \n\nA gravidade da s\u00edndrome hemorr\u00e1gica induzida por Lonomia sp. incentivou o \n\ndesenvolvimento de um soro eficaz em neutralizar a a\u00e7\u00e3o do veneno. Dispon\u00edvel desde \n\n1996, o soro antilon\u00f4mico \u00e9 produzido no Instituto Butantan a partir da imuniza\u00e7\u00e3o de \n\neq\u00fc\u00ednos com o extrato bruto de esp\u00edculas da lagarta (DIAS DA SILVA et al., 1996; \n\nROCHA-CAMPOS et al., 2001). A correta utiliza\u00e7\u00e3o do soro antilon\u00f4mico \u00e9 capaz de \n\nsolucionar ou reduzir a gravidade do quadro hemorr\u00e1gico, sendo a terapia de escolha em \n\ncasos de envenenamento pela taturana. O esquema de tratamento segue recomenda\u00e7\u00e3o \n\ndo Minist\u00e9rio da Sa\u00fade que indica a dose de soro antilon\u00f4mico levando em \n\nconsidera\u00e7\u00e3o se o envenenamento \u00e9 leve, moderado ou grave. Pacientes com \n\nenvenenamento leve s\u00e3o aqueles que apresentam apenas manifesta\u00e7\u00e3o de dor ou \n\nsensa\u00e7\u00e3o de queima\u00e7\u00e3o no local do contato e sem altera\u00e7\u00e3o de coagula\u00e7\u00e3o ou \n\nsangramento at\u00e9 72 horas ap\u00f3s o acidente. Em geral, esses pacientes recebem apenas \n\ntratamento sintom\u00e1tico com analg\u00e9sicos, evitando-se os salicilatos. Os casos de \n\nenvenenamento moderado apresentam altera\u00e7\u00f5es de coagula\u00e7\u00e3o ou manifesta\u00e7\u00f5es \n\nhemorr\u00e1gicas (gengivorragia, equimose, hematoma ou hemat\u00faria), mas sem altera\u00e7\u00f5es \n\nhemodin\u00e2micas (hipotens\u00e3o, taquicardia ou choque) ou evid\u00eancia de comprometimento \n\nrenal. Esses pacientes recebem tratamento sintom\u00e1tico para dor e 5 ampolas de soro \n\nantilon\u00f4mico via intravenosa (10 mL/ampola, sendo que cada ampola \u00e9 capaz de \n\nneutralizar 3,5 mg do veneno). Pacientes graves s\u00e3o aqueles com altera\u00e7\u00f5es de \n\ncoagula\u00e7\u00e3o, manifesta\u00e7\u00f5es hemorr\u00e1gicas em v\u00edsceras (hemat\u00eamese, hemat\u00faria, \n\nhipermenorragia, hemorragia pulmonar ou intracraniana) ou instabilidade \n\nhemodin\u00e2mica ou les\u00e3o renal. Para esses pacientes \u00e9 recomendado al\u00e9m do tratamento \n\nsintom\u00e1tico e de suporte, 10 ampolas de soro antilon\u00f4mico (MINIST\u00c9RIO DA SA\u00daDE, \n\n1998; CAOVILLA &amp; BARROS, 2004). A administra\u00e7\u00e3o de drogas anticoagulantes ou \n\ndo \u00e1cido ?-aminocapr\u00f3ico (inibidor da fibrin\u00f3lise) isoladamente ou em associa\u00e7\u00e3o com \n\na soroterapia n\u00e3o \u00e9 recomendada, devido ao risco de se exacerbar o quadro hemorr\u00e1gico \n\n\n\nIntrodu\u00e7\u00e3o \n\n37 \n\n \n\nou tromb\u00f3tico, conforme j\u00e1 demonstrado em modelos animais (GON\u00c7ALVES et al., \n\n2007). A infus\u00e3o de sangue total ou plasma fresco para corrigir os n\u00edveis dos fatores de \n\ncoagula\u00e7\u00e3o tamb\u00e9m \u00e9 contraindicada, pois pode acentuar a coagulopatia de consumo. \n\nApesar da efic\u00e1cia, ainda permanece como desafio a produ\u00e7\u00e3o do soro em quantidade \n\nsuficiente para atender \u00e0 crescente demanda devido ao aumento dos acidentes e a \n\nnecessidade de disponibilizar o produto em tempo h\u00e1bil para o tratamento em locais \n\ndistantes onde os acidentes v\u00eam ocorrendo com mais frequ\u00eancia.  \n\n \n\n1.2.4  Composi\u00e7\u00e3o bioqu\u00edmica do veneno  \n\n \n\nO veneno da lagarta L. obliqua \u00e9 constitu\u00eddo por princ\u00edpios ativos na sua maioria \n\nde natureza proteica ou pept\u00eddica com diferentes atividades t\u00f3xicas. Dados obtidos a \n\npartir de uma biblioteca de cDNA das cerdas da lagarta permitiram indicar que, do \n\ngrupo de sequ\u00eancias expressas, cerca de 25 % codificam prote\u00ednas hom\u00f3logas \u00e0 serino-\n\nproteinases. Outros grupos de sequ\u00eancias codificam prote\u00ednas com homologia \u00e0 \n\nlipocalinas (15 %), lectinas (15 %), serpinas 15 %), ciste\u00edno-proteinases (10 %), \n\ninibidores do tipo Kazal (10 %), fosfolipases A2 (5 %) e cininog\u00eanios (5%) (VEIGA et \n\nal., 2005, http://www.ncbi.nlm.nih.gov/projects/omes/). A an\u00e1lise do extrato das cerdas \n\npor espectrometria de massas tamb\u00e9m permitiu identificar serino-proteinases, \n\nlipocalinas e inibidores de proteases como prote\u00ednas majorit\u00e1rias na secre\u00e7\u00e3o venenosa \n\n(RICCI-SILVA et al., 2008). De fato, algumas toxinas pertencentes a essas e a outras \n\nclasses v\u00eam sendo isoladas com o objetivo de entender a contribui\u00e7\u00e3o de cada \n\ncomponente para o quadro cl\u00ednico do envenenamento. Na Tabela 3 est\u00e3o listadas as \n\ntoxinas isoladas do veneno at\u00e9 o momento; um breve coment\u00e1rio sobre o que se sabe a \n\nrespeito do papel de cada uma para o envenenamento \u00e9 apresentado a seguir. Maiores \n\ndetalhes podem ser encontrados no primeiro artigo apresentado na se\u00e7\u00e3o \u201cResultados\u201d.   \n\n \n\nAtivadores de protrombina. Uma das primeiras atividades caracterizadas no veneno de \n\nL. obliqua foi o efeito procoagulante (DONATO et al., 1998). O extrato das esp\u00edculas \n\nda lagarta possui alta atividade proteol\u00edtica e \u00e9 capaz de reduzir significativamente o \n\ntempo normal de coagula\u00e7\u00e3o do plasma pela ativa\u00e7\u00e3o direta de protrombina e fator X \n\n(VEIGA et al., 2003; PINTO et al., 2006). Um desses componentes capaz de promover \n\na ativa\u00e7\u00e3o de protrombina foi isolado e denominado LOPAP (\"Lonomia obliqua \n\nprothrombin activator protease\") (REIS et al., 2001a). A LOPAP nativa \u00e9 descrita \n\n\n\nIntrodu\u00e7\u00e3o \n\n38 \n\n \n\ncomo sendo uma lipocalina tetram\u00e9rica de massa molecular igual a 69 kDa e n\u00e3o possui \n\nhomologia de sequ\u00eancia com qualquer outro ativador j\u00e1 identificado em venenos. Tanto \n\na LOPAP nativa (69 kDa) quanto a recombinante monom\u00e9rica (20 kDa) s\u00e3o capazes de \n\ngerar trombina a partir de protrombina de maneira dose-dependente na presen\u00e7a de \u00edons \n\nc\u00e1lcio e reduzem o tempo de coagula\u00e7\u00e3o do plasma (REIS et al., 2006). A atividade \n\nativadora de protrombina \u00e9 completamente abolida na presen\u00e7a de inibidores cl\u00e1ssicos \n\nde serino-proteinases. Segundo esses autores, o mecanismo de ativa\u00e7\u00e3o da protrombina \n\npela LOPAP \u00e9 semelhante ao do fator Xa do plasma, clivando a protrombina para \n\nformar pretrombina 2 e n\u00e3o mesotrombina como outros ativadores de veneno de \n\nserpentes que s\u00e3o tipicamente metaloproteinases (REIS et al., 2001a; REIS et al., 2006). \n\nQuando injetado por via intravenosa em ratos, a LOPAP reproduz o quadro de \n\ncoagulopatia de consumo observado nos pacientes envenenados. Os animais apresentam \n\nincoagulabilidade sangu\u00ednea, baixos n\u00edveis de fibrinog\u00eanio, trombocitopenia, e \n\ndep\u00f3sitos de fibrina nos capilares glomerulares e pulmonares (REIS et al., 2001b). Em \n\nc\u00e9lulas endoteliais tratadas com o ativador de protrombina h\u00e1 aumento na produ\u00e7\u00e3o de \n\nNO e de prostaciclinas (PGI2) e aumento na express\u00e3o de interleucina-8 (IL-8), o que \n\nsugere que a LOPAP pode estar envolvida na modula\u00e7\u00e3o do processo inflamat\u00f3rio \n\ndurante o envenenamento (FRITZEN et al., 2005). \n\n \n\nAtivadores de fator X. Outra toxina pr\u00f3-coagulante, atuando como ativador de fator X, \n\ntamb\u00e9m foi isolada a partir do extrato de esp\u00edculas da taturana. LOSAC (\"Lonomia \n\nobliqua stuart-factor activator\") \u00e9 uma serino-proteinase de cadeia polipept\u00eddica \u00fanica \n\ncom massa molecular de 45 kDa. A enzima purificada \u00e9 capaz de ativar o fator X de \n\nmaneira dose-dependente na aus\u00eancia de \u00edons c\u00e1lcio, tem a\u00e7\u00e3o pr\u00f3-coagulante no \n\nplasma e induz produ\u00e7\u00e3o de NO e aumento de express\u00e3o do ativador de plasminog\u00eanio \n\ntecidual (t-PA) em c\u00e9lulas endoteliais (ALVAREZ-FLORES et al., 2006). Seus efeitos \n\nin vivo s\u00e3o desconhecidos at\u00e9 o momento. \n\n \n\nFibrinogenases. Al\u00e9m da a\u00e7\u00e3o procoagulante, o veneno de L. obliqua tamb\u00e9m possui \n\natividade fibrinol\u00edtica, sendo capaz de degradar diretamente fibrinog\u00eanio e fibrina \n\n(PINTO et al., 2006). A enzima respons\u00e1vel por essa atividade \u00e9 uma serino-proteinase \n\nde 35 kDa denominada lonofibrase. A lonofibrase degrada as cadeias ??e ??do \n\nfibrinog\u00eanio, mostrando uma maior especificidade para a cadeia ?. A enzima inibe a \n\ncoagula\u00e7\u00e3o do fibrinog\u00eanio induzida pela trombina e tamb\u00e9m possui potente atividade \n\n\n\nIntrodu\u00e7\u00e3o \n\n39 \n\n \n\nsobre fibrina, apresentando um padr\u00e3o de degrada\u00e7\u00e3o diferente do obtido para plasmina, \n\no que sugere que esta fibrinogenase apresenta mecanismo de a\u00e7\u00e3o diferenciado e pode \n\npotencializar o quadro de ativa\u00e7\u00e3o do sistema fibrinol\u00edtico observado durante o \n\nenvenenamento (PINTO et al., 2004). \n\n \n\nFosfolipases A2. As fosfolipases est\u00e3o presentes em praticamente todos os venenos \n\nanimais. As fosfolipases A2 hidrolisam fosfolip\u00eddeos gerando \u00e1cidos graxos livres e \n\nlisofosfolip\u00eddeos, podendo, assim, causar hem\u00f3lise indireta. Tamb\u00e9m podem interferir \n\ndiretamente no processo de coagula\u00e7\u00e3o sangu\u00ednea e agrega\u00e7\u00e3o plaquet\u00e1ria (KINI, 2003). \n\nSeibert et al. (2003) encontraram uma atividade hemol\u00edtica no extrato de esp\u00edculas da L. \n\nobliqua. Segundo estes autores, o veneno foi capaz de induzir hem\u00f3lise direta e indireta \n\nem eritr\u00f3citos humanos e de ratos. Al\u00e9m disso, a inje\u00e7\u00e3o do extrato de esp\u00edculas por via \n\nsubcut\u00e2nea em ratos leva a uma redu\u00e7\u00e3o importante da contagem de eritr\u00f3citos, \n\naumento dos n\u00edveis plasm\u00e1ticos de hemoglobina e diminui\u00e7\u00e3o de haptoglobina \n\n(SEIBERT et al., 2004). Casos de hem\u00f3lise intravascular tamb\u00e9m j\u00e1 foram observados \n\nem pacientes envenenados (MALAQUE et al., 2006). Sabe-se que uma fosfolipase A2 \n\nisolada do veneno contribui para esse efeito hemol\u00edtico. A enzima possui massa \n\nmolecular de 15 kDa e homologia de sequ\u00eancia de amino\u00e1cidos com fosfolipases A2 \n\nencontradas em veneno de abelhas. A enzima purificada tem atividade hemol\u00edtica \n\nindireta e tamb\u00e9m causa hem\u00f3lise intravascular em ratos (SEIBERT et al., 2006). \n\nAdicionalmente, o veneno possui uma atividade tipo fosfolipase A2 capaz de induzir \n\nades\u00e3o e agrega\u00e7\u00e3o plaquet\u00e1ria in vitro (BERGER et al., 2010b). No entanto, a \n\nidentidade da mol\u00e9cula respons\u00e1vel por esse efeito ainda permanece desconhecida.  \n\n \n\nHialuronidases. As hialuronidases s\u00e3o enzimas bem caracterizadas nos venenos de \n\nserpentes, aranhas, abelhas e escorpi\u00f5es. Atuam in vivo, degradando componentes da \n\nmatriz extracelular dos tecidos e da parede dos vasos sangu\u00edneos. Dessa forma, estas \n\nenzimas agem aumentando a distribui\u00e7\u00e3o de outras toxinas para os demais tecidos e \n\n\u00f3rg\u00e3os, favorecendo as manifesta\u00e7\u00f5es sist\u00eamicas dos envenenamentos (SAMPAIO et \n\nal., 1991; MARKOVI-HOUSLEY et al., 2000; KUDO &amp; TU, 2001; DA SILVA et al., \n\n2004).  Especificamente no veneno de L. obliqua foram identificadas duas \n\nhialuronidases de 53 e 49 kDa, chamadas lonogliases. As enzimas s\u00e3o capazes de \n\nhidrolisar \u00e1cido hialur\u00f4nico e sulfato de condroitina, sendo caracterizadas como ?-\n\nendohexosaminidases. Estudos utilizando pele de coelhos demonstraram que as \n\n\n\nIntrodu\u00e7\u00e3o \n\n40 \n\n \n\nlonogliases s\u00e3o capazes de hidrolisar o \u00e1cido hialur\u00f4nico presente na matriz \n\nextracelular, o que facilita a penetra\u00e7\u00e3o das toxinas na derme (GOUVEIA et al., 2005).   \n\n\n\nIntrodu\u00e7\u00e3o \n\n41 \n\n \n\nTabela 3.  Toxinas isoladas do veneno de Lonomia obliqua.   \n\nMM: massa molecular; Lopap: Lonomia obliqua prothrombin activator protease; Losac: Lonomia obliqua \n\nstuart-factor activator. \n\nToxina Identifica\u00e7\u00e3o MM \n\n(Da) \n\nCaracter\u00edsticas Refer\u00eancia \n\nFibrinogenase \n\n \n\nLonofibrase 35.000 Degrada cadeias ??e \n\n??do fibrinog\u00eanio e \n\nfibrina. Inibe a \n\ncoagula\u00e7\u00e3o do \n\nfibrinog\u00eanio \n\ninduzida por \n\ntrombina. \n\nPinto et al., 2004; \n\nVeiga et al., 2005 \n\nAtivador de \n\nprotrombina \n\nLopap 69.000 Possui atividade pr\u00f3-\n\ncoagulante no \n\nplasma e ativa \n\nprotrombina. Induz \n\ncoagulopatia de \n\nconsumo e \n\ntrombocitopenia em \n\nratos. Aumenta a \n\nprodu\u00e7\u00e3o de NO, \n\nPGI2 e IL-8 em \n\nc\u00e9lulas endoteliais \n\nReis et al., 2001; \n\nFritzen et al., \n\n2005; Reis et al., \n\n2006 \n\nAtivador de \n\nfator X \n\nLosac 45.000 Possui atividade pr\u00f3-\n\ncoagulante no \n\nplasma e ativa fator \n\nX. Em c\u00e9lulas \n\nendoteliais, induz \n\nprodu\u00e7\u00e3o de NO e \n\ntPA. \n\nAlvarez-Flores et \n\nal., 2006 \n\n \n\nHialuronidases Lonogliases 53.000 \n\n49.000 \n\nAtividade hidrol\u00edtica \n\nsobre componentes \n\nda matriz \n\nextracelular. \n\nFacilitam a \n\nbiodistribui\u00e7\u00e3o das \n\ntoxinas atrav\u00e9s da \n\npele. \n\nGouveia et al., \n\n2005 \n\n \n\nFosfolipase A2 - 15.000 Atividade hemol\u00edtica \n\nindireta in vitro. \n\nInduz hem\u00f3lise \n\nintravascular in vivo. \n\nSeibert et al., 2006 \n\n \n\n\n\nIntrodu\u00e7\u00e3o \n\n42 \n\n \n\n1.3 Insufici\u00eancia renal aguda nos envenenamentos por animais pe\u00e7onhentos \n\n \n\nA insufici\u00eancia renal aguda (IRA) representa uma das principais complica\u00e7\u00f5es \n\ncl\u00ednicas dos acidentes com animais pe\u00e7onhentos. Os venenos de serpentes s\u00e3o, em sua \n\nmaioria, altamente nefrot\u00f3xicos, por\u00e9m casos mais graves e frequentes s\u00e3o observados \n\nem acidentes com serpentes asi\u00e1ticas e africanas tais como Daboia russelli siamensis \n\n(\"Russell's viper\"), Echis carinatus (\"Saw-scaled viper\") e Bitis arietans (\"Puff Adder\"); \n\ne tamb\u00e9m com serpentes da Am\u00e9rica do Sul como as do g\u00eanero Bothrops (jararacas) e \n\nCrotalus (cascav\u00e9is) (RODRIGUES-SGRIGNOLLI et al., 2011; PINHO et al., 2008; \n\nSITPRIJA, 2006). Al\u00e9m das serpentes, aranhas do g\u00eanero Loxsosceles (aranha-marron) \n\ne as abelhas africanizadas (Apis mellifera) s\u00e3o respons\u00e1veis por parcela significativa dos \n\ncasos de IRA, principalmente no Brasil (ABDULKADER et al., 2008). De maneira \n\ngeral, as principais altera\u00e7\u00f5es renais descritas s\u00e3o necrose tubular aguda, redu\u00e7\u00e3o do \n\nritmo de filtra\u00e7\u00e3o glomerular e olig\u00faria. O mecanismo envolvido vem sendo alvo de \n\nintensa investiga\u00e7\u00e3o e, ao que tudo indica, \u00e9 multifatorial. Diferentes modelos \n\nexperimentais indicam que pode haver tanto uma a\u00e7\u00e3o citot\u00f3xica direta do veneno sobre \n\ndiferentes estruturas renais (como \u00e9 o caso da toxina dermonecr\u00f3tica de Loxsosceles que \n\nse liga especificamente em c\u00e9lulas tubulares, induzindo altera\u00e7\u00f5es estruturais e morte \n\ncelular), quanto uma resposta inflamat\u00f3ria secund\u00e1ria desencadeada em resposta ao \n\nenvenenamento, que leva \u00e0 libera\u00e7\u00e3o de citocinas e esp\u00e9cies reativas de oxig\u00eanio \n\n(BERGER et al., 2012; PINHO et al., 2008; CHAIM et al., 2006). H\u00e1 tamb\u00e9m uma \n\ncontribui\u00e7\u00e3o importante decorrente da libera\u00e7\u00e3o de mioglobina e hemoglobina muito \n\ncomum nos envenenamentos por Crotalus e A. mellifera (GRISOTTO et al., 2006; \n\nPINHO et al., 2005).  \n\nAs complica\u00e7\u00f5es renais tamb\u00e9m s\u00e3o frequentes e usualmente graves nos \n\nenvenenamentos por L. obliqua. Durante a d\u00e9cada de 80, dados retrospectivos de \n\nacidentes ocorridos em Santa Catarina apontaram uma incid\u00eancia de IRA de 18 %, \n\nsendo que a taxa de mortalidade chegou a 50 % entre os pacientes que desenvolveram \n\nIRA ap\u00f3s o contato com a lagarta (DUARTE et al., 1990; 1994). Em Passo Fundo (RS), \n\nde 134 v\u00edtimas de envenenamento atendidas no per\u00edodo de 1989 a 1998, 6 % \n\ndesenvolveram IRA, dentre os quais 25 % foram \u00e0 \u00f3bito devido ao dano renal \n\n(WALTER, 1999). Em outro estudo retrospectivo pelo qual foram analisados 2.067 \n\npacientes envenenados tamb\u00e9m em Santa Catarina no per\u00edodo de 1989 at\u00e9 2003, um \n\ntotal de 39 pacientes (1,9 %) desenvolveram IRA (GAMBORGI et al., 2006). Dos \n\n\n\nIntrodu\u00e7\u00e3o \n\n43 \n\n \n\npacientes com IRA, cerca de 32 % (11) necessitaram de hemodi\u00e1lise e 10,3 % (4) dos \n\ncasos evolu\u00edram para insufici\u00eancia renal cr\u00f4nica (IRC). Sete \u00f3bitos foram registrados \n\nnesse per\u00edodo devido \u00e0s complica\u00e7\u00f5es renais. O uso do soro antilon\u00f4mico a partir de \n\n1995 n\u00e3o diminuiu a incid\u00eancia de IRA (que permaneceu em torno de 2 % entre 1995-\n\n2003), mas diminuiu a gravidade dos casos e o n\u00famero de pacientes que evolu\u00edram para \n\nIRC. Os pacientes com IRA tamb\u00e9m apresentaram concomitantemente altera\u00e7\u00f5es \n\nhemorr\u00e1gicas. Tempo de coagula\u00e7\u00e3o prolongado (10 a 30 minutos) foi detectado em 18 \n\n% e incoagul\u00e1vel (maior que 30 minutos) em 83 % dos pacientes com IRA. A contagem \n\nde plaquetas, hemat\u00f3crito e hemoglobina tamb\u00e9m foram menores nesses pacientes \n\n(GAMBORGI et al., 2006).  \n\nOutra caracter\u00edstica cl\u00e1ssica do envenenamento por L. obliqua e estreitamente \n\nrelacionada ao desenvolvimento de IRA \u00e9 a hemat\u00faria. A maioria dos estudos \n\nretrospectivos e relatos cl\u00ednicos descrevem que 80 a 87 % dos pacientes com IRA \n\napresentam hemat\u00faria macrosc\u00f3pica (Figura 8A) (GAMBORGI et al., 2006; \n\nMALAQUE et al., 2006; WALTER, 1999; BURDMANN et al., 1996). O mesmo \u00e9 \n\nobservado em ratos injetados com o extrato de esp\u00edculas da lagarta (Figura 8B). Por \n\nexame direto do sedimento urin\u00e1rio \u00e9 poss\u00edvel visualizar hem\u00e1cias intactas e leuc\u00f3citos \n\n(Figura 8C).  \n\n \n\n \n\nFigura 8. Hemat\u00faria. A. Amostras de urina de paciente envenenado por L. obliqua. B. Urina de ratos \n\ninjetados com extrato de esp\u00edculas de L. obliqua (1,5 mg/kg, via subcut\u00e2nea) ap\u00f3s diferentes tempos de \n\nenvenenamento. c: urina de animal injetado com solu\u00e7\u00e3o salina. C. Sedimento urin\u00e1rio de animal injetado \n\ncom extrato de esp\u00edculas ap\u00f3s 6 horas de envenenamento. Notar a presen\u00e7a de hem\u00e1cias intactas (setas \n\npretas) e leuc\u00f3citos (setas brancas). Colora\u00e7\u00e3o: May-Gr\u00fcnwald-Giemsa. Aumento: 40 X. Fonte: A. \n\nDUARTE et al., 1994. B e C, M. BERGER (resultados experimentais).   \n\n\n\nIntrodu\u00e7\u00e3o \n\n44 \n\n \n\nO mecanismo da IRA induzida por L. obliqua e mesmo as altera\u00e7\u00f5es patol\u00f3gicas \n\nrenais decorrentes do envenenamento s\u00e3o pouco conhecidas. N\u00e3o existe qualquer estudo \n\nde investiga\u00e7\u00e3o experimental e h\u00e1 apenas dois casos relatados na literatura em que foi \n\nrealizada bi\u00f3psia renal para exame de altera\u00e7\u00f5es histopatol\u00f3gicas. Em um deles, \n\nBurdmann et al. (1996) descreveram o caso de uma paciente com 67 anos que \n\napresentou IRA do tipo an\u00farica ap\u00f3s contato com in\u00fameras lagartas. A paciente foi \n\nsubmetida \u00e0 bi\u00f3psia renal depois de 17 dias do acidente e apresentou glom\u00e9rulos de \n\napar\u00eancia normal, apesar de um espessamento da parede da c\u00e1psula de Bowman e \n\natrofia tubular focal. Foi mantida em hemodi\u00e1lise por 26 dias e recuperou a fun\u00e7\u00e3o \n\nrenal. No outro relato \u00e9 descrito o caso de uma paciente de 37 anos, gr\u00e1vida de 37 \n\nsemanas, que teve contato com a palma da m\u00e3o direita com aproximadamente 15 \n\nlagartas e apresentou gengivorragia, an\u00faria e sangramento genital ap\u00f3s 24 horas do \n\ncontato. Devido ao descolamento precoce de placenta, o parto foi realizado e a paciente \n\ndeu \u00e0 luz a uma crian\u00e7a saud\u00e1vel. Os n\u00edveis de creatinina plasm\u00e1tica da paciente \n\naumentaram de 4 mg/dL no 1\no\n dia ap\u00f3s o acidente para 10,1 mg/dL no 4\n\no\n dia. Os n\u00edveis \n\nde ureia aumentaram de 41 mg/dL para 169 mg/dL no mesmo per\u00edodo. O tratamento por \n\nhemodi\u00e1lise foi iniciado no 5\no\n dia e os n\u00edveis de creatinina diminu\u00edram para 3,8 mg/dL \n\nno 36\no\n dia. Apenas no 27\n\no\n dia (quando o quadro hemorr\u00e1gico j\u00e1 havia sido revertido) \n\numa bi\u00f3psia renal foi realizada e se evidenciou a presen\u00e7a de necrose tubular aguda em \n\nregenera\u00e7\u00e3o (FAN et al., 1998). Certamente, a impossibilidade de se fazer bi\u00f3psia \n\nprecoce, em fun\u00e7\u00e3o dos dist\u00farbios de coagula\u00e7\u00e3o inerentes ao acidente, tem dificultado \n\numa an\u00e1lise mais adequada das altera\u00e7\u00f5es anatomopatol\u00f3gicas renais. Portanto, este fato \n\npor si s\u00f3 e a gravidade dos casos de IRA justificam a import\u00e2ncia do uso de modelos \n\nanimais experimentais para o estudo dos mecanismos fisiopatol\u00f3gicos renais durante o \n\nenvenenamento, o que tamb\u00e9m pode gerar conhecimento para o desenvolvimento de \n\nformas alternativas de tratamento. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nIntrodu\u00e7\u00e3o \n\n45 \n\n \n\n1.4 O sistema calicre\u00edna-cininas \n\n \n\n O sistema calicre\u00edna-cininas (SCC) \u00e9 composto por enzimas e pept\u00eddeos \n\nbiologicamente ativos que participam de diferentes processos fisiopatol\u00f3gicos. Al\u00e9m de \n\nestar envolvido na regula\u00e7\u00e3o direta de sistemas end\u00f3genos, o SCC est\u00e1 intimamente \n\nrelacionado com v\u00e1rios mecanismos plasm\u00e1ticos de ativa\u00e7\u00e3o enzim\u00e1tica por prote\u00f3lise \n\nlimitada como coagula\u00e7\u00e3o sangu\u00ednea, fibrin\u00f3lise, sistema renina-angiotensina e sistema \n\ncomplemento (MOVAT, 1979). \n\n O mecanismo b\u00e1sico de funcionamento do SCC consiste na ativa\u00e7\u00e3o da \n\nprecalicre\u00edna (uma serinoprotease que pode ser encontrada sob duas formas: calicre\u00edna \n\nplasm\u00e1tica e tissular) que age sobre mol\u00e9culas do precursor cininog\u00eanio gerando \n\npept\u00eddeos genericamente conhecidos como cininas. A precalicre\u00edna pode ser ativada \n\nenzimaticamente pela a\u00e7\u00e3o de proteases como o fator XIIa e a tripsina (SHARIAT-\n\nMADAR et al., 2002). Ap\u00f3s ativa\u00e7\u00e3o, a calicre\u00edna plasm\u00e1tica (que \u00e9 sintetizada no \n\nf\u00edgado) age sobre o cininog\u00eanio de alto peso molecular (HMWK, do ingl\u00eas, high \n\nmolecular weight kininogen; 114 kDa), que circula conjugado a ela, gerando o \n\nnonapept\u00eddeo ativo, a bradicinina (BK, do ingl\u00eas, bradykinin; Arg\n1\n-Pro\n\n2\n-Pro\n\n3\n-Gly\n\n4\n-\n\nPhe\n5\n-Ser\n\n6\n-Pro\n\n7\n-Phe\n\n8\n-Arg\n\n9\n). J\u00e1 a calicre\u00edna tissular diferencia-se da plasm\u00e1tica quanto \u00e0s \n\ncaracter\u00edsticas moleculares, f\u00edsico-qu\u00edmicas e enzim\u00e1ticas, e hidrolisa preferencialmente \n\no cininog\u00eanio de baixo peso molecular (LMWK, do ingl\u00eas, low molecular weight \n\nkininogen; 68 kDa) gerando calidina (Lys-BK) (PIERCE &amp; GUIMAR\u00c3ES, 1976; \n\nSCHMAIER et al., 1999). A calicre\u00edna tissular \u00e9 sintetizada e presente em \u00f3rg\u00e3os como \n\ngl\u00e2ndulas salivares, rins e p\u00e2ncreas, e secretada em fluidos biol\u00f3gicos (urina, saliva e \n\nsuor). No rim, a Lys-BK pode ser convertida \u00e0 BK por aminopeptidases presentes no \n\nplasma e urina ou a BK \u00e9 liberada diretamente pela calicre\u00edna renal (GUIMAR\u00c3ES et \n\nal., 1973; 1976; VIEIRA et al., 1994). Al\u00e9m da BK e da calidina, diversas outras \n\ncininas existem como a T-cinina (Ile-Ser-BK), descrita pela primeira vez no plasma de \n\nratos tratados com tripsina (OKAMOTO &amp; GREENBAUM, 1983), e a des-Arg\n9\n-BK, \n\nque atua exclusivamente em receptores B1 (ERD\u00d6S, 1979).  \n\n As cininas possuem um tempo de meia-vida muito curto no organismo, sendo \n\ninferior a um minuto, pois logo ap\u00f3s serem liberadas elas sofrem r\u00e1pida inativa\u00e7\u00e3o pela \n\na\u00e7\u00e3o de enzimas conhecidas como cininases (FERREIRA &amp; VANE, 1987). As \n\ncininases s\u00e3o metaloproteases zinco-dependentes encontradas nos tecidos e no plasma. \n\nEm estados n\u00e3o patol\u00f3gicos, s\u00e3o descritas sete metaloproteases respons\u00e1veis pela \n\n\n\nIntrodu\u00e7\u00e3o \n\n46 \n\n \n\nclivagem de cininas em mam\u00edferos: a mais conhecida \u00e9 a enzima conversora de \n\nangiotensina (ECA) ou cininase II (uma dipeptidil-peptidase), a qual cliva entre os \n\nres\u00edduos Pro\n7\n-Phe\n\n8 \ne logo ap\u00f3s entre Phe\n\n5\n-Ser\n\n6\n. Contudo, carboxipeptidases (M e N), \n\nconhecidas como cininases do tipo I; aminopeptidases e endopeptidases (como a \n\nprolilendopeptidase) tamb\u00e9m est\u00e3o envolvidas no metabolismo das cininas (ERD\u00d6S, \n\n1979).  \n\n As cininas exercem seus efeitos biol\u00f3gicos por meio do est\u00edmulo de, pelo menos, \n\ndois tipos de receptores transmembrana acoplados \u00e0 prote\u00edna G, denominados \n\nreceptores B1 (B1R) e B2 (B2R). BK e Lys-BK exercem a maioria de seus efeitos via \n\nB2R. J\u00e1 a des-Arg\n9\n-BK e a Lys-des-Arg\n\n9\n-BK atuam preferencialmente por liga\u00e7\u00e3o ao \n\nB1R (REGOLI &amp; BARAB\u00c9, 1980). O B2R \u00e9 constitutivamente expresso em diferentes \n\ntecidos e o B1R \u00e9 normalmente ausente em tecidos n\u00e3o-traumatizados, tendo sua \n\nexpress\u00e3o induzida em condi\u00e7\u00f5es espec\u00edficas de estresse, les\u00e3o tissular, infec\u00e7\u00e3o ou \n\ninflama\u00e7\u00e3o (PESQUERO et al., 1996; CALIXTO et al., 2000). De fato, citocinas \n\nproinflamat\u00f3rias como a interleucina-1? (IL-1?) e o fator de necrose tumoral-? (TNF-?) \n\ns\u00e3o capazes de regular a express\u00e3o do B1R atrav\u00e9s do fator de transcri\u00e7\u00e3o NF-?B \n\n(MEDEIROS et al., 2001; 2004; CALIXTO et al., 2004). Ao se ligarem a seus \n\nreceptores, as cininas desencadeiam uma s\u00e9rie de eventos intracelulares como \n\nmobiliza\u00e7\u00e3o de c\u00e1lcio, ativa\u00e7\u00e3o das fosfolipases A e C, produ\u00e7\u00e3o de NO e prostaciclina \n\n(BHOOLA, 1992). A libera\u00e7\u00e3o de NO e prostaciclina leva a uma s\u00e9rie de efeitos \n\nfisiol\u00f3gicos tais como vasodilata\u00e7\u00e3o perif\u00e9rica e aumento do fluxo sangu\u00edneo, \n\nextravasamento vascular, quimiotaxia e ativa\u00e7\u00e3o de mast\u00f3citos e macr\u00f3fagos, contra\u00e7\u00e3o \n\nda musculatura lisa visceral, libera\u00e7\u00e3o de autac\u00f3ides e prostan\u00f3ides, nocicep\u00e7\u00e3o \n\n(CALIXTO et al., 2000) e de modo antag\u00f4nico hipotens\u00e3o sist\u00eamica (ALVING et al., \n\n1978) e hipertens\u00e3o portal hep\u00e1tica (BORGES et al., 1976).  \n\n Diferentes toxinas presentes em venenos animais podem interferir com o \n\nfuncionamento normal do SCC. Entre elas, destacam-se as enzimas semelhantes \u00e0 \n\ncalicre\u00edna, as cininogenases, as cininases, os potenciadores de cininas e os pept\u00eddeos que \n\npossuem efeitos biol\u00f3gicos semelhantes \u00e0s cininas. Al\u00e9m disso, existem venenos com a \n\ncapacidade peculiar de ativar o SCC mesmo sem apresentar qualquer enzima \n\nsemelhante \u00e0 calicre\u00edna, ap\u00f3s desnatura\u00e7\u00e3o proteica (HAMBERG &amp; ROCHA E SILVA, \n\n1957) ou, mesmo, que podem ativar o SCC sem ter atividade proteol\u00edtica importante \n\n(DEUTSCH &amp; DINIZ, 1955). No caso da lagarta L. obliqua, foi demonstrado que o \n\nveneno \u00e9 capaz de induzir ativa\u00e7\u00e3o de precalicre\u00edna plasm\u00e1tica apesar de ser desprovido \n\n\n\nIntrodu\u00e7\u00e3o \n\n47 \n\n \n\nde significante atividade do tipo calicre\u00edna (BOHRER et al., 2007). O mecanismo de \n\na\u00e7\u00e3o permanece n\u00e3o esclarecido apesar depoder haver participa\u00e7\u00e3o de mediadores \n\nliberados por c\u00e9lulas inflamat\u00f3rias, visto a importante libera\u00e7\u00e3o de histamina mediada \n\npelo veneno (DE CASTRO BASTOS et al., 2004), de proteases pulmonares e de c\u00e9lulas \n\nendoteliais ativadas, e de mol\u00e9culas de membrana basal, tipo col\u00e1geno, expostas em \n\nles\u00f5es vasculares. O veneno da taturana tamb\u00e9m possui atividade cininogen\u00e1sica, sendo \n\ncapaz de liberar BK a partir do LMWK. Quando injetado por via intravenosa, o extrato \n\nde esp\u00edculas da lagarta (3 ?g/kg) \u00e9 capaz de induzir queda na press\u00e3o arterial m\u00e9dia de \n\nratos. O efeito observado \u00e9 compar\u00e1vel ao produzido pela BK. A administra\u00e7\u00e3o de \n\naprotinina (um inibidor de calicre\u00edna plasm\u00e1tica) ou HOE-140 (um antagonista de B2R) \n\nprevine a atividade hipotensora do veneno. Esses dados indicam que o efeito observado \n\n\u00e9 dependente da a\u00e7\u00e3o da calicre\u00edna plasm\u00e1tica e mediado diretamente pela BK \n\n(BOHRER et al., 2007). Da mesma forma, a a\u00e7\u00e3o edematog\u00eanica do veneno \u00e9 inibida \n\npor aprotinina, HOE-140 e loratadina (um antagonista de receptor H1 de histamina), o \n\nque demonstra a import\u00e2ncia da ativa\u00e7\u00e3o do SCC para as diferentes altera\u00e7\u00f5es \n\nfisiopatol\u00f3gicas que ocorrem durante o envenenamento (DE CASTRO BASTOS et al., \n\n2004; BOHRER et al., 2007). \n\n Neste trabalho, levantamos a hip\u00f3tese de que a ativa\u00e7\u00e3o do SCC induzida pelo \n\nveneno de L. obliqua tamb\u00e9m est\u00e1 envolvida na disfun\u00e7\u00e3o renal descrita nos pacientes \n\nenvenenados. H\u00e1 tr\u00eas evid\u00eancias principais que sustentam essa hip\u00f3tese: (i) Todos os \n\ncomponentes do SCC s\u00e3o expressos no rim; (ii) o SCC participa do controle \n\nhemodin\u00e2mico, regula\u00e7\u00e3o da filtra\u00e7\u00e3o glomerular e do equil\u00edbrio hidro-eletrol\u00edtico e (iii) \n\ncomponentes do SCC est\u00e3o envolvidos em diferentes patologias, incluindo a nefropatia \n\ndiab\u00e9tica, a les\u00e3o renal por isquemia-reperfus\u00e3o, a glomerulonefrite e a fibrose renal \n\n(KAKOKI et al., 2004; WANG et al., 2008; KLEIN et al., 2009; KLEIN et al., 2010).  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n48 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n  \n\n  \n\n  \n\n  \n\n  \n\n  \n\n  \n\n22..  OOBBJJEETTIIVVOOSS \n \n\n \n\n\n\nObjetivos \n\n49 \n\n \n\n2.  OBJETIVOS \n\n \n\n Apesar do conhecimento adquirido at\u00e9 o momento sobre as toxinas e as \n\ndisfun\u00e7\u00f5es hemost\u00e1ticas, pouco se sabe sobre os mecanismos de toxicidade sist\u00eamica no \n\nenvenenamento pela taturana L. obliqua. Portanto, o presente trabalho foi desenvolvido \n\ncom o objetivo geral de investigar as altera\u00e7\u00f5es fisiopatol\u00f3gicas induzidas pelo veneno \n\nem diferentes \u00f3rg\u00e3os, dando particular aten\u00e7\u00e3o aos dist\u00farbios renais e vasculares que \n\ns\u00e3o descritos como a principal causa de \u00f3bito neste tipo de envenenamento. \n\n  \n\n Para tanto, os objetivos espec\u00edficos propostos foram: \n\n \n\n? Caracterizar as principais altera\u00e7\u00f5es histopatol\u00f3gicas, hematol\u00f3gicas, \n\nbioqu\u00edmicas e genot\u00f3xicas sist\u00eamicas induzidas pelo veneno em diferentes \n\n\u00f3rg\u00e3os utilizando um modelo experimental in vivo em ratos; \n\n \n\n? Avaliar a capacidade do soro antiveneno (soro antilon\u00f4mico) em neutralizar os \n\nprincipais efeitos t\u00f3xicos sist\u00eamicos in vivo; \n\n \n\n? Investigar os mecanismos envolvidos na disfun\u00e7\u00e3o renal induzida pelo veneno: \n\nAvaliar a fun\u00e7\u00e3o glomerular, tubular, equil\u00edbrio hidroeletrol\u00edtico, hemodin\u00e2mica  \n\ne as altera\u00e7\u00f5es histopatol\u00f3gicas renais de ratos experimentalmente envenenados \n\npor L. obliqua; \n\n \n\n? Analisar a express\u00e3o diferencial de prote\u00ednas no rim de animais envenenados \n\nbuscando identificar marcadores e vias de sinaliza\u00e7\u00e3o associadas \u00e0 les\u00e3o renal; \n\n \n\n? Avaliar os n\u00edveis de express\u00e3o dos componentes do sistema calicre\u00edna-cininas no \n\nrim durante o envenenamento; \n\n \n\n? Investigar a contribui\u00e7\u00e3o de componentes do sistema calicre\u00edna-cininas para a \n\nles\u00e3o renal induzida pelo veneno.   \n\n \n\n \n\n\n\n \n\n50 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n 33..  RREESSUULLTTAADDOOSS \n \n\n \n\n\n\nResultados \n\n51 \n\n \n\n3.  RESULTADOS \n \n\n A se\u00e7\u00e3o de resultados apresentada a seguir est\u00e1 dividida em cinco cap\u00edtulos que \n\ncorrespondem aos manuscritos produzidos ao longo do per\u00edodo de doutoramento. A \n\nformata\u00e7\u00e3o do texto utilizada nesta se\u00e7\u00e3o segue as normas exigidas pelos peri\u00f3dicos \n\ncient\u00edficos internacionais. Cada cap\u00edtulo inicia com um breve texto introdut\u00f3rio sobre o \n\nassunto abordado, em portugu\u00eas, seguido de uma c\u00f3pia do artigo ou do manuscrito, em \n\ningl\u00eas. \n\n \n\n3.1  Cap\u00edtulo I \n\n \n\nLonomia obliqua venom: In vivo effects and molecular aspects associated with the \n\nhemorrhagic syndrome \n\n \n\n  Neste trabalho, uma revis\u00e3o a respeito dos diferentes aspectos envolvidos na \n\ns\u00edndrome hemorr\u00e1gica que ocorre nos envenenamentos pela taturana L. obliqua foi \n\nrealizada. \u00canfase foi dada para os efeitos do veneno in vivo em modelos animais e, \n\ntamb\u00e9m, para os aspectos cl\u00ednicos extra\u00eddos de relatos de casos de v\u00edtimas envenenadas. \n\nA revis\u00e3o permitiu a constru\u00e7\u00e3o de uma vis\u00e3o geral e atualizada dos efeitos biol\u00f3gicos \n\ndo veneno, bem como auxiliou a planejar as metas experimentais perseguidas nos \n\ndemais trabalhos.     \n\n  \n\nO artigo foi publicado no peri\u00f3dico Toxicon em janeiro de 2010. O formato do texto \n\napresentado segue as normas exigidas pelo peri\u00f3dico.     \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nilable at ScienceDirect\n\nToxicon 56 (2010) 1103\u20131112\nContents lists ava\nToxicon\n\nj o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / t o x i c o n\nReview\n\nLonomia obliqua venom: In vivo effects and molecular aspects\nassociated with the hemorrhagic syndrome\n\nAnto?nio F.M. Pinto, Markus Berger, Jose? Reck Jr., Renata M.S. Terra, Jorge A. Guimara?es*\n\nLaborato?rio de Bioqu??mica Farmacolo?gica, Centro de Biotecnologia (UFRGS), Av. Bento Gon\u00e7alves, 9500, CEP 91501-970, Porto Alegre, RS, Brazil\na r t i c l e i n f o\n\nArticle history:\nReceived 8 November 2009\nReceived in revised form 6 January 2010\nAccepted 19 January 2010\nAvailable online 28 January 2010\n\nKeywords:\nLonomia obliqua\nCaterpillar\nEnvenomation\nVenom\nExperimental model\nHemorrhagic syndrome\n* Corresponding author. Tel.: \u00fe55 51 33086068; f\nE-mail address: guimar@cbiot.ufrgs.br (J.A. Guim\n\n0041-0101/$ \u2013 see front matter ? 2010 Elsevier Ltd\ndoi:10.1016/j.toxicon.2010.01.013\na b s t r a c t\n\nCaterpillar envenomation has been an emergent health issue. Lonomia obliqua is a medi-\ncally important animal that causes a hemorrhagic syndrome that can progress to acute\nrenal failure, intracranial hemorrhage and death. In the past few years the molecular\ncharacterization of L. obliqua venom in addition to experimental models has provided\nfundamental information to the understanding of the envenomation syndrome. Herein\nstudies from several authors which characterized the complex toxic-pharmacological\nactions of whole venom are reviewed.\n\n? 2010 Elsevier Ltd. All rights reserved.\n1. Introduction\n\nAccidental contact with some lepidopteran caterpillars\ncan inflict serious human injuries ranging from simple skin\nirritation to serious burns, allergic reactions, renal failure and\nhemorrhagic disturbances (Diaz, 2005). Like other venomous\nanimals, such as snakes and spiders, these caterpillars\nproduce a variety of toxic components that affect the vascular\nsystem, blood coagulation, fibrinolysis and platelet function\n(Arocha-Pin?ango et al., 2000). However, different from snakes\nand spiders, that use their venoms to immobilize and digest\nthe prey, the caterpillar venomous components are useful for\ndefense against predators.\n\nFrom the medically important Saturniidae family,\nLonomia genus has been attributed to cause human enve-\nnomations since late 1960s in Venezuela (Arocha-Pin?ango\nand Larysse, 1969). In Southern Brazil, Lonomia obliqua\n(Fig. 1a) caterpillar is becoming the most important\nax \u00fe55 51 33087309.\nara?es).\n\n. All rights reserved.\nvenomous animal responsible for severe injuries, hemor-\nrhagic disorders and often fatal outcome since the 1980s\n(Duarte et al., 1990). For instance, in the State of Rio Grande\ndo Sul, located in this Brazilian region, more than a thou-\nsand accidents have been registered in the 1997 to 2005\nperiod (Abella et al., 2006). In fact, based in the data for the\nyear 2008, the Brazilian Ministry of Health registered an\nincidence of 8 lepidopteran envenomations per 100,000\ninhabitants in Southern Brazil (SVS, 2009). Actually, this\nnumbers are greatly underestimated due to the fact that\nmost accidents are occurring in distant rural areas, where\nthe cases are poorly reported. The emergent importance of\nL. obliqua accidents seems to be consequence to the\nextensive deforestation of rural areas and replacement of\nthe native forest by fruit tree plantation, a rich source of\nfood for this lepidopteran. The L. obliqua has gregarious\nhabits, and this characteristic complicate the patient\nprognosis, since the accidents usually involve the contact of\nthe victim with a caterpillar colony containing dozens or\nhundreds of caterpillars lying on the surface of tree trunks.\n\nL. obliqua is venomous only in the larval stages (1st to\n6th instars), when the body of the insect is covered by\n52\n\nmailto:guimar@cbiot.ufrgs.br\nwww.sciencedirect.com/science/journal/00410101\nhttp://www.elsevier.com/locate/toxicon\n\n\nFig. 1. The Lonomia obliqua caterpillar. A. L. obliqua (6th instar). B. Detail of L. obliqua bristles.\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u201311121104\nchitinous bristles (Fig. 1b). These structures are hard and\nspiny evaginations of the cuticle underneath. Contrarily to\nother venomous animals, there is no specialized venomous\ngland in L. obliqua and the venom is produced by a secre-\ntory epithelium localized under the cuticle (Veiga et al.,\n2001). The bristles have a hollow canal by which the\nvenom is injected in the victim. The accident occurs when\nthe whole animal is crushed by the victim; the insect\u2019s\nchitinous bristles are broken and the venomous secretions\npenetrate the human skin reaching blood circulation (Veiga\net al., 2001).\n\nIn this review, we focused in studies that provided\nsignificant contributions to the comprehension of the bio-\nlogical effects of the whole venom in experimental models.\nIn fact, these reports are responsible for identification and\ncharacterization of venom mechanisms capable of repro-\nducing some of the main physiopathological aspects of the\nclinical envenomation.\n2. Clinical aspects of human envenomation\n\nClinical symptoms of L. obliqua envenomation include\nlocal pain and inflammatory reaction, which starts imme-\ndiately after contact; systemic reactions such as headache,\nfever, vomiting and asthenia, which appear a few hours after\nexposure; and bleeding diathesis characterized by hema-\ntomas and ecchymosis, hematuria, pulmonary and intrace-\nrebral hemorrhage and acute renal failure (Burdmann et al.,\n1996; Kowacs et al., 2006; Garcia and Danni-Oliveira, 2007).\n\nPoisoned patients present a severe prolongation of the\ncoagulation parameters such as prothrombin time (PT) and\npartial activated thromboplastin time (aPTT). Laboratory\nfindings include a decrease in plasma levels of fibrinogen,\nfactors V and XIII, pre-kallikrein, plasminogen, protein C\nand a2-antiplasmin, and an increase in the levels of\nthrombin-antithrombin complex (TAT), fragment 1 \u00fe2\nfrom prothrombin activation (F1.2) and D-dimers. No\nalterations in von Willebrand Factor, factors X and II levels\nwere found (Kelen et al., 1995; Zannin et al., 2003). Taken\ntogether, these clinical data indicate that a significant\namount of intravascular thrombin is generated and the\nfibrinolytic system is activated in L. obliqua envenomation.\nThe activation of blood coagulation and fibrinolysis causes\nthe consumption of plasmatic factors leading to\na consumption coagulopathy characteristic of this type of\nenvenomation.\n\nDespite this intense consumption coagulopathy, the\nplatelet number appears to be diminished only in the most\nsevere cases, been normal in mild ones (Zannin et al.,\n2003). However, the platelet function of these patients\nduring envenomation has not been evaluated. Considering\nthat platelets participate in several steps of the hemostatic\nprocess, including the amplification and propagation pha-\nses of the blood coagulation (Monroe and Hoffman, 2006;\nHoffman and Monroe, 2001), these elements probably\nmake a decisive contribution to the appearance of hemor-\nrhagic syndrome during envenomation. Analogously,\npatients envenomed by Bothrops jararaca snakes presented\na significant impairment of the platelet function that has\nbeen associated with the bleeding disorders observed after\nenvenomation (Sano-Martins et al., 1997).\n\nBesides the bleeding disorders, Lonomia-envenomed\npatients also develop renal problems. Hematuria is\nobserved in most patients and may evolve to acute renal\nfailure (Burdmann et al., 1996). A few histological reports of\nrenal tissue of envenomed patients are consistent with\ntubular necrosis (Burdmann et al., 1996; Fan et al., 1998),\nbut the pathogenesis of acute renal failure in L. obliqua\nenvenomation is poorly understood. The difficulty of\nconducting early renal biopsies due the coagulation\ndisturbances inherent to the incidents has contributed to\nthis lack of knowledge. Although, the massive deposition of\nfibrin in the glomeruli capillaries due to intravascular\ncoagulation and/or a direct action of the venom on the\nrenal microcirculation cannot be discharged as causes of\nrenal damage (Gamborgi et al., 2006).\n\nIntracerebral hemorrhage is the main cause of deaths by L.\nobliqua envenomation. In the state of Parana?, also in Southern\nBrazil, hemorrhage of the central nervous system accounted\nfor the death of 50% of Lonomia-envenomed patients regis-\ntered from 1989 to 2005 (Kowacs et al., 2006). However, the\nmechanisms that lead to intracerebral hemorrhage in enve-\nnomed patients are also poorly understood.\n3. Pharmacology and molecular aspects\nof experimental envenomation\n\nThe dramatic effects of L. obliqua venom in humans have\nbeen partially reproduced in a number of experimental\n53\n\n\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u20131112 1105\nmodels. The biodistribution of venom components in\nanimal models was studied by immunochemical and radio-\nlabeling (Rocha-Campos et al., 2001; Da Silva et al., 2004b).\nVenom components could be detected in high quantities in\nkidneys, blood and urine as soon as one hour after intra-\nperitoneal injection. Lower amounts of venom could be also\ndetected in lungs, liver, spleen, heart, skeletal muscle and\nbrain. Two hours after injection, most of the venom has\nbeen already eliminated by urine or remained in kidney\ntissue (Rocha-Campos et al., 2001). Furthermore, residual\namounts of venom components could be detected up to 6\nand 18 h after injection on the liver and kidneys, respec-\ntively (Da Silva et al., 2004b).\n\n3.1. Coagulation and platelet aggregation disturbances\n\nVarious in vivo studies have been carried out to\nunderstand the mechanisms of hemostatic disturbances\ntriggered by L. obliqua caterpillar venom (Kelen et al.,\n1995; Rocha-Campos et al., 2001; Prezoto et al., 2002;\nBerger et al., 2010). The coagulation disorders observed\nin humans after contact with Lonomia caterpillars can be\nreproduced in experimental animals. Administration of\nthe crude extract of L. obliqua bristles to rats, rabbits and\nmice causes a dose-dependent increase of clotting time\n(PT, aPTT, thrombin time and whole blood clotting time)\nand can render the unclottable blood. Bristle extract also\nreduced plasma levels of fibrinogen and factor XIII and\nincreased fibrin degradation products (Kelen et al., 1995;\nPrezoto et al., 2002; Berger et al., 2010). Furthermore,\nwhen crude bristle extract was administered in rats and\nthe bleeding time assay was continuously monitored,\na dose-dependent hemorrhagic effect of the venom was\nclearly observed (unpublished results). Envenomed rats\nalso presented high levels of thrombin, plasmin and\nurokinase activities in plasma, indicating that coagulation\nand fibrinolysis are activated during L. obliqua enveno-\nmation (Berger et al., 2010).\n\nIn addition to the coagulation disorders, we have\ndemonstrated that rats experimentally envenomed with\nbristle extract also presented an accentuated impairment of\nthe platelet aggregation function. The aggregation response,\ninduced by either ADP or collagen, is decreased in rats\u2019\nplasma during the time course of envenomation. Maximum\ndecrease in platelet aggregation occurred 6 h after venom\ninjection for both agonists. At this time, even in the presence\nof thrombin (the most potent platelet aggregating agent),\ninhibition in aggregation was sustained in platelet rich\nplasma (PRP). On the other hand, it was found that enve-\nnomed animals presented only a slight reduction of\napproximately 26 % in the platelet count at 6 h, being\nnormalized after 24 h of envenomation (Berger et al., 2010).\nThese results are in accordance with those observed by\nZannin et al. (2003), who analyzed a group of 105 patients\nenvenomed with L. obliqua, in which only 9% presented\nthrombocytopenia (platelet counts &lt;150,000/mL).\n\nThe mechanisms involved in platelet aggregation inhibi-\ntion also have been investigated. In our model of experi-\nmental envenomation, the platelet hypoaggregation was not\nrelated to the low levels of plasma fibrinogen as well, since\nfibrinogen replacement in PRP did not reestablished normal\nfunction. Interestingly, normoaggregation was observed\nwhen platelets were separated from plasma through\na washing procedure. In addition, incubation of plasma from\nenvenomed rats inhibits aggregation response of normal\nwashed platelets, which indicates that an aggregation\ninhibitor is generated in plasma during envenomation.\nMoreover, experimentally envenomed animals presented an\nincrease in nitric oxide (NO) plasmatic levels which coincided\nwith the maximum inhibitory effect upon platelet aggrega-\ntion. Indeed, the in vivo blockade of NO synthase activity by\nNG-nitro-L-arginine-methyl-ester (L-NAME) pretreatment\npartially revert the platelet hypoaggregation response\ninduced by envenomation, thus suggesting that NO can be\none of the mediators that participate in platelet dysfunctions\n(Berger et al., 2010). The generation of fibrinogen/fibrin\ndegradation products (FfDP) and D-dimers during enveno-\nmation can also participate in platelet hypoaggregation, since\nfragments deriving from fibrin and/or fibrinogen degradation\ncould bind to the GPIIb\u2013IIIa receptors and prevent normal\nplatelet aggregation (Thorsen et al.,1986). In fact, envenomed\npatients presented high levels of FfDP (Zannin et al., 2003)\nand the plasmatic activities of plasmin and urokinase were\nsignificantly increased in envenomed animals (Berger et al.,\n2010).\n\nSeveral toxins of L. obliqua venom could be directly or\nindirectly involved with the hemostatic disturbances\nobserved in humans and experimental animals (Table 1).\nIndeed, the venom possesses high proteolytic, procoagu-\nlant and fibrin(ogen)olytic activities (Veiga et al., 2003;\nPinto et al., 2006). As shown in Fig. 2, the active princi-\nples present in L. obliqua venom can interfere in several key\npoints of the victims\u2019 hemostatic system. The enzymes\nresponsible for these activities are mainly prothrombin and\nfactor X activators and a fibrinogenase that have been\nalready isolated and characterized from different\nvenomous secretions of L. obliqua caterpillars (Donato et al.,\n1998; Reis et al., 1999; Pinto et al., 2004; Alvarez-Flores\net al., 2006). The prothrombin and factor X activators\ngenerate significant amounts of intravascular thrombin,\nwhich leads to the activation of coagulation system and to\nconsumption of fibrinogen and other coagulation factors.\nThe fibrin(ogen)olytic enzymes degrade both fibrinogen\nand fibrin, contributing to the reduction of fibrinogen levels\nand to blood incoagulability. Furthermore, fibrin(ogen)o-\nlytic enzymes can also participate in generation of FfDP,\nwhich are probably involved in the platelet aggregation\ndisturbances. Thus, these toxins acts synergistically to\nproduce the hemostatic disturbances observed in humans\nand animal models.\n\n3.2. Intravascular hemolysis\n\nIt has been reported that L. obliqua crude venom (bristle\nextract) causes intravascular hemolysis in rats, with\na reduction in the number of circulating erythrocytes,\nincrease in plasma hemoglobin in the first 6 h, with\na decrease in total hemoglobin levels 24 h after enveno-\nmation, together with a decrease in haptoglobin levels\n(Seibert et al., 2004). Also, the urine of the animals was dark-\nred due to the presence of free hemoglobin (no erythrocytes\nwere found), confirming the occurrence of hemoglobinuria\n54\n\n\n\nTable 1\nLonomia obliqua toxins which may be involved in envenomation.\n\nToxin Gen Bank Predicted Mw/observed\nMw (Da)\n\nIdentification\nmethology\n\nReference\n\nFibrinogenase NA 35,000 Isolation Pinto et al. (2004)\nProthrombin activator AY908986 69,000 Isolation Reis et al. (2001)\nFactor X activator NA 45,000 Isolation Alvarez-Flores et al. (2006)\nSerine proteinases AY829844 Unknown Transcriptome Veiga et al. (2005)\n\nAY829818 55,200\nAY829819 Unknown\nAY829820 Unknown\nAY829821 Unknown\nAY829842 Unknown\nAY829843 30,100\nAY829841 Unknown\n\nHyaluronidases NA 53,000 Isolation Gouveia et al. (2005)\n49,000\n\nPhospholipase A2 NA 15,000 Isolation Seibert et al. (2006)\nPhospholipase A2 AY829845 9,600 Transcriptome Veiga et al. (2005)\nLectins AY829822 33,700 Transcriptome Veiga et al. (2005)\n\nAY829836 33,900\nAY829849 Unknown\nAY829846 16,300\n\nLipocalins AY829833 20,600 Transcriptome Veiga et al. (2005)\nAY829856 13,500\nAY829809 Unknown\n\nSerpins AY829814 50,200 Transcriptome Veiga et al. (2005)\nAY829815 41,600\nAY829816 Unknown\nAY829817 Unknown\nAY829847 Unknown\n\nOther protease inhibitors AY829810 14,600 Transcriptome Veiga et al. (2005)\nAY829811 41,800\nAY829812 8600\nAY829813 7300\nAY829839 7200\nAY829835 8000\nAY829837 4100\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u201311121106\nin these animals. Such hemolytic activity presented by cat-\nerpillar\u2019s venom seems to be higher in animal models than\nin human. As a matter of fact, intravascular hemolysis has\nbeen observed only in cases where the victim gets in contact\nwith a large number of caterpillars (Malaque et al., 2006).\n\nA hemolytic activity has been described in crude bristle\nextract, which causes direct and indirect hemolysis of\nhuman and rat erythrocytes; such action was assigned to\na phospholipase A2 (Table 1) present in this venomous\npreparation. Besides, degradation of cell membrane\nproteins was also detected, corroborating with the hemo-\nlytic effect observed in animal models (Seibert et al., 2006).\nIn addition, hemolysis might be also due to deposits of\nmicrothrombi in the vasculature, as observed in thrombotic\nmicroangiopathy. In this case, the thrombi in capillaries\ncreate abnormally high levels of shear stress that fragments\nthe red blood cells (Tsai, 2006).\n\n3.3. Inflammation and vascular disorders\n\nIn addition to hemorrhagic syndrome, the L. obliqua\nenvenomation could lead to many local effects at the\ncontact site, such as burning sensation, pain, edema and\nerythema (Fan et al., 1998; Correa et al., 2004). These\nfindings are probably related to the activation of the\ninflammation response elicited by the venom injection in\nthe victim\u2019s body (Da Silva et al., 2004a; Bohrer et al., 2007).\nThe local pain due to the contact with Lonomia genus\ncaterpillars is a common event. The pharmacological\nmechanisms of L. obliqua induced pain were studied by our\ngroup, using the rat paw model of nociception (De Castro\nBastos et al., 2004). The nociception, evinced as noci-\nfensive behavior, was more prominent 5\u201310 min after the\nvenom injection, being however, significantly reduced by\nthe pre-treatment of rats with indomethacin (nonselective\ninhibitor of cyclooxygenase), indicating that local pain\ninduced by L. obliqua envenomation is, at least partially,\nmediated by prostaglandins (PG) (De Castro Bastos et al.,\n2004).\n\nDespite the clear participation of PG in the nociception\ninduced by L. obliqua envenomation, other mediators,\nnamely bradykinin (BK), could contribute to the overall\nnociceptive/painful effect, since BK, one of the most\npowerful nociceptive agents known to date (Wang et al.,\n2006), is produced in L. obliqua envenomation (Bohrer\net al., 2007). We have demonstrated that L. obliqua\nvenom induces the activation of the kallikrein-kinin\nsystem (KKS) via plasma pre-kallikrein activation. It was\nalso demonstrated, using guinea pig ileum bioassay, that\nthe venom was able to generate BK directly from low\nmolecular weight kininogen (LMWK) (Bohrer et al., 2007).\n\nIn this sense, the KKS seems to be the major responsible\nfor edema formation induced by the contact with L. obliqua\ncaterpillars (Bohrer et al., 2007). Using mice paw edema\n55\n\n\n\nFig. 2. Diagrammatic representation of the cell-based model of hemostasis. The coagulation reaction occurs in three different phases: initiation, amplification\nand propagation (for a review see Monroe and Hoffman, 2006). The sites of action of L. obliqua toxins are indicated by the presence of caterpillars. TF, tissue factor;\nvWF, Von Willebrand factor; tPA, tissue plasminogen activator.\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u20131112 1107\nbioassay, we have characterized the edematogenic activity\nof L. obliqua venom. The paw edema remains prominent up\nto 4\u20136 h post-envenomation (De Castro Bastos et al., 2004;\nBohrer et al., 2007). Mice pre-treatment with HOE-140 (BK\nB2 receptor antagonist) or aprotinin (kallikrein inhibitor)\nleads to 50\u201360% inhibition of the edematogenic response\nwhile loratadine (histamine H1 receptor antagonist) pre-\ntreatment slightly suppressed the edematogenic activity of\nthe venom (De Castro Bastos et al., 2004; Bohrer et al.,\n2007). On the other hand, pre-treatment of mice with\nguanethidine (noradrenergic blocker) or indomethacin has\nno effect in L. obliqua induced edema (De Castro Bastos\net al., 2004).\n\nIn spite of the local inflammatory effect, L. obliqua\nvenom seems to be mainly dependent of the humoral\nfactors (BK, PG, histamine); it also could be related with\ncellular responses. The migration and infiltration of\ninflammatory cells into the site of venom inoculation\noccurs mainly in a late phase (24 h post-envenomation),\nand this exudate is composed namely by neutrophils and\nmonocytes (Ramos et al., 2004).\n\nThe pro-inflammatory properties of the venom are\nresponsible not only for local effects, but also for systemic\ndisturbances due to its ability to modulate the properties of\nthe vascular system (Da Silva et al., 2004a; Bohrer et al.,\n2007). It is important to note that in some envenomed\npatients, mainly in severe cases, systemic vascular and\ninflammatory disorders were observed, such as the occur-\nrence of drop in blood pressure followed by blood extrav-\nasation into the brain (Fan et al., 1998; Kowacs et al., 2006).\n\nExperimental models showed that L. obliqua venom\ninduces systemic alterations in the vascular tonus and in\n56\n\n\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u201311121108\nvessel wall structure (Da Silva et al., 2004a; Bohrer et al.,\n2007). The occurrence of intra-cranial hemorrhages and\nneurological disturbances in some patients could be related\nwith the disruption of the blood brain barrier (BBB).\nExperimental envenomation of rats leads to the increase of\nthe BBB permeability, evinced by the observation of\nlanthanum ions deposition in tissues as seen by electron\nmicroscopy (Da Silva et al., 2004a). This increase in BBB\npermeability seems to be related with an alteration in\nmicrovessels diameter, probably via action of pro-inflam-\nmaory molecules, such as BK (Da Silva et al., 2004a). The\nmain alterations in the central nervous system (CNS) are\nthe presence of vacuoles (namely in hippocampus and\ncerebellum) and vasogenic edema, which could lead to\nblood leakage and hemorrhage into the CNS (Da Silva et al.,\n2004a).\n\nIn addition, we have shown that L. obliqua venom also\ninduces a systemic transient drop in mean arterial blood\npressure in experimental envenomation (Bohrer et al.,\n2007). This hypotensive effect is totally dependent of the\nKKS activation by venom, since the pre-treatment of the\nrats with HOE-140 or aprotinin completely abolishes\nthe vasodilatatory effect (Bohrer et al., 2007).\n\nAll the inflammatory and vascular actions of the L.\nobliqua venom discussed above could not be related with\nonly one specific toxin, and also seem to be independent of\nthe activity of the procoagulant fraction of the venom (De\nCastro Bastos et al., 2004; Da Silva et al., 2004a; Ramos\net al., 2004; Bohrer et al., 2007). This fact supports the\nhypothesis that the venom overall effect and the enveno-\nmation syndrome are the result of the synergistic action of\na cocktail of compounds.\n\n3.4. Gene expression alterations induced by Lonomia\nobliqua envenomation\n\nIn addition to venom direct actions, L. obliqua bristle\nextract produces indirect effects by triggering host cellular\nresponses. We have demonstrated gene expression\nchanges in envenomed fibroblasts through the microarray\ntechnology (Pinto et al., 2008). L. obliqua venom produces\na cellular response through up-regulation of several genes\nthat could be involved in the generation and/or amplifica-\ntion of some known clinical manifestations.\n\nOne of these effects is involved with activation and\nmigration of inflammatory cells. Bristle extract induces up-\nregulation of pro-inflammatory mediators such as IL-8, IL-\n6, CCL2 and CXCL1. These mediators may be released by\nseveral cell types after inflammatory stimuli and are che-\nmoattractants of monocytes, neutrophiles, basophiles and\nT-cells, thus modulating the inflammatory response.\nAdditionally, up-regulation of the adhesive protein ICAM-3\nstimulates the inflammatory cell infiltration in injured\ntissues. Moreover, prostaglandin-endoperoxide synthase 2\n(PTGS2), also known as cyclooxygenase 2, a pro-inflam-\nmatory enzyme that triggers prostanoid biosinthesis, is also\nup-regulated. Together, these mediators probably play\na key role in several inflammatory processes which occurs\nin the envenomation syndrome (Pinto et al., 2008).\n\nAlso, cellular response to envenomation could be\npartially involved in other manifestations such as edema,\npain sensation and hypotension (De Castro Bastos et al.,\n2004; Bohrer et al., 2007), through up-regulation of\ndimethylarginine dimethylaminohydrolase 1 (DDAR), an\nenzyme involved in the biosynthesis of NO. In fact, we have\ndemonstrated that NO level increases in experimental in\nvivo envenomation and participates in platelet aggregation\ndisturbances (Berger et al., 2010).\n\nDifferently from Lonomia achelous (Arocha-Pin?ango\net al., 2000), to date there is no report of a plasminogen\nactivating activity on L. obliqua venom. However, our gene\nexpression study revealed up-regulation of urokinase\nplasminogen activator receptor (uPAR). This data supports\nthe hypothesis that indirect fibrinolytic system activation\nmay occur via action of cell plasminogen activators (Pinto\net al., 2008). This activation of the fibrinolytic system may\ngenerate a site of intense proteolytic activity which may be\nresponsible not only for fibrin degradation but also can\naffect extracellular matrix proteins thus activating matrix\nmetalloprotases, which facilitates cell migration and tissue\nremodeling. Moreover, it could be also capable of inacti-\nvating coagulation factors V and VIII (Vaughan and\nDeclerck, 1998).\n\nIn addition, microarray results have shown an over-\nexpression of tissue factor (TF) in envenomed cells. Indeed,\nwe have demonstrated the cell culture supernatant of\nenvenomed cells has a procoagulant activity that is not\nneutralized by anti-lonomic serum (ALS) suggesting an\nindirect venom effect in which cellular response would be\nresponsible for the amplification of procoagulant stimulus\n(Pinto et al., 2008). Taken together, it is reasonable to\npropose that L. obliqua venom induces liberation of either\nprocoagulant microparticles containing TF or a soluble\nform of TF (Bogdanov et al., 2003).\n\n3.5. Lonomia obliqua transcriptome\n\nAccording to a transcriptomic study performed by our\ngroup, it is estimated that there are at least four important\nprotein families (Table 1) that could be related to the\nenvenomation symptomatology, especially regarding\nhemostatic disturbances (Veiga et al., 2005). Serine\nproteinases are the most relevant protein family when\nconsidering their potential of interfering with blood coag-\nulation. Moreover, serine proteases are an expressive\ngroup, representing 16.7 and 25% of the clusters derived\nfrom tegument and bristle transcriptome, respectively\n(Veiga et al., 2005). This protein group presents coagulation\nfactors-like activities, so it is expected that these enzymes\nparticipate in the generation of thrombin, by activation of\nFX and prothrombin (Donato et al., 1998), and in the acti-\nvation of the fibrinolytic system, contributing directly and\nindirectly to fibrinogen degradation (Pinto et al., 2004) and\nresulting in the hemorrhagic disorder. In fact, a fibrinoge-\nnolytic enzyme has been purified and characterized by our\ngroup (Pinto et al., 2004).\n\nPhospholipases and lectins are other known groups of\nproteins that disturb hemostasis and can effectively affect\nblood coagulation and platelet aggregation. These proteins\nare important components of many other animals\u2019 venoms \u2013\nsuch as snakes, bees and scorpions \u2013 and have been well\ncharacterized as important players in the modulation of the\n57\n\n\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u20131112 1109\nhemostatic system. Phospholipases are enzymes that can\ndirectly modulate platelet aggregation and, also, they may\ndestabilize coagulation complexes by degradation of\nphospholipids (Kerns et al., 1999; Kini, 2003). In addition,\nthese enzymes are able to disrupt cell membranes and thus\nthe hemolytic activity of L. obliqua bristle extract has been\nattributed to a phospholipase activity (Seibert et al., 2004).\nLectins, particularly c-type lectins, are a relatively well-\nstudied group of proteins in snake venoms that may exert\nan additional function in hemostasis modulation by inter-\nacting with coagulations factors and/or platelet receptors.\nThree lectin clusters were found in the bristle cDNA library,\nbeing LOqua-lect5 a protein with homology to many snake\nvenom lectins being then another important candidate\ncontributing to the hemorrhagic disorder.\n\nBesides the enzymatic activities present in the\nvenomous secretions, hemostasis can also be impaired by\nthe action of proteinase inhibitors. Among this class of\nproteins, it is of special interest the serine proteases\ninhibitors (serpins). Serpins are known to have an impor-\ntant role in the physiology of insects but, more than that,\nthey can function as key effectors in hemostasis, by inhi-\nbition of coagulation factors. They seem to be also an\nimportant component of the venom representing 27.8 and\n10% of the clusters in tegument and bristle, respectively\n(Veiga et al., 2005).\n\nThe specific properties, functional characteristic and\nmechanisms of action of the great majority of the enzymes\nor protein classes that constitute L. obliqua venom is still\npoorly known and, more than that, the manner by which\nthese proteins interact with each other and the way they\naffect the victim\u2019s physiology is unclear. The trancriptomic\nanalysis has provided information to new and testable\nhypothesis (Veiga et al., 2005).\n\n4. Treatment of Lonomia obliqua hemorrhagic\nsyndrome\n\nAnti-lonomic serum (ALS) has been produced by\nInstituto Butantan through successive intramuscular\ninjections of bristle extract in horses. Initially, ALS con-\nsisted of whole IgG proteins purified from serum and\nsterilized by filtration (Dias da Silva et al., 1996). More\nrecently, ALS preparation was refined by large scale\nproduction of horse serum rich in F(ab0)2 immunoglobulin\nfragments able to neutralize L. obliqua venom components\n(Rocha-Campos et al., 2001). One milliliter of ALS is\ncapable of neutralizing the toxic effects present in 3 ID50\n(incoagulation-inducing dose 50%, meaning the minimal\ndose of L. obliqua bristle extract that delays the blood\nclotting time in at least 15 min on 50% of mice tested)\n(Rocha-Campos et al., 2001).\n\nFrom a therapeutic standpoint, ALS has been success-\nfully used to re-establish the physiological coagulation\nparameters in poisoned patients (Ricci-Silva et al., 2008).\nA randomized, prospective controlled trial conducted in\nSouthern Brazil between 2000 and 2002 with 44 patients\nin two distinct treatment groups showed that ALS was\neffective in reversing the clinical findings of L. obliqua\nenvenomation syndrome with no significant adverse\nreactions. This study also demonstrated that approximately\nthree ALS vials of 10 mL were effective for the treatment of\ntypical envenomation cases (Caovilla and Barros, 2004).\n\nRecently, through a proteomic approach, the ability of\nALS to recognize specific proteins from the crude venom was\nused to evaluate the venom immunogenicity (Ricci-Silva\net al., 2008). In some specific experimental conditions the\nbidimensional map (by 2D electrophoresis) of L. obliqua\nbristle extract exhibit 157 silver-stained spots, being about\nof 97% of the spots immunochemically revealed by immu-\nnoblotting analysis with ALS (Ricci-Silva et al., 2008).\nAlthough no significant novel relevant information about\nvenom biochemical composition was obtained, since\napproximately only 20 spots were further evaluated for\nprotein identification (Ricci-Silva et al., 2008), the immu-\nnoproteomic study support the hypothesis that the L. obli-\nqua venom was a complex mixture of several largely\nimmunogenic compounds with no specific(s) toxin(s) as\nmajor candidate(s) for ALS targeting. In fact, the low amount\nof L. obliqua venom used to immunize horses compared to\nother schemes of venom production and the high antibody\ntiter obtained also suggests that the caterpillar\u2019s venom\ncomponents are strong immunogens (Rocha-Campos et al.,\n2001).\n\nDespite the clinical efficacy of the L. obliqua ALS, the\npromptly availability of this anti-venom in the regions of\nhigh incidence of accidents still remains a public health\nconcern, namely in rural areas of Southern Brazil. In this\nsense, the use of synthetic drugs to treat the clinical\nsyndrome induced by venomous animals always was\na promising alternative to heterologous serotherapy, since\nthese drugs, in general, seem to have more stability, a lower\ncost of production, and none of the collateral effects of\nheterologous therapy (Gutie?rrez et al., 2007).\n\nBefore the development of ALS in Brazil, the use of anti-\nfibrinolytic drugs, such as e-aminocaproic acid (EACA), was\nofficially recommended as therapy against L. obliqua enve-\nnomation by the Brazilian Ministry of Health based on the\nclinical experience with L. achelous in Venezuela (FUNASA,\n2001). Although the use of EACA has been a relative\nsuccess in the cessation of clinical evidence of bleeding in\nenvenomation by L. achelous (Arocha-Pin?ango et al., 1992),\nrecent data suggest that its use to treat the L. obliqua enve-\nnomation should be dismissed (Gon\u00e7alves et al., 2007).\n\nIn experimental models of L. obliqua envenomation, the\nanimals treated with EACA after 1 or 6 h post-envenoma-\ntion, displayed neither fibrinogen level recovery nor\nnormalization of coagulation parameters, similarly to\nanimals treated only with saline. Contrarily, the hemostatic\nparameters of the rats treated with ALS return to the\nnormal values. Moreover, a high death rate was observed in\nthe group which received an early EACA treatment (15 min.\npost-envenomation) (Gon\u00e7alves et al., 2007).\n\nConsidering the severity of L. obliqua hemorrhagic\nsyndrome, it is demanding urgent the search for new\nnatural or synthetic venom inhibitors able to replace or, at\nleast, be used as a complementary option to serotherapy.\nMoreover, this may allow significant advances in the field\nand thus, more deep research in the subject is needed. In\nfact, several components obtained predominantly from\nnatural sources have been used to counteract the toxic\neffects of different venomous animals (Maiorano et al.,\n58\n\n\n\nFig. 3. Biological effects of Lonomia obliqua venom. A summary of the biological effects of L. obliqua venom discussed in this review are presented. KKS, kallikrein\u2013\nkinin system; TF, tissue factor; uPAR, urokinase plasminogen activator receptor; NO, nitric oxide; BK, bradykinin; FfDP, fibrinogen/fibrin degradation product; PG,\nprostaglandin; BBB, blood brain barrier.\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u201311121110\n2005). For L. obliqua venom, we recently demonstrated that\nmarine algae extracts of Canistrocarpus cervicornis, Stypo-\npodium zonale and Dictyota pfaffi were able to antagonize\nthe in vitro procoagulant effect of the venom. In addition,\nthe extract of D. pfaffi was also able to inhibit the hemolytic\nactivity (Domingos et al., 2009). Thus, marine algae may be\nused as antivenoms or may contribute to the development\nof compounds with antilonomic effects.\n5. Final remarks\n\nIn spite of the emerging and crescent importance of L.\nobliqua envenomations, the biochemical mechanisms of\naction and the pathological basis behind the hemorrhagic\nsyndrome still remains not fully understood. Fig. 3\nsummarizes all data known to date, concerning the inter-\naction of the venom components with the hemostatic and\ninflammatory processes as well as with the vascular system.\nL. obliqua venom is able to directly and indirectly activate\ncoagulation and fibrinolysis leading to a consumption coa-\ngulopathy. These events, in addition to platelet hypoag-\ngregation phenomenon triggers the hemorrhagic syndrome\nobserved in envenomed patients and experimental models.\nBesides, venom has a direct action upon erythrocytes,\ncausing hemolysis and hemoglobinuria. Likewise, induction\nof inflammation and disturbances in the vascular system\ninduces hypotension, pain, edema, cellular infiltration and\nincreases BBB permeability. Altogether, this physiopatho-\nlogical manifestations account for the severe clinical profile\nobserved in L. obliqua envenomation.\n\nTaken together, the results discussed in this review\nsupport the concept that at least part of the physiopatho-\nlogical alterations in envenomation are due to indirect effects\ntriggered by venom interaction with victims\u2019 proteins, cells,\ntissues and organs. Regardless of all information accumulated\nto date, important biochemical and pharmacological prop-\nerties of the venom, including its composition and the\nmechanism of the envenomation itself, they all remain open\nresearch avenues to be explored. Prospectively it could be\nconsidered the need for a comprehensive proteomic char-\nacterization of L. obliqua venomous secretions; identification\nof the physiopathological mechanisms behind the acute renal\nfailure and a complete pathological characterization of\nvenom toxic effects in specific organs.\n\nAcknowledgements\n\nThe authors are grateful to CAPES (Coordena\u00e7a?o de\nAperfei\u00e7oamento de Pessoal de N??vel Superior) and CNPq\n(Conselho Nacional de Desenvolvimento Cient??fico e Tec-\nnolo?gico) for funding and fellowships. Special thanks to\nDr. Walter Beys (Centro de Biotecnologia -UFRGS) for his\nvaluable suggestions and to Dr. Ce?lia Carlini (Dep. de\nBiof??sica \u2013 UFRGS) for her encouragement.\n\nConflicts of interest\n\nThe authors declare that there are no conflicts of\ninterest.\n\nReferences\n\nAbella, H.B., Marques, M.G.B., Silva, K.R.L.M., Rossoni, M.G., Torres, J.B.,\n2006. Acidentes com lagartas do ge?nero Lonomia registrados no\nCentro de Informa\u00e7a?o Toxicolo?gica do Rio Grande do Sul no per??odo\nde 1997 a 2005. In: Nicolella, A. (Ed.), Toxicovogila?ncia \u2013 toxicologia\ncl??nica: dados e indicadores selecionados. Secretaria da Sau?de Fun-\nda\u00e7a?o Estadual de Produ\u00e7a?o e Pesquisa em Sau?de. Centro de Infor-\nma\u00e7a?o Toxicolo?gica, Porto Alegre, pp. 29\u201334.\n\nAlvarez-Flores, M.P., Fritzen, M., Reis, C.V., Chudzinski-Tavassi, A.M., 2006.\nLosac, a factor X activator from Lonomia obliqua bristle extract: its role\nin the pathophysiological mechanisms and cell survival. Biochem.\nBiophys. Res. Commun 343, 1216\u20131223.\n59\n\n\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u20131112 1111\nArocha-Pin?ango, C.L., de Bosch, N.B., Torres, A., Goldstein, C., Nouel, A.,\nArgu?ello, A., Carvajal, Z., Guerrero, B., Ojeda, A., Rodriguez, A., et al.,\n1992. Six new cases of a caterpillar-induced bleeding syndrome.\nThromb. Haemost. 67, 402\u2013407.\n\nArocha-Pin?ango, C.L., Marval, E., Guerrero, B., 2000. Lonomia genus\ncaterpillar toxins: biochemical aspects. Biochimie 82, 937\u2013942.\n\nArocha-Pin?ango, C.L., Larysse, M., 1969. Fibrinolysis produced by contact\nwith a caterpillar. Lancet 1, 810\u2013812.\n\nBerger, M., Reck Jr., J., Terra, R.M.S., Pinto, A.F.M., Termignoni, C.,\nGuimara?es, J.A., 2010. Lonomia obliqua caterpillar envenomation\ncauses platelet hypoaggregation and blood incoagulability in rats.\nToxicon 55, 33\u201344.\n\nBogdanov, V.Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M.,\nNemerson, Y., 2003. Alternatively spliced human tissue factor:\na circulating, soluble, thrombogenic protein. Nat. Med. 9 (4), 458\u2013462.\n\nBohrer, C.B., Reck Jr., J., Fernandes, D., Sordi, R., Guimara?es, J.A., Assreuy, J.,\nTermignoni, C., 2007. Kallikrein-kinin system activation by Lonomia\nobliqua caterpillar bristles: involvement in edema and hypotension\nresponses to envenomation. Toxicon 49, 663\u2013669.\n\nBurdmann, E.A., Antunes, I., Saldanha, L.B., Abdulkader, R.C.M.R., 1996.\nSevere acute renal failure induced by the venom of Lonomia cater-\npillars. Clin. Nephrol. 46, 337\u2013339.\n\nCaovilla, J.J., Barros, E.J., 2004. Efficacy of two different doses of anti-\nlonomic serum in the resolution of hemorrhagic syndrome resulting\nfrom envenoming by Lonomia obliqua caterpillars: a randomized\ncontrolled trial. Toxicon 43, 811\u2013818.\n\nCorrea, M.S., Batista, R.S., Gomes, A.P., Barbosa, A.F., Verzola, A.C.,\nOliveira, F., Squeff, F.A., Leal-Filho, J.M., Tavares, R.H., Amorim, D.S.,\nMoreira, N.L., Santos, S.S., 2004. Erucismo por Lonomia spp em Ter-\neso?polis, RJ, Brasil: relato de um caso prova?vel e revisa?o da literatura.\nRev. Soc. Bras. Med. Trop 37, 418\u2013421.\n\nDa Silva, G.H., Hyslop, S., Cruz-Ho?fling, M.A., 2004a. Lonomia obliqua\ncaterpillar venom increases permeability of the blood-brain barrier in\nrats. Toxicon 44, 625\u2013634.\n\nDa Silva, G.H., Panunto, P.C., Hyslop, S., Da Cruz-Ho?fling, M.A., 2004b.\nImmunochemical detection of Lonomia obliqua caterpillar venom in\nrats. Microsc. Res. Tech 65, 276\u2013281.\n\nDe Castro Bastos, L., Veiga, A.B., Guimara?es, J.A., Tonussi, C.R., 2004.\nNociceptive and edematogenic responses elicited by a crude bristle\nextract of Lonomia obliqua caterpillars. Toxicon 43, 273\u2013278.\n\nDias da Silva, W., Campos, C.M., Gon\u00e7alves, L.R., Sousa-e-Silva, M.C., Higashi, H.\nG., Yamagushi, I.K., Kelen, E.M., 1996. Development of an antivenom\nagainst toxins of Lonomia obliqua caterpillars. Toxicon 34, 1045\u20131049.\n\nDiaz, J.H., 2005. The evolving global epidemiology, syndromic classifica-\ntion, management, and prevention of caterpillar envenoming. Am. J.\nTrop. Med. Hyg. 72, 347\u2013357.\n\nDomingos, T.F.S., Carvalho, C., Moura, L.A., Teixeira, V.L., Pereira, R.C.,\nBianco, E.M., Ferreira, W.J., Ramos, C.J.B., Miranda, A.L.P., Melo, P.A.,\nGuimara?es, J.A., Fuly, A.L., 2009. Antilonomic effects of Brazilian\nbrown seaweed extracts. Nat. Prod. Commun. 4, 1075\u20131078.\n\nDonato, J.L., Moreno, R.A., Hyslop, S., Duarte, A., Antunes, E., Le Bonniec, B.\nF., Rendu, F., de Nucci, G., 1998. Lonomia obliqua caterpillar spicules\ntrigger human blood coagulation via activation of factor X and\nprothrombin. Thromb. Haemost. 79, 539\u2013542.\n\nDuarte, A.C., Caovilla, J., Lorini, D., Mantovani, G., Sumida, J., Manfre, P.C.,\nSilveira, R.C., de Moura, S.P., 1990. Insuficie?ncia renal aguda por\nacidentes com lagartas. J. Bras. Nefrol. 12, 184\u2013186.\n\nFan, H.W., Cardoso, J.L.C., Olmos, R.D., Almeida, F.J., Viana, R.P.,\nMartinez, A.P.P., 1998. Hemorrhagic syndrome and acute renal failure\nin a pregnant woman after contact with Lonomia caterpillars: a case\nreport. Rev. Inst. Med. Top. S. Paulo 40, 119\u2013120.\n\nFUNASA, 2001. Acidentes por Lepido?pteros. Manual de diagno?stico e\ntratamento de acidentes por animais pe\u00e7onhentos. Funda\u00e7a?o Nacio-\nnal de Sau?de (FUNASA), Ministe?rio da Sau?de, Brasil. Bras??lia, pp.\n67\u201376.\n\nGamborgi, G.P., Metcalf, E.B., Barros, E.J.G., 2006. Acute renal failure\nprovoked by toxin from caterpillars of the species Lonomia obliqua.\nToxicon 47, 68\u201374.\n\nGarcia, C.M., Danni-Oliveira, I.M., 2007. Occurence of accidents caused by\nLonomia obliqua Walker, in state of Parana? between 1989 and 2001.\nRev. Soc. Bras. Med. Trop. 40, 242\u2013246.\n\nGon\u00e7alves, L.R., Sousa-e-Silva, M.C., Tomy, S.C., Sano-Martins, I.S., 2007.\nEfficacy of serum therapy on the treatment of rats experimentally\nenvenomed by bristle extract of the caterpillar Lonomia obliqua:\ncomparison with epsilon-aminocaproic acid therapy. Toxicon 50,\n349\u2013356.\n\nGutie?rrez, J.M., Lomonte, B., Leo?n, G., Rucavado, A., Chaves, F., Angulo, Y., 2007.\nTrends in snakebite envenomation therapy: scientific, technological and\npublic health considerations. Curr. Pharm. Des. 13, 2935\u20132950.\nHoffman, M., Monroe, D.M., 2001. A cell-based model of hemostasis.\nThromb. Haemost. 85, 958\u2013965.\n\nKelen, E.M.A., Picarelli, Z.P., Duarte, A.C., 1995. Hemorrhagic syndrome\ninduced by contact with caterpillars of the genus Lonomia (Sat-\nurniidae, Hemileucinae). J. Toxicol. Toxin Rev. 14, 283\u2013308.\n\nKerns, R.T., Kini, R.M., Stefansson, S., Evans, H.J., 1999. Targeting of\nvenom phospholipases: the strongly anticoagulant phospholipase\nA2 from Naja nigricollis venom binds to coagulation factor Xa to\ninhibit the prothrombinase complex. Arch. Biochem. Biophys. 369,\n107\u2013113.\n\nKini, R.M., 2003. Excitement ahead: structure, function and mecha-\nnism of snake venom phospholipase A2 enzymes. Toxicon 42,\n827\u2013840.\n\nKowacs, P.A., Cardoso, J., Entres, M., Novak, E.M., Werneck, L.C., 2006. Fatal\nintracerebral hemorrhage secondary to Lonomia obliqua caterpillar\nenvenoming, a case report. Arq. Neuropsiquiatr. 64, 1030\u20131032.\n\nMaiorano, V.A., Marcussi, S., Daher, M.A.F., Oliveira, C.F., Couto, L.B., Gomes, O.\nA., Franc, S.C., Soares, A.M., Pereira, P.S., 2005. Antiophidian properties of\nthe aqueous extract of Mikania glomerata. Toxicon 102, 364\u2013370.\n\nMalaque, C.M.S., Andrade, L., Madalosso, G., Tomy, S., Tavares, F.L.,\nSeguro, A.C., 2006. Short report: a case of hemolysis resulting from\ncontact with a Lonomia caterpillar in southern Brazil. Am. J. Trop.\nMed. Hyg. 74, 807\u2013809.\n\nMonroe, D.M., Hoffman, M., 2006. What does it take to make the perfect\nclot? Arterioscler. Thromb. Vasc. Biol. 26, 41\u201348.\n\nPinto, A.F.M., Dobrovolski, R., Veiga, A.B.G., Guimara?es, J.A., 2004. Lono-\nfibrase, a novel a-fibrinogenase from Lonomia obliqua caterpillars.\nThromb. Res. 113, 147\u2013154.\n\nPinto, A.F.M., Dragulev, B., Guimara?es, J.A., Fox, J.W., 2008. Novel\nperspectives in the pathogenesis of Lonomia obliqua caterpillar\nenvenomation based on assessment of host response by gene\nexpression analysis. Toxicon 51, 1119\u20131128.\n\nPinto, A.F.M., Silva, K.R.L.M., Guimaraes, J.A., 2006. Proteases from Lono-\nmia obliqua venomous secretions: comparison of procoagulant,\nfibrin(ogen)olytic and amidolytic activities. Toxicon 47, 113\u2013121.\n\nPrezoto, B.C., Maffei, F.H.A., Mattar, L., Chudzinski-Tavassi, A.M., Curi, P.R.,\n2002. Antithrombotic effect of Lonomia obliqua caterpillar bristle extract\non experimental venous thrombosis. Braz. J. Med. Biol. Res. 35, 703\u2013712.\n\nRamos, A.T., Gon\u00e7alves, L.R., Ribeiro, O.G., Rocha Campos, A.C.,\nSant\u2019Anna, O.A., 2004. Effects of Lonomia obliqua (lepidoptera, sat-\nurniidae) toxin on clotting, inflammatory and antibody responsive-\nness in genetically selected lines of mice. Toxicon 43, 761\u2013768.\n\nReis, C.V., Kelen, E.M.A., Farsky, S.H.P., Portaro, F.C.V., Sampaio, C.A.M.,\nFernandes, B.L., Camargo, A.C.M., Chudzinski-Tavassi, A.M., 1999. A\nCa2\u00fe activated serine protease (LOPAP) could be responsible for the\nhaemorrhagic syndrome caused by the caterpillar Lonomia obliqua.\nLancet 353, 1942.\n\nRicci-Silva, M.E., Valente, R.H., Leo?n, I.R., Tambourgi, D.V., Ramos, O.H.,\nPerales, J., Chudzinski-Tavassi, A.M., 2008. Immunochemical and\nproteomic technologies as tools for unravelling toxins involved in\nenvenoming by accidental contact with Lonomia obliqua caterpillars.\nToxicon 51, 1017\u20131028.\n\nRocha-Campos, A.C., Gon\u00e7alves, L.R., Higasshi, H.G., Yamagushi, I.K.,\nFernandes, I., Oliveira, J.E., Ribela, M.T., Sousa-e-Silva, M.C., Dias da\nSilva, W., 2001. Specific heterologous F(ab0)2 antibodies revert blood\nincoagulability resulting from envenoming by Lonomia oblique\ncaterpillars. Am. J. Trop. Med. Hyg. 64, 283\u2013289.\n\nSano-Martins, I.S., Santoro, M.L., Castro, S.C.B., Fan, H.W., Cardoso, J.L.C.,\nTheakston, R.D.G., 1997. Platelet aggregation in patients bitten by the\nBrazilian snake Bothrops jararaca. Thromb. Res. 87, 183\u2013195.\n\nSeibert, C.S., Oliveira, M.R.L., Gon\u00e7alves, L.R.C., Santoro, M.L., Sano-\nMartins, I.S., 2004. Intravascular hemolysis induced by Lonomia obli-\nqua caterpillar bristle extract: an experimental model of envenoma-\ntion in rats. Toxicon 44, 793\u2013799.\n\nSeibert, C.S., Tanaka-Azevedo, A.M., Santoro, M.L., Mackessy, S.P.,\nTorquato, R.J.S., Lebrun, I., Tanaka, A.S., Sano-Martins, I.S., 2006.\nPurification of a phospholipase A2 from Lonomia obliqua caterpillar\nbristle extract. Biochem. Biophys. Res. Commun 342., 1027\u20131033.\n\nSecretaria de Vigila?ncia em Sau?de, Ministe?rio da Sau?de SVS, 2009. Sit-\nua\u00e7a?o Epidemiolo?gica das Zoonoses de Interesse a? Sau?de Pu?blica.\nBoletim Eletro?nico Epidemiolo?gico 9 (1), 17. Bras??lia.\n\nThorsen, L.I., Brosstad, F., Gogstad, G., Sletten, K., Solum, N.O., 1986. Compe-\ntitions between fibrinogen with its degradation products for interactions\nwith the platelet-fibrinogen receptor. Thromb. Res. 44, 611\u2013623.\n\nTsai, H.M., 2006. The molecular biology of thrombotic microangiopathy.\nKidney Int. 70 (1), 16\u201323.\n\nVaughan, D.E., Declerck, P.J., 1998. Fibrinolysis and its regulation. In:\nLoscalso, J., Schafer, A.I. (Eds.), Thrombosis and Hemorrhage. Williams\n&amp; Wilkins, Baltimore, pp. 155\u2013170.\n60\n\n\n\nA.F.M. Pinto et al. / Toxicon 56 (2010) 1103\u201311121112\nVeiga, A.B.G., Blochtein, B., Guimara?es, J.A., 2001. Structures involved\nproduction, secretion and injection of the venom produced by the cater-\npillar Lonomia obliqua (Lepidoptera, saturniidae). Toxicon 39, 1343\u20131351.\n\nVeiga, A.B.G., Pinto, A.F.M., Guimara?es, J.A., 2003. Fibrinogenolytic and\nprocoagulant activities in the hemorrhagic syndrome caused by\nLonomia obliqua caterpillars. Thromb. Res. 111, 95\u2013101.\n\nVeiga, A.B.G., Ribeiro, J.M., Guimara?es, J.A., Francischetti, I.M., 2005. A\ncatalog for the transcripts from the venomous structures of the\ncaterpillar Lonomia obliqua: identification of the proteins potentially\ninvolved in the coagulation disorder and hemorrhagic syndrome.\nGene 355, 11\u201327.\n\nWang, H., Ehnert, C., Brenner, G.J., Woolf, C.J., 2006. Bradykinin and\nperipheral sensitization. Biol. Chem. 387, 11\u201314.\n\nZannin, M., Louren\u00e7o, D.M., Motta, G., Costa, L.R.D., Grando, M., Gamborgi, G.\nP., Noguti, M.A., Chudzinski-Tavassi, A.M., 2003. Blood coagulation and\nfibrinolytic factors in 105 patients with hemorrhagic syndrome caused\nby accidental contact with Lonomia obliqua caterpillar in Santa Cata-\nrina, Southern Brazil. Thromb. Haemost. 89, 355\u2013364.\n61\n\n\n\nResultados \n\n62 \n\n \n\n3.2 Cap\u00edtulo II   \n\n \n\nAcute Lonomia obliqua caterpillar envenomation-induced physiopathological \n\nalterations in rats: Evidence of new toxic venom activities and the efficacy of \n\nserum therapy to counteract systemic tissue damage \n\n \n\n Neste trabalho est\u00e3o descritas as altera\u00e7\u00f5es de toxicidade aguda sist\u00eamica do \n\nveneno de L. obliqua em ratos. Os principais resultados obtidos foram:  \n\n \n\n? Al\u00e9m dos dist\u00farbios hemorr\u00e1gicos cl\u00e1ssicos j\u00e1 descritos, o veneno tamb\u00e9m \u00e9 \n\ncapaz de induzir les\u00e3o em m\u00faltiplos \u00f3rg\u00e3os. Importantes altera\u00e7\u00f5es bioqu\u00edmicas, \n\nhematol\u00f3gicas e morfol\u00f3gicas foram observadas e relacionadas principalmente \n\n\u00e0s les\u00f5es card\u00edaca, renal, pulmonar e espl\u00eanica;  \n\n? Tamb\u00e9m h\u00e1 les\u00e3o muscular esquel\u00e9tica e o veneno induz dano genot\u00f3xico em \n\ndiferentes \u00f3rg\u00e3os incluindo f\u00edgado, pulm\u00e3o, rim, cora\u00e7\u00e3o e c\u00e9lulas sangu\u00edneas \n\ncomo linf\u00f3citos. H\u00e1 indicativo de que o dano genot\u00f3xico \u00e9 mediado por esp\u00e9cies \n\nreativas de oxig\u00eanio; \n\n? A administra\u00e7\u00e3o do soro antilon\u00f4mico na fase inicial do envenenamento \n\n(primeiras 2 h) \u00e9 de fundamental import\u00e2ncia para a neutraliza\u00e7\u00e3o dos efeitos \n\nt\u00f3xicos sist\u00eamicos do veneno. Se administrado ap\u00f3s 6 h de envenenamento, o \n\nsoro \u00e9 ineficaz em neutralizar os danos renal e card\u00edaco e o efeito hemol\u00edtico, \n\napesar de reverter a coagulopatia de consumo;  \n\n? Os efeitos cardiot\u00f3xicos e genot\u00f3xicos do veneno foram descritos pela primeira \n\nvez neste trabalho.  \n\n \n\n O manuscrito a seguir foi submetido para publica\u00e7\u00e3o no peri\u00f3dico Toxicon em \n\nabril de 2013, revisado em julho de 2013 e aceito para publica\u00e7\u00e3o em agosto de 2013. \n\nAtualmente o artigo est\u00e1 dispon\u00edvel on-line (in press) em: \n\nhttp://www.sciencedirect.com/science/journal/aip/00410101.  \n\nDOI: 10.1016/j.toxicon.2013.08.061.  \n\n \n\n \n\n \n\n \n\nhttp://www.sciencedirect.com/science/journal/aip/00410101\n\n\nResultados \n\n63 \n\n \n\nDecision Letter \n\n \n\n \n \nFrom: Toxicon&lt;toxcon@elsevier.com> \nTo: guimar@cbiot.ufrgs.br \nCc:  \nDate: 13 Aug 2013 14:14:46 +0100 \nSubject: Your Submission - TOXCON-D-13-00182R1 \nMs. Ref. No.:  TOXCON-D-13-00182R1 \nTitle: Acute Lonomia obliqua caterpillar envenomation-induced physiopathological alterations in rats: Evidence of \nnew toxic venom activities and the efficacy of serum therapy to counteract systemic tissue damage \nToxicon \n \nDear Prof. Jorge Almeida Guimar\u00e3es, \n \nI am pleased to confirm that your paper \"Acute Lonomia obliqua caterpillar envenomation-induced \nphysiopathological alterations in rats: Evidence of new toxic venom activities and the efficacy of serum therapy to \ncounteract systemic tissue damage\" has been accepted for publication in Toxicon. \n \nWhen your paper is published on ScienceDirect, you want to make sure it gets the attention it deserves. To help you \nget your message across, Elsevier has developed a new, free service called AudioSlides: brief, webcast-style \npresentations that are shown (publicly available) next to your published article. This format gives you the \nopportunity to explain your research in your own words and attract interest. You will receive an invitation email to \ncreate an AudioSlides presentation shortly. For more information and examples, please \nvisit http://www.elsevier.com/audioslides. \n \nThank you for submitting your work to this journal. \n \nWith kind regards, \n \nAlan Harvey \nEditor in Chief \nToxicon \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nmailto:toxcon@elsevier.com\nmailto:guimar@cbiot.ufrgs.br\nhttp://www.elsevier.com/audioslides\n\n\nAuthor's personal copy\n\nAcute Lonomia obliqua caterpillar envenomation-induced\nphysiopathological alterations in rats: Evidence of new toxic\nvenom activities and the efficacy of serum therapy to\ncounteract systemic tissue damage\n\nMarkus Berger a, Walter Orlando Beys-da-Silva b, Luc\u00e9lia Santi b,\nIuri Marques de Oliveira c, Patr\u00edcia Mendes Jorge c,\nJo\u00e3o Ant\u00f4nio P\u00eagas Henriques c, David Driemeier d,\nMaria Aparecida Ribeiro Vieira e, Jorge Almeida Guimar\u00e3es a,*\na Laborat\u00f3rio de Bioqu\u00edmica Farmacol\u00f3gica, Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Bento\nGon\u00e7alves, 9500, Cep 91501-970, Porto Alegre, RS, Brazil\nb Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, United States\nc Departamento de Biof\u00edsica, Instituto de Bioci\u00eancias, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil\nd Departamento de Patologia Cl\u00ednica Veterin\u00e1ria, Faculdade de Medicina Veterin\u00e1ria, Universidade Federal do Rio Grande do Sul (UFRGS),\nPorto Alegre, RS, Brazil\ne Laborat\u00f3rio de Fisiologia Renal, Departamento de Fisiologia e Biof\u00edsica, Instituto de Ci\u00eancias Biol\u00f3gicas, Universidade Federal de Minas\nGerais (UFMG), Belo Horizonte, MG, Brazil\n\na r t i c l e i n f o\n\nArticle history:\nReceived 4 May 2013\nReceived in revised form 30 July 2013\nAccepted 13 August 2013\nAvailable online 29 August 2013\n\nKeywords:\nLonomia\nCaterpillar\nVenom\nHemorrhagic syndrome\nGenotoxicity\nNephrotoxicity\n\na b s t r a c t\n\nThe clinical manifestations of Lonomia obliqua caterpillar envenomation are systemic\nhemorrhage and acute kidney injury. In an effort to better understand the physiopatho-\nlogical mechanisms of envenomation, a rat model was established to study systemic tissue\ndamage during L. obliqua envenomation. An array of acute venom effects was characterized,\nincluding biochemical, hematological, histopathological, myotoxic and genotoxic alter-\nations. Rapid increases in serum alanine and aspartate transaminases, g-glutamyl trans-\nferase, lactate dehydrogenase, hemoglobin, bilirubin, creatinine, urea and uric acid were\nobserved, indicating that intravascular hemolysis and liver and kidney damage had occurred.\nTreatment with a specific antivenom (antilonomic serum) for up to 2 h post-venom injection\nneutralized the biochemical alterations. However, treatment after 6 h post-venom injection\nfailed to normalize all biochemical parameters, despite its efficacy in reversing coagulation\ndysfunction. The hematological findings were consistent with hemolytic anemia and\nneutrophilic leukocytosis. The histopathological alterations were mainly related to hemor-\nrhage and inflammation in the subcutaneous tissue, lung, heart and kidneys. Signs of\ncongestion and hemosiderosis were evident in the spleen, and hemoglobin and/or\nmyoglobin casts were also detected in the renal tubules. Increased levels of creatine kinase\nand creatine kinase-MB were correlated with the myocardial necrosis observed in vivo and\nconfirmed the myotoxicity detected in vitro in isolated extensor digitorum longus muscles.\nSignificant DNA damage was observed in the kidneys, heart, lung, liver and lymphocytes. The\nmajority of the DNA lesions in the kidney were due to oxidative damage. The results pre-\nsented here will aid in understanding the pathology underlying Lonomia\u2019s envenomation.\n\n? 2013 Elsevier Ltd. All rights reserved.\n\n* Corresponding author. Tel.: \u00fe55 51 33086068; fax: \u00fe55 51 33087309.\nE-mail address: guimar@cbiot.ufrgs.br (J.A. Guimar\u00e3es).\n\nContents lists available at ScienceDirect\n\nToxicon\n\nj o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / t o x i c o n\n\n0041-0101/$ \u2013 see front matter ? 2013 Elsevier Ltd. All rights reserved.\nhttp://dx.doi.org/10.1016/j.toxicon.2013.08.061\n\nToxicon 74 (2013) 179\u2013192\n\n64\n\n\n\nAuthor's personal copy\n\n1. Introduction\n\nContact dermatitis and urticarial cutaneous reactions\nare well known signs of accidental contact with the hairs\nand spines of many lepidopterous larvae (Hossler, 2010).\nThe consequences of these reactions are usually limited to\nlocal skin inflammation without any systemic tissue dam-\nage. However, contact with Lonomia spp. has been associ-\nated with potentially fatal systemic disorders, such as\nhemorrhage and acute kidney injury (AKI) (Arocha-\nPi\u00f1ango et al., 2000; Pinto et al., 2010). One of these spe-\ncies is the moth Lonomia obliqua (Lepidoptera, Saturniidae),\nwhich is highly venomous in the larval stages. Larval forms\noccur during spring and summer in the southern regions of\nBrazil (mainly in the states of Rio Grande do Sul, Santa\nCatarina and Paran\u00e1) where envenomation by this animal is\nan important public health problem due to its high inci-\ndence (Veiga et al., 2009; Pinto et al., 2010; Guimar\u00e3es,\n2011). In fact, this caterpillar is responsible for severe and\nsometimes fatal accidents caused by skin contact with the\nbristles that cover the animal\u2019s body. Unlike snakes, spiders\nand scorpions, there is no specialized venomous gland in L.\nobliqua. The venom is produced by secretory epithelial cells\nof the tegument and stored in a hollow internal channel in\neach bristle. Because the bristles have weak articulations at\ntheir tips, only a slight contact with the skin is enough to\nbreak off these chitinous structures, injecting the venom\ninto the subcutaneous tissue of victims (Veiga et al., 2001).\nFurthermore, accidents frequently involve colonies of\ndozens or hundreds of caterpillars that are camouflaged at\ntree trunks, which makes accidental contact more\ndangerous due to the venom quantities absorbed by the\nvictim.\n\nClinical symptoms include local pain (burning sensa-\ntion) and an inflammatory reaction, which starts immedi-\nately after contact, followed by systemic reactions,\nincluding headache, fever, vomiting and hypotension. Signs\nof bleeding diathesis, characterized by hematomas, ecchy-\nmosis, gross hematuria, hematemesis and melena are\nfrequently observed between 6 and 72 h after contact. If the\nvictim is not promptly treated, the clinical profile can\nevolve to intracerebral hemorrhage, AKI and death (Zannin\net al., 2003; Kowacs et al., 2006; Garcia and Danni-Oliveira,\n2007). Actually, the unique specific treatment available for\nL. obliqua envenomation is the early intravenous adminis-\ntration of anti-lonomic serum (ALS), an animal-derived\nantivenom. ALS is a concentrated pool of immunoglobu-\nlins (usually pepsin-refined F(ab0)2 fragments of whole IgG)\nthat is purified from the plasma of a horse that has been\nimmunized with the venom (obtained from bristle ho-\nmogenates) (Rocha-Campos et al., 2001). In Brazil, ALS is\nproduced by the Butantan Institute (S\u00e3o Paulo) and has\nbeen successfully used to re-establish physiological coag-\nulation parameters in envenomed patients and experi-\nmental models (Caovilla and Barros, 2004). Despite its\nclinical efficacy, the prompt availability of ALS and a correct\nmedical diagnosis in the regions of high incidence of acci-\ndents still remain public health concerns, namely, in rural\nareas of Southern Brazil. Another important problem is the\nfact that administration of ALS does not decrease the inci-\ndence of AKI, which is likely also related to the lack of\n\nknowledge about the mechanisms involved in kidney\ndamage and its management (Gamborgi et al., 2006).\n\nRecently, molecular biology and proteomic studies have\ncontributed to the increasing number of toxins that have\nbeen identified in L. obliqua venomous secretions,\nproviding valuable information regarding how this toxin\ncocktail acts on biological tissues (Veiga et al., 2005; Ricci-\nSilva et al., 2008). Toxins related to envenomation symp-\ntomatology, especially those that cause hemostatic distur-\nbances, such as serine proteases, phospholipases A2, lectins\nand protease inhibitors, were identified. These toxins are\nable to directly modulate the victim\u2019s hemostatic system by\nproteolytic activation of the coagulation and fibrinolytic\ncascades, generating high concentrations of intravascular\nthrombin, plasmin, urokinase and kallikrein (Reis et al.,\n2006; Pinto et al., 2008; Berger et al., 2010a). As a conse-\nquence, consumption coagulopathy with decreased levels\nof fibrinogen, factors V and XIII, pre-kallikrein, plasmin-\nogen, protein C and a2-antiplasmin occurs (Zannin et al.,\n2003). Platelet aggregation function is also markedly\nimpaired during envenomation, which contributes signifi-\ncantly to the bleeding disorders (Berger et al., 2010a,b).\nMoreover, the venom also triggers an acute inflammatory\nresponse and disturbances in the vascular system, inducing\nincreases in blood\u2013brain barrier permeability, hypotension\nand the nociceptive and edematogenic responses (Da Silva\net al., 2004a; De Castro Bastos et al., 2004; Bohrer et al.,\n2007; Nascimento-Silva et al., 2012).\n\nDespite understanding the mechanisms involved in the\nhemorrhagic syndrome, little is known about the systemic\nphysiopathological effects induced by L. obliqua venom.\nAlthough venom components have been detected in several\norgans (including the kidneys, lungs, liver, spleen, heart and\nskeletal muscle) of rats following a single subcutaneous\ninjection of the venom, the systemic tissue damage in these\norgans remains poorly characterized (Rocha-Campos et al.,\n2001; Da Silva et al., 2004b). For example, the current level\nof knowledge regarding the kidney damage is based only on\na few clinical case reports in which hematuria and high\nlevels of serum creatinine are described as the main features\nof L. obliqua-induced AKI (Burdmann et al., 1996). The\nvenom-induced pathology in other organs remains\ncompletely unknown. In human patients, the impossibility\nof conducting early tissue biopsies, due to the coagulation\ndisturbances inherent to the envenomation, has made it\ndifficult to analyze the acute anatomopathological alter-\nations. For these reasons, we believe that animal models of\nenvenomation may be useful not only to characterize the\nunderlying physiopathology but also to identify previously\nunknown toxic activities of the venom. Therefore, the aim of\nthe present work was to develop a rat model to study sys-\ntemic tissue damage during L. obliqua envenomation. An\narray of acute effects of the venom was characterized,\nincluding biochemical, hematological, histopathological,\nmyotoxic and genotoxic alterations.\n\nIn summary, our data indicate that in addition to hemo-\nstatic abnormalities, there are also signs of multi-organ\ndamage, mainly in the lungs, heart, kidneys and spleen.\nTreatment with ALS is only effective at counteracting the\nsystemic physiopathological effects if it is administered dur-\ning the initial phase of envenomation. In addition, this study\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192180\n\n65\n\n\n\nAuthor's personal copy\n\nprovides the first experimental evidence of the cardiotoxic,\nmyotoxic and genotoxic activities of L. obliqua venom.\n\n2. Materials and methods\n\n2.1. Venom extraction and antivenom\n\nL. obliqua caterpillars were kindly provided by the\nCentro de Informa\u00e7\u00f5es Toxicol\u00f3gicas (CIT), Porto Alegre, Rio\nGrande do Sul, Brazil. The specimens used in this study\nwere collected in the cities of Bom Princ\u00edpio (Rio Grande do\nSul, Brazil) and Videira (Santa Catarina, Brazil). L. obliqua\nvenom was obtained by cutting the bristles at the cater-\npillar\u2019s tegument insertion, and the excised material was\nkept at 4 ?C prior to the preparation of the extract, which\noccurred immediately after dissection. The bristles were\nmacerated in cold phosphate-buffered saline (PBS),\npH \u00bc 7.4, and centrifuged at 9600 ? g for 20 min. The su-\npernatant, designated Lonomia obliqua Bristle Extract\n(LOBE), was used as the venomous secretion in all experi-\nments. The protein content of the LOBE samples was\ndetermined using a BCA assay kit (Pierce, Rockford, Illinois,\nUSA) and the aliquots were stored at ?80 ?C prior to use.\nThe total number of caterpillars used for bristle extract\npreparation was 187 specimens and the protein concen-\ntration of the LOBE samples was 3.83 mg/mL. The total\namount of venom extracted per caterpillar was 1.2 mg. All\nof the LOBE samples had similar in vitro pro-coagulant ac-\ntivities and the protein compositions were also similar, as\nmonitored by electrophoresis and gel filtration chroma-\ntography (Pinto et al., 2006; Berger et al., 2010a,b).\n\nL. obliqua antivenom (antilonomic serum \u2013 ALS) was\nprovided by the Butantan Institute (S\u00e3o Paulo, Brazil). Each\nampoule of ALS (10 mL/vial) is able to neutralize 3.5 mg of\nthe LOBE. The ALS used here is the same one distributed to\nhospitals to treat envenomed patients.\n\n2.2. Animals and ethical statements\n\nAdult male Wistar rats, weighing 250\u2013300 g, were\nsupplied by the Central Animal Facility (CREAL), Institute of\nBasic Health Sciences, Federal University of Rio Grande do\nSul, Brazil. They were housed in plastic cages (5 animals per\ncage) within a temperature controlled room (22\u201323 ?C, on a\n12 h light/dark cycle, with the lights on at 7:00 am) and had\nfree access to water and food. All procedures involving\nanimals were carried out in accordance with the Guiding\nPrinciples for the Use of Animals in Toxicology (Interna-\ntional Society of Toxicology, http://www.toxicology.org)\nand the Brazilian College of Animal Experimentation\n(COBEA). The experimental protocol was approved by the\nethical committee on research animal care of the Federal\nUniversity of Rio Grande do Sul, Brazil (register number\n2008177/2009).\n\n2.3. Experimental design\n\n2.3.1. Venom treatment\nTo follow the time course of physiopathological alter-\n\nations, we developed an experimental model of enven-\nomation in rats. The animals were divided into two groups:\n\n(i) Control group (CTRL) \u2013 Animals (n\u00bc6 per sampling time)\nwere injected subcutaneously (s.c.) with 100 mL of sterile\nPBS solution. (ii) Experimental group (LOBE) \u2013 Animals\n(n \u00bc 8 per sampling time) were injected s.c. with a solution\ncontaining 1.0 mg of the LOBE per kg of body weight in a\nfinal volume of 100 mL. At several time points post-venom\ninjection (2, 6, 12, 24, 48 and 96 h), blood and various or-\ngans were collected for biochemical, hematological and\nhistopathological analysis. This venom dose was selected\nbased on the results of our previous experiments using rats\nas an animal model (Berger et al., 2010a) and was also\nbased on other studies that have used similar doses to\nreproduce the consumption coagulopathy observed in\nhumans (Dias da Silva et al., 1996; Rocha-Campos et al.,\n2001).\n\n2.3.2. Antivenom treatment\nThe neutralizing ability of the antivenom was tested\n\nusing the experimental model of envenomation. Rats that\nhad previously been injected with the LOBE (1.0 mg/kg, s.c.)\nwere treated 2 or 6 h after venom injection. At these time\nintervals, the animals (n \u00bc 8/group) were intravenously\n(i.v.) administered through the caudal vein with a sterile\nPBS solution (1 mL/100 g of body weight) or ALS (1 mL/\n100 g of body weight). Additional control groups (n \u00bc 6/\ngroup) were injected only with PBS or ALS under the same\nconditions. At 24 h after the treatments, blood was\ncollected to measure biochemical and hematological\nmarkers of tissue damage. The dose of ALS used here is\nsufficient to completely neutralize the in vitro pro-\ncoagulant activity of the LOBE. Moreover, the same dose\nwas used in a previous study to compare the efficacy be-\ntween ALS and antifibrinolytic drugs (Gon\u00e7alves et al.,\n2007).\n\n2.4. Blood samples\n\nAfter treatment, animals from the different groups were\nanesthetized intraperitoneally (i.p.) with a mixture of ke-\ntamine (75 mg/kg) (Syntec, S\u00e3o Paulo, Brazil) and xylazine\n(10 mg/kg) (Syntec, S\u00e3o Paulo, Brazil), and blood was\ncollected by cardiac puncture. For the coagulation and he-\nmatological assays, the blood samples were collected in\n1:10 (v/v) 3.8% trisodium citrate (Merck, Darmstadt, Ger-\nmany) or 1:16 (v/v) 10% Na2-EDTA (Merck, Darmstadt,\nGermany), respectively, while for the biochemical assays,\nno anticoagulants were used. All samples had 2% (v/v) ALS\nadded to block the activity of the toxin after blood collec-\ntion. Plasma and serum were obtained by centrifugation at\n1500 ? g for 10 min and stored at ?80 ?C prior to use.\n\n2.5. Biochemical parameters\n\nSerum samples were used to measure several\nbiochemical markers of tissue injury. Blood urea nitrogen\n(BUN), creatinine (Cr), uric acid (UA), creatine kinase (CK),\ncreatine kinase \u2013 MB fraction (CK-MB), aspartate amino-\ntransferase (AST), alanine aminotransferase (ALT), g-glu-\ntamyl transferase (g-GT), lactate dehydrogenase (LDH),\nplasma free hemoglobin (Hb) and bilirubin (BIL) levels\nwere determined using commercially available kits\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192 181\n\n66\n\n\n\nAuthor's personal copy\n\n(BioClin/Quibasa, Belo Horizonte, Brazil), following the\nmanufacturer\u2019s recommended instructions. The absor-\nbance was read using a SP-220 spectrophotometer (Bio-\nSpectro, Paran\u00e1, Brazil), or the protocol was adapted for use\nin 96-well plates and the reads were performed using a\nSpectraMAX microplate reader (Molecular Devices Co.,\nSunnyvale, USA). Free hemoglobin (Hb) was measured in\nthe plasma samples that had been collected with Na2-\nEDTA. In these cases, plasma Hb levels were determined\ndirectly by spectrophotometry using a standard curve\nmade with known concentrations of purified Hb (Sigma\u2013\nAldrich, Saint Louis, MO, USA). Samples with levels of free\nHb higher than 180 mg/dL due to LOBE-induced intravas-\ncular hemolysis were diluted to avoid interference during\nthe determination of other parameters.\n\n2.6. Hematological parameters\n\nComplete blood cell counts were carried out on plasma\nsamples containing the anticoagulant Na2-EDTA. Hemo-\nglobin concentration (Hb), hematocrit (Hct), red blood cell\ncounts (RBC), white blood cell counts (WBC) and the\nhematimetric indices (mean corpuscular volume [MCV],\nmean corpuscular hemoglobin [MCH] and mean corpus-\ncular hemoglobin concentration [MCHC]) were determined\nusing an automated cell counter (ABX Micros ESV 60,\nHoriba, S\u00e3o Paulo, Brazil). Platelet counts (PLT) were per-\nformed using a hemocytometer (Neubauer chamber) with\n10% ammonium oxalate (Merck, Darmstadt, Germany) as\ndiluent. Blood smears stained with May-Gr\u00fcnwald Giemsa\n(BioClin/Quibasa, Belo Horizonte, Brazil) were prepared for\ndirect examination of red blood cell morphology, platelet\nmorphology and leukocyte differential counts under light\nmicroscopy. Reticulocyte counts (Retic) were also deter-\nmined in blood smears with Brilliant Cresyl Blue (Laborclin,\nParan\u00e1, Brazil) staining immediately after blood collection.\nRetic values were expressed as the % of total RBC counts.\nBlood coagulation parameters (activated partial thrombo-\nplastin time [aPTT] and fibrinogen concentration [FBG])\nwere measured in plasma that had been collected with\ntrisodium citrate by following a previously described pro-\ntocol (Berger et al., 2010a).\n\n2.7. Histopathological analyses\n\nAll animals from the control and envenomed groups (at\neach sampling time) were necropsied and gross macro-\nscopic alterations were examined. The kidneys, spleen,\nliver, heart, lungs, brain, cerebellum and skin (at the site of\nvenom injection) were then carefully removed and fixed in\na 10% neutral buffered formaldehyde solution. The tissues\nwere dehydrated in gradual alcohol from 50% to 100%,\ncleared in xylene and embedded in paraffin. Subsequently,\nthe samples were sectioned and stained with hematoxylin\nand eosin (H&amp;E) for further analysis by light microscopy.\n\n2.8. In vitro myotoxic activity\n\nThe in vitro myotoxic activity assays were performed as\npreviously described (Melo and Suarez-Kurtz, 1988; Fuly\net al., 2003). Briefly, rats were anesthetized (as described\n\nabove) and the extensor digitorum longus (EDL) muscles\nwere carefully dissected, weighed and transferred to a bath\nchamber with a 2.5 mL capacity. The muscles were super-\nfused continuously with a physiological solution (135 mM\nNaCl; 5 mM KCl, 2 mM CaCl2; 1 mM MgCl2; 1 mM NaHPO4;\n15 mM NaHCO3 and 11 mM dextrose, pH \u00bc 7.35) that was\nequilibrated with 95% O2/5% CO2. During superfusion,\ndifferent concentrations of the LOBE (40 and 80 mg/mL), or\nthe LOBE (40 mg/mL) that had been previously incubated\nwith ALS (800 mL), were added to the bath. Bothrops jar-\naraca snake venom (Butantan Institute, S\u00e3o Paulo, Brazil),\nand Triton X-100 (Sigma\u2013Aldrich, Saint Louis, MO, USA)\nwere used as positive controls for muscle damage under\nthe same conditions. Preincubation of the venom with\nantivenom was performed at room temperature 30 min\nprior to addition to the perfusion bath. Samples of the\nperfusate (0.4 mL) were collected at 30 min intervals over a\ntotal period of 120 min and replaced with fresh solution.\nThe collected samples were stored at 4 ?C and their creatine\nkinase (CK) activity was determined according to the pro-\ncedure described above (Subsection 2.5). EDL preparations\nwere mounted in the bath chambers for a period of 60 min\nprior to the experiment for measurements of basal CK\nrelease rates, which were defined as the amount of enzyme\nreleased from the muscles into the perfusion bath prior to\nthe addition of venom. The increase in CK released from\nEDL muscles after addition of LOBE was considered to be\nindicative of direct myotoxic activity. CK activity was\nexpressed as enzyme units released into the medium per\ngram of muscle (U/g). One enzyme unit was defined as the\namount that catalyzes the transformation of 1 mmol of\nsubstrate per min at 25 ?C.\n\n2.9. Determination of DNA damage and oxidized bases\n\n2.9.1. Sample preparation\nThe genotoxic activity was detected in vivo using the\n\nmodel of envenomation described in Subsection 2.3.1. The\nblood, liver, lungs, heart and kidneys were collected at 6, 12\nand 48 h after LOBE injection (1 mg/kg, s.c.). The organs\nwere gently homogenized in a cold PBS solution (2 mL) to\nobtain a cell suspension. Total blood was used for the\ndetection of DNA damage in lymphocytes. Genotoxicity was\nthen evaluated using the comet assay.\n\n2.9.2. Comet assay\nThe alkaline comet assay was performed as described by\n\nSingh et al. (1988), with minor modifications (Azqueta\net al., 2009; Tice et al., 2000). Briefly, 20 mL of homoge-\nnized organs and blood were mixed with 0.75% low-\nmelting point agarose and immediately spread onto a\nglass microscope slide that had been pre-coated with a\nlayer of 1% normal-melting point agarose. The slides were\nthen incubated in an ice-cold lysis solution (2.5 M NaCl,\n10 mM Tris, 100 mM EDTA, 1% Triton X-100 and 10% DMSO,\npH \u00bc 10.0; Gibco BRL, Grand Island, NY) at 4 ?C for at least\n1 h to remove the cellular proteins and membranes, leaving\nthe DNA as \u201cnucleoids\u201d. In the modified version of comet\nassay, the slides were removed from the lysis solution and\nwashed three times in enzyme buffer (40 mM HEPES,\n100 mM KCl, 0.5 mM Na2-EDTA, and 0.2 mg/mL BSA,\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192182\n\n67\n\n\n\nAuthor's personal copy\n\npH \u00bc 8.0), were drained and were incubated at 37 ?C in this\nbuffer with one of the following: 70 mL of Fpg (New England\nBiolabs, Beverly, MA, USA) at 100 mU per gel for 45 min (for\nthe detection of oxidized purines) or 70 mL of Endo III (New\nEngland Biolabs, Beverly, MA, USA) at 100 mU per gel for\n30 min (for the detection of oxidized pyrimidines). After\nlysis, the slides were placed in a horizontal electrophoresis\nunit that had been filled with fresh buffer (300 mM NaOH\nand 1 mM EDTA, pH > 13.0), which was left to cover the\nslides for 20 min at 4 ?C to allow the DNA to unwind and\nreveal the expression of alkali-labile sites. Electrophoresis\nwas conducted for 20 min at 25 V (78 V/cm) and 300 mA.\nAll of the steps outlined above were performed under\nyellow light or in the dark to prevent additional DNA\ndamage. The slides were then neutralized (0.4 M Tris,\npH \u00bc 7.5), washed in double-distilled water and stained\nusing a silver staining protocol, as described by Nadin et al.\n(2001). After the staining step, the gels were left to dry at\nroom temperature overnight and were analyzed using an\noptical microscope. To ensure adequate electrophoresis\nconditions and efficiency, negative and positive internal\ncontrols (human blood with and without 40 mM methyl\nmethanesulfonate [MMS, Sigma\u2013Aldrich, Saint Louis, MO,\nUSA] treatment) were included in each experiment. Test\nslides were scored only when the internal controls showed\nclearly positive or negative results (Greggio et al., 2009).\nOne hundred cells (50 cells from each of two replicate\nslides of each organ) were selected and analyzed for DNA\nmigration. When selecting the cells, cells around the edges\nor air bubbles were excluded (Azqueta et al., 2009). The\ncells were scored visually into five classes according to tail\nlength: class 0: undamaged, without a tail; class 1: with a\ntail shorter than the diameter of the head (nucleus); class 2:\nwith a tail length 1\u20132 times the diameter of the head; class\n3: with a tail longer than 2 times the diameter of the head;\nand class 4: comets with no heads. International guidelines\nand recommendations for the comet assay consider visual\nscoring of the comets to be a well-validated evaluation\nmethod (Burlinson et al., 2007). The genotoxic effects were\nestimated based on two different parameters: damage\nindex (DI) and damage frequency (DF). The damage index\nranged from 0 (completely undamaged: 100 cells ? 0) to\n400 (with maximum damage: 100 cells ? 4). The damage\nfrequency (%) was calculated based on the number of cells\nwith tails compared to the number of cells with no tails.\nLevels of Endo III and Fpg-sensitive sites were calculated\nfrom the DI score obtained with enzyme treatment minus\nthe score without enzyme treatment (buffered). The\nvehicle was used as a negative control, and treatment with\n4 ? 10?5 M MMS for 1 h was used as a positive control.\n\n2.10. Statistical analyses\n\nStatistical analyses were performed using GraphPad\nPrism 5.0 (GraphPad Software Inc., San Diego, CA, USA). The\nresults were expressed as the means ? standard error (SE).\nAll biochemical and coagulation parameters were measured\nin triplicate. The significant differences between the mean\nvalues of two experimental groups were determined using\nthe Student\u2019s t test. When more than two groups were\ncompared, an analysis of variance was used, followed by\n\nBonferroni\u2019s post-hoc test to compare pairs of means. P\nvalues less than 0.05 were chosen to establish significance.\n\n3. Results\n\n3.1. Clinical features and post mortem findings\n\nBetween 2 and 6 h after LOBE administration (1 mg/kg,\ns.c.), the rats presented signs of acute toxicity, including\nprogressive malaise, lethargy, dyspnea, tachycardia, pros-\ntration and high sensitivity at the venom injection site.\nDespite general weakness, the animals showed no clear\nsigns of neuromuscular toxicity, such as muscle trembling,\nparalysis or convulsions. Most of the envenomed animals\ndisplayed hematuria (dark-brown urine at 6\u201312 h), but no\nsigns of macroscopic skin hemorrhage, petechiae, ecchy-\nmosis, suffusions or nasal and eye bleeding were observed.\nAfter 48 h, all of the rats had gradually recovered from the\nclinical symptoms and returned to normal. Until the end of\nthe experiments (96 h), no deaths were registered. The\nanimals in the control group (injected s.c. with PBS solu-\ntion) exhibited no ill effects.\n\nPost-mortem examinations showed evidence of sys-\ntemic effects of the venom. During the first 12 h period, the\nanimals displayed blood in the abdominal cavity, signs of\nlung hemorrhage (hemorrhagic spots), spleen and kidney\nenlargement and congestion (Fig. 1). The kidneys also\nseemed to have darkened slightly and had black spots on\ntheir surface (Fig. 1). The bladder was often edematous and\nenlarged. The brain and gastrointestinal system appeared\nto be macroscopically normal (not shown).\n\n3.2. Biochemical and hematological parameters\n\nTo evaluate the acute systemic physiopathological ef-\nfects of the venom, several biochemical and hematological\nmarkers of tissue lesions were measured (Table 1). Subcu-\ntaneous injection of L. obliqua venom caused a marked in-\ncrease in serum AST, peaking between 12 and 48 h.\nAlthough less markedly than AST, serum ALT also increased\nrapidly after the first 2 h, reaching a maximum at 12 h.\nSerum levels of g-GT increased over the first 6 h and\nremained elevated until 48 h. In comparison to the controls,\nhigh levels of plasma free hemoglobin, LDH and bilirubin\nwere detected at 6 and 12 h, indicating that intravascular\nhemolysis had occurred. Markers of renal damage, such as\ncreatinine, BUN and uric acid, also displayed important\nalterations. Serum creatinine increased mainly between 6\nand 96 h, reaching maximal values at 48 h, whereas BUN\nincreased 12, 24 and 48 h after venom injection, returning\nto normal levels thereafter. The animals had hyperuricemia\nthroughout the time of envenomation, with the levels of\nuric acid reaching 8 times the control values (p &lt;0.001)\n(Table 1).\n\nHematological parameters were evaluated at 6, 12 and\n48 h post-envenomation. The obtained results are sum-\nmarized in Table 2. LOBE injection caused a statistically\nsignificant decrease in red blood cell count and hemoglobin\nat 12 and 48 h, whereas the platelet count decreased\nslightly at 12 h and returned to normal after 48 h. Hemat-\nocrit values were lower when compared to the controls at\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192 183\n\n68\n\n\n\nAuthor's personal copy\n\nall of the time points evaluated. The reticulocyte number\n(immature red cells) increased in the blood stream as a\nresult of hemolysis and anemia. The hematimetric indices,\nMCV and MCH, also increased at 48 h, whereas MCHC and\ntotal protein remained unchanged. Envenomed rats dis-\nplayed leukocytosis between 6 and 12 h, mainly due to high\nneutrophil (6\u201348 h) and lymphocyte (6\u201312 h) counts.\nCompared to control values, a 15-fold increase was\nobserved only in neutrophil numbers at 6 h. A less\nexpressive increase in monocytes and eosinophil counts\nwas also observed at the same time. Under light micro-\nscopy, the blood smears revealed fragmented erythrocytes,\nspherocytes and significant anisocytosis. The leukocytes\nappeared to have normal morphology (data not shown).\n\n3.3. Histopathological alterations\n\nEvidence of tissue damage was observed mainly be-\ntween 6 and 48 h of envenomation. Skin microscopy, at the\nsite of LOBE injection, showed hemorrhagic lesions, muscle\nnecrosis and focal inflammatory infiltration that was\nassociated with edema of varying intensities (Fig. 2A and\nB). At 6 h, the kidneys displayed red-brown and hyaline\npigments, which formed intra-tubular cylinders and/or\naccumulated within the tubular epithelial cells (Fig. 2C and\ninsert in 2D). At 48 h, an inflammatory infiltrate was\nobserved in the medullar region of the kidneys (Fig. 2D).\nMarked diffuse congestion and erythrophagocytosis were\nobserved in the spleens at 6 h, whereas large aggregates of\nhemosiderin engulfed macrophages were noted at 48 h\n(Fig. 2E and F). The lungs displayed intense hemorrhaging,\nwhich was evidenced by the presence of abundant eryth-\nrocytes in the bronchiolar and alveolar spaces mainly at 6 h.\nLung sections also demonstrated mixed inflammatory\ninfiltrate of polymorphonuclear and mononuclear cells that\ndilated the alveolar septa (48 h), edema in the pulmonary\nparenchyma and perivascular edema (12 h) (Fig. 3). No\nmorphological changes were observed in the liver, brain\nand cerebellum at any of the time points evaluated. After\n96 h of envenomation, all organs displayed normal\nmorphology. The animals in the control group (those that\nhad been injected with PBS) exhibited no alterations at all.\n\n3.4. Myotoxicity\n\nThe myotoxicity of L. obliqua venom was evaluated both\nin vivo (Fig. 4) and in vitro (Fig. 5) by measuring the release\nof creatine-kinase (CK) and its cardiac isoform, creatine-\nkinase-MB (CK-MB), and was also evaluated by morpho-\nlogical examination. After subcutaneous injection of LOBE\n(1 mg/kg), the rats displayed high levels of serum CK, which\nwas the first evidence of skeletal muscle damage. At 12 h,\nserum CK activity had increased 20-fold, reaching levels 40\ntimes higher than control values at 48 h (Fig. 4A). There was\nalso a significant increase in serum CK-MB activity, which\nreached a maximum at 12 h (53.6?7.5 U/L) as compared to\nthe control group (5.8 ? 0.4 U/L), indicating that cardiac\n\nFig. 1. Macroscopic organ alterations after L. obliqua envenomation in rats.\nRepresentative images of: A. The lungs from a control animal (one that had\nbeen injected with PBS solution, s.c.), showing normal morphology. B. Lungs\nfrom an animal that had been injected with LOBE (1 mg/kg, s.c.) after 6 h of\nenvenomation, showing signs of petechial hemorrhage (arrowheads). C.\nAbdominal cavity of a control animal with normal appearance. D. Abdominal\ncavity of an animal 12 h post-envenomation, evidencing the occurrence of\nbleeding. Also note the kidneys, which appear to be slightly darkened and\nhave black spots on their surface.\n\nTable 1\nBiochemical markers of tissue injury during the time course of L. obliqua envenomation in rats.\n\nParameter Time after envenomation (h)\n\nCTRL 2 6 12 24 48 96\n\nAST (U/mL) 11.8 ? 0.2 32.3 ? 0.4 30.7 ? 2.6 119.1 ? 15.2a 113.5 ? 6.8a 139.5 ? 12.3a 17.9 ? 1.4\nALT (U/mL) 22.4 ? 0.6 51.9 ? 0.9a 43.9 ? 3.5a 69.8 ? 3.9a 67.3 ? 3.3a 49.2 ? 2.4a 29.9 ? 1.2\ng-GT (U/L) 9.2 ? 0.6 14.1 ? 0.9 23.4 ? 1.4b 30.6 ? 2.0a 36.6 ? 3.5a 38.9 ? 3.0a 15.8 ? 1.7\nHb (mg/dL) 57.7 ? 4.6 131.1 ? 4.4 399.9 ? 62.5a 300.7 ? 8.9b 135.5 ? 42.0 47.1 ? 15.4 44.1 ? 11.6\nLDH (U/L) 431.8 ? 40 2288 ? 167 7374 ? 882a 8578 ? 1484a 1484 ? 216 928.8 ? 55 735.2 ? 123\nBIL-T (mg/dL) 0.2 ? 0.08 0.6 ? 0.07 1.8 ? 0.2a 1.7 ? 0.2a 0.8 ? 0.05 0.2 ? 0.08 0.3 ? 0.07\nBIL-D (mg/dL) 0.07 ? 0.03 0.4 ? 0.06 0.9 ? 0.08a 1.0 ? 0.1a 0.5 ? 0.04 0.07 ? 0.03 0.06 ? 0.01\nBIL-I (mg/dL) 0.1 ? 0.05 0.2 ? 0.01 0.9 ? 0.09a 0.7 ? 0.09a 0.3 ? 0.03 0.1 ? 0.05 0.2 ? 0.01\nCr (mg/dL) 0.3?0.03 0.7 ? 0.1 1.4 ? 0.3c 2.5 ? 0.4a 2.3 ? 0.1a 3.5 ? 0.3a 1.3 ? 0.1c\nBUN (mg/dL) 43.3 ? 0.6 53.8 ? 1.6 74.5 ? 2.3 104.7 ? 6.3a 193.8 ? 9.6a 211.0 ? 9.5a 50.5 ? 0.9\nUA (mg/dL) 0.6 ? 0.04 1.6 ? 0.06c 1.8 ? 0.1b 3.0 ? 0.1a 3.6 ? 0.2a 4.8 ? 0.2a 3.8 ? 0.3a\n\nCTRL: control (animals injected with PBS); AST: aspartate aminotransferase; ALT: alanine aminotransferase; g-GT: g-glutamyl transferase; Hb: plasma\nhemoglobin; LDH: lactate dehydrogenase; BIL-T: total bilirubin; BIL-D: direct bilirubin; BIL-I: indirect bilirubin; Cr: creatinine; BUN: blood urea nitrogen;\nUA: uric acid. Data are presented as means ? SE of 6 animals (controls) and 8 animals (LOBE, 1 mg/kg, via s.c). Values of a(p &lt;0.0001), b(p &lt;0.001) and\nc(p &lt;0.05) were considered statistically different when compared to the basal levels of control rats (ANOVA followed by Bonferroni\u2019s post hoc test).\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192184\n\n69\n\n\n\nAuthor's personal copy\n\ndamage had occurred. These values remained elevated at\n24 h (45.6 ? 3.4 U/L) and 48 h (40.0 ? 0.9 U/L) (Fig. 4B).\nHeart histopathological analyses confirmed the cardiotox-\nicity of the venom. Necrosis of cardiomyocytes was asso-\nciated with inflammation and myocardial hemorrhage\nbetween 6 and 48 h (Fig. 4C\u2013E).\n\nTo investigate a possible direct myotoxic effect of the\nLOBE, an isolated muscle preparation was used. As shown\nin Fig. 5A, when two different concentrations of the LOBE\nwere added to the extensor digitorum longus (EDL) prepa-\nrations, dose- and time-dependent increases in CK release\nrates were observed in comparison to the controls (EDL\ntreated with PBS). This result indicated that the venom has\nspecific myotoxins that are able to act directly on muscle\ncells, which confirms the data obtained systemically in\nenvenomed rats. When compared with the snake venom\nfrom B. jararaca (a well characterized myotoxic venom), the\nLOBE presented a myotoxic activity that was approximately\n32.6% lower at the same dose (Fig. 5B). In addition, the\nprevious incubation of the LOBE with antilonomic serum\n(ALS) resulted in a reduction of 70.6% in CK release rate\nfrom the EDL. The highest level of released CK was\nobserved upon the addition of the cytotoxic compound\nTriton X-100 (0.01%), which was used as a non-specific,\nnon-biological positive control. Taking the muscle injury\ninduced by Triton X-100 to be 100%, the myotoxic damage\nof the B. jararaca and L. obliqua venoms reached 58.8% and\n39.6%, respectively, in our experimental conditions.\n\n3.5. Genotoxicity\n\nBecause the maintenanceof genomicstabilityis essential\nfor cellular function, we measured the genotoxic effects\ninduced by L. obliqua experimental envenomation in vivo\n(Fig. 6). In the first set of experiments, DNA damage in the\ndifferent organs and lymphocytes of rats 12 h after LOBE\ninjection (1 mg/kg, s.c.) was assessed using the alkaline\n\ncomet assay. For all samples, cell viability was evaluated\nusing the trypan blue exclusion method and was found to be\ngreater than 90% in every experiment. The internal controls\nfor the comet assay, using human blood cells, showed low\ndamage in the negative control (DI\u00bc0\u201310) and high damage\nin the positive control (DI \u00bc 180\u2013300), thus validating the\ntest conditions. As expected, exposure of the lymphocytes,\nheart, lungs, liver and kidney cells that had been isolated\nfrom normal animals to methyl methanesulfonate (MMS),\nwhich was used as positive control, resulted in a significant\nincrease in DNA damage (not shown). As shown in Fig. 6A,\nenvenomed rats displayed high levels of DNA damage in the\ncells of all organs evaluated, as well as in the lymphocytes.\nThe damage levels in the cells of the control animals (those\nthat had been injected with PBS) did not change signifi-\ncantly. The damage index in lymphocytes and kidneys\nreached levels that were 6.4 and 5.4 times higher than the\nlevels in their respective controls.\n\nIn another set of experiments, the kidneys were chosen\nto determine the temporal pattern of DNA damage at\ndistinct time points after LOBE injection. In such cases,\nkidneys were selected because they had the highest dam-\nage index among the organs examined and also due to the\nhigh incidence of renal injury observed in human patients\n(Gamborgi et al., 2006). At 6 h, kidney DNA damage had\nincreased, reaching a maximal level at 12 h. After 48 h, the\ndamage index decreased but was still significantly different\nfrom the controls (Fig. 6B). In order to verify the oxidative\nnature of the DNA damage detected in the kidney cells of\nLOBE-injected rats, we carried out a modified comet assay.\nWhile the alkaline test normally detects primarily repair-\nable DNA single- and double-strand breaks and alkali-labile\nsites, the modified version is more specific to oxidative\ndamage than the standard method. The modified version\nincludes an incubation step with lesion-specific endonu-\ncleases that recognize resultant abasic sites and convert\nthem into single-strand breaks. In the present study, we\n\nTable 2\nHematological parameters during the time course of L. obliqua envenomation in rats.\n\nParameters Time after envenomation (h)\n\nCTRL 6 12 48\n\nErythrocytes\nRBC (?1012/L) 8.6 ? 0.01 7.9 ? 0.1 7.2 ? 0.3b 4.4 ? 0.3a\nRetic (%) 1.7 ? 0.2 2.8 ? 0.1 9.4 ? 0.9a 14.7 ? 1.1a\nPLT (?103/mL) 465.7 ? 43.1 349.8 ? 16.1 316.3 ? 44.7c 506.6 ? 34.3\nHb (g/dL) 15.6 ? 0.07 14.5 ? 0.2 13.8 ? 0.1b 10 ? 0.6a\nHct (%) 48.5 ? 0.7 43 ? 0.7c 41 ? 0.4a 32 ? 1.7a\nMCV (fL) 57.7 ? 0.3 56.5 ? 0.03 57 ? 2.1 72.1 ? 1.1a\nMCH (pg) 18.2 ? 0.1 18.2 ? 0.01 19.3 ? 0.7 23.5 ? 0.2a\nMCHC (g/dL) 31.9 ? 0.3 32.9 ? 0.4 33.7 ? 0.1 31.2 ? 0.3\nTP (mg/dL) 67 ? 3.1 66.5 ? 1.5 71 ? 1.1 71 ? 1.2\nLeukocytes\nWBC (?109/L) 3.8 ? 0.08 16.5 ? 1.3a 14.1 ? 0.5a 5.6 ? 0.5\nLymph (?109/L) 2.5 ? 0.1 4.6 ? 0.3a 7.5 ? 0.3a 2.4 ? 0.1\nNeut (?109/L) 0.8 ? 0.1 11.9 ? 0.5a 5.3 ? 0.3a 2.8 ? 0.4b\nMono (?109/L) 0.2 ? 0.04 0.7 ? 0.07c 1.3 ? 0.1a 0.3 ? 0.04\nEosino (?109/L) 0.01 ? 0.001 0.2 ? 0.04c 0.1 ? 0.03 0.02 ? 0.001\nBaso (?109/L) 0.03 ? 0.009 0.02 ? 0.008 0.02 ? 0.007 0.02 ? 0.008\n\nCTRL: control (animals injected with PBS); RBC: red blood cells; Retic: reticulocytes; PLT: platelets; Hb: hemoglobin; Hct: hematocrit; MCV: mean corpuscular\nvolume; MCH: mean corpuscular haemoglobin; MCHC: mean corpuscular haemoglobin concentration; TP: total protein; WBC: white blood cells; Lymph:\nlymphocytes; Neut: neutrophils; Mono: monocytes; Eosino: eosinophils; Baso: basophils. Data are presented as means ? SE of 6 animals (controls) and 8\nanimals (LOBE, 1 mg/kg, via s.c). Values of a (p &lt;0.0001), b (p &lt;0.001) and c (p &lt;0.05) were considered statistically different when compared to the basal levels\nof control rats (ANOVA followed by Bonferroni post hoc test).\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192 185\n\n70\n\n\n\nAuthor's personal copy\n\nused Fpg, which is specific for oxidized purines, and Endo\nIII, which targets oxidized pyrimidines. Thus, increases in\nthe damage index after enzyme incubation specifically\nrepresent the extent of oxidative DNA damage. As shown in\nFig. 6C and D, there was an increase in the oxidative\ndamage score after incubation with Fpg and Endo III,\nindicating the presence of oxidized purines and pyrimi-\ndines. As the levels of ordinary and oxidatively generated\nDNA adducts were similar (mainly between 6 and 12 h), the\nmajority of the DNA damage observed in the kidneys was\nlikely due to oxidative insult (Fig. 6B\u2013D).\n\n3.6. Effects of antivenom treatment on markers of systemic\ntissue damage\n\nSince the administration of antilonomic serum (ALS) is\nthe only specific treatment actually available for L. obliqua\nenvenomation, we decided to test its efficacy in\n\nneutralizing biochemical and coagulation abnormalities\nusing our experimental model. For this purpose, ALS was\nintravenously administered at 2 or 6 h post-LOBE injection\n(1 mg/kg, s.c.). After 24 h of envenomation, different\nbiochemical markers and coagulation parameters were\ndetermined (Table 3). Generally, treatment with ALS is able\nto neutralize LOBE-induced biochemical alterations only if\nadministered within the first 2 h of envenomation. For\nexample, animals treated with ALS at 2 h had a decrease of\n3.6- and 2.5-fold in the levels of serum creatinine and urea,\nrespectively, when compared with the group treated 6 h\nafter LOBE injection. In addition, both the creatinine and\nurea levels of the envenomed animals that had been\ntreated at 2 h with ALS were not significantly different from\nthe values observed in non-envenomed rats that had been\ntreated with PBS or ALS, indicating that these levels had\nreturned to control values. Similar results were obtained\nfor other parameters, such as CK, CK-MB, AST and ALT,\n\nFig. 2. Light micrographs showing the histopathological changes induced by L. obliqua venom in the vital organs of rats. A. Skin, 6 h post-envenomation, pre-\nsenting subcutaneous hemorrhage at the site of venom injection (arrowheads). B. Skin, 12 h post-envenomation. Note the skeletal muscle necrosis (N) and\ninflammatory infiltrate (white asterisk). C. Kidney, 6 h post-envenomation. Cortical sections showing the deposits of a red-brown material in the tubules forming\ngranular casts (arrows). Insert: Detail of an intra-tubular cast. D. Kidney, 48 h post-envenomation. Medullar section evidencing inflammatory infiltrate (white\nasterisk). Insert: Cortical section showing tubules with hyaline casts (arrows). E. Spleen, 6 h post-envenomation. Note the marked diffuse congestion and\nerythrophagocytosis. Insert: Detail of erythrophagocytosis (arrowhead). F. Spleen, 48 h post-envenomation. Note the large aggregates of hemosiderin engulfed\nmacrophages (arrowheads). All sections were stained with H&amp;E. Magnifications: 10? (Panels A, C, D, inserts in D and E); 40? (Panels B, inserts in C, E and F).\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192186\n\n71\n\n\n\nAuthor's personal copy\n\nwhich became normalized only in envenomed rats that had\nreceived ALS within the first 2 h. Likewise, plasma hemo-\nglobin levels were also decreased in envenomed rats when\nALS was injected at 2 h. However, this reduction was not\nstatistically significant in comparison to envenomed ani-\nmals that had been treated with PBS instead of ALS. Thus,\nALS was not able to completely reverse intravascular he-\nmolysis, even if given early after envenomation.\n\nAs expected, envenomed animals that were treated with\nPBS developed consumptive coagulopathy, with lower\nlevels of fibrinogen and prolonged activated partial\nthromboplastin time (Table 3). In this case, the treatment\nwith ALS both at 2 or 6 h after venom injection normalized\nthe coagulation parameters. The macroscopic and\n\nhistological signs of hemorrhage were also absent in the\nenvenomed groups that had received ALS injections at 2 or\n6 h (results not shown).\n\n4. Discussion\n\nIn the present study, we used an experimental model in\nrats to investigate the acute physiopathological effects of L.\nobliqua venom. This model allowed for the broad charac-\nterization of venom-induced tissue damage, including\nbiochemical, hematological, histopathological, myotoxic,\ncardiotoxic and genotoxic alterations.\n\nEnvenomed animals showed macroscopic and histo-\nlogical evidence of systemic hemorrhages, confirming the\nmain clinical profile observed in human patients (Zannin\net al., 2003). Bleeding in the abdominal cavity and subcu-\ntaneous tissue, hematuria and hemorrhages in the\nmyocardium and pulmonary parenchyma were observed in\nour experimental animals. Actually it is known that\ndifferent venom toxins are involved in these hemorrhagic\nalterations. Most of the toxins are serine proteases, an\nexpressive group representing 16.7% and 25% of the clusters\nderived from the tegument and bristle transcriptomes,\nrespectively (Veiga et al., 2005). This protein group displays\ncoagulation factor-like activities, so these enzymes are ex-\npected to participate in the generation of thrombin by\nactivation of factor X and prothrombin (Veiga et al., 2009;\nBerger et al., 2010a) and in the activation of the fibrino-\nlytic system, contributing directly and indirectly to fibrin-\nogen degradation (Pinto et al., 2006), resulting in\nconsumption coagulopathy. In fact, serine proteases with\nfibrinogenolytic, prothrombin and factor X activating ac-\ntivities have been purified and characterized in this venom\n(Alvarez-Flores et al., 2006; Pinto et al., 2004; Reis et al.,\n2006). Rats injected intravenously with one of these en-\nzymes, a purified prothrombin activator, displayed coa-\ngulopathy that was associated with reduced levels of\nfibrinogen, pulmonary hemorrhage and leukocyte infiltra-\ntion in the lungs (Reis et al., 2001), which was similar to the\nobservations presented here for whole venom.\n\nIn addition to the hemostatic abnormalities, the rats\ndisplayed intravascular hemolysis, as evidenced by alter-\nations in several parameters, such as high levels of free\nhemoglobin, increased unconjugated bilirubin levels, high\nserum LDH activity, decreased RBC counts and hematocrit,\nand the presence of reticulocytes (immature RBCs), spher-\nocytes and fragmented RBCs in the blood smears. The\nspleens of the envenomed animals also presented signs of\nerythrophagocytosis and deposits of hemosiderin, indi-\ncating high clearance of defective RBCs and the accumu-\nlation of hemoglobin metabolic products. An important\ncontribution of this hemolytic process to venom-induced\npathology is most likely related to the deposition of he-\nmoglobin in the renal tubules. Hemolysis-related AKI is\ncharacterized by the formation of tubular hemoglobin\ncasts, which are highly nephrotoxic (Zager, 1996). In the\npresent study, envenomed animals presented red-brown\nand hyaline pigments with a granular appearance in their\nrenal tubules which were most likely due to the formation\nof hemoglobin and/or myoglobin deposits. Reports\ndescribing a human case of hemolysis-related AKI, and also\n\nFig. 3. Light micrographs showing the histopathological changes in the\nlungs of rats that had been injected with L. obliqua venom. Section of the\nlungs from envenomed animals presented extensive hemorrhage mainly 6 h\npost-venom injection (A), signs of inflammation such as edema (B) and\nperivascular edema (insert in B) at 12 h, and inflammatory cell infiltrate (C)\nat 48 h. All sections were stained with H&amp;E. Asterisks and arrowheads in\npanel B indicate areas of edema and perivascular edema, respectively.\nMagnification: 10? (Panels A\u2013C).\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192 187\n\n72\n\n\n\nAuthor's personal copy\n\nan experimental study confirming the occurrence of\nintravascular hemolysis, have already been published\n(Seibert et al., 2004; Malaque et al., 2006). However, little is\nknown regarding the ability of ALS to neutralize hemolytic\neffects. Our data indicate that ALS was not able to\ncompletely reverse intravascular hemolysis, even if\nadministered early in the envenomation. The case report of\nhemolysis-related AKI also indicated that treatment with\nALS did not reduce hemoglobin levels to normal values and\nthe patient did not completely recover renal function until\n1 month after the accident, despite improvements in\ncoagulation tests (Malaque et al., 2006). Until now, the\nmain component with high in vitro hemolytic activity iso-\nlated from this venom was the phospholipase A2 enzyme,\nalthough the presence of proteolytic enzymes that act\nspecifically on the membrane glycoproteins of erythrocytes\ncannot be ruled out (Seibert et al., 2006, 2010).\n\nSince myotoxins are commonly described in several\nsnake, spider and bee venoms, the presence of myotoxic\nactivity in L. obliqua was investigated using specific\nbiochemical markers, in vitro experiments and histological\nanalyses. In this sense, elevations of serum CK and CK-MB\nactivities were detected, indicating systemic damage to\nskeletal and cardiac muscles. CK is a dimer with M and B\nsubunits that is found primarily in the muscle, myocardium,\nbrain and lung tissues and exists as three dimeric iso-\nenzymes: CK-MM, CK-MB and CK-BB. CK-MB accounts for\n5%\u201350% of total CK activity in the myocardium and is well-\nestablished to be a clinical marker that can confirm acute\nmyocardial infarction both in humans and experimental\nanimals (Apple and Preese, 1994; Shashidharamurthy et al.,\n\nFig. 4. In vivo myotoxic and cardiotoxic activities. Serum levels of creatine kinase (A) and creatine kinase-MB (B) during the time-course of L. obliqua enven-\nomation in rats. Histopathological analyses of the heart confirmed the cardiotoxicity of the venom. At 6 h of envenomation, there were extensive areas of\nmyocardial hemorrhage (C). Necrosis of cardiomyocytes (D) and inflammation (E) were observed mainly at 12 and 48 h, respectively. These alterations are shown\nin detail in the insert of each image. Arrowheads in panel D indicate necrotic cells. All sections were stained with H&amp;E. Magnifications: 10? (Panels C, D and E);\n20? (Insert in C); 40? (Inserts in D and E). Biochemical data are presented as the means ? SE. Each sample from the control (CTRL, n \u00bc 6, injected with PBS, s.c.)\nor envenomed animals (n \u00bc 8, injected with LOBE, 1 mg/kg, s.c.) was measured in triplicate. Values of p &lt;0.001 were considered to be significantly different from\nthe controls.\n\nFig. 5. In vitro myotoxic activity. The effects of L. obliqua venom were tested\non isolated EDL muscles. A. At time \u00bc 0, PBS (control, CTRL) or different\nconcentrations of LOBE were added to the perfusion bath containing the EDL\nmuscles. Aliquots were taken at the indicated times to determine creatine\nkinase (CK) levels. Each time point represents the means ? SE of six inde-\npendent experiments. The levels of CK that were released from EDL previ-\nously treated with LOBE differed from the controls at all time points\n(p &lt;0.05). B. The myotoxic activity of LOBE was also compared in the\npresence or absence of antilonomic serum (ALS). Bothrops jararaca venom\n(BjV) and Triton X-100 (0.01%) were used as positive controls for myotoxic\nactivity. After 120 min, aliquots were taken for the CK determinations. Data\nare expressed as the means ? SE (n \u00bc 6/group). Values of p &lt;0.05 were\nconsidered to be statistically significant for the comparisons among the\ngroups.\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192188\n\n73\n\n\n\nAuthor's personal copy\n\n2010). Correlated with the increases in CK and CK-MB, his-\ntological analyses revealed extensive muscle damage\nmainly in the subcutaneous tissue (at the local site of venom\ninjection) and myocardial necrosis. These observations\nsupport the idea that the LOBE has cardiotoxic activity,\nwhich was unknown up until now. Clinical reports of human\nenvenomation that are available in the literature do not\ndescribe symptoms of cardiac dysfunction, and CK or CK-MB\nlevels are rarely measured in these patients, making it\ndifficult to make any comparisons with our experimental\ndata. Our hypothesis is that the contribution of muscle\ndamage observed herein is more related to myoglobin\nrelease from the myocytes or cardiomyocytes than to a\nmechanism that is associated with heart dysfunction.\nIndeed, similar to hemoglobin, myoglobin can also precipi-\ntate in renal tubules, after being filtered by the glomeruli,\nand forms obstructive casts. The direct myotoxic activity of\nLOBE was confirmed in vitro by the experiments with iso-\nlated EDL muscles. LOBE showed a dose- and time-\ndependent myotoxicity in isolated EDL, although its po-\ntency was lower when compared to B. jararaca venom. In\nfact, different myotoxins have been described in B. jararaca\nvenom, including metalloproteinases and myotoxic\n\nphospholipaseA2 (Zelanisetal., 2011), whilein L. obliquathe\ntoxins responsible for this activity remain completely un-\nknown. However, L. obliqua myotoxins seem to be recog-\nnized by ALS because treatment with this serum was able to\nreverse CK release in vitro (from EDL muscle) and in vivo if\nadministered within 2 h of envenomation.\n\nThough AKI is the leading cause of death following L.\nobliqua envenomation, the mechanisms involved in kidney\ndisorders are poorly understood (Gamborgi et al., 2006).\nThe current knowledge is based on clinical data from\nhuman victims in which hematuria, high levels of serum\ncreatinine and acute tubular necrosis were described to be\nthe main features of L. obliqua-induced AKI (Burdmann\net al., 1996). In our experimental model, in addition to the\nhigh levels of serum creatinine, the rats also displayed\nuremia and hyperuricemia, suggesting impaired renal\nfunction. Generally, the mechanism underlying venom-\ninduced AKI is complex and appears to be multifactorial.\nUntil now, studies performed with a variety of nephrotoxic\nvenoms have indicated that AKI is associated with both the\ndirect cytotoxic action of the venom on renal structures and\na secondary response of the whole organism resulting from\nsystemic envenomation (Abdulkader et al., 2008; Berger\n\nFig. 6. Genotoxic activity. A. DNA damage in the different organs of the control (CTRL, injected with PBS, s.c.) and envenomed animals (injected with the LOBE,\n1 mg/kg, s.c.) was assessed using the alkaline comet assay 12 h post-venom injection. B. The temporal pattern of DNA damage in the kidneys of the control and\nenvenomed animals at different time points. C and D. Oxidative DNA damage in the kidneys was also determined at different times post-venom administration\nusing the modified version of the comet assay with Fpg (C) and Endo III (D) enzymes. Data are expressed as the means ? SE (n \u00bc 6 rats/group). Values of p &lt;0.05\nand p &lt;0.001 (*) were considered to be statistically significant in comparison to the control groups.\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192 189\n\n74\n\n\n\nAuthor's personal copy\n\net al., 2012). The secondary response is usually triggered by\nrenal inflammation, oxidative damage and the release of\ncytokines and vasoactive substances that lead to changes in\nrenal function and hemodynamics. Hemolysis, rhabdo-\nmyolysis and/or the intravascular deposition of platelets\nand fibrin in the kidney microcirculation are also important\ncontributors to this process (Sitprija, 2006). Recently, high\nlevels of uric acid were observed to play an important role\nin AKI induced by Crotalus envenomation, since the treat-\nment with allopurinol, a hypouricemiant agent, signifi-\ncantly reduced the lethality rate and ameliorated renal\nhistopathological changes (Frezzatti and Silveira, 2011).\nMarked hyperuricemia is known to cause AKI by the su-\npersaturation, crystallization and deposition of urate crys-\ntals, as well as by contributing to renal vasoconstriction,\nsince soluble uric acid has been shown to inhibit endo-\nthelial NO bioavailability (Yamasaki et al., 2008; Ejaz et al.,\n2007). During L. obliqua envenomation, the rats also pre-\nsented high levels of uric acid, tubular obstructive casts and\ninflammatory infiltrates in the kidneys. However, the actual\ncontribution of these elements to AKI requires further\nstudy. Interestingly, antivenom serotherapy was able to\nreduce creatinine and urea levels only if administered\nwithin 2 h of LOBE injection. Antivenom treatment after 6 h\nwas unable to fully correct the renal parameters, despite its\nability to normalize coagulation abnormalities. Thus, it\nseems that the time elapsed between the accident and the\nadministration of antivenom is crucial for a successful renal\ntherapy. Confirming our observations, it was demonstrated\nthat a time interval of more than 2 h between the accident\nand administration of the antivenom was associated with\nthe development of AKI, as well as with the risk of death or\npermanent injuries after Bothrops and Crotalus envenom-\nation (Otero et al., 2002; Pinho et al., 2005).\n\nUnlike the lungs, kidneys, spleens and hearts, no\nmorphological changes were observed in the livers, brains\nand cerebellums of rats that had been injected with L.\nobliqua venom. Nevertheless, biochemical markers of acute\nliver injury (AST, ALT and g-GT) were increased in the\nserum of animals after envenomation. As it is known that\nsome of these enzymes are not specific to the liver, it is\npossible that they were derived from other sources, such as\nthe red blood cells or skeletal muscle. For instance, in-\ncreases in AST activity are also associated with damage to\ncardiac and skeletal muscle and the kidneys (Prado et al.,\n2010; Shashidharamurthy et al., 2010). Despite these\napparently conflicting observations, we cannot rule out the\n\noccurrence of liver injury, mainly because evidence of DNA\ndamage was detected in liver cells using the comet assay.\nProbably, these findings indicate that the extent of acute\nhepatic injury in this model of envenomation was subtle\nand did not lead to gross histological alterations.\n\nAs mentioned above, L. obliqua envenomation may have\ntriggered an intense inflammatory response, which may be\ninvolved in several of the clinical manifestations. The acti-\nvation of the kallikrein-kinin system and the consequent\nrelease of vasoactive mediators (mainly bradykinin, hista-\nmine and prostaglandins) seems to play an essential role in\nthe edematogenic, nociceptive and vascular effects (Bohrer\net al., 2007). Accordingly, we have shown that during en-\nvenomation the animals experienced neutrophilic leuko-\ncytosis, indicating that a systemic inflammatory response\nhad occurred. Histological sections also provided evidence\nof inflammatory cell infiltrates in the heart, lungs and\nkidneys. Corroborating these results, a clear activation in\nthe vascular bed that was characterized by an increase in\nleukocyte rolling and adhesion to the endothelium was\nobserved in hamster cheek pouch venules that had previ-\nously been incubated with low doses of LOBE (Nascimento-\nSilva et al., 2012). The up-regulated expression of genes\nfrom pro-inflammatory mediators and adhesion molecules,\nsuch as IL-8, IL-6, CCL2, CXCL1, E-selectin, VCAM-1 and\nICAM-3, was also detected in endothelial cells and fibro-\nblasts after incubation with LOBE. Once released, these\nmediators acted as chemoattractants, inducing inflamma-\ntory cell migration to the sites of injury (Pinto et al., 2008;\nNascimento-Silva et al., 2012).\n\nRecently, classical methods of genetic toxicology have\nbeen applied to the identification of potential therapeutic\nagents in animal venoms (mainly for the treatment of some\ntypes of cancer) and have also provided a better under-\nstanding of the toxic mechanisms of action of these venoms\nin the human body (Marcussi et al., 2011, 2013). During\nenvenomation, genotoxic damage can occur directly due to\nthe cytotoxic activity of the venom or indirectly through\nthe production of cytotoxic mediators (such as free radicals,\nfor example) in response to tissue injury. In both cases, the\ndamage could lead to DNA fragmentation and eventually,\ncell death. In the case of cell survival, DNA lesions not\ncorrected during the cell repair process might result in\npermanent mutations and changes to cellular morphology\nor physiology that could also be transmitted hereditarily to\nfuture generations. Therefore, it is possible that the geno-\ntoxic effects are involved not only in the acute toxicity, but\n\nTable 3\nEffects of treatment with anti-lonomic serum (ALS) on markers of systemic tissue damage during L. obliqua envenomation.\n\nTreatment group Cr (mg/dL) BUN (mg/dL) CK (U/L) CK-MB (U/L) Hb (mg/dL) AST (U/mL) ALT (U/mL) FBG (g/L) aPTT (s)\n\nPBS 0.3 ? 0.04 67.1 ? 2.9 16.7 ? 1.1 6.0 ? 0.5 65.2 ? 5.1 16.5 ? 1.6 14.9 ? 2.1 1.6 ? 0.04 31.7 ? 3.8\nALS 0.3 ? 0.07b,c 65.5 ? 3.7b,c 18.9 ? 1.5b,c 5.3 ? 0.4b,c 62.2 ? 2.3c 36.3 ? 3.1b,c 42.1 ? 1.9a,b,c 2.1 ? 0.4b 32.7 ? 2.8\nLOBE \u00fe PBS 1.9 ? 0.2a 175.3 ? 18.8a 244.2 ? 26.6a 54.3 ? 7.1a 215.6 ? 72.6a 106.7 ? 20.8a 72.1 ? 5.1a 0.5 ? 0.04a 79.9 ? 17a\nLOBE \u00fe ALS (2 h) 0.5 ? 0.05b,c 53.2 ? 2.0b,c 32.9 ? 4.7b,c 5.8 ? 0.8b,c 137.4 ? 19.8 30.3 ? 1.0b,c 26.3 ? 1.7b,c 2.3 ? 0.3b 22.5 ? 1.5b\nLOBE \u00fe ALS (6 h) 1.8 ? 0.2a 133.3 ? 4.6a,b 278.9 ? 25.5a 41.1 ? 5.1a,b 271.1 ? 53.9a 90.9 ? 5.9a 67.0 ? 6.3a 1.6 ? 0.2b 36.4 ? 5.6b\n\nCr: creatinine; BUN: blood urea nitrogen; CK: creatine kinase; CK-MB: creatine kinase isoenzyme MB; Hb: plasma hemoglobin; AST: aspartate amino-\ntransferase; ALT: alanine aminotransferase; FBG: fibrinogen; aPTT: activated partial thromboplastin time. Envenomed animals (n \u00bc 8/group) were treated\nwith PBS or ALS after 2 or 6 h of LOBE injection (1 mg/kg, via s.c). Control animals (n \u00bc 6/group) were injected only with PBS or ALS. After 24 h, samples of\nplasma and serum were collected. Data are presented as means ? SE. Statistical analyses were performed by ANOVA followed by Bonferroni\u2019s post hoc test.\na(p &lt;0.05 vs PBS), b(p &lt;0.05 vs LOBE \u00fe PBS) and c(p &lt;0.05 vs LOBE \u00fe ALS 6 h).\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192190\n\n75\n\n\n\nAuthor's personal copy\n\nalso in chronic diseases, and may even be involved in\nmutagenic and carcinogenic events resulting from enven-\nomation. In this sense, it has been shown that some\nBothrops toxins are able to induce genotoxic and mutagenic\neffects in isolated human lymphocytes, as evidenced by the\ncomet and micronucleus assays, respectively (Marcussi\net al., 2013). Here, various organs of animals that had\nbeen injected with L. obliqua venom presented DNA lesions,\nindicating the high genotoxic potential of this venom. DNA\ndamage was detected in the kidneys, heart, lungs, liver and\nlymphocytes of envenomed rats. Specifically, DNA lesions\nin the kidneys were prominent 6, 12 and 48 h post-\nenvenomation, and the majority of these lesions were\ndue to oxidative damage because oxidized purines and\npyrimidines were detected. In fact, the possible production\nof free radicals during envenomation should be considered\nin an effort to understand the complex mechanisms\ninvolved in kidney dysfunction. In this case, the presence of\nhemoglobin and/or myoglobin deposits in the renal tubules\nmay contribute to kidney dysfunction, since the degrada-\ntion of these molecules releases free iron and heme, which\ncatalyze the production of free radicals and induce lipid\nperoxidation, respectively (Zager, 1996; Yamasaki et al.,\n2008). The participation of oxidative damage was\nconfirmed in a model of Crotalus-induced AKI, in which\ntreatment with antioxidant agents protects against venom-\nmediated nephrotoxicity (Alegre et al., 2010).\n\n5. Conclusions\n\nIn this work, we characterized a series of acute physio-\npathological effects induced by the subcutaneous injection\nof L. obliqua venom in rats. Our data reveal important\nbiochemical, hematological and histopathological alter-\nations, suggesting the occurrence of multi-organ damage\nand confirming that the rat is a good animal model for\nstudying hemorrhagic disturbances, as well as organ spe-\ncific injuries, such as AKI. Interestingly, myotoxic, car-\ndiotoxic and genotoxic activities were identified during our\nexperiments. To our knowledge, this is the first study to\nshow these activities of L. obliqua venom. Finally, the\nfindings presented here emphasize the fact that a correct\ndiagnosis and early treatment is essential for successful\nantivenom serotherapy, since the efficacy of serotherapy in\nneutralizing the physiopathological alterations is only\nobserved if serotherapy is administered during the initial\nphase of envenomation.\n\nAcknowledgments\n\nWe would like to thank Dr. Carlos Termignoni (Departa-\nmento de Bioqu\u00edmica e Centro de Biotecnologia \u2013 Uni-\nversidade Federaldo Rio Grande do Sul)forhiscriticalreview\nof themanuscript. We are also indebted to Mrs. Zelma Regina\nde Almeida for her animal handling. This work was sup-\nported by funding and fellowships from the Brazilian\nAgencies: Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de\nN\u00edvel Superior, Minist\u00e9rio da Educa\u00e7\u00e3o, Brazil (CAPES-MEC)\n\u2013 Edital Toxinologia (Processo: 23038.006277/2011-85)\nand Conselho Nacional de Desenvolvimento Cient\u00edfico e\n\nTecnol\u00f3gico, Minist\u00e9rio da Ci\u00eancia e Tecnologia, Brazil\n(CNPq-MCT).\n\nConflict of interest statement\n\nThe authors declare that there are no conflicts of\ninterest.\n\nReferences\n\nAbdulkader, R.C., Barbaro, K.C., Barros, E.J., Burdmann, E.A., 2008. Neph-\nrotoxicity of insect and spider venoms in Latin America. Semin.\nNephrol. 28 (4), 373\u2013382.\n\nAlegre, V.S., Barone, J.M., Yamasaki, S.C., Zambotti-Villela, L., Silveira, P.F.,\n2010. Lipoic acid effects on renal function, aminopeptidase activities\nand oxidative stress in Crotalus durissus terrificus envenomation in\nmice. Toxicon 56 (3), 402\u2013410.\n\nAlvarez-Flores, M.P., Fritzen, M., Reis, C.V., Chudzinski-Tavassi, A.M., 2006.\nLosac, a factor X activator from Lonomia obliqua bristle extract: its role\nin the pathophysiological mechanisms and cell survival. Biochem.\nBiophys. Res. Commun. 343, 1216\u20131223.\n\nApple, F.S., Preese, L.M., 1994. Creatine kinase-MB: detection of myocar-\ndial infarction and monitoring reperfusion. J. Clin. Immunoass. 17, 24\u2013\n29.\n\nArocha-Pi\u00f1ango, C.L., Marval, E., Guerrero, B., 2000. Lonomia genus\ncaterpillar toxins: biochemical aspects. Biochimie 82, 937\u2013942.\n\nAzqueta, A., Shaposhnikov, S., Collins, A.R., 2009. DNA oxidation: inves-\ntigating its key role in environmental mutagenesis with the comet\nassay. Mutat. Res. 674 (1\u20132), 101\u2013108.\n\nBerger, M., Reck Jr., J., Terra, R.M., Pinto, A.F., Termignoni, C.,\nGuimar\u00e3es, J.A., 2010a. Lonomia obliqua caterpillar envenomation\ncauses platelet hypoaggregation and blood incoagulability in rats.\nToxicon 55 (1), 33\u201344.\n\nBerger, M., Reck Jr., J., Terra, R.M., Beys da Silva, W.O., Santi, L., Pinto, A.F.,\nVainstein, M.H., Termignoni, C., Guimar\u00e3es, J.A., 2010b. Lonomia\nobliqua venomous secretion induces human platelet adhesion and\naggregation. J. Thromb. Thrombolysis 30 (3), 300\u2013310.\n\nBerger, M., Vieira, M.A.R., Guimaraes, J.A., 2012. Acute kidney injury\ninduced by snake and arthropod venoms. In: Polenakovic, M. (Ed.),\nRenal Failure \u2013 the Facts. InTech-Open, Rijeka, Croatia, ISBN 978953-\n51-0630-2, pp. 157\u2013186.\n\nBohrer, C.B., Reck Jr., J., Fernandes, D., Sordi, R., Guimar\u00e3es, J.A., Assreuy, J.,\nTermignoni, C., 2007. Kallikrein-kinin system activation by Lonomia\nobliqua caterpillar bristles: involvement in edema and hypotension\nresponses to envenomation. Toxicon 49, 663\u2013669.\n\nBurdmann, E.A., Antunes, I., Saldanha, L.B., Abdulkader, R.C., 1996. Severe\nacute renal failure induced by the venom of Lonomia caterpillars. Clin.\nNephrology 46 (5), 337\u2013339.\n\nBurlinson, B., Tice, R.R., Speit, G., Agurell, E., Brendler-Schwaab, S.Y.,\nCollins, A.R., Escobar, P., Honma, M., Kumaravel, T.S., Nakajima, M.,\nSasaki, Y.F., Thybaud, V., Uno, Y., Vasquez, M., Hartmann, A., 2007.\nFourth international workgroup on genotoxicity testing: results of the\nin vivo Comet assay workgroup. Mutat. Res. 627, 31\u201335.\n\nCaovilla, J.J., Barros, E.J., 2004. Efficacy of two different doses of anti-\nlonomic serum in the resolution of hemorrhagic syndrome resulting\nfrom envenoming by Lonomia obliqua caterpillars: a randomized\ncontrolled trial. Toxicon 43, 811\u2013818.\n\nDa Silva, G.H., Hyslop, S., Cruz-H\u00f6fling, M.A., 2004a. Lonomia obliqua\ncaterpillar venom increases permeability of the blood\u2013brain barrier\nin rats. Toxicon 44, 625\u2013634.\n\nDa Silva, G.H., Panunto, P.C., Hyslop, S., Da Cruz-H\u00f6fling, M.A., 2004b.\nImmunochemical detection of Lonomia obliqua caterpillar venom in\nrats. Microsc. Res. Tech. 65, 276\u2013281.\n\nDe Castro Bastos, L., Veiga, A.B., Guimar\u00e3es, J.A., Tonussi, C.R., 2004.\nNociceptive and edematogenic responses elicited by a crude bristle\nextract of Lonomia obliqua caterpillars. Toxicon 43, 273\u2013278.\n\nDias da Silva, W., Campos, C.M., Gon\u00e7alves, L.R., Sousa-e-Silva, M.C.,\nHigashi, H.G., Yamagushi, I.K., Kelen, E.M., 1996. Development of an\nantivenom against toxins of Lonomia obliqua caterpillars. Toxicon 34,\n1045\u20131049.\n\nEjaz, A.A., Mu, W., Kang, D.H., Roncal, C., Sautin, Y.Y., Henderson, G.,\nTabah-Fisch, I., Keller, B., Beaver, T.M., Nakagawa, T., Johnson, R.J.,\n2007. Could uric acid have a role in acute renal failure. Clin. J. Am. Soc.\nNephrol. 2 (1), 16\u201321.\n\nFrezzatti, R., Silveira, P.F., 2011. Allopurinol reduces the lethality associ-\nated with acute renal failure induced by Crotalus durissus terrificus\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192 191\n\n76\n\n\n\nAuthor's personal copy\n\nsnake venom: comparison with probenecid. PLoS Negl. Trop. Dis. 5\n(9), e1312.\n\nFuly, A.L., Calil-Elias, S., Martinez, A.M., Melo, P.A., Guimar\u00e3es, J.A., 2003.\nMyotoxicity induced by an acidic Asp-49 phospholipase A(2) isolated\nfrom Lachesis muta snake venom. Comparison with lysophosphati-\ndylcholine. Int. J. Biochem. Cell Biol. 35 (10), 1470\u20131481.\n\nGamborgi, G.P., Metcalf, E.B., Barros, E.J.G., 2006. Acute renal failure\nprovoked by toxin from caterpillars of the species Lonomia obliqua.\nToxicon 47, 68\u201374.\n\nGarcia, C.M., Danni-Oliveira, I.M., 2007. Occurrence of accidents caused by\nLonomia obliqua Walker, in state of Paran\u00e1 between 1989 and 2001.\nRev. Soc. Bras. Med. Trop. 40, 242\u2013246.\n\nGon\u00e7alves, L.R., Sousa-e-Silva, M.C., Tomy, S.C., Sano-Martins, I.S., 2007.\nEfficacy of serum therapy on the treatment of rats experimentally\nenvenomed by bristle extract of the caterpillar Lonomia obliqua:\ncomparison with epsilon-aminocaproic acid therapy. Toxicon 50,\n349\u2013356.\n\nGreggio, S., Rosa, R.M., Dolganov, A., de Oliveira, I.M., Menegat, F.D.,\nHenriques, J.A.P., Da Costa, J.C., 2009. NAP prevents hippocampal\noxidative damage in neonatal rats subjected to hypoxia-induced\nseizures. Neurobiol. Dis. 36, 435\u2013444.\n\nGuimar\u00e3es, J.A., 2011. Toxinas: Envenenamento por animais pe\u00e7onhentos.\nSitua\u00e7\u00e3o no Brasil. In: de Souza, W. (Ed.), Doen\u00e7as Negligenciadas.\nAcademia Brasileira de Ci\u00eancias \u2013 Ci\u00eancia e Tecnologia para o\nDesenvolvimento \u2013 Estudos Estrat\u00e9gicos, Rio de Janeiro, Brazil,\npp. 34\u201338.\n\nHossler, E.W., 2010. Caterpillars and moths: part II. Dermatologic mani-\nfestations of encounters with Lepidoptera. J. Am. Acad. Dermatol. 62\n(1), 13\u201328.\n\nKowacs, P.A., Cardoso, J., Entres, M., Novak, E.M., Werneck, L.C., 2006. Fatal\nintracerebral hemorrhage secondary to Lonomia obliqua caterpillar\nenvenoming, a case report. Arq. Neuropsiquiatr. 64, 1030\u20131032.\n\nMalaque, C.M.S., Andrade, L., Madalosso, G., Tomy, S., Tavares, F.L.,\nSeguro, A.C., 2006. Short report: a case of hemolysis resulting from\ncontact with a Lonomia caterpillar in southern Brazil. Am. J. Trop.\nMed. Hyg. 74, 807\u2013809.\n\nMarcussi, S., Santos, P.R., Menaldo, D.L., Silveira, L.B., Santos-Filho, N.A.,\nMazzi, M.V., da Silva, S.L., St\u00e1beli, R.G., Antunes, L.M., Soares, A.M.,\n2011. Evaluation of the genotoxicity of Crotalus durissus terrificus\nsnake venom and its isolated toxins on human lymphocytes. Mutat.\nRes. 724 (1\u20132), 59\u201363.\n\nMarcussi,S., St\u00e1beli, R.G., Santos-Filho, N.A.,Menaldo,D.L., Silva Pereira,L.L.,\nZuliani, J.P., Calderon, L.A., da Silva, S.L., Greggi Antunes, L.M.,\nSoares, A.M., 2013. Genotoxic effect of Bothrops snake venoms and\nisolated toxins on human lymphocyte DNA. Toxicon 65, 9\u201314.\n\nMelo, P.A., Suarez-Kurtz, G., 1988. Release of creatine kinase from skeletal\nmuscles by Bothrops venoms: heparin potentiation of inhibition by\nantivenin. Braz. J. Med. Biol. Res. 21 (3), 545\u2013548.\n\nNadin, S.B., Vargas-Roig, L.M., Ciocca, D.R., 2001. A silver staining method\nfor single-cell gel assay. J. Histochem. Cytochem. 49, 1183\u20131186.\n\nNascimento-Silva, V., Rodrigues da Silva, G., Moraes, J.A., Cyrino, F.Z.,\nSeabra, S.H., Bouskela, E., Almeida Guimar\u00e3es, J., Barja-Fidalgo, C.,\n2012. A pro-inflammatory profile of endothelial cell in Lonomia\nobliqua envenomation. Toxicon 60 (1), 50\u201360.\n\nOtero, R., Guti\u00e9rrez, J., Beatriz-Mesa, M., Duque, E., Rodr\u00edguez, O., Luis-\nArango, J., G\u00f3mez, F., Toro, A., Cano, F., Mar\u00eda-Rodr\u00edguez, L., Caro, E.,\nMart\u00ednez, J., Cornejo, W., Mariano-G\u00f3mez, L., Luis-Uribe, F.,\nC\u00e1rdenas, S., N\u00fa\u00f1ez, V., D\u00edaz, A., 2002. Complications of Bothrops,\nPorthidium, and Bothriechis snakebites in Colombia. A clinical and\nepidemiological study of 39 cases attended in a university hospital.\nToxicon 40 (8), 1107\u20131114.\n\nPinho, F.M., Zanetta, D.M., Burdmann, E.A., 2005. Acute renal failure after\nCrotalus durissus snakebite: a prospective survey on 100 patients.\nKidney Int. 67 (2), 659\u2013667.\n\nPinto, A.F.M., Dobrovolski, R., Veiga, A.B.G., Guimar\u00e3es, J.A., 2004. Lono-\nfibrase, a novel a-fibrinogenase from Lonomia obliqua caterpillars.\nThromb. Res. 113, 147\u2013154.\n\nPinto, A.F.M., Silva, K.R.L.M., Guimaraes, J.A., 2006. Proteases from Lono-\nmia obliqua venomous secretions: comparison of procoagulant,\nfibrin(ogen)olytic and amidolytic activities. Toxicon 47, 113\u2013121.\n\nPinto, A.F.M., Dragulev, B., Guimar\u00e3es, J.A., Fox, J.W., 2008. Novel per-\nspectives in the pathogenesis of Lonomia obliqua caterpillar enven-\nomation based on assessment of host response by gene expression\nanalysis. Toxicon 51, 1119\u20131128.\n\nPinto, A.F.M., Berger, M., Reck- Jr., J., Terra, R.M., Guimar\u00e3es, J.A., 2010.\nLonomia obliqua venom: In vivo effects and molecular aspects asso-\nciated with the hemorrhagic syndrome. Toxicon 56 (7), 1103\u20131112.\n\nPrado, M., Solano-Trejos, G., Lomonte, B., 2010. Acute physiopathological\neffects of honeybee (Apis mellifera) envenoming by subcutaneous\nroute in a mouse model. Toxicon 56 (6), 1007\u20131017.\n\nReis, C.V., Farsky, S.H., Fernandes, B.L., Santoro, M.L., Oliva, M.L.,\nMariano, M., Chudzinski-Tavassi, A.M., 2001. In vivo characterization\nof Lopap, a prothrombin activator serine protease from the Lonomia\nobliqua caterpillar venom. Thromb. Res. 102 (5), 437\u2013443.\n\nReis, C.V., Andrade, S.A., Ramos, O.H., Ramos, C.R., Ho, P.L., Batista, I.F.,\nChudzinski-Tavassi, A.M., 2006. Lopap, a prothrombin activator from\nLonomia obliqua belonging to the lipocalin family: recombinant pro-\nduction, biochemical characterization and structure\u2013function in-\nsights. Biochem. J. 398 (2), 295\u2013302.\n\nRicci-Silva, M.E., Valente, R.H., Le\u00f3n, I.R., Tambourgi, D.V., Ramos, O.H.,\nPerales, J., Chudzinski-Tavassi, A.M., 2008. Immunochemical and\nproteomic technologies as tools for unravelling toxins involved in\nenvenoming by accidental contact with Lonomia obliqua caterpillars.\nToxicon 51, 1017\u20131028.\n\nRocha-Campos, A.C., Gon\u00e7alves, L.R., Higasshi, H.G., Yamagushi, I.K.,\nFernandes, I., Oliveira, J.E., Ribela, M.T., Sousa-e-Silva, M.C., Dias da\nSilva, W., 2001. Specific heterologous F(ab0)2 antibodies revert blood\nincoagulability resulting from envenoming by Lonomia obliqua cat-\nerpillars. Am. J. Trop. Med. Hyg. 64, 283\u2013289.\n\nSeibert, C.S., Oliveira, M.R.L., Gon\u00e7alves, L.R.C., Santoro, M.L., Sano-\nMartins, I.S., 2004. Intravascular hemolysis induced by Lonomia obli-\nqua caterpillar bristle extract: an experimental model of envenom-\nation in rats. Toxicon 44, 793\u2013799.\n\nSeibert, C.S., Tanaka-Azevedo, A.M., Santoro, M.L., Mackessy, S.P.,\nTorquato, R.J.S., Lebrun, I., Tanaka, A.S., Sano-Martins, I.S., 2006. Pu-\nrification of a phospholipase A2 from Lonomia obliqua caterpillar\nbristle extract. Biochem. Biophys. Res. Commun. 342, 1027\u20131033.\n\nSeibert, C.S., Santoro, M.L., Tambourgi, D.V., Sampaio, S.C., Takahashi, H.K.,\nPeres, C.M., Curi, R., Sano-Martins, I.S., 2010. Lonomia obliqua (Lepidop-\ntera,Saturniidae)caterpillarbristle extract induces direct lysis bycleaving\nerythrocyte membrane glycoproteins. Toxicon 55 (7), 1323\u20131330.\n\nSingh, N.P., McCoy, M.T., Tice, R.R., Schneider, E.L., 1988. A simple tech-\nnique for quantitation of low levels of DNA damage in individual cells.\nExp. Cell Res. 175, 184\u2013191.\n\nSitprija, V., 2006. Snakebite nephropathy. Nephrology (Carlton) 11 (5),\n442\u2013448.\n\nShashidharamurthy, R., Mahadeswaraswamy, Y.H., Ragupathi, L.,\nVishwanath, B.S., Kemparaju, K., 2010. Systemic pathological effects\ninduced by cobra (Naja naja) venom from geographically distinct\norigins of Indian peninsula. Exp. Toxicol. Pathol. 62 (6), 587\u2013592.\n\nTice, R.R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A.,\nKobayashi, H., Miyamae, Y., Rojas, E., Ryu, J.C., Sasaki, Y.F., 2000. Single\ncell gel/comet assay: guidelines for in vitro and in vivo genetic toxi-\ncology testing. Environ. Mol. Mutagen. 35, 206\u2013221.\n\nVeiga, A.B.G., Blochtein, B., Guimar\u00e3es, J.A., 2001. Structures involved\nproduction, secretion and injection of the venom produced by the\ncaterpillar Lonomia obliqua (Lepidoptera, saturniidae). Toxicon 39,\n1343\u20131351.\n\nVeiga, A.B.G., Ribeiro, J.M., Guimar\u00e3es, J.A., Francischetti, I.M., 2005. A\ncatalog for the transcripts from the venomous structures of the\ncaterpillar Lonomia obliqua: identification of the proteins potentially\ninvolved in the coagulation disorder and hemorrhagic syndrome.\nGene 355, 11\u201327.\n\nVeiga, A.B.G., Berger, M., Guimar\u00e3es, J.A., 2009. Lonomia obliquavenom:\npharmaco-toxicological effects and biotechnological perspectives. In:\nDe Lima, M.E., Pimenta, A.M., Martin-Eauclaire, M.F., Zingali, R.B.,\nRochat, H. (Eds.), Animal Toxins: the State of the Art. Perspectives on\nHealth and Biotechnology. Editora da UFMG, Belo Horizonte Brazil,\nISBN 978-85-7041-735-0, pp. 371\u2013390.\n\nYamasaki, S.C., Villarroel, J.S., Barone, J.M., Zambotti-Villela, L.,\nSilveira, P.F., 2008. Aminopeptidase activities, oxidative stress and\nrenal function in Crotalus durissus terrificus envenomation in mice.\nToxicon 52 (3), 345\u2013354.\n\nZannin, M., Louren\u00e7o, D.M., Motta, G., Costa, L.R.D., Grando, M.,\nGamborgi, G.P., Noguti, M.A., Chudzinski-Tavassi, A.M., 2003. Blood\ncoagulation and fibrinolytic factors in 105 patients with hemorrhagic\nsyndrome caused by accidental contact with Lonomia obliqua caterpillar\nin Santa Catarina, Southern Brazil. Thromb. Haemost. 89, 355\u2013364.\n\nZager, R.A., 1996. Rhabdomyolysis and myohemoglobinuric acute renal\nfailure. Kidney Int. 49 (2), 314\u2013326.\n\nZelanis, A., Tashima, A.K., Pinto, A.F., Leme, A.F., Stuginski, D.R.,\nFurtado, M.F., Sherman, N.E., Ho, P.L., Fox, J.W., Serrano, S.M., 2011.\nBothrops jararaca venom proteome rearrangement upon neonate to\nadult transition. Proteomics 11 (21), 4218\u20134228.\n\nM. Berger et al. / Toxicon 74 (2013) 179\u2013192192\n\n77\n\n\n\nResultados \n\n78 \n\n \n\n3.3 Cap\u00edtulo III   \n\n \n\nAcute kidney injury induced by snake and arthropod venoms  \n\n \n\n Considerando que a les\u00e3o renal aguda \u00e9 a principal complica\u00e7\u00e3o cl\u00ednica dos \n\nacidentes com animais pe\u00e7onhentos, os principais fatores que contribuem para a \n\ngravidade desses casos s\u00e3o examinados e discutidos em detalhes no presente trabalho.  \n\n \n\nOs seguintes aspectos foram abordados: \n\n \n\n? Epidemiologia geral e dos casos de les\u00e3o renal aguda causados por serpentes e \n\nartr\u00f3podos venenosos prevalentes no Brasil; \n\n? Toxinas de venenos de serpentes e artr\u00f3podos venenosos com atividade \n\nnefrot\u00f3xica, dando \u00eanfase para aquelas toxinas encontradas em animais que \n\ncausam acidentes no Brasil; \n\n? Fisiopatologia das altera\u00e7\u00f5es renais causadas por venenos animais; \n\n? Formas de tratamento e manejo dos pacientes com insufici\u00eancia renal \n\ndecorrente dos acidentes com animais pe\u00e7onhentos. \n\n \n\n O artigo apresentado a seguir foi publicado em maio de 2012 como um cap\u00edtulo \n\nde livro intitulado: \"Renal Failure - The Facts\". Editor: Dr. Momir Polenakovic. \n\nPublicado por: InTech-Open, Rijeka, Croatia, ISBN: 978953-51-0630-2/DOI \n\n10.5772/37025 (pp. 157-186). O livro completo est\u00e1 dispon\u00edvel em: \n\nhttp://www.intechopen.com/books/renal-failure-the-facts.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nhttp://www.intechopen.com/books/renal-failure-the-facts\n\n\n RENAL FAILURE \n \u2013 THE FACTS \n\n \nEdited by Momir Polenakovic \n\n \n\n  \n\n79\n\n\n\n \n \n \n \n \n \n \n \nRenal Failure \u2013 The Facts \nEdited by Momir Polenakovic \n \n \nPublished by InTech \nJaneza Trdine 9, 51000 Rijeka, Croatia \n \nCopyright \u00a9 2012 InTech \nAll chapters are Open Access distributed under the Creative Commons Attribution 3.0 \nlicense, which allows users to download, copy and build upon published articles even for \ncommercial purposes, as long as the author and publisher are properly credited, which \nensures maximum dissemination and a wider impact of our publications. After this work \nhas been published by InTech, authors have the right to republish it, in whole or part, in \nany publication of which they are the author, and to make other personal use of the \nwork. Any republication, referencing or personal use of the work must explicitly identify \nthe original source. \n \nAs for readers, this license allows users to download, copy and build upon published \nchapters even for commercial purposes, as long as the author and publisher are properly \ncredited, which ensures maximum dissemination and a wider impact of our publications. \n \nNotice \nStatements and opinions expressed in the chapters are these of the individual contributors \nand not necessarily those of the editors or publisher. No responsibility is accepted for the \naccuracy of information contained in the published chapters. The publisher assumes no \nresponsibility for any damage or injury to persons or property arising out of the use of any \nmaterials, instructions, methods or ideas contained in the book. \n  \nPublishing Process Manager Maja Bozicevic \nTechnical Editor Teodora Smiljanic \nCover Designer InTech Design Team \n \nFirst published May, 2012 \nPrinted in Croatia \n \nA free online edition of this book is available at www.intechopen.com \nAdditional hard copies can be obtained from orders@intechopen.com \n \n \nRenal Failure \u2013 The Facts, Edited by Momir Polenakovic  \n    p. cm.  \nISBN 978-953-51-0630-2  \n\n80\n\n\n\n9 \n\nAcute Kidney Injury  \nInduced by Snake and Arthropod Venoms  \n\nMarkus Berger1, Maria Aparecida Ribeiro Vieira2  \nand Jorge Almeida Guimar\u00e3es1 \n\n1Center of Biotechnology, Departament of Molecular Biology and Biotechnology, \n Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, \n\n2Institute of Biological Sciences, Department of Fisiology and Biology,  \nFederal University of Minas Gerais (UFMG)   \n\nBrazil \n\n1. Introduction  \n\nSnakebites and accidents caused by venomous arthropods (mainly spiders, scorpions, \nbees, wasps and caterpillars) are important public health problem. Despite of this, public \nhealth authorities, nationally and internationally, have given little attention to this \nproblem worldwide (Warrell, 2010; Williams et al., 2010). As a consequence, the morbidity \nand mortality associated with snake and arthropod envenoming produce a great impact \non the population and on the health-care systems. One of the most important and lethal \neffect of these animal venoms is nephrotoxicity (Sitprija, 2006). Specifically in South \nAmerica and Brazil, the main snakes responsible for cases of acute kidney injury (AKI) are \nthose from Bothrops and Crotalus genus. Among venomous arthropods, AKI has been \nreported after accidents with bees, spiders of the genus Loxosceles and caterpillars of the \ngenus Lonomia.  \n\nTaking in account the importance of accidents with these venomous animals, in this chapter \nwe reviewed the main mechanisms that play a role in AKI induced by the most common \nsnakes and arthropods found in South America. The following key aspects are addressed: \nEpidemiology, clinical renal manifestations, renal pathophysiology, diagnosis, clinical \nmanagement of AKI and the currently experimental models used to study the venom- \ninduced AKI.  \n\n2. Epidemiology and prevalence of venomous snakes and arthropods in \nSouth America \n\nGiven the wide distribution of venomous animals, particularly in tropical and subtropical \nregions, the extensive number of accidents and the complexity of the clinical conditions it \ncauses, the distint types of envenomation can be considered a global problem because they \nassume great public health importance, especially in the poorest areas of the world  (World \nHealth Organization [WHO], 2007). This environmental and occupational disease affects \nmainly agricultural workers and their children in some of the most impoverished rural \n\n81\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n158 \n\ncommunities of developing countries in Africa, Asia, Latin America and Oceania. \nPopulations in these regions experience high morbidity and mortality because of the poor \naccess to health services, which are often suboptimal, and, in some instances, a scarcity of \nantivenom, which is the only specific treatment so far tecnically possible to be available. A \nlarge number of victims survive with permanent physical and psychological sequelae \n(Guti\u00e9rrez et al., 2010; Kasturiratne et al., 2008; Warrell, 2010).  \n\nA group of venomous animals is responsible for medically important accidents: snakes, \nscorpions, spiders, caterpillars, bees and wasps. Global epidemiological data on accidents \nwith these different types of animals are scarce and often depend on the existence of \ncountry-specific estimates based on hospital admissions data and community-based \npopulation surveys. Unfortunately, in the low-income countries, where most accidents \noccur, there is not such a well organized health systems in order to correctly report the \nenvenomation cases (Kasturiratne et al., 2008; Williams et al., 2010). Nevertheless, after the \nincorporation of snakebite envenomations on the World Health Organization list of \nneglected tropical diseases in 2009 (www.who.int/neglected_diseases/diseases/ \nsnakebites/en/), more attention has been given to the lack of information on the true \nepidemiological impact of accidents, especially in the cases of snakebites. Current data \nindicate that 5.4 to 5.5 million people are bitten by snakes each year, resulting in near \n400,000 amputations, and between 20,000 to 125,000 deaths (Chippaux, 1998, Kasturiratne et \nal., 2008; Williams et al., 2010). The highest burden of snakebite was identified in South and \nSoutheast Asia, sub-Saharan Africa and Central and South America. Annually, Asia and \nAfrica have incidence rates of 1.2 million and 1 million bites with 60,000 and 20,000 deaths, \nrespectively. In Central and South America, epidemiological data indicate the occurrence of \n300,000 snakebites per year which result in 4,000 deaths and approximately 12,000 cases of \nphysical sequelae (Chippaux, 2011; Guti\u00e9rrez et al., 2010).  \n\nSpecifically in Brazil, data from the System of Health Surveillance of the Ministry of Health \nindicate the ocorrence of 107,364 accidents with venomous animals in the year of 2009 \n(including cases of snake, scorpion, spider, caterpillar and bee envenomations) which \nresulted in 290 deaths. When compared to the 2008 year  there were an increase of 12 % and \n16 % in the total number of accidents and deaths, respectively (Boletim eletr\u00f4nico \nepidemiol\u00f3gico, 2010). The majority of reported cases was caused by snakes and scorpions, \nwhich were also responsible for the highest rates of lethality (Table 1). Most snakebite (53 %) \noccurred from January to May, which reflect the influence of seasonal factors, such as an \nincrease in temperature and humidity associated with the rainy season in some regions of \nBrazil. Human agricultural activities were also associated with envenomations, since 78 % of \naccidents occurred in rural areas. Snakes of Bothrops genus (Lance-headed pit vipers) were \nresponsible for 90.5 % of the accidents while snakes of Crotalus genus (South American \nrattlesnakes) accounted for 7.7 % of total cases, showing however, a much higher lethality \nindex (1.25 %) than that for Bothrops snakes (0.35 %) (Minist\u00e9rio da Sa\u00fade, 2001). Analysing \nthe different regions of Brazil, the highest proportion of snakebites in relation to the \npopulation is localized in the North Region (Amazon Forest) with 53.9 accidents/100,000 \ninhabitants, probably due to the difficulty of patients to access health services and/or to the \ndelay in the administration of antivenom (Table 1). Among all venomous animals, the \nscorpion stands out for its high and growing number of accidents in Brazil. Compared to the \n2008 year, there was an increase of 7,050 cases in 2009 (45,721 versus 38,671 cases in 2008). \n\n82\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n159 \n\nAccording to Chippaux and Goyffon (2008), scorpions are responsible annually for 1.2 \nmillion accidents and for about 3,250 deaths in the world. In Brazil, the increased number of \nscorpion accidents has been attributed to its adaptation to urban and domiciliar areas \n(Minist\u00e9rio da Sa\u00fade, 2001). In this case, the highest incidence was registred in the Northeast \nRegion (Table 1). In contrast, accidents with spiders, caterpillars and bees are a growing \nproblem in states of Southern Brazil. Specifically in the state of Paran\u00e1 the brown spider \n(Loxosceles genus) is the most important venomous animal responsible for the high incidence \nof spider envenomation in the whole South Region (da Silva et al., 2004). In contrast, in the \nstates of Rio Grande do Sul and Santa Catarina the caterpillar Lonomia obliqua, also called \ntaturana (from the American-Indian Tupi-Guarani tat\u00e1, which means fire, and ran\u00e1, similar \nto), has been associated with severe cases of hemorrhagic syndrome (Veiga et al., 2009). In \nthis  case, although accidents may occur throughout the year, 80 % of cases were reported \nduring summer, when the animal is in the larval stage of its life cycle. Between 1997 and \n2005 there were 984 accidents only in the state of Rio Grande do Sul, resulting in a mortality \nrate of 0.5 % (Abella et al., 2006). Currently, the therapeutic use of specific antivenom \n(antilonomic serum) has decreased the number of deaths (Table 1). Among bee accidents, \nthe most dangerous are caused by Apis mellifera (Africanized bees). In these cases the high \nnumber of deaths (30 in 2009) has been associated mainly with the absence of a specific \nantivenom and the occurence of allergic reactions (Boletim eletr\u00f4nico epidemiol\u00f3gico, \n2010).   \n \n\nACCIDENTS WITH VENOMOUS ANIMALS IN BRAZIL. REPORTED DATA: \nYEAR  2009 *.\n\n Snakes Spiders Scorpions Caterpillars Bees \nTotal number of accidents 27,655 23,515 45,721 4,028 6,445 \n\nIncidence per 100,000 \ninhabitants \n\n14.4 12.3 24 2.1 3.4 \n\nNumber of deaths 125 26 104 5 30 \nLethality (%) 0.45 0.11 0.23 0.13 0.05 \n\nBrazilian Regions Incidence per 100,000 inhabitants \n\nNorth 53.9 3.6 16.2 1.7 1.9 \nNortheast 14.6 1.3 39.6 0.4 2.5 \nMidwest 20 2.6 13.3 0.7 2.2 \nSoutheast 7.4 7.1 23.7 1.7 3.2 \n\nSouth 10.1 58.5 3.5 7.3 7 \n\n* Data from Brazilian Ministry of Health, 2010 (Boletim Eletr\u00f4nico Epidemiol\u00f3gico, April 2010). \n\nTable 1. Epidemiological data of accidents with venomous animals in Brazil. \n\n3. Clinical renal manifestations due to snake and arthropod envenomation \n\nA broad clinical spectrum of renal function impairment has been reported in snake and \narthropod envenomations (Sitprija, 2006). As the kidneys are highly vascularized organs \nand have the ability to concentrate substances into the urine they are particularly susceptible \n\n83\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n160 \n\nto venom toxins. The most common clinical renal manifestations seen in human patients is \nacute tubular necrosis, but all renal structures may be involved. Thus, the occurrence of \nacute tubulointerstitial nephritis, renal cortical necrosis, mesangiolysis, vasculitis, \nglomerulonephritis, proteinuria, haematuria and myoglobinuria have also been described \n(Sitprija, 2006). \n\nIn this subsection, we reviewed the clinical characteristics of human accidents with snakes \nand arthropods that cause AKI which are highly prevalent in Brazil and other regions of \nLatin America. Envenomations by the following animals were analysed: Bothrops and \nCrotalus snakes, the brown spider Loxosceles, africanized bees, wasps and the caterpillars of \ngenus Lonomia. Despite the significant number of accidents with scorpions (Table 1), cases of \nAKI have not been associated to them. In fact, it is known that the main target of scorpion \nvenom is the nervous and cardiac systems (Cologna et al., 2009). \n\n3.1 Snakebite envenomation \n\nEnvenomation by snakebite, indenpendently of the species responsible for the bite, enforces \nmedical emergencies since different organs and tissues can be affected at the same time. In \nBrazil, most severe cases result from bites by snakes of the family Viperidae (pit vipers and \ntrue vipers). Within this family are the Bothrops and Crotalus snakes. Specifically in the \nBothrops genus there are more than 30 species distributed from southern Mexico to \nArgentina, including Brazil. The most important species are Bothrops asper, B. jararaca, B. \natrox, B. moojeni, B. jararacussu and B. alternatus. Bothrops snakes preferentially inhabit rural \nareas and moist forest environments. But these snakes also invade cultivated areas and \nambients with rodents\u2019 proliferation. Bothrops snakes have nocturnal habits and an \naggressive defensive behavior and its venom present proteolytic, coagulant and \nhemorrhagic active principles that are directly or indirectly implicated in the local and \nsystemic effects observed upon envenoming  acidents (Warrel, 2010). Local effects due to the \nenvenoming by these snakes are characterized by bleeding, swelling, pain and sometimes \nblisters, and can be frenquently complicated by the development of local abscesses and \nnecrosis. Occasionally, compartmental syndrome may develop, which results in functional \nor anatomic loss of the bitten limb (Guti\u00e9rrez et al., 2006). Signs of systemic envenoming \ninclude gingival hemorrhage, microscopic hematuria, ecchymosis and consumption \ncoagulopathy and, more rarely, epistaxis, hemoptosis, menorrhagia and hematemesis \n(Guti\u00e9rrez et al., 2006; Otero et al., 2002). Disturbances of hemostasis also include severe \nafibrinogenemia, thrombocytopenia and platelet aggregation dysfunction (Santoro and \nSano-Martins, 2004). Deaths are usually attributed to renal injury, shock, severe bleeding, \nand complicating sepsis. \n\nRenal dysfunction can occur early in the human bothropic envenomation which often \ninduces oliguria and is accompanied by an increase in the plasma creatinine concentration. \nThe need for dialysis ranges from 33 % to 75 % of cases (Pinho et al., 2008). AKI is mainly \ndue to acute tubular necrosis and acute cortical necrosis and occasionally \nglomerulonephritis (Table 2) (Rodrigues-Sgrignolli et al., 2011). These renal pathological \nalterations have been attributed mainly to hemodynamic changes in response to \nenvenomation, hemoglobinuria, intravascular clot formation and direct venom \nnephrotoxicity. \n\n84\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n161 \n\nBy analyzing a series of retrospective studies, Pinho et al. (2008) reported that the prevalence \nof AKI after Bothrops envenomation ranges from 1.6 % to 38.5 %. In most of these reports \nAKI diagnosis was based on the increase in the plasma creatinine and/or blood nitrogen \nurea being, the creatinine clearance barely estimated. The main reported factors influencing \nAKI prevalence upon such envenomation are: the patient\u2019s age (children under 10 year of \nage have been shown to be more susceptible to develop AKI); the snake\u2019s age (venom \ncomposition can vary even within the same species, according to the snake\u2019s age); bite site \nand amount of inoculated venom; and the time elapsed until antivenom treatment. \nMoreover, pre-existing diseases such as hypertension, diabetes or previous nephropathies \nmay become patients more vulnerable to the effects of venom (Rodrigues-Sgrignolli et al., \n2011; Zelanis et al., 2010). Taking in consideration all the above factors, the mortality rate of \nBothrops venom-induced AKI range from 13 % to 19 %. \n\nOther snakes well known for their nephrotoxicity are the South American rattlesnakes \n(Crotalus snakes). In Brazil, the Crotalus genus is represented by a single specie, Crotalus \ndurissus, that is composed of six subspecies: Crotalus durissus terrificus, C. d.collilineatus, C.d. \ncascavella, C.d. ruruima, C.d. marajoensis and C.d. trigonicus. Besides sharing some common \ncharacteristics with other venomous snakes, the Crotalus genus presents a rattle at the end of \nits tail, which is a particular characteristic of these snakes making easier their identification. \nIn general the Crotalus snakes are found in rocky and drier regions. They are rarely found in \nhumid forests and feed mainly of small rodents. They are robust (may reach 1 meter in \nlength) and are less agressive than Bothrops snakes (Minist\u00e9rio da Sa\u00fade, 2001). \n\nAmong the six different subspecies, C.d. terrificus is the most frequently implicated in \nenvenomation cases registered in Brazil. The venom has neurotoxic, myotoxic, and \nnephrotoxic activities (Table 2). In neuromuscular junctions, the venom leads to a powerful \npresynaptic inhibition of acetylcholine release, which is responsible for the neuromuscular \nblockade and progressive flaccid paralysis of variable degrees. Eyelid ptosis, blurred and/or \ndouble vision, ophthalmoplegia and facial muscle paralysis are common manifestations of \nvenom neurotoxicity. The myotoxic activity of the venom also produces severe skeletal \nmuscle injury leading to myalgia and rhabdomyolysis with the subsequent release of \nmyoglobin from damaged skeletal muscle into serum and urine (Azevedo-Marques et al., \n1987). Indeed, the serum creatine kinase (CK) levels are significantly higher (260-folds that \nof normal values) in patients who develop AKI after a Crotalus bite. Other markers of \nrhabdomyolysis, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT) \nand lactate dehydrogenase (LDH) are also increased in patients with AKI (Pinho et al., \n2005). High serum and urine levels of myoglobin are potentially nephrotoxic, leading to \nacute tubular necrosis, which is the primary and most serious complication of human \ncrotalid envenomation. Tissue damage at the site of the bite has been reported to be minimal \nor absent, a feature that differentiates the South American rattlesnake from other species of \nCrotalus and from Bothrops envenomations. Spontaneous bleeding has only been rarely \nobserved in human patients, despite the presence of blood incoagulability in some cases \n(Jorge &amp; Ribeiro, 1992). AKI is the main cause of death among patients surviving to the early \neffects of Crotalus snakebites. \n\nIn a study of 100 cases of Crotalus bites, Pinho et al. (2005) showed that AKI develops within \nthe first 24 to 48 hours after envenomation. Envenomed patients presented a significant \n\n85\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n162 \n\nreduction in glomerular filtration rate (estimated by the creatinine clearance). AKI patients \nalso presented dark-brown urine and a fractional excretion of sodium significantly higher \nthan the normal (Pinho et al., 2005). The major kidney pathological alteration is acute \ntubular necrosis, although interstitial nephritis has also been observed (Amaral et al., 1986; \nAzevedo-Marques et al., 1985) (Table 2). In this type of envenomation the occurrence of \nsevere rhabdomyolysis is one of the more accepted explanations for the acute tubular \nnecrosis. Other factors potentially associated with venom-induced AKI such as shock, \nhypotension and hemolysis are present in some cases, but have not been confirmed in \nCrotalus envenomation (Azevedo-Marques et al., 1987; Pinho et al., 2008). Despite of in vitro \nhemolytic activity of Crotalus venom, it was confirmed that in vivo C.d. terrificus \nenvenomation causes myolysis rather than intravascular hemolysis (Azevedo-Marques et \nal., 1987). \n\nThe prevalence of AKI associated with Crotalid envenomation ranges from 10 to 29 % and \n68 to 77 % of AKI patients require dialysis treatment. The mortality rate of Crotalus venom-\ninduced AKI ranges from 8 to 17 % (Amaral et al., 1986; Pinho et al., 2008; Silveira &amp; \nNishioka, 1992). Although most risk factors for AKI are very similar to those described for \nbothropic envenomation it was reported that early after Crotalus snakebite the plasma levels \nof CK (higher than 2,000 U/L) were associated with a 12-fold increase in the risk of \ndeveloping AKI (Pinho et al., 2005). \n\n3.2 Brown spider envenomation \n\nAmong arthropods, spider and scorpion bites are the most frequent and of medical care \nimportance. Although the number of accidents with scorpions often overcome those with \nspiders, reports of AKI after human envenomation with scorpion are scarce (Abdulkader et \nal., 2008). One species of spider that can cause severe renal injury is the brown spider \n(Loxosceles genus). Spiders of the genus Loxosceles have a worldwide distribution, since they \ncan live under variable conditions such as temperature ranging from 8 to 43\u00b0C and that \nthey can stay long time intervals living without food or water (Hogan et al., 2004; \nSwanson and Vetter, 2006). In Brazil, seven species have been described, but some of them \nare the most frequently implicated in bites in humans, namely Loxosceles intermedia, L. \ngaucho and L. laeta. These spiders are commonly found inside the residences both in rural \nand urban areas. They are small, measuring between 8 and 15 mm of body length while \ntheir legs measure 8-30 mm. Their colour varies from a pale brown (L. laeta) to a dark \nbrown (L. gaucho). Loxosceles spiders are not aggressive and the bites usually occur when \nthey are pressed against the body, mainly while the victim is sleeping or dressing (da \nSilva et al., 2004).  \n\nThe venom has proteolytic, dermonecrotic, hemolytic and nephrotoxic activities (Isbister &amp; \nFan, 2011) (Table 2). The accident may have local and systemic manifestations that are \nexhibited in two different clinical forms: cutaneous and viscerocutaneous loxoscelism (da \nSilva et al., 2004). Most patients have only the local manifestation or cutaneous \nloxoscelism. In these cases, the accident may cause mild cutaneous inflammatory reaction \nor a local injury characterized by pain, edema and erithrema, later developing to \ndermonecrosis with gravitational spreading. In the minority of cases loxoscelism can \ncause a systemic injury or the viscerocutaneous loxoscelism. This form occurs \n\n86\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n163 \n\npredominantly in children, and patients can develop AKI, which is considered the main \ncause of death after brown spider envenomation. Viscerocutaneous loxoscelism is \ncharacterized by fever, malaise, weakness, nausea and vomiting, hemolysis, hematuria, \njaundice, thrombocytopenia and disseminated intravascular coagulation. This severe \nmultisystemic clinical picture can occur as early as 24 hours after the bite (Abdulkader et \nal., 2008; da Silva et al., 2004; Isbister &amp; Fan, 2011).  \n\nAnalysis of 267 loxoscelism cases reported in Brazil showed that the viscerocutaneous form \nwas diagnosed in 13.1 % of the cases, where L laeta was the main specie implicated in the \naccidents. The investigators reported jaundice in 68.6 %, oliguria in 45.7 %, anuria in 8.6 %, \ndark urine in 28.6 %, hemorrhage in 25.7 %, and shock in 2.9 % of the patients. AKI \noccurred in 6.4 % of the patients, and most of them were diagnosed more than 24 hours \nafter the bite. Four patients died (1.5 %), all of them were children under 14 years old \n(Sezerino et al., 1998). The main factors likely associated with AKI development are \nhemolysis, hypotension/shock, and direct venom nephrotoxicity (Table 2). Pigment-\ninduced acute tubular necrosis was reported in human necropsies of viscerocutaneous \nloxoscelism (Zambrano et al., 2005). Thus, it was suggested that the pathological effect of \nthe venom on the kidney may reflect hematological disturbances, such as intravascular \nhemolysis and disseminated intravascular coagulation (Abdulkader et al., 2008). Although \nonly low myotoxic activity has been reported in Loxosceles venom, rhabdomyolysis can also \noccur after envenomation. In this cases, high levels of  serum CK and deposits of \nmyoglobin in tubular cells have been observed (Fran\u00e7a et al., 2002; Lucato-Junior et al., \n2011).  \n\n3.3 Bee and wasp envenomation \n\nStings of insects from the order Hymenoptera, which includes several species of bees, \nhornets, wasps and yellow jacks, have also been implicated in cases of human envenomation \n(Vetter et al., 1999). \n\nIn general the victims present only local allergic reactions after one or a few stings. \nHowever, after a massive attack with hundreds or thousands of stings, a systemic \nenvenomation may occur (Abdulkader et al., 2008). The majority of envenomation cases \nwith medical importance is caused by the so-called Africanized bees (Apis genus). These \nbees are hybrids between bees of European origin (Apis mellifera mellifera and Apis mellifera \nligustica) and African bees (Apis mellifera scutellata) which were originated by the \nintroduction of different species in Brazil since 1957. Currently, due to the migratory \nbehavior and a high reproductive rate they are found throughout South America, Central \nAmerica and parts of North America. Because of their aggressive behavior and the number \nof accidents associated with them, the Africanized bees are also known as \u201ckiller bees\u201d \n(Abdulkader et al., 2008; Fran\u00e7a et al., 1994). \n\nThe main venom activities are hemolytic, myotoxic, cardiotoxic and nephrotoxic (Table 2). \nClinical manifestations can be divided into allergic and systemic reactions. Allergic reactions \nusually are observed in patients with a history of previous bee stings or asthma or other \nhypersensitivity disease. These reactions occur immediately after a single sting and can lead \nto anaphylaxis and death by laryngeal edema. Systemic reactions usually occur after \nmultiple stings and are characterized by pain, erythema, urticaria, release of histamine, \n\n87\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n164 \n\nnausea, vomiting, respiratory failure, hypotension and shock (Abdulkader et al., 2008). \nRhabdomyolysis and hemolysis can be detected a few hours after the accident (Chao et al., \n2004). Fatalities are typically the result of renal damage or from cardiac arrest due to \ncomplications of the venom toxicity (Vetter et al., 1999).  \n\nAKI has been observed in cases of massive attacks with 150 stings to more than 1,500 stings. \nEnvenomed patients commonly have anuria or oliguria, high levels of serum creatinine (10-\n30 mg/dL) and CK (>2,000 U/L), hypotension, tachycardia, myocardial damage and anemia \n(Daher et al., 2003; Gabriel et al., 2004; Fran\u00e7a et al., 1994; Xuan et al., 2010). Acute tubular \nnecrosis is the main histologic finding in human beings, domestic dogs, and in experimental \nanimals after bee and wasp envenomations. Allergic interstitial nephritis with concurrent \npigment tubulopathy resulting from both hemoglobin and myoglobin has also been \ndescribed after wasp stings (Chao et al., 2004; Zhang et al., 2001) (Table 2). A direct \nnephrotoxicity of the venom and/or hypotension caused by anaphylactic reaction are also \nmechanisms implicated in AKI induced by bees of Apis genus (Grisotto et al., 2006). By \nanalyzing five cases of severe envenomation by Africanized bees, Fran\u00e7a et al. (1994) found \nhigh venom concentrations in serum and urine which remain for more than 50 h after the \nstings in two fatal cases; in one of them the total circulating unbound whole venom \ncomponents was estimated at 27 mg, one hour after the attack. Despite the treatment with \ndialysis, antihistamines, corticosteroids, bronchodilators, vasodilators, bicarbonate, \nmannitol and mechanical ventilation, three out four patients died between 22 and 71 h after \nthe attacks. However, in the majority of cases, the renal damage is usually reversible \nresponding well to the dialysis. Complete recovery may require 3-6 weeks (Vetter et al., \n1999).  \n\n3.4 Caterpillar envenomation \n\nThe accidental contact with some lepidopteran caterpillars can also cause human \nenvenomation cases that vary from simple skin irritation and local allergic reactions to a \nsystemic disease characterized by renal damage and hemorrhagic disturbances (Pinto et al., \n2010; Veiga et al., 2009). From the medically important Saturniidae family, Lonomia genus \nhas been attributed to cause human envenomations since late 1960\u2019s in Venezuela (Arocha-\nPi\u00f1ango et al., 2000). In Southern Brazil, Lonomia obliqua caterpillar is becoming the most \nimportant venomous animal responsible for severe injuries, hemorrhagic disorders and \noften fatal outcome since the 1980\u2019s (Duarte et al., 1990). For instance, in the State of Rio \nGrande do Sul, located in this Brazilian region, more than a thousand accidents have been \nregistered in the period from 1997 to 2005 (Abella et al., 2006). In fact, based on data from \nthe year 2009, the Brazilian Ministry of Health registered an incidence of 7.3 lepidopteran \nenvenomations per 100,000 inhabitants in Southern Brazil (Boletim eletr\u00f4nico \nepidemiol\u00f3gico, 2010) (Table 1). Actually, these numbers are greatly underestimated due to \nthe fact that most accidents are occurring in distant rural areas, where the cases are poorly \nreported. Lonomia\u2019s accidents usually occur when the victim, leaning against tree trunks \ncontaining dozens or hundreds of caterpillars, comes into contact with their bristles. These \nstructures are hard and spiny evaginations of the cuticle, underneath which the toxins are \nstored. Often, the whole animal is smashed in the accident, the insect\u2019s chitinous bristles get \nbroken and the venomous secretions, including hemolymph, penetrate the human skin and \nenter the circulation (Veiga et al., 2001a). \n\n88\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n165 \n\nThe venom presents procoagulant, fibrinogenolytic, proteolytic and hemolytic activities \n(Table 2). Clinical symptoms of Lonomia envenomation include local pain (burning \nsensation) and inflammatory reaction, which starts immediately after contact; systemic \nreactions such as headache, fever, vomiting and asthenia, which appear a few hours after \nexposure; and bleeding diathesis characterized by hematomas and ecchymosis, gross \nhematuria, hematemesis, melena, pulmonary and intracerebral hemorrhage and AKI (Pinto \net al., 2010). Intravascular hemolysis has also been described in human envenomation and \nexperimental studies (Malaque et al., 2006; Seibert et al., 2004). The activation of blood \ncoagulation, fibrinolysis and the systemic inhibition of platelet function are mechanisms that \nseem to contribute to the hemorrhagic syndrome commonly observed in Lonomia \nenvenomation (Berger et al., 2010a). In human patients, this hemorrhagic syndrome \nmanifests as a consumptive coagulopathy without thrombocytopenia (Berger et al., 2010a; \nZannin et al., 2003). \n\nThe incidence of AKI varies from 2 to 5 % of envenomation cases reported in the literature \n(Duarte et al., 1990; Gamborgi et al., 2006). Of the 2,067 patients evaluated in southern Brazil \n(period from 1989 to 2003), 39 (1.9 %) developed AKI (serum creatinine levels > 1.5 mg/dL). \nEleven (32 %) of these patients were treated with dialysis and four (10.3 %) developed \nchronic renal injury (CRI). All victims with AKI presented concomitantly coagulation \ndisturbances and hematuria and/or hemoglobinuria. Seven deaths (4%) occurred during the \nperiod (Gamborgi et al., 2006). The impossibility of conducting early renal biopsies, due the \ncoagulation disturbances inherent to the envenomation, has made it difficult to analyze the \nacute anatomopathological alterations. The few reports existing in the literature describe \nthickening of the Bowman\u2019s capsule, focal tubular atrophy and acute tubular necrosis \n(Burdmann et al., 1996; Fan et al., 1998) (Table 2). Similarly, the contribution of other factors \npossibly associated with AKI, such as hypotension or glomerular fibrin deposition, remains \nstill obscure in Lonomia envenomation. \n\n4. Toxins of snake and arthropod venoms and their role in the \npathophysiology of acute kidney injury \n\nAnimal venoms are mixtures of biologically active proteins and peptides, and also non-\nprotein toxins, carbohydrates, lipids, amines, and other small molecules. The clinical \nfeatures of envenomation reflect the effects of these different venom components and thus, \nthe contribution of the venom toxins to the pathophysiology of renal injury is complex and \nmultifactorial (Sitprija, 2006).  \n\nBased on the current knowledge, the hypothesis for pathogenesis of venom-induced AKI \ninclude both a direct cytotoxic action of the venom on different renal structures, and a \nsecondary response of the whole organism resulting from systemic envenomation. The  \nsecondary response is usually triggered by inflammation, release of cytokines and \nvasoactive substances that leads to changes in renal function and hemodynamics (Fig. 1). In \nfact, there is an increase in plasma concentration of different cytokines and vasoactive \nsubstances such as TNF-?, interleukins, nitric oxide, histamine, bradykinin and eicosanoids \nfollowing several types of envenomations (Petricevich et al., 2000). The elevation of \ncytokines are mainly due to accumulation of pro-inflammatory cells and immune system \nresponse. Together, all these mediators can impair renal function ultimately contributing to \n\n89\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n166 \n\na decrease in renal perfusion pressure, renal blood flow and glomerular filtration rate. As a \nresult in association with the systemic hypotension (Table 2), there will be an inadequate \ntissue and cellular oxygen delivery which can generate an ischemic process. Since the \nintermediary metabolism and energy production have an absolute dependence on oxygen, \nand oxygen cannot be stored intracellularly, the inadequate oxygen availability rapidly \nleads to cellular dysfunction, injury, and cell death by necrosis (Deitch, 1992). Important \ncontribution to venom-induced renal ischemia is also derived from the process of hemolysis, \nrhabdomyolysis and/or intravascular deposition of platelets and fibrin in the \nmicrocirculation (Table 2). The presence of hemoglobin and myoglobin also have a direct \ncytotoxic effect on renal tubules (Fig.1) (Khan, 2009; Zager, 1996). Thus, it seems that \ndifferent, but interrelated processes may contribute to the nephrotoxicity and even to other \npathological features observed in envenomed patients. \n \n\nVenomous \nanimals \n\nMain venom \nactivities \n\nGeneral clinical \nmanifestations \n\nCharacteristics of AKI \nand renal pathology \n\nBothrops \nsnakes \n\nHemorrhagic, \nProcoagulant, \n\nProteolytic and \nNephrotoxic \n\nLocal abscesses and \nnecrosis, Spontaneous \n\nbleeding, DIC, \nHypotension \n\nOliguria/anuria, \nHemoglobinuria, \n\nHematuria, ATN, AIN, \nRCN, GFD \n\nCrotalus \nsnakes \n\nNeurotoxic, Myotoxic \nand Nephrotoxic \n\nFlaccid paralysis, \nMyalgia, \n\nRhabdomyolysis \n\nDecrease in GFR, \nMyoglobinuria, ATN, AIN \n\nBrown \nspiders \n\n(Loxsosceles) \n\nDermonecrotic, \nProteolytic, Hemolytic \n\nand Nephrotoxic \n\nLocal abscesses and \nnecrosis, Hemolysis, \n\nRhabdomyolysis, DIC, \nHypotension \n\nHematuria, \nHemoglobinuria, \n\nMyoglobinuria, ATN \n\nAfricanized \nBees (Apis \nmellifera) \n\nHemolytic, Myotoxic, \nCardiotoxic and \n\nNephrotoxic \n\nAllergic reaction \n(anaphylaxis), \nHypotension, \n\nHemolysis, \nRhabdomyolysis \n\nOliguria/anuria,ATN, \nAIN, Hemoglobinuria, \n\nMyoglobinuria \n\nLonomia \ncaterpillars \n\nProcoagulant, \nFibrinogenolytic, \nProteolytic and \n\nHemolytic \n\nEcchymosis, \nSpontaneous bleeding, \n\nDIC, Hemolysis \n\nHematuria, \nHemoglobinuria, ATN \n\nDIC - Disseminated Intravascular Coagulation; ATN - Acute tubular necrosis, AIN - Allergic interstitial \nnephritis, RCN - Renal Cortical Necrosis, GFD - Glomerular Fibrin Deposition, GFR - Glomerular \nFiltration Rate. \n\nTable 2. Clinical aspects of venom-induced Acute Kidney Injury (AKI).     \n\nRecently, advances in molecular biology, proteomics and transcriptomics, facilitated the \nisolation of toxins and contributed significantly to the study of their mechanisms of action \non renal tissue. In this subsection, we reviewed the renal physiopathological effects of snake \nand arthropod venoms and their main isolated toxins. Special emphasis was given to \n\n90\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n167 \n\nexperimental studies with venomous animals highly prevalent in Brazil and other regions of \nLatin America. As in the previous subsection the following animals were included: Bothrops \nand Crotalus snakes, the brown spider Loxosceles, africanized bees, wasps and the caterpillars \nof genus Lonomia.   \n\n \nFig. 1. Schematic summary of pathophysiological phenomena involved in the venom-\ninduced acute kidney injury (AKI). RBF \u2013 Renal Blood Flow; GFR \u2013 Glomerular Filtratiton \nRate; ATN \u2013 Acute Tubular Necrosis; ACN \u2013 Acute Cortical Necrosis. \n\n4.1 Snake venoms \n\n4.1.1 Bothrops venom \n\nThe venom of bothrops snakes can cause prominent local tissue damage usually \ncharacterized by swelling, blistering, hemorrhage and necrosis of skeletal muscle. Such local \npathology is mostly due to the venom proteolytic action (Guti\u00e9rrez et al., 2006). Snake \nvenom metalloproteinases (SVMPs), phospholipases A2, , serine proteinases, esterases, L-\namino acid oxidases, hyaluronidases, C-type lectins-like and bradykinin-potentiating \npeptides (BPPs) are the main venom components that acts inducing cellular injury or \nreleasing inflammatory and vasoactive mediators (Warrell, 2010). Transcriptomic and \nproteomic studies have showed that SVMPs and serine proteinases are the major toxins in \nthe venom, which explained the high local damage and hemorrhage seen in envenomed \npatients (Table 2) (Cidade et al., 2006; Zelanis et al., 2010). Bothrops toxins are also known for \ntheir multiple effects on hemostasis. In fact, the venom have thrombin-like enzymes, factor \n\n91\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n168 \n\nX and prothrombin activators that are able to directly convert fibrinogen into fibrin (Berger \net al., 2008; White, 2005). These actions produce intravascular coagulation and may lead to \nblood incoagulability by consumption coagulopathy. Systemic inhibition of platelet \naggregation and thrombocytopenia are common (Rucavado et al., 2005; Santoro &amp; Sano-\nMartins, 2004). Moreover, anti-hemostatic principles, such as thrombin and platelet \naggregation inhibitors, are also found in bothrops venoms (Kamiguti , 2005; Zingali et al., \n2005).    \n\nRegarding renal function, Boer-Lima et al. (1999) observed that the intravenous injection of \nB. moojeni venom in rats, produced renal tubular disturbances including an increase in \nproximal and post-proximal fractional excretion of sodium associated with acute tubular \nnecrosis. The glomerular filtration rate decreased significantly, despite the absence of \nsystemic hypotension. Severe morphologic disturbances in the renal glomeruli also \noccurred. The changes included mesangiolysis, glomerular microaneurysms, and \nglomerular basement membrane abnormalities. In addition, there was a reduction in the \nnumber and width of podocyte pedicels, which caused a reduction in the number of \nfiltration slits. The morphophysiological changes observed in experimental animals also \ncorrelated with the levels of proteinuria (Boer-Lima et al., 2002). Similar renal functional \nalterations were observed after intravenous injection of B. jararaca venom into rats. In these \nanimals, differently of human envenomation, B. jararaca venom was not able to induce \nsystemic hypotension but significantly reduced the renal plasma flow and increased renal \nvascular resistance (Burdmann et al., 1993). There was no increase in CK, indicating that \nrhabdomyolysis is not an important consequence of B. jararaca envenomation. However, the \nvenom caused marked fibrinogen consumption and intravascular hemolysis. Indeed, kidney \nof rats and rabbits envenomed with B. jararaca showed an extensive intraglomerular \ndeposition of fibrin and platelets (Burdmann et al., 1993; Santoro &amp; Sano-Martins, 2004). \nContrarily to the findings with B. jararaca venom, Boer-Lima et al. (1999) did not observed \nany glomerular fibrin deposition in the B. moojeni envenomation. They suggested that the \nglomerular injury is more likely to be related to structural disorganization of the glomerular \ncapillary tuft, consequent to a direct action of the venom on the mesangial matrix, \nglomerular basement membrane and podocytes rather than to fibrin deposition in the \ncapillaries. \n\nStudying the kinetic of renal distribution of injected B. alternatus venom in rats, Mello et al. \n(2010) detected the highest venom concentration in renal tissue 30 min post-venom injection. \nAfter this time, venom concentration decreased progressively. Venom components were \nalso detected into urine 3, 6 and 24 h post-venom injection. By immunohistochemistry, \nvenom proteins were detected in glomeruli, proximal and distal tubules, and vascular and \nperivascular tissue, suggesting that toxins bind to kidney structures where they probably \nexert a direct nephrotoxic action. In accordance to this observation, it was showed that B. \nalternatus venom is cytotoxic to canine renal epithelial cells (MDCK) in culture and causes \nextensive cytoskeletal alterations inducing impairment of the cell-matrix interaction \n(Nascimento et al., 2007). Additionally, it was described that B. jararaca venom also causes in \nvitro injury of isolated renal proximal tubules and that the B. moojeni venom increases cell \nrelease of lactate dehydrogenase and decreased cellular uptake of the vital neutral red in \nMDCK cells (de Castro et al., 2004; Collares-Buzato et al., 2002). Functionally, B. alternatus \nvenom induced oliguria, urine acidification, decreased in glomerular filtration rate and \n\n92\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n169 \n\nhematuria. Morphologically, the venom caused lobulation of the capillary tufts, dilation of \nBowman's capsular space, disruption of renal tubule brush border, and fibrosis around \nglomeruli and proximal tubules that persisted 7 days after envenomation (Linardi et al., \n2011; Mello et al., 2010).    \n\nSome purified Bothrops toxins are able to reproduce the renal effects obtained with whole \nvenom. Studies on the isolated perfused rat kidney have shown that L-amino acid oxidase \n(Braga et al., 2008), C-type lectins (Braga et al., 2006), phospholipase A2 myotoxins (Barbosa \net al., 2005; Evangelista et al., 2010) and thrombin-like enzyme (Braga et al., 2007) from \nBothrops venoms can alter renal function. The isolated perfused kidney technique also \nconfirmed the direct acute tubular nephrotoxicity of Bothrops venoms and showed that \nplatelet activating factor might play a role in some renal functional disturbances such as the \ndecreased in glomerular filtration rate (Monteiro and Fonteles, 1999). However, the systemic \ninjection of baltergin, a purified metalloproteinase from B. alternatus venom, only mildly \naffected the kidney structure. At high doses, baltergin causes congestion, subcapsular \nhemorrhage and inflammatory infiltrate (Gay et al., 2009). There was no detection of tubular \nnecrosis indicating that different toxins act synergistically to produce the AKI observed in \nanimals treated with whole venom.  \n\n4.1.2 Crotalus venom \n\nThe venom of Crotalus rattlesnakes is a complex combination of different enzymes and toxic \npeptides that mainly display neurotoxic and myotoxic activities (Boldrini-Fran\u00e7a et al., \n2010). Toxins affecting hemostasis, such as thrombin-like enzymes and platelet activators are \nalso found. The main protein families identified by proteomics included phospholipases A2, \nserine proteinases, cysteine-rich secretory proteins (CRISP), vascular endothelial growth \nfactor-like molecules (VEGF), L-amino acid oxidases, C-type lectins-like, and snake venom \nmetalloproteinases (SVMP). Crotoxin, a neurotoxic phospholipase A2, represents more than \n60 % of the proteins in the whole venom and is the major component responsible for its \nneurotoxic and myotoxic effects (Boldrini-Fran\u00e7a et al., 2010). Additionally, crotoxin also \nexhibits cardiotoxic and direct nephrotoxic activities. Structurally, crotoxin is a \nheterodimeric ?-neurotoxin that consists of a toxic basic phospholipase A2 and a \nnonenzymatic, non-toxic acidic component (crotapotin). Crotapotin potentiates the activity \nof crotoxin, since it prevents the basic phospholipase subunit binding to non-specific sites \n(Sampaio et al., 2010; Soares et al., 2001). Crotoxin targets neuromuscular junctions and \ninhibits the release of acetylcholine, which leads to neuromuscular blockade and muscular \nand respiratory paralysis. In the muscle tissue, crotoxin causes selective injury of skeletal \nmuscle groups composed of type I and IIa fibers, which are extremely vascularized and rich \nin myoglobin (Sampaio et al., 2010). Other important toxins are crotamine, convulxin and \ngyroxin. Crotamine is a toxic peptide with myonecrotic activity (Martins et al., 2002). \nConvulxin is a C-type lectin-like glycoprotein with high affinity to specific receptors in \nrabbit and human platelets. Convulxin binds to the putative collagen receptor glycoprotein \nVI (GPVI) and mediates platelet adhesion, aggregation and intracellular calcium \nmobilization (Francischetti et al., 1997). Gyroxin is a serine proteinase that displays several \nactivities including the induction of blood coagulation (thrombin-like activity), vasodilation \nand neurotoxicity (Alves da Silva et al., 2011). \n\n93\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n170 \n\nIntraperitoneal injection of C.d. terrificus venom in mice increased plasma creatinine and uric \nacid and caused urinary hypoosmolality. When compared to control groups injected with \nsaline, the incidence of hypercreatinemia and hyperuricemia (plasma values higher than 1.8 \nmg/dL) occurred in 60 % and 100 % of the experimental animals, respectively (Yamasaki et \nal., 2008). Crotalus experimental envenomation was also associated with significant renal \nblood flow and glomerular filtration rate decreases and ischemia with consequent acute \ntubular necrosis. In isolated perfused rat kidneys treated with crude venom or crotoxin, a \nlarge amount of protein material was observed in the glomeruli, probably due to a direct \ntoxic effect of the venom on the glomeruli and tubules and/or to an increase in vascular \npermeability (Monteiro et al., 2001). Prostaglandins and TNF-? release seems to be \nimportant since the treatment with indomethacin and pentoxifylline (inhibitors of \ncyclooxygenase and TNF-? synthesis, respectively) were able to blockade the renal effects \ninduced by supernatant of macrophages activated with Crotalus venom (Martins et al., 2003; \nMartins et al., 2004). Among the main venom components, crotoxin was able to induce \nsignificant changes in glomerular filtration rate and electrolyte transport in isolated kidney. \nGyroxin caused only mild alteration in renal parameters and convulxin had no effects \n(Martins et al., 2002). \n\nRhabdomyolysis is a well-known cause of AKI and is commonly observed in envenomed \npatients and envenomed experimental animals. Myoglobin toxicity has been related to renal \nvasoconstriction, intraluminal cast formation and direct heme-protein cytotoxicity. \nMyoglobin can contribute to renal vasoconstriction by directly binding to nitric oxide (NO). \nThus, acting as NO scavenging molecules, heme-proteins (including myoglobin or \nhemoglobin) lead to renal hypoperfusion, reductions in the storage of ATP, ischemia and \ntissue injury (Zager, 1996). Intraluminal casts are formed due to the precipitation of \nmyoglobin inside the renal tubules, forming obstructive casts. Precipitated myoglobin also \ncan be degraded resulting in the release of free iron and heme. Once released, free iron and \nheme contribute to renal injury by generate reactive oxygen species (ROS) and lipid \nperoxidation (Khan, 2009; Zager, 1996). Indeed, Yamasaki et al. (2008), showed an increase \nof oxidized glutathione/reduced glutathione ratio (GSSG/GSH) in renal tissue during \nCrotalus envenomation. This data indicates a rise in the ROS generation by consumption of \nreduced glutathione (GSH) and production of oxidized glutathione (GSSH) which are the \nmain antioxidant and oxido-reducing agents, respectively. Confirming the participation of \nROS in Crotalus induced renal injury, envenomed animals treated with lipoic acid (an \nantioxidant molecule) had their GSSG/GSH ratios normalized when compared to control \ngroups (Alegre et al., 2010). In addition to deleterious effects of obstructive myoglobin casts \nformation, the high levels of uric acid found in envenomed animals also contribute to \ntubular obstruction (Yamasaki et al., 2008). Marked hyperuricemia is known to cause AKI \nby supersaturation, crystallisation and deposition of crystals inside renal tubules (acute \nurate nephropathy). Moreover, experimental hyperuricemia causes renal vasoconstriction \nand soluble uric acid has been shown to inhibit endothelial NO bioavailability (Ejaz et al., \n2007). Recently, it was observed that systemic inhibition of uric acid synthesis, by \nallopurinol treatment, significantly reduced lethality rate, normalized GSSG/GSH ratio and \nameliorate the renal histopathological changes. Thus, uric acid also seems to have an \nimportant role in renal pathophysiology of Crotalus envenomation (Frezzatti &amp; Silveira, \n2011).   \n\n94\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n171 \n\n4.2 Loxosceles venom \n\nThe bites of brown spiders (Loxosceles genus) led to several clinical manifestations such as \nnecrotic skin degeneration and gravitational spread at the bite site, renal injury and \nhematological disturbances. Several studies concerning the structural and biological roles of \nvarious venom components have shown the complex nature of these venomous secretions. \nLikewise, the venom of Loxosceles spiders is a complex mixture of protein-based toxins with \na molecular mass profile ranging from 5 to 40 kDa. The main components belong to the \nclasses of phospholipases D (or dermonecrotic toxins), serine proteinases, venom allergens, \nhyaluronidases, astacin-like metalloproteinases and insecticidal peptides (Gremski et al., \n2010). Dermonecrotic toxins and astacin-like metalloproteinases are considered the major \ncomponents responsible for the clinical profile observed in envenomed victims (Table 2) (da \nSilva et al., 2004). In fact, a transcriptomic study indicated that phospholipases D and \nastacin-like metalloproteinases represent 20.2 % and 22.6 % of total toxin-encoding \ntranscripts, respectively. Other toxins also important to envenomation, such as serine \nproteinases, venom allergens and hyaluronidases represent the minority of encoding \ntranscripts (Gremski et al., 2010).  \n\nAmong all the toxins found in Loxosceles spider venom, dermonecrotic toxin is undoubtedly \nthe component most investigated and characterized. This toxin is able to reproduce the \nmajor biological effects induced by whole venom. It is involved with the development of \ndermonecrotic lesions and can trigger neutrophil migration, complement system activation, \ncytokine and chemokine release, platelet aggregation, lysis of red blood cells, among other \neffects (Abdulkader et al., 2008; da Silva et al., 2004). Dermonecrotic toxin comprises a \nfamily of toxins with different related isoforms that have biological, amino acid and \nimmunological similarities which are found in several Loxosceles species. Only in L. \nintermedia venom, many isoforms were described being 9 out of them already expressed as \nrecombinant proteins (Gremski et al., 2010). Loxosceles dermonecrotic toxins belong to \nphospholipases D (30\u201335 kDa) class of enzymes which was primarily designated as \nsphingomyelinases D due to their ability to convert sphingomyelin to choline and ceramide \n1-phosphate (N-acylsphingosine1-phosphate). As some Loxosceles sphingomyelinases D \nhave broad substrate specificity, being able to hydrolyze not only sphingophospholipids but \nalso lysoglycerophospholipids, they are now classified as phospholipases D (Lee and Lynch, \n2005). Due to sequence, structural and biochemical differences these toxins are grouped in \ntwo classes and their structures and substrate specificities have been recently elucidated (de \nGiuseppe et al., 2011; Murakami et al., 2005). Other important components of Loxosceles \nvenom are the metalloproteinases. The enzymes have molecular weights ranging from 20 to \n35 kDa displaying gelatinolytic, fibronectinolytic and fibrinogenolytic activities. They are \nzinc endopeptidases homologous to the astacin family of metalloproteinases from the \ncrayfish, Astacus astacus. The Loxosceles astacin-like metalloproteinases possess a digestive \nfunction used to initiate the degradation of prey molecules, facilitating the posterior \ningestion process (Trevizan-Silva et al., 2010). Furthermore, these enzymes have an \nimportant role in the pathogenesis observed in envenomation, particularly inducing \nhemorrhage into the dermis, injury of blood vessels, imperfect platelet adhesion, and the \ndefective wound healing observed in some cases. Likewise, these metalloproteases can also \nrender tissue structures more permeable, facilitating other noxious toxins to spread \nthroughout the body of victims (Veiga et al., 2000; Veiga et al., 2001b). \n\n95\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n172 \n\nThe nephrotoxic effect of the L. intermidia spider venom was demonstrated experimentally \nin mice exposed to the whole venom (Luciano et al., 2004). Histhopathological analysis \nshowed morphological renal alterations including hyalinization of proximal and distal \ntubules, erythrocytes in Bowman\u2019s space, glomerular collapse, tubule epithelial cell blebs \nand vacuoles, interstitial edema, and deposition of a protein-rich material inside the \nBowman\u2019s space and tubule lumen. Morphometric analysis showed that 75\u201380 % of the \nkidney area was affected by the venom and no glomerular or tubule leukocyte infiltration \nwas described, suggesting that the involvement of inflammatory process is not important to \nrenal injury in this type of envenomation. Despite the presence of erythrocytes and protein \ndeposits in glomerular and tubular structures, no signs of intravascular hemolysis or \nhemoglobin were detected in envenomed animals. Supporting the evidence that L. intermidia \nvenom has toxins with direct nephrotoxicity, confocal microscopy studies with antibodies \nagainst venom proteins were able to show direct binding of toxins to renal structures. \nVenom proteins were detected in glomerular and tubular epithelial cells and in renal \nbasement membranes. Toxins with molecular weights of 30 kDa were also identified in renal \ntissue extracts by immunoblotting (Luciano et al., 2004). One of these venom proteins that \ncan bind to the kidney tissue is the dermonecrotic toxin. Chaim et al. (2006), injecting the \nrecombinant dermonecrotic toxin in mice, found glomerular edema and tubular necrosis \nwithout signs of inflammatory response. Additionally, the dermonecrotic toxin was detected \nin kidney tissue and induced changes in renal function such as urine alkalinization, \nhematuria and elevation of blood urea nitrogen levels. The treatment of renal epithelial cells \n(MDCK) with recombinant dermonecrotic toxin also caused morphological alterations \nand reduced the cell viability, confirming its direct citotoxicity (Chaim et al., 2006). Both \neffects upon renal structures in vivo and renal cells in vitro were dependent of the \nphospholipase D catalytic activity, since a mutated toxin without phospholipase activity \nshowed no nephrotoxic effect (Kusma et al., 2008). Another mechanism involved in AKI \ninduced by Loxosceles venom is the renal vasoconstriction and rhabdomyolysis. Recently, \nit was reported that L. gaucho caused a sharp and significant drop in glomerular filtration \nrate, renal blood flow and urinary output and increased renal vascular resistance in rats \n(Lucato-J\u00fanior et al., 2011). In this model, the authors also found deposits of myoglobin in \ntubular cells and degenerative lesions indicative of an ischemic process (Lucato-J\u00fanior et \nal., 2011).     \n\n4.3 Bee and wasp venoms \n\nBee and wasp venoms are composed of a mixture of proteins, peptides, and small \nmolecules, which are related to different mechanisms of envenomation. In the Africanized \nbee (Apis mellifera) venom the most important components are melittin and phospholipase \nA2. Melittin is a highly toxic peptide and the most abundant component of bee venom \ncomprising about 50 % of its dry weight. This peptide is able to disrupt biological \nmembranes, producing many effects on living cells (Fletcher et al., 1993). Melittin has \nantibacterial activity, induces voltage-gated channel formation and can also produce \nmicellization of phospholipids bilayers due to its membrane-interacting effect. This peptide \nis responsible for the direct hemolytic effect of Apis venom (Dempsey, 1990; Terra et al., \n2007). The enzyme phospholipase A2 represents approximately 11 % of whole venom and \nacts synergically with melittin. Once melittin has disrupted the membrane, phospholipase \n\n96\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n173 \n\nA2 cleaves bonds in the fatty acid portion of the bilipid membrane layer (Vetter et al., 1999; \nLee et al., 2001). In association, melittin and phospholipase A2, can act on erythrocytes, \nmyocytes, hepatocytes, fibroblasts, mast cells, and leukocytes (Abdulkader et al., 2008; \nFletcher et al., 1993; Habermann, 1972). Additionally, bee venom also has hyaluronidase (an \nenzyme that disrupts the hyaluronic acid in connective-tissue matrix), apamin (a \nneurotoxin), mast cell degranulating peptide (a peptide that releases histamine from mast \ncells) and other small molecules such as histamine, dopamine, and noradrenaline. Among \nall Apis mellifera venom components the main allergens are melittin, phospholipase A2 and \nhyaluronidase (Vetter et al., 1999). In wasp venoms the components are active amines \n(serotonin, histamine, tyramine, catecholamines); wasp kinins (similar in composition to \nbradykinin), which are mostly responsible for pain; and histamine-releasing peptides, which \nare responsible for the inflammatory response. The major allergens identified in wasp \nvenoms are phospholipase A1, a hyaluronidase and a serine-protease (Pantera et al., 2003; \nVetter et al., 1999).  \n\nDespite the current knowledge on the composition of wasp venoms, little is known about \nthe participation of its components, and even the whole venom, on the AKI observed in \nenvenomed patients. On the other hand, the mechanisms of bee venom-induced AKI have \nbeen more explored in experimental models in vivo and in vitro. In the case of bee \nenvenomation, the experimental injection of venom in rats caused a significant and early \nreduction in glomerular filtration rate and diuresis and an increase in plasma creatinine \nlevels (dos Reis et al., 1997; Grisotto et al., 2006). Tubular alterations such as increased \nfractional sodium and potassium excretions and a reduced water transport through \ncollecting tubules, were also described (dos Reis et al., 1997). The early glomerular filtration \nrate reduction was concomitant with marked cortical and medullary renal blood flow \ndecrease (Grisotto et al., 2006). Neither hypertension and hypotension nor intravascular \nhemolysis were detected in experimental models. Despite of the absence of hemolysis, \nrhabdomyolysis was present with massive myoglobin deposition in the lumen of the tubules \nas well as into the tubular cells (dos Reis et al., 1997; Grisotto et al., 2006). The injection of \npurified melittin or phospholipase A2 also induced rhabdomyolysis, due to their capacity to \ndisrupt the membranes of myocytes (Ownby et al., 1997). Additionally, in vitro studies have \nbeen demonstrated that bee venom is citotoxic to cultured isolated proximal tubule cells \n(Grisotto et al., 2006). Histological analysis showed acute tubular necrosis mainly in cortex \nand outer medulla, and cast formation in the distal and collecting tubules (dos Reis et al., \n1998). These degenerative lesions observed in AKI induced by the bee venom have been \nassociated with the ischemic process induced by melittin, phospholipase A2 and histamine \n(Abdulkader et al., 2008; Grisotto et al., 2006). Indeed, melittin and phospholipase A2 may \nbe related to impaired renal blood flow by causing direct vasoconstriction, smooth muscle \ncell contraction, increased renal renin secretion and release of vasoconstrictor eicosanoids \nand catecholamines. Histamine and the mast cell degranulating peptides present in the \nvenom also play a role in renal blood flow decrease, since histamine can directly induce \nvascular changes (Cerne et al., 2010; Churchill et al., 1990).  \n\n4.4 Lonomia venom \n\nCaterpillars of the species L. obliqua are well known in Southern Brazil by causing a severe \nhemorrhagic syndrome characterized by coagulation disorders, AKI and generalized \n\n97\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n174 \n\nhemorrhage. The venom is composed of several active principles, including procoagulant \nand fibrinolytic activities (Pinto et al., 2010). Even though many studies have been \nperformed with toxic secretions from L. obliqua aiming a better elucidation of the \nhemorrhagic syndrome resulting from this envenomation, few active principles have been \npurified from the venom and fully characterized so far. Thus, most of the molecules \nidentified in this caterpillar have been characterized as putative enzymes and other proteins \nbased solely on cDNA and amino acid sequences obtained by transcriptomic and proteomic \nmethods (Ricci-Silva et al., 2008; Veiga et al., 2005). Through these techniques, the major \nprotein found in Lonomia is a biliverdin-binding protein of the lipocalin family, which is \nmainly concentrated in the bristles and plays an important role in the caterpillar\u2019s \ncamouflage behavior. Along with the lipocalin and other housekeeping proteins, L. obliqua\u2019s \nintegument, hemolymph and bristles produce and store a variety of active principles. \nAmong these proteins, the most abundant ones are serine proteases and their inhibitors \n(serpins) in the integument, and serine proteases, kininogen and lectins in the bristles. \nBesides these molecules, cysteine proteinases, phospholipase A2, cystatins, Kazal-type \ninhibitors and other protease inhibitors are also found. Serine proteases are the most \nrelevant protein family when considering their potential of interfering with blood \ncoagulation. Moreover, serine proteases are an expressive group, representing 16.7 % and 25 \n% of the clusters derived from tegument and bristle transcriptome, respectively (Veiga et al., \n2005). This protein group presents coagulation factors-like activities, so it is expected that \nthese enzymes participate in the generation of thrombin, by activation of factor X and \nprothrombin (Berger et al., 2010a; Veiga et al., 2003), and in the activation of the fibrinolytic \nsystem, contributing directly and indirectly to fibrinogen degradation (Pinto et al., 2006) and \nresulting in the hemorrhagic disorder. In fact, proteases with fibrinogenolytic, prothrombin \nand factor X activating activities have been purified and characterized in this venom \n(Alvarez-Flores et al., 2006; Pinto et al., 2004; Reis et al., 2006). The phospholipase A2 \nenzyme also has a function in envenomation. This enzyme was isolated and characterized \nas the major component responsible to the in vitro and in vivo hemolytic activity of L. \nobliqua venom (Seibert et al., 2004; Seibert et al., 2006). Additionally, the phospholipase A2 \nseems to be involved in platelet aggregation inducing activity present in the venom \n(Berger et al., 2010b). Lectins, particularly c-type lectins, are a relatively well-studied \ngroup of proteins in snake venoms that may exert an additional function in hemostasis \nmodulation by interacting with coagulations factors and/or platelet receptors. Three \nlectin clusters were found in the bristle cDNA library with homology to many snake \nvenom lectins being then another important candidate contributing to the hemorrhagic \ndisorder (Veiga et al., 2005). \n\nAlthough AKI is the leading cause of death in L. obliqua envenomation, the mechanisms \ninvolved in kidney disorders are poorly understood. In contrast to hemostatic disturbances, \nto date, there is no experimental studies describing the renal effects of L. obliqua venom. \nCurrent knowledge is based only on a few case reports in which hematuria, high levels of \nserum creatinine and acute tubular necrosis are described as the main features of L. obliqua \ninduced AKI. Due to this lack of knowledge, nowadays we are focused on the investigation \nof the effects of L. obliqua venom on renal function in rats. Preliminary results, indicate that \nsubcutaneous injection of L. obliqua bristle extract caused severe hematuria with the \npresence of intact erythrocytes and leukocytes in urinary sediment (Berger et al., \n\n98\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n175 \n\nunpublished data). Envenomed animals also show proteinuria and significant changes in \nglomerular filtration rate and tubular electrolytic transport (Berger et al., unpublished data). \nCurrently, the contribution of intravascular coagulation, deposits of hemoglobin in renal \ntubules and hemodynamic changes are under investigation. \n\n5. Diagnosis and management of acute kidney injury in snake and arthropod \nenvenomation \n\nThe early intravenous administration of animal-derived antivenoms is the only specific \ntreatment against snake and arthropod envenomations. Antivenoms are concentrated of \nimmunoglobulins (usually pepsin-refined F(ab\u2019)2 fragment of whole IgG) purified from the \nplasma of a horse or sheep that has been immunized with the venoms of one or more \nspecies of venomous animal (WHO, 2010a). The preparation of antivenoms is expensive and \ntechnically demanding. Around the world different manufacturers, which include public \nand private laboratories of diverse sizes and strengths, are able to produce the antivenoms \n(Guti\u00e9rrez et al., 2010; Williams et al., 2010). Some of them are small facilities, mostly located \nin public institutions, which manufacture for the needs of specific countries. Others are \nlarger laboratories that manufacture and distribute antivenoms throughout various \ncountries or regions. Although some countries or regions manufacture enough antivenom \nfor their national and regional needs, as in Europe, USA, Brazil, Central America, Mexico, \nAustralia, Thailand and Japan, in other parts of the world, specially in some regions of \nAfrica, there are very few antivenom producers (Guti\u00e9rrez et al., 2010). In Brazil, three main \nInstitutions are responsible for production of antivenoms: Instituto Butantan, Funda\u00e7\u00e3o \nEzequiel Dias and Hospital Vital Brasil. The manufacture is government-subsidized and the \nantivenom is usually provided free to the patients. However, failures in the distribution of \nantivenoms to places where they are needed still contribute to the maintenance of high \nmortality rates (Table 1). In some instances, antivenoms are held in the main cities, where \nenvenomations are rare, instead of being distributed to peripheral health clinics in rural \nareas where the accidents are frequent. This reflects defective distribution planning which is \nassociated with a lack of coordination between those who understand the epidemiological \npattern of the disease and those responsible for the antivenom distribution. Also, inadequate \nstorage and transportation of antivenoms may result in physical destruction of vials and \nampoules (e.g. by freezing of liquid antivenom) (WHO, 2010a). Besides the inadequate \nsupply, distribution and accessibility to safe and effective antivenoms, another major issue is \nthe lack of trained of health workers on how to use these products and how to conduct \nappropriate clinical management of medical emergencies. In fact, it is estimated that in \nBrazil in 2009, 37% of accidents with scorpions and 9% of accidents with spiders received \ninadequate treatment with antivenom, mainly because the health authorities are uninformed \nof the treatment protocols (Boletim eletr\u00f4nico epidemiol\u00f3gico, 2010).   \n\nThe treatment with antivenom is indicated in moderate and severe cases when systemic \nsigns of envenomation are observed. In general, patients with hemostatic abnormalities, \nneurotoxic signs, cardiovascular abnormalities, AKI, hemoglobinuria and myoglobinuria \nshould receive antivenom therapy (WHO, 2010a). In these cases the time elapsed between \nthe occurrence of the accident and administration of a correct dose of antivenom is decisive \nfor a sucessful therapy. It was demonstrated that the time interval between the accident and \n\n99\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n176 \n\nadministration of the antivenom of more than 2 hours was associated with the development \nof AKI, as well as with the risk of death or permanent injuries after Bothrops and Crotalus \nenvenomations (Otero et al., 2002; Pinho et al., 2005). Although the correct use of antivenom \nis an effective form of treatment, the sorotherapy is also associated with the occurrence of \nsevere adverse effects. The most serious adverse effect is anaphylactic reactions. Clinical \nfeatures such as urticaria, itching, fever, tachycardia, vomiting, abdominal colic, headache, \nbronchospasm, hypotension and angioedema have been described after antivenom \ntreatment (Fan et al., 1999; Minist\u00e9rio da Sa\u00fade, 2001). The incidence of adverse effects \ndepends on the quality, dose and speed of intravenous injection or infusion. With \nantivenoms of good quality profile, there is a low incidence (less than 10%) of generally mild \nadverse reactions, mostly urticaria and itching. However, for products containing \ncontaminant proteins, the incidence of such reactions may be as high as 85 %, including \npotentially life-threatening systemic disturbances such as hypotension and bronchospasm \n(WHO, 2007). Thus the adverse effects are directly associated with lack of good \nmanufacturing practices adopted by laboratories that manufacture antivenoms. Recently, in \nan attempt to improve the quality of antivenom production the WHO established the \nguidelines for production, control and regulation of snake antivenom immunoglobulins. \nThese guidelines provide detailed information on the recommended steps for antivenom \nmanufacture and control (WHO, 2010b).   \n\nA number of additional interventions besides antivenom  may be necessary to restore renal \nfunction in patients who developed AKI. Special attention should be given to hypotension, \nshock, electrolyte balance and maintenance of an adequate state of hydration. An urinary \nflow of 30 to 40 mL/h/kg is recommended for adults and 1 to 3 mL/h/kg for children to \nprevent AKI after snake envenomations (Minist\u00e9rio da Sa\u00fade, 2001; Pinho et al., 2008). \nPatients presenting oliguria or anuria, despite of fluid administration, are usually treated \nwith intravenous furosemide or mannitol (WHO, 2010a). In these cases, a higher urinary \nflow may decrease the expousure of tubular cells to venom components and myoglobin or \nhemoglobin, which result in injury attenuation and prevention of tubular lumen obstruction \n(Zager, 1996). Cases that are unresponsive to fluid intake and diuretics are referred to renal \nunits for dialysis (Pinho et al., 2008). Early alkalinization of urine by sodium bicarbonate in \npatients with myoglobinuria or hemoglobinuria is also recommended, because in the \npresence of acidic urine, myoglobin and uric acid precipitate and form obstructive cast \n(Khan, 2009). \n\n6. Conclusion \n\nEnvenomation by different venomous snakes and arthropods is a neglected disease that \nafflicts the most impoverished inhabitants of rural areas in tropical developing countries. In \nthis chapter, we reviewed some important aspects related to epidemiology, prevalence, \nclinical manifestations, pathophysiology and treatment of venom-induced AKI, which is one \nof the most significant and lethal effect of animal venoms. Despite of actual knowledge \ndiscussed here, several aspects involving the renal manifestations remain still unclear. Thus, \nfurther research are needed to cover the following key points: (i) biochemical composition of \ndifferent animal venoms and their individual contribution to renal injury; (ii) renal \npathological mechanisms induced by some specific venoms that are still unexplored; (iii) \n\n100\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n177 \n\ndiscovery of new and more specific therapeutic alternatives to treat envenomation cases and \n(iv) improvement in the production, distribution and availability of the antivenoms \ncurrently used. \n\n7. Acknowledgments \n\nThe authors are grateful to Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior, \nMinist\u00e9rio da Educa\u00e7\u00e3o, Brasil (CAPES-MEC) and Conselho Nacional de Desenvolvimento \nCient\u00edfico e Tecnol\u00f3gico, Minist\u00e9rio da Ci\u00eancia e Tecnologia, Brasil (CNPq-MCT) for \nfunding and fellowships. \n\n8. References \n\nAbella, H.B; Marques, M.G.B.; Silva, K.R.L.M.; Rossoni, M.G. &amp; Torres, J.B. (2006). Acidentes \ncom lagartas do g\u00eanero Lonomia registrados no Centro de Informa\u00e7\u00e3o Toxicol\u00f3gica \ndo Rio Grande do Sul no per\u00edodo de 1997 a 2005, In: Nicolella, A. (Ed.), \nToxicovogil\u00e2ncia \u2013 toxicologia cl\u00ednica: dados e indicadores selecionados. Secretaria da \nSa\u00fade. Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade. Centro de \nInforma\u00e7\u00e3o Toxicol\u00f3gica, Porto Alegre, pp. 29-34. \n\nAbdulkader, R.C.; Barbaro, K.C.; Barros, E.J. &amp; Burdmann, E.A. (2008). Nephrotoxicity of \ninsect and spider venoms in Latin America. Seminars in Nephrology. Vol.28, No.4, \npp. 373-82. \n\nAlegre, V.S.; Barone, J.M.; Yamasaki, S.C.; Zambotti-Villela, L. &amp; Silveira, P.F. (2010). Lipoic \nacid effects on renal function, aminopeptidase activities and oxidative stress in \nCrotalus durissus terrificus envenomation in mice. Toxicon. Vol.56, No.3, pp.402-10. \n\nAlvarez-Flores, M.P.; Fritzen, M.; Reis, C.V. &amp; Chudzinski-Tavassi, A.M. (2006). Losac, a \nfactor X activator from Lonomia obliqua bristle extract: its role in the \npathophysiological mechanisms and cell survival. Biochemical and Biophysical \nResearch Communications. Vol. 343, No. 4, pp. 1216-23.  \n\nAlves da Silva, J.A.; Oliveira, K.C. &amp; Camillo, M.A. (2011). Gyroxin increases blood-brain \nbarrier permeability to Evans blue dye in mice. Toxicon. Vol.57, No.1, pp.162-7. \n\nAmaral, C.F.; de Rezende, N.A.; da Silva, O.A.; Ribeiro, M.M.; Magalh\u00e3es, R.A.; dos Reis, \nR.J.; Carneiro, J.G. &amp; Castro, J.R. (1986). Acute kidney failure secondary to ophidian \nbothropic and crotalid accidents. Analysis of 63 cases. Revista do Instituto de \nMedicina Tropical de Sao Paulo. Vol.28, No.4, pp. 220-7. \n\nArocha-Pi\u00f1ango, C.L.; Marval, E. &amp; Guerrero, B. (2000). Lonomia genus caterpillar toxins: \nbiochemical aspects. Biochimie. Vol.82, No.9-10, pp.937-42. \n\nAzevedo-Marques, M.M.; Cupo, P.; Coimbra, T.M.; Hering, S.E.; Rossi, M.A. &amp; Laure, C.J. \n(1985). Myonecrosis, myoglobinuria and acute renal failure induced by South \nAmerican rattlesnake (Crotalus durissus terrificus) envenomation in Brazil. Toxicon. \nVol.23, No.4, pp. 631-6. \n\nAzevedo-Marques, M.M.; Hering, S.E. &amp; Cupo, P. (1987). Evidence that Crotalus durissus \nterrificus (South American rattlesnake) envenomation in humans causes myolysis \nrather than hemolysis. Toxicon. Vol.25, No.11, pp. 1163-8. \n\nBarbosa, P.S.; Martins, A.M.; Havt, A.; Toyama, D.O.; Evangelista, J.S.; Ferreira, D.P.; \nJoazeiro, P.P.; Beriam, L.O.; Toyama, M.H.; Fonteles, M.C. &amp; Monteiro, H.S. (2005). \n\n101\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n178 \n\nRenal and antibacterial effects induced by myotoxin I and II isolated from Bothrops \njararacussu venom. Toxicon. Vol.15, No.4, pp 376-86. \n\nBerger, M.; Pinto, A.F. &amp; Guimar\u00e3es, J.A. (2008). Purification and functional characterization \nof bothrojaractivase, a prothrombin-activating metalloproteinase isolated from \nBothrops jararaca snake venom. Toxicon. Vol.51, No.4, pp. 488-501. \n\nBerger, M.; Reck-Jr, J.; Terra, R.M.; Pinto, A.F.; Termignoni, C. &amp; Guimar\u00e3es, J.A. (2010a) \nLonomia obliqua caterpillar envenomation causes platelet hypoaggregation and \nblood incoagulability in rats. Toxicon. Vol.55, No.1, pp. 33-44. \n\nBerger, M.; Reck-Jr, J.; Terra, R.M.; Beys da Silva, W.O; Santi, L.; Pinto, A.F.; Vainstein, M.H.; \nTermignoni, C. &amp; Guimar\u00e3es, J.A. (2010b). Lonomia obliqua venomous secretion \ninduces human platelet adhesion and aggregation. Journal of Thrombosis and \nThrombolysis. Vol.30, No.3, pp. 300-10. \n\nBoer-Lima, P.A.; Gontijo, J.A. &amp; da Cruz-H\u00f6fling, M.A. (1999). Histologic and functional \nrenal alterations caused by Bothrops moojeni snake venom in rats. American Journal of \nTropical Medicine and Hygiene. Vol.61, No.5, pp. 698-706.  \n\nBoer-Lima, P.A.; Gontijo, J.A. &amp; Cruz-H\u00f6fling, M.A. (2002). Bothrops moojeni snake venom-\ninduced renal glomeruli changes in rat. American Journal of Tropical Medicine and \nHygiene. Vol.67, No.2, pp. 217-22. \n\nBoldrini-Fran\u00e7a, J.; Corr\u00eaa-Netto, C.; Silva, M.M.; Rodrigues, R.S.; De La Torre, P.; P\u00e9rez, A.; \nSoares, A.M.; Zingali, R.B.; Nogueira, R.A.; Rodrigues, V.M.; Sanz, L. &amp; Calvete, J.J. \n(2010). Snake venomics and antivenomics of Crotalus durissus subspecies from \nBrazil: assessment of geographic variation and its implication on snakebite \nmanagement. Journal of Proteomics. Vol.73, No.9, pp. 1758-76. \n\nBoletim eletr\u00f4nico epidemiol\u00f3gico, 2010. Secretaria de Vigil\u00e2ncia em Sa\u00fade/Minist\u00e9rio da \nSa\u00fade (SVS/MS), Brasil. Available from:   \nwww.portal.saude.gov.br/portal/arquivos/pdf/ano10_n02_sit_epidemiol_zoonos\nes_br.pdf  \n\nBraga, M.D.; Martins, A.M.; Amora, D.N.; de Menezes, D.B.; Toyama, M.H.; Toyama, D.O.; \nMarangoni, S.; Barbosa, P.S.; de Sousa Alves, R.; Fonteles, M.C. &amp; Monteiro, H.S. \n(2006) Purification and biological effects of C-type lectin isolated from Bothrops \ninsularis venom. Toxicon. Vol.47, No.8, pp. 859-67.  \n\nBraga, M.D.; Martins, A.M.; de Menezes, D.B.; Barbosa, P.S.; Evangelista, J.S.; Toyama, M.H.; \nToyama, D.O.; Fonteles, M.C. &amp; Monteiro, H.S. (2007). Purification and biological \nactivity of the thrombin-like substance isolated from Bothrops insularis venom. \nToxicon. Vol.49, No.3, pp. 329-38.  \n\nBraga, M.D.; Martins, A.M.; Amora, D.N.; de Menezes, D.B.; Toyama, M.H.; Toyama, D.O.; \nMarangoni, S.; Alves, C.D.; Barbosa, P.S.; de Sousa Alves, R.; Fonteles, M.C. &amp; \nMonteiro HS. (2008). Purification and biological effects of L-amino acid oxidase \nisolated from Bothrops insularis venom. Toxicon. Vol.51, No.2, pp. 199-207. \n\nBurdmann, E.A.; Woronik, V.; Prado, E.B.; Abdulkader, R.C.; Saldanha, L.B.; Barreto, O.C. &amp; \nMarcondes, M. (1993). Snakebite-induced acute renal failure: an experimental \nmodel. American Journal of Tropical Medicine and Hygiene. Vol.48, No.1, pp. 82-8. \n\nBurdmann, E.A.; Antunes, I.; Saldanha, L.B. &amp; Abdulkader, R.C. (1996). Severe acute renal \nfailure induced by the venom of Lonomia caterpillars. Clinical Nephrololgy. Vol.46, \nNo.5, pp. 337-9. \n\n102\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n179 \n\nCerne, K.; Kristan, K.C.; Budihna, M.V. &amp; Stanovnik, L. (2010). Mechanisms of changes in \ncoronary arterial tone induced by bee venom toxins. Toxicon. Vol.56, No.3, pp. 305-\n12. \n\nChaim, O.M.; Sade, Y.B.; da Silveira, R.B.; Toma, L.; Kalapothakis, E.; Ch\u00e1vez-Ol\u00f3rtegui, C.; \nMangili, O.C.; Gremski, W.; von Dietrich, C.P.; Nader, H.B. &amp; Veiga S.S. (2006). \nBrown spider dermonecrotic toxin directly induces nephrotoxicity. Toxicology and \nApplied Pharmacology. Vol.211, No.1, pp. 64-77. \n\nChao, Y.W.; Yang, A.H.; Ng, Y.Y. &amp; Yang, W.C. (2004). Acute interstitial nephritis and \npigmented tubulopathy in a patient after wasp stings. American Journal of Kidney \nDiseases. Vol.43, No.2, pp. 15-19. \n\nChippaux, J.P. (1998). Snake-bites: appraisal of the global situation. Bulletin of the World \nHealth Organization. Vol.76, No.5, pp. 515-24. \n\nChippaux, J.P. &amp; Goyffon, M. (2008). Epidemiology of scorpionism: a global appraisal. Acta \nTropica. Vol.107, No.2, pp. 71-9. \n\nChippaux, J.P. (2011). Estimate of the burden of snakebites in sub-Saharan Africa: a meta-\nanalytic approach. Toxicon. Vol.57, No.4, pp. 586-99. \n\nChurchill, P.C.; Rossi, N.F.; Churchill, M.C. &amp; Ellis, V.R. (1990). Effect of melittin or renin \nand prostaglandin E2 release from rat renal cortical slices. Journal of Physiolology. \nVol.428, pp. 233\u2013241. \n\nCidade, D.A.; Sim\u00e3o, T.A.; D\u00e1vila, A.M.; Wagner, G.; Junqueira-de-Azevedo, I.L.; Ho, P.L.; \nBon, C.; Zingali, R.B. &amp; Albano, R.M. (2006). Bothrops jararaca venom gland \ntranscriptome: analysis of the gene expression pattern. Toxicon. Vol.48, No.4, pp. \n437-61.  \n\nCollares-Buzato, C.B.; de Paula Le Sueur, L. &amp; da Cruz-H\u00f6fling, M.A. (2002). Impairment of \nthe cell-to-matrix adhesion and cytotoxicity induced by Bothrops moojeni snake \nvenom in cultured renal tubular epithelia. Toxicology and Applied Pharmacolology. \nVol.181, No.2, pp. 124-32. \n\nCologna, C.T.; Marcussi, S.; Giglio, J.R.; Soares, A.M. &amp; Arantes, E.C. (2009). Tityus serrulatus \nscorpion venom and toxins: an overview. Protein and Peptide Letters. Vol.16, No.8, \npp. 920-32. \n\nDaher, E.F.; Silva-Junior, G.B.; Bezerra, G.P.; Pontes, L.B.; Martins, A.M.C. &amp; Guimar\u00e3es, J.A. \n(2003). Acute renal failure after massive honeybee stings. Revista do Instituto de \nMedicina Tropical de Sao Paulo. Vol.45, No.1, pp. 45-50. \n\nda Silva, P.H.; da Silveira, R.B.; Appel, M.H.; Mangili, O.C.; Gremski, W. &amp; Veiga, S.S. \n(2004). Brown spiders and loxoscelism. Toxicon. Vol.44, No.7, pp. 693-709. \n\nde Castro, I.; Burdmann, E.A.; Seguro, A.C. &amp; Yu, L. (2004). Bothrops venom induces direct \nrenal tubular injury: role for lipid peroxidation and prevention by antivenom. \nToxicon. Vol.43, No.7, pp. 833-9. \n\nde Giuseppe, P.O.; Ullah, A.; Silva, D.T.; Gremski, L.H.; Wille, A.C.; Chaves-Moreira, D.; \nRibeiro, A.S.; Chaim, O.M.; Murakami, M.T.; Veiga, S.S. &amp; Arni, R.K. (2011). \nStructure of a novel class II phospholipase D: catalytic cleft is modified by a \ndisulphide bridge. Biochemical and Biophysical Research Communications. Vol. 409, \nNo.4, pp. 622-7. \n\nDeitch, E.A. (1992). Multiple organ failure. Pathophysiology and potential future therapy. \nAnnals of Surgery. Vol. 216, No. 2, pp. 117-34. \n\n103\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n180 \n\nDempsey, C.E. (1990). The actions of melittin on membranes. Biochimica et Biophysica Acta. \nVol.1031, No.2, pp. 143-61. \n\ndos Reis, M.A.; Costa, R.S.; Coimbra, T.M.; Dantas, M. &amp; Gomes, U.A. (1997). Renal changes \ninduced by envenomation with Africanized bee venom in female Wistar rats. \nKidney and Blood Pressure Research. Vol. 20, No. 4, pp. 271-7. \n\ndos Reis MA.; Costa, R.S.; Coimbra, T.M.; Teixeira, V.P. (1998). Acute renal failure in \nexperimental envenomation with Africanized bee venom. Renal Failure. Vol.20, \nNo.1, pp. 39-51. \n\nDuarte, A.C.; Caovilla, J.J.; Lorini, J.D.; Mantovani, G.; Sumida, J.; Manfre, P.C.; Silveira, R.C. \n&amp; de Moura, S.P. (1990). Insufici\u00eancia renal aguda por acidentes com lagartas. Jornal \nBrasileiro de Nefrologia. Vol.12, pp. 184-7. \n\nEjaz, A.A.; Mu, W.; Kang, D.H.; Roncal, C.; Sautin, Y.Y.; Henderson, G.; Tabah-Fisch, I.; \nKeller, B.; Beaver, T.M.; Nakagawa, T. &amp; Johnson, R.J. (2007). Could uric acid have a \nrole in acute renal failure. Clinical Journal of the American Society of Nephrology. Vol.2, \nNo.1, pp. 16-21.  \n\nEvangelista, I.L.; Martins, A.M.; Nascimento, N.R.; Havt, A.; Evangelista, J.S.; de Nor\u00f5es, \nT.B.; Toyama, M.H.; Diz-Filho, E.B.; Toyama, O.; Fonteles, M.C. &amp; Monteiro, H.S. \n(2010) Renal and cardiovascular effects of Bothrops marajoensis venom and \nphospholipase A2. Toxicon. Vol. 55, No. 6, pp. 1061-70.   \n\nFan, H.W.; Marcopito, L.F.; Cardoso, J.L.; Fran\u00e7a, F.O.; Malaque, C.M.; Ferrari, R.A.; \nTheakston, R.D. &amp; Warrell, D.A. (1999). Sequential randomised and double blind \ntrial of promethazine prophylaxis against early anaphylactic reactions to \nantivenom for Bothrops snakebites. British Medical Journal (BMJ). Vol. 318, pp. 1451\u2013\n1453. \n\nFan, H.W.; Cardoso, J.L.; Olmos, R.D.; Almeida, F.J.; Viana, R.P. &amp; Martinez, A.P. (1998). \nHemorrhagic syndrome and acute renal failure in a pregnant woman after contact \nwith Lonomia caterpillars: a case report. Revista do Instituto de Medicina Tropical de \nS\u00e3o Paulo. Vol. 40, No. 2, pp. 119-20. \n\nFletcher, J.E. &amp; Jiang, M.S. (1993). Possible mechanisms of action of cobra snake venom \ncardiotoxins and bee venom melittin. Toxicon. Vol. 31, No. 6, pp. 669-95. \n\nFran\u00e7a, F.O.; Benvenuti, L.A.; Fan, H.W.; dos Santos, D.R.; Hain, S.H.; Picchi-Martins, F.R.; \nCardoso, J.L.; Kamiguti, A.S.; Theakston, R.D. &amp; Warrell, D.A. (1994). Severe and \nfatal mass attacks by 'killer' bees (Africanized honey bees-Apis mellifera scutellata) in \nBrazil: clinicopathological studies with measurement of serum venom \nconcentrations. The Quarterly Journal of Medicine (Q J Med). Vol. 87, No. 5, pp. 269-\n82. \n\nFran\u00e7a, F.O.; Barbaro, K.C. &amp; Abdulkader, R.C. (2002). Rhabdomyolysis in presumed \nviscero-cutaneous loxoscelism: report of two cases. Transactions of the Royal Society \nof Tropical Medicine and Hygiene. Vol. 96, No. 3, pp. 287-90. \n\nFrancischetti, I.M.; Saliou, B.; Leduc, M.; Carlini, C.R.; Hatmi, M.; Randon, J.; Faili, A. &amp; Bon, \nC. (1997). Convulxin, a potent platelet-aggregating protein from Crotalus durissus \nterrificus venom, specifically binds to platelets. Toxicon. Vol. 35, No. 8, pp. 1217-28. \n\nFrezzatti, R. &amp; Silveira, P.F. (2011). Allopurinol Reduces the Lethality Associated with Acute \nRenal Failure Induced by Crotalus durissus terrificus Snake Venom: Comparison \nwith Probenecid. PLoS Neglected Tropical Diseases. Vol. 5, No. 9, pp. e1312. \n\n104\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n181 \n\nGabriel, D.P.; Rodrigues, A.G.; Barsante, R.C.; dos Santos-Silva, V.; Caramori, J.T.; Martim, \nL.C.; Barretti, P. &amp; Balbi, A.L. (2004). Severe acute renal failure after massive attack \nof Africanized bees. Nephrology, Dialysis, Transplantation. Vol. 19, No. 10, pp. 2680. \n\nGamborgi, G.P.; Metcalf, E.B. &amp; Barros, E.J. (2006). Acute renal failure provoked by toxin \nfrom caterpillars of the species Lonomia obliqua. Toxicon. Vol. 47, No. 1, pp. 68-74.  \n\nGay, C.C.; Marunak, S.L.; Teibler, P.; Ruiz, R.; Acosta de P\u00e9rez, O.C. &amp; Leiva, L.C. (2009). \nSystemic alterations induced by a Bothrops alternatus hemorrhagic \nmetalloproteinase (baltergin) in mice. Toxicon. Vol. 53, No. 1, pp. 53-9. \n\nGremski, L.H.; da Silveira, R.B.; Chaim, O.M.; Probst, C.M.; Ferrer, V.P.; Nowatzki, J.; \nWeinschutz, H.C.; Madeira, H.M.; Gremski, W.; Nader, H.B.; Senff-Ribeiro, A. &amp; \nVeiga, S.S. (2010). A novel expression profile of the Loxosceles intermedia spider \nvenomous gland revealed by transcriptome analysis. Molecular Biosystems. Vol. 6, \nNo. 12, pp. 2403-16. \n\nGrisotto, L.S.; Mendes, G.E.; Castro, I.; Baptista, M.A.; Alves, V.A.; Yu, L. &amp; Burdmann, E.A. \n(2006). Mechanisms of bee venom-induced acute renal failure. Toxicon. Vol. 48, No. \n1, pp. 44-54. \n\nGuti\u00e9rrez, J.M.; Theakston, R.D. &amp; Warrell, D.A. (2006). Confronting the neglected problem \nof snake bite envenoming: the need for a global partnership. PLoS Medicine. Vol. 3, \nNo. 6, pp. e150. \n\nGuti\u00e9rrez, J.M.; Williams, D.; Fan, H.W. &amp; Warrell, D.A. (2010). Snakebite envenoming from \na global perspective: Towards an integrated approach. Toxicon. Vol. 56, No 7, pp. \n1223-35. \n\nHabermann, E. (1972). Bee and wasp venoms. Science. Vol. 177, No. 46, pp. 314-22. \nHogan, C.J.; Barbaro, K.C. &amp; Winkel, K. (2004). Loxoscelism: old obstacles, new directions. \n\nAnnals of Emergency Medicine. Vol. 44, pp. 608-622. \nIsbister, G.K. &amp; Fan, H.W. (2011). Spider bite. Lancet. (in press) \nJorge, M.T. &amp; Ribeiro, L.A. (1992). The epidemiology and clinical picture of an accidental \n\nbite by the South American rattlesnake (Crotalus durissus). Revista do Instituto de \nMedicina Tropical de S\u00e3o Paulo. Vol. 34, No. 4, pp. 347-54. \n\nKamiguti, A.S. (2005). Platelets as targets of snake venom metalloproteinases. Toxicon. Vol. \n45, No. 8, pp. 1041-9. \n\nKasturiratne, A.; Wickremasinghe, A.R.; de Silva, N.; Gunawardena, N.K.; Pathmeswaran, \nA.; Premaratna, R.; Savioli, L.; Lalloo, D.G. &amp; de Silva, H.J. (2008). The global \nburden of snakebite: a literature analysis and modelling based on regional \nestimates of envenoming and deaths. PLoS Medicine. Vol. 5, No. 11, pp. e218. \n\nKhan, FY. (2009). Rhabdomyolysis: a review of the literature. Netherland Journal of Medicine. \nVol. 67, No. 9, pp. 272-83. \n\nKusma, J.; Chaim, O.M.; Wille, A.C.; Ferrer, V.P.; Sade, Y.B.; Donatti, L.; Gremski, W.; \nMangili, O.C. &amp; Veiga, S.S. (2008). Nephrotoxicity caused by brown spider venom \nphospholipase-D (dermonecrotic toxin) depends on catalytic activity. Biochimie. \nVol. 90, No. 11-12, pp. 1722-36. \n\nLee, S. &amp; Lynch, K.R. (2005). Brown recluse spider (Loxosceles reclusa) venom phospholipase \nD (PLD) generates lysophosphatidic acid (LPA). Biochemical Journal. Vol. 391, No. 2, \npp. 317-23. \n\n105\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n182 \n\nLee, S.Y.; Park, H.S.; Lee, S.J. &amp; Choi, M. (2001). Melittin exerts multiple effects on the release \nof free fatty acids from L1210 cells: lack of selective activation of phospholipase A2 \nby melittin. Archives of Biochemistry and Biophysics. Vol. 389, pp. 57-67. \n\nLinardi, A.; Rocha e Silva, T.A.; Miyabara, E.H.; Franco-Penteado, C.F.; Cardoso, K.C.; Boer, \nP.A.; Moriscot, A.S.; Gontijo, J.A.; Joazeiro, P.P.; Collares-Buzato, C.B. &amp; Hyslop, S. \n(2011). Histological and functional renal alterations caused by Bothrops alternatus \nsnake venom: expression and activity of Na+/K+-ATPase. Biochimica et Biophysica \nActa. Vol. 1810, No. 9, pp. 895-906.  \n\nLucato-Junior, R.V.; Abdulkader, R.C.; Barbaro, K.C.; Mendes, G.E.; Castro, I.; Baptista, \nM.A.; Cury, P.M.; Malheiros, D.M.; Schor, N.; Yu, L. &amp; Burdmann, E.A. (2011). \nLoxosceles gaucho venom-induced acute kidney injury - in vivo and in vitro studies. \nPLoS Neglected Tropical Diseases. Vol. 5, No. 5, pp. e1182. \n\nLuciano, M.N.; da Silva, P.H.; Chaim, O.M.; dos Santos, V.L.; Franco, C.R.; Soares, M.F.; \nZanata, S.M.; Mangili, O.C.; Gremski, W. &amp; Veiga, S.S. (2004). Experimental \nevidence for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom in \nrenal tissue. Journal of Histochemistry and Cytochemistry. Vol. 52, No. 4, pp. 455-67. \n\nMalaque, C.M.; Andrade, L.; Madalosso, G.; Tomy, S.; Tavares, F.L. &amp; Seguro, A.C. (2006). \nShort report: A case of hemolysis resulting from contact with a Lonomia caterpillar \nin southern Brazil. American Journal of Tropical Medicine and Hygiene. Vol. 74, No. 5, \npp. 807-9. \n\nMartins, A.M.; Toyama, M.H.; Havt, A.; Novello, J.C.; Marangoni, S.; Fonteles, M.C. &amp; \nMonteiro, H.S. (2002). Determination of Crotalus durissus cascavella venom \ncomponents that induce renal toxicity in isolated rat kidneys. Toxicon. Vol. 40, No. \n8, pp. 1165-171.  \n\nMartins, A.M.; Lima, A.A.; Toyama, M.H.; Marangoni, S.; Fonteles, M.C. &amp; Monteiro, H.S. \n(2003). Renal effects of supernatant from macrophages activated by Crotalus \ndurissus cascavella venom: the role of phospholipase A2 and cyclooxygenase. \nPharmacology &amp; Toxicology. Vol. 92, No. 1, pp. 14-20. \n\nMartins, A.M.; Nobre, A.C.; Almeida, A.C.; Bezerra, G.; Lima, A.A.; Fonteles, M.C. &amp; \nMonteiro, H.S. (2004). Thalidomide and pentoxifylline block the renal effects of \nsupernatants of macrophages activated with Crotalus durissus cascavella venom. \nBrazilian Journal of Medical and Biological Research. Vol. 37, No. 10, pp. 1525-30.   \n\nMello, S.M.; Linardi, A.; Renn\u00f3, A.L.; Tarsitano, C.A.; Pereira, E.M. &amp; Hyslop, S. (2010). \nRenal kinetics of Bothrops alternatus (Urutu) snake venom in rats. Toxicon. Vol. 55, \nNo. 2-3, pp. 470-80.   \n\nMinist\u00e9rio da Sa\u00fade (2001). Manual de Diagn\u00f3stico e Tratamento por Animais Pe\u00e7onhentos. \nFunda\u00e7\u00e3o Nacional da Sa\u00fade, Brasil. Available from:   \nhttp://portal.saude.gov.br/portal/saude/visualizar_texto.cfm?idtxt=21182. \n\nMonteiro, H.S. &amp; Fonteles, M.C. (1999). The effect of Bothrops jararaca venom on rat kidney \nafter short-term exposure: preliminary results. Pharmacology &amp; Toxicology. Vol. 85, \nNo. 4, pp. 198-200. \n\nMonteiro, H.S.; da Silva, I.M.; Martins, A.M. &amp; Fonteles, M.C. (2001). Actions of Crotalus \ndurissus terrificus venom and crotoxin on the isolated rat kidney. Brazilian Journal of \nMedical and Biological Research. Vol. 34, No. 10, pp. 1347-52. \n\n106\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n183 \n\nMurakami, M.T.; Fernandes-Pedrosa, M.F.; Tambourgi, D.V. &amp; Arni, R.K. (2005). Structural \nbasis for metal ion coordination and the catalytic mechanism of sphingomyelinases \nD. Journal of Biological Chemistry. Vol. 280, No. 14, pp. 13658-64. \n\nNascimento, J.M.; Franchi, G.C.; Nowill, A.E.; Collares-Buzato, C.B. &amp; Hyslop, S. (2007). \nCytoskeletal rearrangement and cell death induced by Bothrops alternatus snake \nvenom in cultured Madin-Darby canine kidney cells. Biochemistry and Cell Biology. \nVol. 85, No. 5, pp. 591-605. \n\nOwnby, C.L.; Powell, J.R.; Jiang, M.S. &amp; Fletcher, J.E. (1997). Melittin and phospholipase A2 \nfrom bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo. \nToxicon. Vol. 35, pp. 67-80. \n\nOtero, R.; Guti\u00e9rrez, J.; Beatriz-Mesa, M.; Duque, E.; Rodr\u00edguez, O.; Luis-Arango, J.; G\u00f3mez, \nF.; Toro, A.; Cano, F.; Mar\u00eda-Rodr\u00edguez, L.; Caro, E.; Mart\u00ednez, J.; Cornejo, W.; \nMariano-G\u00f3mez, L.; Luis-Uribe, F.; C\u00e1rdenas, S.; N\u00fa\u00f1ez, V. &amp; D\u00edaz, A. (2002). \nComplications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A \nclinical and epidemiological study of 39 cases attended in a university hospital. \nToxicon. Vol. 40, No. 8, pp. 1107-114. \n\nPantera, B.; Hoffman, D.R.; Carresi, L.; Cappugi, G.; Turillazzi, S.; Manao, G.; Severino, M.; \nSpadolini, I.; Orsomando, G.; Moneti, G. &amp; Pazzagli, L. (2003). Characterization of \nthe major allergens purified from the venom of the paper wasp Polistes gallicus. \nBiochimica et Biophysica Acta. Vol. 1623, No. 2-3, pp. 72-81. \n\nPetricevich, V.L.; Teixeira, C.F.P.; Tambourgi, D.V. &amp; Guti\u00e9rrez, J.M. (2000). Increments in \nserum cytokine and nitric oxide levels in mice injected with Bothrops asper and \nBothrops jararaca snake venoms. Toxicon. Vol. 38, No. 9, pp. 1253\u201366. \n\nPinho, F.M.; Zanetta, D.M. &amp; Burdmann, E.A. (2005). Acute renal failure after Crotalus \ndurissus snakebite: a prospective survey on 100 patients. Kidney International. Vol. \n67, No. 2, pp. 659-67. \n\nPinho, F.M.; Yu, L. &amp; Burdmann EA. (2008). Snakebite-induced acute kidney injury in Latin \nAmerica. Seminars in Nephrology. Vol. 28, No. 4, pp. 354-62. \n\nPinto, A.F.; Dobrovolski, R.; Veiga, A.B. &amp; Guimar\u00e3es, J.A. (2004). Lonofibrase, a novel \nalpha-fibrinogenase from Lonomia obliqua caterpillars. Thrombosis Research. Vol.113, \nNo. 2, pp. 147-54.  \n\nPinto, A.F.; Silva, K.R. &amp; Guimar\u00e3es, J.A. (2006). Proteases from Lonomia obliqua venomous \nsecretions: comparison of procoagulant, fibrin(ogen)olytic and amidolytic activities. \nToxicon. Vol. 47, No. 1, pp.113-21. \n\nPinto, A.F.; Berger, M.; Reck-Jr, J.; Terra, R.M. &amp; Guimar\u00e3es, J.A. (2010). Lonomia obliqua \nvenom: In vivo effects and molecular aspects associated with the hemorrhagic \nsyndrome. Toxicon. Vol. 56, No. 7, pp. 1103-12. \n\nReis, C.V.; Andrade, S.A.; Ramos, O.H.; Ramos, C.R.; Ho, P.L.; Batista, I.F. &amp; Chudzinski-\nTavassi, A.M. (2006). Lopap, a prothrombin activator from Lonomia obliqua \nbelonging to the lipocalin family: recombinant production, biochemical \ncharacterization and structure-function insights. Biochemical Journal. Vol. 398, No. 2, \npp. 295-302. \n\nRicci-Silva, M.E.; Valente, R.H.; Le\u00f3n, I.R.; Tambourgi, D.V.; Ramos, O.H.; Perales, J. &amp; \nChudzinski-Tavassi, A.M. (2008). Immunochemical and proteomic technologies as \ntools for unravelling toxins involved in envenoming by accidental contact with \nLonomia obliqua caterpillars. Toxicon. Vol. 51, No. 6, pp. 1017-28. \n\n107\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n184 \n\nRodrigues-Sgrignolli, L.; Florido-Mendes, G.E.; Carlos, C.P.; Burdmann, E.A. (2011). Acute \nkidney injury caused by Bothrops snake venom. Nephron Clinical Practice. Vol. 119, \nNo. 2 pp. c131-7. \n\nRucavado, A.; Soto, M.; Escalante, T.; Lor\u00eda, G.D.; Arni, R. &amp; Guti\u00e9rrez, J.M. (2005). \nThrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake \nvenom. Toxins involved and their contribution to metalloproteinase-induced \npulmonary hemorrhage. Thrombosis and Haemostasis. Vol. 94, No. 1, pp. 123-31. \n\nSampaio, S.C.; Hyslop, S.; Fontes, M.R.; Prado-Franceschi, J.; Zambelli, V.O.; Magro, A.J.; \nBrigatte, P.; Guti\u00e9rrez, V.P. &amp; Cury, Y. (2010). Crotoxin: novel activities for a classic \nbeta-neurotoxin. Toxicon. Vol. 55, No. 6, pp. 1045-60. \n\nSantoro, ML. &amp; Sano-Martins, I.S. (2004). Platelet dysfunction during Bothrops jararaca snake \nenvenomation in rabbits. Thrombosis and Haemostasis. Vol. 92, No. 2, pp.369-83. \n\nSeibert, C.S.; Oliveira, M.R.; Gon\u00e7alves, L.R.; Santoro, M.L. &amp; Sano-Martins, I.S. (2004). \nIntravascular hemolysis induced by Lonomia obliqua caterpillar bristle extract: an \nexperimental model of envenomation in rats. Toxicon. Vol. 44, No. 7, pp. 793-9. \n\nSeibert, C.S.; Tanaka-Azevedo, A.M.; Santoro, M.L.; Mackessy, S.P.; Soares-Torquato, R.J.; \nLebrun, I.; Tanaka, A.S. &amp; Sano-Martins, I.S. (2006). Purification of a phospholipase \nA2 from Lonomia obliqua caterpillar bristle extract. Biochemical and Biophysical \nResearch Communications. Vol. 342, No. 4, pp. 1027-33.  \n\nSezerino, U.M.; Zannin, M.; Coelho, L.K.; Gon\u00e7alves-J\u00fanior, J.; Grando, M.; Mattosinho, S.G.; \nCardoso, J.L.; von Eickstedt, V.R.; Fran\u00e7a, F.O.; Barbaro, K.C. &amp; Fan, H.W. (1998). A \nclinical and epidemiological study of Loxosceles spider envenoming in Santa \nCatarina, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene. \nVol. 92, No. 5, pp. 546-8. \n\nSilveira, P.V. &amp; Nishioka, A. (1992). South American rattlesnake bite in a Brazilian teaching \nhospital. Clinical and epidemiological study of 87 cases, with analysis of factors \npredictive of renal failure. Transactions of the Royal Society of Tropical Medicine and \nHygiene. Vol. 86, No. 5, pp. 562-4. \n\nSitprija, V. (2006). Snakebite nephropathy. Nephrology (Carlton). Vol. 11, No. 5, pp. 442-8. \nSoares, A.M.; Mancin, A.C.; Cecchini, A.L.; Arantes, E.C.; Fran\u00e7a, S.C.; Guti\u00e9rrez, J.M. &amp; \n\nGiglio, J.R. (2001). Effects of chemical modifications of crotoxin B, the \nphospholipase A(2) subunit of crotoxin from Crotalus durissus terrificus snake \nvenom, on its enzymatic and pharmacological activities. International Journal of \nBiochemistry and Cell Biology. Vol. 33, No. 9, pp. 877-88. \n\nSwanson, D.L.; Vetter, R.S. (2006). Loxoscelism. Clinics in Dermatology. Vol. 24, pp. 213-221. \nTerra, R.M.; Guimar\u00e3es, J.A. &amp; Verli, H. (2007). Structural and functional behavior of \n\nbiologically active monomeric melittin. Journal of Molecular Graphics and Modelling. \nVol. 25, No. 6, pp. 767-72. \n\nTrevisan-Silva, D.; Gremski, L.H.; Chaim, O.M.; da Silveira, R.B.; Meissner, G.O.; Mangili, \nO.C.; Barbaro, K.C.; Gremski, W.; Veiga, S.S. &amp; Senff-Ribeiro, A. (2010). Astacin-like \nmetalloproteases are a gene family of toxins present in the venom of different \nspecies of the brown spider (genus Loxosceles). Biochimie. Vol. 92, No. 1, pp. 21-32. \n\nVeiga, A.B.; Blochtein, B. &amp; Guimar\u00e3es, J.A. (2001a). Structures involved in production, \nsecretion and injection of the venom produced by the caterpillar Lonomia obliqua \n(Lepidoptera, Saturniidae). Toxicon. Vol. 39, No., 9, pp. 1343-51. \n\n108\n\n\n\n \nAcute Kidney Injury Induced by Snake and Arthropod Venoms \n\n \n\n185 \n\nVeiga, A.B.; Pinto, A.F. &amp; Guimar\u00e3es, J.A. (2003). Fibrinogenolytic and procoagulant \nactivities in the hemorrhagic syndrome caused by Lonomia obliqua caterpillars. \nThrombosis Research. Vol. 111, No. 1-2, pp. 95-101. \n\nVeiga, A.B.; Ribeiro, J.M.; Guimar\u00e3es, J.A. &amp; Francischetti, I.M. (2005). A catalog for the \ntranscripts from the venomous structures of the caterpillar Lonomia obliqua: \nidentification of the proteins potentially involved in the coagulation disorder and \nhemorrhagic syndrome. Gene. Vol. 355, pp. 11-27.  \n\nVeiga, A.B.; Berger, M. &amp; Guimar\u00e3es, J.A. (2009). Lonomia obliqua venom: pharmaco-\ntoxicological effects and biotechnological perspectives. In: Animal toxins: the state of \nthe art. Perspectives on health and biotechnology. De Lima, M.E.; Pimenta, A.M; Martin-\nEauclaire, M.F.; Zingali, R.B. &amp; Rochat, H. (editors), pp. 371-390, UFMG, ISBN 978-\n85-7041-735-0, Belo Horizonte, Brazil. \n\nVeiga, S.S.; Feitosa, L.; dos Santos, V.L.; de Souza, G.A.; Ribeiro, A.S.; Mangili, O.C.; \nPorcionatto, M.A.; Nader, H.B.; Dietrich, C.P.; Brentani, R.R. &amp; Gremski, W. (2000). \nEffect of brown spider venom on basement membrane structures. Histochemical \nJournal. Vol. 32, No. 7, pp. 397-408. \n\nVeiga, S.S.; Zanetti, V.C.; Franco, C.R.; Trindade, E.S.; Porcionatto, M.A.; Mangili, O.C.; \nGremski, W.; Dietrich, C.P. &amp; Nader, H.B. (2001b). In vivo and in vitro cytotoxicity \nof brown spider venom for blood vessel endothelial cells. Thrombosis Research. Vol. \n102, No. 3, pp. 229-37. \n\nVetter, R.S.; Visscher, P.K. &amp; Camazine, S. (1999). Mass envenomations by honey bees and \nwasps. Western Journal of Medicine. Vol. 170, No. 4, pp. 223-7. \n\nWarrell, D.A. (2010). Snake bite. Lancet. Vol. 375, No. 9708, pp. 77-88. \nWhite, J. (2005). Snake venoms and coagulopathy. Toxicon. Vol. 45, No. 8, pp. 951-67. \nWilliams, D.; Guti\u00e9rrez, J.M.; Harrison, R.; Warrell, D.A.; White, J.; Winkel, K.D. &amp; \n\nGopalakrishnakone, P. (2010). Global Snake Bite Initiative Working Group; \nInternational Society on Toxinology. The Global Snake Bite Initiative: an antidote \nfor snake bite. Lancet. Vol. 375, No. 9708, pp. 89-91. \n\nWHO, 2007. Rabies and Envenomings. A Neglected Public Health Issue. World Health \nOrganization, Geneva. Available from:   \nwww.who.int/rabies/relevant_documents/en/index.html \n\nWHO, 2010a. Guidelines for the management of snake-bites. World Health Organization, \nGeneva. Available from: apps.who.int/medicinedocs/en/m/abstract/Js17111e/ \n\nWHO, 2010b. Guidelines for the Production, Control and Regulation of Snake Antivenom \nImmunoglobulins. World Health Organization, Geneva. Available from:   \nwww.who.int/bloodproducts/snake_antivenoms/snakeantivenomguide/en/inde\nx.html \n\nXuan, B.H.; Mai, H.L.; Thi, T.X.; Thi, M.T.; Nguyen, H.N. &amp; Rabenou, R.A. (2010). Swarming \nhornet attacks: shock and acute kidney injury - a large case series from Vietnam. \nNephrology, Dialysis, Transplantation. Vol. 25, No. 4, pp. 1146-50. \n\nYamasaki, S.C.; Villarroel, J.S.; Barone, J.M.; Zambotti-Villela, L. &amp; Silveira, P.F. (2008). \nAminopeptidase activities, oxidative stress and renal function in Crotalus durissus \nterrificus envenomation in mice. Toxicon. Vol. 52, No. 3, pp. 345-54. \n\nZager, R.A. (1996). Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney \nInternational. Vol. 49, No. 2, pp. 314-26. \n\n109\n\n\n\n \nRenal Failure \u2013 The Facts \n\n \n\n186 \n\nZambrano, A.; Gonz\u00e1lez, J. &amp; Callejas, G. (2005). Severe loxoscelism with lethal outcome. \nReport of one case. Revista M\u00e9dica de Chile. Vol. 133, No. 2, pp. 219-23. \n\nZannin, M.; Louren\u00e7o, D.M.; Motta, G.; Dalla Costa, L.R.; Grando, M.; Gamborgi, G.P.; \nNoguti, M.A. &amp; Chudzinski-Tavassi, A.M. (2003). Blood coagulation and \nfibrinolytic factors in 105 patients with hemorrhagic syndrome caused by \naccidental contact with Lonomia obliqua caterpillar in Santa Catarina, southern \nBrazil. Thrombosis and Haemostasis. Vol. 89, No. 2, pp. 355-64. \n\nZelanis, A.; Tashima, A.K.; Rocha, M.M.; Furtado, M.F.; Camargo, A.C.; Ho, P.L. &amp; Serrano, \nS.M. (2010). Analysis of the ontogenetic variation in the venom \nproteome/peptidome of Bothrops jararaca reveals different strategies to deal with \nprey. Journal of Proteome Research. Vol. 9, No. 5, pp. 2278-91.  \n\nZingali, R.B.; Ferreira, M.S.; Assafim, M.; Frattani, F.S. &amp; Monteiro RQ. (2005). Bothrojaracin, \na Bothrops jararaca snake venom-derived (pro)thrombin inhibitor, as an anti-\nthrombotic molecule. Pathophysiology of Haemostasis and Thrombosis. Vol. 34, No. 4-5, \npp. 160-3. \n\nZhang, R.; Meleg-Smith, S. &amp; Batuman, V. (2001). Acute tubulointerstitial nephritis after \nwasp stings. American Journal of Kidney Diseases. Vol. 38, No. 6, pp. E33. \n\n110\n\n\n\nResultados \n\n111 \n\n \n\n3.4 Cap\u00edtulo IV \n\n \n\nAcute kidney injury induced by experimental Lonomia obliqua envenomation. \n\n   \n\n Neste cap\u00edtulo, os mecanismos da insufici\u00eancia renal aguda causada pelo \n\nenvenenamento com L. obliqua foram investigados em um modelo experimental in vivo \n\nem ratos. \n\n \n\nOs principais resultados obtidos foram: \n\n \n\n? O envenenamento causa altera\u00e7\u00f5es hemodin\u00e2micas incluindo hipotens\u00e3o \n\nsist\u00eamica, aumento do d\u00e9bito card\u00edaco, aumento da permeabilidade vascular \n\nrenal, redu\u00e7\u00e3o do ritmo de filtra\u00e7\u00e3o glomerular e altera\u00e7\u00f5es tubulares como \n\nredu\u00e7\u00e3o da capacidade de reabsor\u00e7\u00e3o de \u00e1gua e eletr\u00f3litos; \n\n? As altera\u00e7\u00f5es morfol\u00f3gicas s\u00e3o compat\u00edveis com necrose tubular aguda. \n\nCil\u00edndros hialinos, hem\u00e1ticos e restos de c\u00e9lulas necr\u00f3ticas podem ser \n\nobservados nos t\u00fabulos. Marcadores de les\u00e3o tubular s\u00e3o encontrados nos rins e \n\nurina dos animais envenenados; \n\n? H\u00e1 evid\u00eancias de deposi\u00e7\u00e3o de fibrina nos capilares glomerulares. Aumento de \n\natividade de fator tecidual no rim, presen\u00e7a de material PAS positivo nos \n\nglom\u00e9rulos, presen\u00e7a de fibrina e marcadores que indicam ativa\u00e7\u00e3o da \n\ncoagula\u00e7\u00e3o e complemento no rim; \n\n? A express\u00e3o de prote\u00ednas associadas com inflama\u00e7\u00e3o, dano oxidativo, reparo de \n\nDNA, metabolismo e detoxifica\u00e7\u00e3o de hemoglobina, heme e ferro est\u00e3o \n\naumentadas no rim de animais envenenados; \n\n? Toxinas do veneno foram detectadas no rim, endot\u00e9lio, tecido conjuntivo \n\nperivascular e urina.  \n\n \n\n O manuscrito a seguir ser\u00e1 submetido para publica\u00e7\u00e3o em peri\u00f3dico cient\u00edfico \n\ninternacional.  \n\n  \n\n\n\nResultados \n\n112 \n\n \n\nAcute kidney injury induced by experimental Lonomia obliqua envenomation \n\n \n\nMarkus Berger\n1\n, Luc\u00e9lia Santi\n\n2\n,Walter O. Beys-da-Silva\n\n2\n, Fabr\u00edcio Silva Oliveira\n\n3\n, \n\nMarcelo Vidigal Caliari\n3\n, John R. Yates 3rd\n\n2\n, Maria Aparecida Ribeiro Vieira\n\n4\n &amp; Jorge \n\nAlmeida Guimar\u00e3es\n1*\n\n. \n\n \n\n1. Laborat\u00f3rio de Bioqu\u00edmica Farmacol\u00f3gica, Centro de Biotecnologia, Universidade \n\nFederal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. \n\n2. Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, \n\nUnited States. \n\n3. Laborat\u00f3rio de Protozooses, Departamento de Patologia Geral, Instituto de Ci\u00eancias \n\nBiol\u00f3gicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, \n\nBrazil. \n\n4. Laborat\u00f3rio de Fisiologia Renal, Departamento de Fisiologia e Biof\u00edsica, Instituto de \n\nCi\u00eancias Biol\u00f3gicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, \n\nMG, Brazil. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n? \nCorresponding author: Prof. Dr. Jorge Almeida Guimar\u00e3es, Laborat\u00f3rio de \n\nBioqu\u00edmica Farmacol\u00f3gica, Centro de Biotecnologia (UFRGS). Av. Bento Gon\u00e7alves, \n\n9500, Cep 91501-970, Porto Alegre, RS, Brasil. Tel.: +55 51 33086068. Fax +55 51 \n\n33087309. E-mail: guimar@cbiot.ufrgs.br \n\nmailto:guimar@cbiot.ufrgs.br\n\n\nResultados \n\n113 \n\n \n\nAbstract        \n\nBackground. Lonomia obliqua caterpillar envenomation causes acute kidney injury \n\n(AKI), which can be responsible for its deadly actions. This study evaluates the possible \n\nmechanisms involved in the pathogenesis of renal dysfunction. Methods. To \n\ncharacterize L. obliqua venom effects we subcutaneously injected rats and examined \n\nrenal functional, morphological and biochemical parameters at several time points. We \n\nalso performed discovery based proteomic analysis to measure protein expression to \n\nidentify molecular pathways of renal disease. Results. L. obliqua envenomation causes \n\nacute tubular necrosis, which is associated with renal inflammation; formation of \n\nhematic casts, resulting from intravascular hemolysis; increase in vascular permeability \n\nand fibrosis. The dilation of Bowman\u2019s space and glomerular tuft is related to fluid \n\nleakage and intra-glomerular fibrin deposition, respectively, since tissue factor \n\nprocoagulant activity increases in the kidney. Systemic hypotension also contributes to \n\nthese alterations and to the sudden loss of basic renal functions, including filtration and \n\nexcretion capacities, urinary concentration and maintenance of fluid homeostasis. In \n\naddition, envenomed kidneys increases expression of proteins involved in cell stress, \n\ninflammation, tissue injury, heme-induced oxidative stress, coagulation and \n\ncomplement system activation. Finally, the localization of the venom in renal tissue \n\nagrees with morphological and functional alterations, suggesting also a direct \n\nnephrotoxic activity. Conclusions. Mechanisms of L. obliqua-induced AKI are complex \n\ninvolving mainly glomerular and tubular functional impairment and vascular alterations. \n\nGeneral significance. These results are important to understand the mechanisms of \n\nrenal injury and may suggest more efficient ways to prevent or attenuate the pathology \n\nof Lonomia's envenomation. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nKeywords: Venom, Lonomia, Renal, Acute Kidney Injury, Nephrotoxicity, Acute \n\nTubular Necrosis. \n\n\n\nResultados \n\n114 \n\n \n\n1. Introduction \n\n Accidents caused by venomous animals (mainly snakes, spiders, scorpions, bees, \n\nwasps and caterpillars) are a costly and critically important public health problem. \n\nDespite of this, public health authorities, nationally and internationally, have given little \n\nattention to this problem worldwide (Warrell, 2010; Williams et al., 2010). \n\nConsequentially, the morbidity and mortality associated with envenomation cases \n\nproduce a great impact on the population and healthcare systems. One of the most \n\nimportant and lethal effects of these animal venoms is nephrotoxicity and a broad \n\nclinical spectrum of renal function impairment has been reported in human and \n\nexperimental models of envenomation (Sitprija, 2006; Berger et al., 2012). As kidneys \n\nare highly vascularized organs and have the ability to concentrate substances into urine \n\nthey are particularly susceptible to venom toxins. The most common clinical renal \n\nmanifestation seen in human patients is acute tubular necrosis, but all renal structures \n\nmay be involved. Thus, the occurrences of acute tubulointerstitial nephritis, renal \n\ncortical necrosis, mesangiolysis, vasculitis, glomerulonephritis, proteinuria, hematuria, \n\nhemoglobinuria and myoglobinuria have also been described (Sitprija, 2006). \n\n Lonomia obliqua caterpillars are well known in southern Brazil where they \n\ncause severe hemorrhagic syndrome characterized by perturbed coagulation, \n\necchymosis, acute kidney injury (AKI) and generalized hemorrhage. Since the 1980's \n\nthere has been a considerable increase in the number of hemorrhagic incidents in rural \n\nareas of the southernmost Brazilian states of Rio Grande do Sul, Santa Catarina and \n\nParan\u00e1. The origin of this epidemic is not clear, but can be partially attributed to recent \n\ndeforestation, as well as to a progressive reduction in the number of natural predators. \n\nUsually, accidents occur when the victim, unknowingly leans against a tree trunk \n\ncontaining hundreds of caterpillars and comes into contact with the caterpillar\u2019s \n\nvenomous bristles, which are chitinous evaginations of cuticule. Often, the caterpillar is \n\ncrushed, the bristles are broken and venomous secretions, including hemolymph, \n\npenetrate the human skin (Veiga et al., 2001). The venom is composed of several active \n\nconstituents with procoagulant, fibrinogenolytic, proteolytic and hemolytic activities \n\n(Pinto et al., 2010). Although consumptive coagulopathy secondary to intravascular \n\ndisseminated coagulation is commonly observed in human and experimental animals, \n\nAKI is the leading cause of death from L. obliqua envenomation (Zannin et al., 2003; \n\nGamborgi et al., 2006; Berger et al., 2010).   \n\n\n\nResultados \n\n115 \n\n \n\nEarly in the 1980's, the first registered cases of L. obliqua-induced hemorrhagic \n\nsyndrome indicated that 18 % of envenomed patients had developed AKI. The mortality \n\nrate in these patients reached 50 % (Duarte et al., 1990; Duarte et al., 1994). However, a \n\nlower incidence (5.2 %) was observed in the Brazilian state of Rio Grande do Sul from \n\n1989 to 1995, when only 15 of 286 envenomed patients developed AKI (Duarte et al., \n\n1997). Another study analyzing a larger group of 2,067 envenomed patients in the Santa \n\nCatarina state in Brazil (from 1989 to 2003) reported that 39 victims (1.9 %) developed \n\nAKI (with serum creatinine levels ? 1.5 mg/dL). Eleven (32 %) of these patients were \n\ntreated with dialysis and four (10.3 %) developed chronic renal injury (CRI). All \n\nvictims with AKI presented concomitantly coagulation disturbances and hematuria \n\nand/or hemoglobinuria. Seven deaths (4 %) occurred during this period (Gamborgi et \n\nal., 2006). An important conclusion of this work is that, even after the introduction of \n\nantivenom therapy (with anti-lonomic serum) in 1995, there was no reduction in the \n\nincidence of AKI, despite the significant decrease in the number of deaths and patients \n\nwho developed CRI (Gamborgi et al., 2006). In fact, recently we observe that \n\nantivenom treatment was able to reduce creatinine and urea levels of rats only if \n\nadministered 2 h post venom injection. Serotherapy after 6 h of envenomation fails to \n\nneutralize the rising in biochemical markers of renal injury (Berger et al., 2013). Since \n\nthe average time elapsed between the contact of a person with caterpillars and an \n\nappropriate medical care can vary from 19 to 37 h (Zannin et al., 2003), it seems \n\nimperative to achieve a better understanding of the mechanisms involved in venom-\n\ninduced AKI. It is clear that having such knowledge available it will then make possible \n\nto develop new efficient treatments in order to avoid or at least to reduce the \n\nprogression of renal disease in Lonomia`s  and other kind of animal envenoming. \n\n The risk of conducting early renal biopsies in human patients, due to coagulation \n\ndisturbances inherent to the envenomation, has made it difficult to analyze the acute \n\nkidney pathological alterations. There are only two case reports in the literature \n\ndescribing alterations of Lonomia-induced AKI. The main findings were oliguria, high \n\nlevels of serum creatinine, thickening of the Bowman\u2019s capsule, focal tubular atrophy \n\nand acute tubular necrosis (Burdmann et al., 1996; Fan et al., 1998). Since no \n\nexperimental studies were available until now, the contribution of several factors \n\npossibly associated with AKI, such as hemodynamic changes, vascular permeability \n\nalterations, hemolysis, tubular obstruction, glomerular fibrin deposition and even a \n\ndirect venom nephrotoxicity, remain obscure in Lonomia-induced AKI. \n\n\n\nResultados \n\n116 \n\n \n\n In an attempt to better understand the progression of renal disease commonly \n\nobserved after the contact with L. obliqua caterpillars, we have focused on the action of \n\nvenom in the kidney. Therefore, an experimental rat model was used in order to \n\ncharacterize changes in renal function, tubular hydroelectrolytic transport, \n\nhistopathology and hemodynamics. \n\n \n\n2. Materials and Methods \n\n \n\n2.1 Reagents \n\n Evans blue dye, purified coagulation factors (VII, IX and X) and molecular \n\nweight standards used in SDS-PAGE and western-blot were purchased from Sigma-\n\nAldrich (Saint Louis, MO, USA). Chromogenic substrate for factor Xa (S2222, Bz-Ile-\n\nGlu-Gly-Arg-pNa) was obtained from Chromogenix (Milano, Italy). Ketamine and \n\nxylazine were from Syntec, S\u00e3o Paulo, Brazil. L. obliqua antivenom (antilonomic serum \n\n- ALS), provided by the Butantan Institute (S\u00e3o Paulo, Brazil), was used as primary \n\nantibody for the detection of toxins in urine and renal tissue. ALS is a horse-derived \n\nconcentrate of purified polyclonal antibodies (IgG) that had been raised against L. \n\nobliqua bristle extract (Rocha-Campos et al., 2001). Nonspecific background staining in \n\nimmunohistochemical reactions was blocked using Ultra V Block reagent (Thermo \n\nFisher Scientific, Waltham, MA, USA). \n\n  \n\n  2.2 Venom \n\n L. obliqua caterpillars were kindly provided by the Centro de Informa\u00e7\u00f5es \n\nToxicol\u00f3gicas (CIT), Porto Alegre, Rio Grande do Sul, Brazil. The specimens used in \n\nthis study were collected in the cities of Bom Princ\u00edpio and Progresso, both located in \n\nRio Grande do Sul, Brazil. L. obliqua venom was obtained by homogenizing the bristles \n\nin cold phosphate-buffered saline (PBS), pH 7.4, as previously described (Berger et al., \n\n2010). The venom obtained following this procedure was designated as Lonomia \n\nobliqua Bristle Extract (LOBE). The protein content of the LOBE samples was \n\ndetermined using a BCA assay kit (Pierce, Rockford, USA) and the aliquots were stored \n\nat -80 \u00b0C prior to use. The total number of caterpillars used for bristle extract \n\npreparation was 124 specimens and the protein concentration of the LOBE samples was \n\n4.10 mg/mL. The total amount of venom extracted per caterpillar was 2.4 mg. All of the \n\nLOBE samples had similar in vitro pro-coagulant activities and the protein pattern for \n\n\n\nResultados \n\n117 \n\n \n\neach sample as monitored by SDS-PAGE and gel filtration chromatography (Pinto et \n\nal., 2006; Berger et al., 2010) were also similar. \n\n  \n\n2.3 Ethical statements \n\n All procedures involving animals were carried out in accordance with the \n\nGuiding Principles for the Use of Animals in Toxicology (International Society of \n\nToxicology, http://www.toxicology.org) and the Brazilian College of Animal \n\nExperimentation (COBEA). The experimental protocol was approved by the ethical \n\ncommittee on research animal care of the Federal University of Rio Grande do Sul, \n\nBrazil (register number 2008177/2009) and by the Institute's Animal Ethics Committee \n\nof the Federal University of Minas Gerais, Brazil (protocol 177/2008).  \n\n \n\n2.4 Experimental protocol \n\n \n\n2.4.1 Animals \n\n Adult male Wistar rats, weighing 250-300 g, were supplied by the central animal \n\nfacility of our institution. They were housed in standard conditions within a temperature \n\ncontrolled room (22-23 \u00baC, on a 12 h light/dark cycle, with the lights on at 7:00 am) and \n\nhad free access to water and food. \n\n \n\n2.4.2 Selection of the venom dose \n\n The severity of the natural envenoming is related mainly to the number of \n\ncaterpillars involved as well as to the intensity of the exposure, since the venom is \n\npresent not only in the caterpillar\u2019s bristles but also in their skin and hemolymph (Veiga \n\net al., 2001). Considering that accidents with medical importance involves contact with \n\na colony containing at least 40 to 50 caterpillars (Gamborgi et al., 2006) and that during \n\nvenom extraction, after removal of all spicules, each caterpillar produces approximately \n\n2.4 mg of venom, the total amount of venom injected in an individual weighing 70 kg \n\ncan reach up to 1.4 \u2013 1.7 mg/kg. In fact, these doses were calculated based on an \n\nartificial method of venom extraction, in which the caterpillar\u2019s bristle was macerated in \n\na solution buffer. Thus, in a real envenomation situation the total amount of venom \n\ntransferred is probably lower than the amount calculated. In an attempt to reproduce the \n\nclinical conditions observed in a real envenomation we selected doses of 1.0 and 1.5 \n\nmg/kg injected subcutaneously into rats. These doses were also in accordance with the \n\nhttp://www.toxicology.org/\n\n\nResultados \n\n118 \n\n \n\namount of venom used in other studies to induce coagulopathy and test the efficacy of \n\nantilonomic serum (Berger et al., 2010; Dias da Silva et al., 1996; Rocha-Campos et al., \n\n2001). \n\n \n\n2.4.3 Venom administration \n\n To follow the time course of kidney pathophysiological alterations, we used an \n\nexperimental model of envenomation in rats. For this purpose, animals were divided \n\ninto three groups (n = 6/group): The control animals (CTRL) were injected \n\nsubcutaneously (s.c.) with 100 \u00b5L of sterile PBS solution and the experimental animals \n\nreceived a s.c injection containing 1.0 mg or 1.5 mg of LOBE per kg of body weight in \n\na final volume of 100 \u00b5L. Immediately after treatments, the animals were distributed \n\nindividually into metabolic cages, allowing quantitative urine collections and \n\nmeasurement of water intake. At several time points post-venom injection (2, 6, 12, 24, \n\n48 and 96 h), blood, urine and kidneys were obtained for biochemical, histopathological \n\nand immunohistochemical analyses.  \n\n \n\n2.5 Sample preparation \n\n Blood was collected in conscious rats through the caudal vein in 1:10 (v/v) 3.8 \n\n% trisodium citrate. Plasma was obtained by centrifugation at 1500 x g for 10 min and \n\nstored at \u2013 80 \u00baC prior to use. Urine samples were also centrifuged at 2500 x g for 5 min \n\nand the supernatants stored at the same conditions. After blood collection, animals from \n\nthe different groups were anesthetized by intraperitoneal (i.p.) injection of a mixture of \n\nketamine (75 mg/kg) and xylazine (10 mg/kg). Then, an intracardiac perfusion was \n\nperformed through the left ventricle with PBS solution and a circulatory circuit was \n\nopened by an incision in the right atrium, to ensure the elimination of intravascular \n\nblood. Immediately after perfusion, kidneys were quickly removed. One of them was \n\nfixed for histological analysis and the other was frozen in liquid nitrogen and stored at \u2013 \n\n80 \u00baC for the measurement of tissue factor activity and proteomic analysis. \n\n      \n\n2.6 Biochemical measurements \n\n Urinary and plasma levels of creatinine, urinary ?-glutamyl transferase (?-GT) \n\nactivity and proteinuria were determined by spectrophotometry (Turner SP-830 plus \n\nBarnstead, Dubuque, Iowa, USA) using commercially available kits (BioClin/Quibasa, \n\nBelo Horizonte, Brazil). Plasma and urinary concentrations of Na\n+\n and K\n\n+\n were \n\n\n\nResultados \n\n119 \n\n \n\nmeasured by flame photometry (CELM 180; Belo Horizonte, Minas Gerais, Brazil). \n\nOsmolality was determined in plasma and urine samples by cryoscopic osmometery \n\nusing a Micro-Osmometer 3320 (Advanced Instruments, Norwood, Massachusetts, \n\nUSA). Urine proteins were also analyzed by gel electrophoresis which was performed \n\naccording to Laemmli (1970). Urine samples from animals of different times post-\n\nvenom injection were diluted (10 X) and aliquots of 10 \u00b5L were submitted to SDS-\n\nPAGE on 8-20 % gradient gels under reducing conditions. Toxins excreted in urine \n\nwere detected by Western-blot as previously described (Pinto et al., 2006). Aliquots \n\ncontaining 50 \u00b5g of protein were separated by SDS-PAGE and transferred to PVDF \n\nmembranes. Toxins were recognized using as a primary antibody an equine anti-LOBE \n\nIgG (ALS) diluted 1:100 and as a secondary antibody a peroxidase-labeled anti-horse \n\nIgG diluted 1:1000. \n\n \n\n2.7 Renal function parameters \n\n At the time intervals mentioned above the following renal function parameters \n\nwere determined: Glomerular filtration rate (GFR), osmolar clearance (Cosm), water free \n\nclearance (CH2O), fractional water excretion (FEH2O), fractional sodium excretion \n\n(FENa\n+\n) and fractional potassium excretion (FEK\n\n+\n). GFR (expressed as mL/min/100 g of \n\nbody weight) was estimated by the creatinine clearance (Ccr), using the standard \n\nformula: Ccr = Ucr.V/Pcr, where Ucr is the urinary creatinine concentration, V is the \n\nurinary output and Pcr is the plasma creatinine concentration. Cosm (expressed as \n\nmL/min) was calculated as Cosm = Uosm/Posm.V, whereas Uosm and Posm are the urinary \n\nand plasma osmolalities, respectively. Values of CH2O (mL/min) and FEH2O (%) were \n\nobtained respectively from the equations: CH2O = V - Cosm and FEH2O = V/GFR.100. \n\nFENa\n+\n\n and FEK\n+\n (expressed as %) were calculated according to the equation: FE = \n\nUE/PF.100. UE represents the urinary excretion of each ion and PF is the amount \n\nfiltered in plasma (both expressed as nmol/min). \n\n \n\n2.8 Hemodynamic parameters \n\n Systemic arterial pressure was measured in conscious rats by an indirect tail-cuff \n\nmethod using an electrosphygmomanometer (LE 5001, Harvard Apparatus, Holliston, \n\nMassachusetts, USA) combined with a pneumatic pulse transducer/amplifier, which \n\nprovides output signals proportional to cuff pressure and amplified Korotkoff sounds. \n\n\n\nResultados \n\n120 \n\n \n\nThree consecutive readings of mean arterial pressure and heart rate were recorded \n\nbefore blood collection for each animal in each time post-venom injection. \n\n \n\n2.9 Renal vascular permeability \n\n The extravasation of Evans blue dye into the kidney was used as an index of \n\nincreased vascular permeability (Pompermayer et al., 2005). Rats received Evans blue \n\ndye (30 mg/kg) intravenously (1 mL/kg) via caudal vein 10 min prior to LOBE (1.5 \n\nmg/kg, s.c.) or PBS (100 \u00b5L, s.c.) injection. After 12 or 24 h, animals were anesthetized \n\nand perfused as described above to remove the intravascular Evans Blue. Then, the \n\nkidneys were quickly removed, weighed and allowed to dry for 24 h at 40 \no\nC. The dry \n\nweight was determined and Evans blue dye extracted in 2.5 mL of 1 % formamide (48 h \n\nat 40 \no\nC). The absorbance of extracted solution was measured in triplicate using a \n\nmicroplate reader spectrophotometer (SpectraMAX, Molecular Devices Co., Sunnyvale, \n\nUSA) and the amounts of Evans blue dye were calculated by a standard curve made \n\nwith known concentrations of Evans Blue. Results are presented as the amount of Evans \n\nblue dye extravasated (?g) per 100 mg of kidney tissue. \n\n \n\n2.10 Renal tissue factor activity \n\n Renal tissue factor (TF) was measured indirectly based on its ability to form a \n\ncomplex with factor VIIa (TF/FVIIa) to activate factor IX and X (Morrissey, 1995). \n\nBriefly, the kidneys were collected as described above, homogenized in cold PBS \n\nsolution containing 1 % Triton X-100 and centrifuged at 9500 x g for 15 min. Samples \n\nof supernatants (with 10 \u00b5g of protein) were incubated with a concentrate mixture of \n\nFVII+FIX+FX (total of 15 \u00b5g) in 20 mM Tris-HCl, pH 7.4 containing 10 mM of CaCl2 \n\nfor 10 min at 37 \no\nC. Activated factor Xa (FXa) produced during the reaction was \n\ndetected by the addition of a specific chromogenic substrate (0.2 mM S2222). The \n\nkinetics of p-nitroaniline release was monitored at 405 nm for 30 min in a final volume \n\nof 100 \u00b5L using a microplate reader spectrophotometer (SpectraMAX, Molecular \n\nDevices Co., Sunnyvale, USA). Each sample was measured in triplicate and results \n\nexpressed as \u00b5mol of FXa generated per min per mg of kidney tissue. \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n121 \n\n \n\n2.11 Histology and immunohistochemistry \n\n For renal histopathology, kidneys were collected as described above, sectioned \n\nsagitally and fixed in 10 % buffered formaldehyde, pH 7.2. After processing in alcohol \n\nand xylol, the organs were included in paraffin and 4 ?m thick sections were obtained \n\nand stained with haematoxylin and eosin (H&amp;E), periodic acid-Schiff (PAS) or Picro-\n\nSirius reagent. \n\n For immunohistochemical analysis of venom distribution in renal tissue, the \n\nkidney sections were deparaffinized and treated with 10 % hydrogen peroxide solution \n\nin methanol for 15 min to block endogenous peroxidase activity. Nonspecific binding \n\nsites were blocked with Ultra V Block reagent followed by incubation overnight at 4 \no\nC \n\nwith an equine anti-LOBE IgG (ALS) diluted 1:250 in PBS. After a washing step, the \n\nsections were incubated with the secondary antibody (a biotinylated anti-horse IgG \n\nproduced in goat, diluted 1:100) and streptavidin diluted 1:100. The chromogenic \n\nreaction was developed by incubating the sections with 0.05 % diaminobenzidine \n\nsolution and 0.2 % hydrogen peroxide. The progress of the reaction was monitored by \n\nlight microscopy and stopped by washing the slides. Finally, the sections were \n\ncounterstained with diluted Harris\u2019s haematoxylin. Control reactions were done by \n\nincubating kidney sections from non-envenomed rats with equine anti-LOBE IgG \n\n(ALS) under the same conditions as described above. No positive reactions were \n\nobserved in these sections. Some sections were also used as negative controls. In these \n\ncases, the primary antibody was substituted by PBS. \n\n \n\n2.12 Morphometric analysis \n\n Glomerular morphological alterations were quantified by computer-assisted \n\nmorphometric analysis using a method previously described (Caliari, 1997). Briefly, \n\nimages with 40 X magnification of 30 glomeruli from each animal of different groups \n\nwere randomly digitalized using a JVC TK1270/RGB microcamera (Tokyo, Japan). The \n\nKS300 software coupled to a Carl Zeiss image analyzer (Carl Zeiss, Oberkochen, \n\nGermany) was used to measure the total area (?m\n2\n) of each glomerulus, glomerular tuft \n\nand bowman's space. The pixels of whole glomerulus and those corresponding to the \n\nglomerular tuft were selected and used for the generation of a binary image and \n\nsubsequent calculation of the corresponding areas. The area of Bowman's space was \n\nobtained by the difference between the whole glomerular area and tuft area. The regions \n\n\n\nResultados \n\n122 \n\n \n\nof positive immunohistochemical reaction (expressed as ?m\n2\n) were also measured and \n\nused as a parameter to quantify venom distribution in the renal tissue. \n\n \n\n2.13 Renal tissue proteomics \n\n \n\n2.13.1 Sample preparation for mass spectrometry \n\n The kidneys from controls and envenomed animals (at 24 h post-venom \n\ninjection) were collected as described above, homogenized in cold PBS solution \n\ncontaining 1 % Triton X-100 with protease inhibitor cocktail (Halt protease inhibitor \n\ncocktail, Thermo, Rockford, USA) and centrifuged at 9500 x g for 15 min. The resulting \n\nsupernatants were completely lyophilized and stored at -80 \no\nC until use. Lyophilized \n\nsamples were resuspended in water and precipitated using methanol/chloroform \n\nprotocol. After precipitation samples were dried at room temperature and resuspended \n\nin 8 M urea. Each sample containing 100 \u00b5g of protein was reduced with 5 mM tris-2-\n\ncarboxyethyl-phosphine (TCEP) at room temperature for 20 min and alkylated with 10 \n\nmM iodoacetamide at room temperature in the dark for 20 min. After reduction and \n\nalkylation, proteins were digested with 2 ?g of trypsin (Promega, Madison, WI) by \n\nincubation at 37 \u00b0C during 16 h. Samples were freeze-dried at -80 \no\nC and, after thaw, \n\nformic acid to a final concentration of 5 % was added. Samples were centrifuged at \n\n14,000 rpm for 20 min and the supernatant was collected and stored at -80 \u00b0C. \n\n \n\n2.13.2 MudPIT \n\n The protein digest was pressure-loaded into a 250-?m i.d capillary packed with \n\n2.5 cm of 5-\u00b5m Luna strong cation exchanger (SCX) (Whatman, Clifton, NJ) followed \n\nby 2 cm of 3-\u00b5m Aqua C18 reversed phase (RP) (Phenomenex, Ventura, CA) with a 1 \n\n\u00b5m frit. The column was washed with buffer containing 95 % water, 5 % acetonitrile, \n\nand 0.1 % formic acid. After washing, a 100-\u00b5m i.d. capillary with a 5-\u00b5m pulled tip \n\npacked with 11 cm of 3-\u00b5m Aqua C18 resin (Phenomenex, Ventura, CA) was attached \n\nvia a union according Klein et al. (2012). The entire split-column was placed in line \n\nwith an Agilent 1100 quaternary HPLC (Palo Alto, CA) and analyzed using a modified \n\n11-step separation as described previously (Washburn et al., 2001). The buffer solutions \n\nused were 5 % acetonitrile, 0.1 % formic acid (Buffer A), 80 % acetonitrile, 0.1 % \n\nformic acid (Buffer B), and 500 mM ammonium acetate, 5 % acetonitrile and 0.1 % \n\nformic acid (Buffer C). Step 1 consisted of a 70-min gradient from 0\u2013100 % (vol/vol) \n\n\n\nResultados \n\n123 \n\n \n\nbuffer B. Steps 2\u201310 had a similar profile with the following changes: 5-min in 100 % \n\n(vol/vol) buffer A, 3-min in X % (vol/vol) buffer C, a 6-min gradient from 0 to 15 % \n\n(vol/vol) buffer B, and a 85-min gradient from 15\u2013100 % (vol/vol) buffer B. The 3-min \n\nbuffer C percentages (X) were 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100 % (vol/vol), \n\nrespectively, for the 10-step analysis.  \n\n \n\n2.13.3 LTQ-Orbitrap \n\n As peptides eluted from the microcapillary column, they were electrosprayed \n\ndirectly into a LTQ-Orbitrap (Thermo Fisher) with the application of a distal 2.4-kV \n\nspray voltage. Full MS spectra were acquired in profile mode, with a mass range of 400 \n\n\u2013 1600 in the Orbitrap analyzer with resolution set at 60,000 followed by 10 data-\n\ndependent MS/MS spectra at 35 % normalized collision energy was repeated \n\ncontinuously throughout each step of the multidimensional separation. Minimal signal \n\nfor fragmentation was set to 1,000. Dynamic exclusion was enabled with a repeat count \n\nof 1, duration of 30.00 s, list size of 500, exclusion duration of 180.00 s, and exclusion \n\nmass with high/low of 1.5 m/z. Application of mass spectrometer scan functions and \n\nHPLC solvent gradients were controlled by the Xcalibur data system.  \n\n \n\n2.13.4 Analysis of tandem mass spectra  \n\n MS/MS spectra were analyzed using the following software analysis protocol. \n\nProtein identification and quantification analysis were done with Integrated Proteomics \n\nPipeline (IP2, Integrated Proteomics Applications, Inc. \n\nwww.integratedproteomics.com/). Tandem mass spectra were extracted into ms2 files \n\nfrom raw files using RawExtract 1.9.9 (McDonald et al., 2004) and were searched using \n\nProLuCID algorithm (Xu et al., 2006). MS/MS spectra remaining after filtering were \n\nsearched with the ProLuCID algorithm against the EBI-IPI_rat_3.30_06-28-2007 \n\nconcatenated to a decoy data base in which the sequence for each entry in the original \n\ndata base was reversed (Peng et al., 2003). Searches were performed with cysteine \n\ncarbamidomethylation as a fixed modification. ProLuCID results were assembled and \n\nfiltered using the DTASelect program (Tabb et al., 2002) using two SEQUEST (Eng et \n\nal. 1994) defined parameters: the cross-correlation score (XCorr) and normalized \n\ndifference in cross-correlation scores (DeltaCN) to achieve a false discovery rate of 1 \n\n%. The following parameters were used to filter the peptide candidates: -p 1 -y 1 --\n\ntrypstat --fpf 0.01 --dm. Also, we used 50 ppm as precursor tolerance, fragment mass \n\nhttp://www.integratedproteomics.com/\n\n\nResultados \n\n124 \n\n \n\ntolerance of 600ppm, 3 as number of isotopic peaks and unlimited missed cleavages \n\nwere allowed.  \n\n2.13.5 Assessing differential expression and exclusive proteins / Bioinformatic tools \n\n The software PatternLab (Carvalho et al. 2008, 2012) was used to identify \n\nexclusive proteins found in the control and treated conditions. PatternLab\u2019s \n\nApproximately Area Proportional Venn Diagram (AAPVD) module was used for \n\npinpointing proteins uniquely identified in each condition. The following parameter was \n\nused: proteins that were not detected in at least 2 out of 3 runs per condition were not \n\nconsidered. G-test spectral counting quantitation was performed in a pair-wise \n\ncomparison between the two groups, as previously reported (Ambatipudi et al. 2009). \n\nProteins are considered differentially expressed with P &lt;0.1. Ingenuity Pathway \n\nAnalysis tool (Ingenuity Systems; http://www.ingenuity.com) was used to generate \n\nfunctional annotations of identified proteins in known molecular pathways and/or \n\nbiologic function in disease. The significance of the canonical pathways and biologic \n\nfunction defined by identified proteins was measured in two ways: (1) The number of \n\nproteins identified from the data set that map to a known pathway or function in disease \n\nand (2) a P value (Fisher exact test) determining the probability that the association \n\nbetween the proteins in the data set and the canonical pathway or function in disease is \n\nexplained by chance alone. \n\n \n\n2.14 Statistical Analyses \n\n Results are expressed as mean \u00b1 SE. When appropriate, statistical comparisons \n\nwere done by using one or two-way analysis of variance followed by the Bonferroni's \n\ntest. A P value of less than 0.05 was chosen to establish significance. Statistical analysis \n\nwas performed using GraphPad Prism (GraphPad Software Inc., San Diego, CA, USA). \n\n \n\n3. Results \n\n \n\n3.1 Renal function  \n\n To follow renal alterations in rats several physiological parameters were \n\nmeasured at different times post Lonomia obliqua venom injection. The results are \n\npresented in Fig. 1. Between 2 and 6 h after LOBE administration (doses of 1 mg/kg or \n\n1.5 mg/kg, s.c.), the animals showed signs of acute toxicity, including progressive \n\nweakness, lethargy and dyspnea. Compared to PBS-treated animals there was a \n\n\n\nResultados \n\n125 \n\n \n\nreduction of body weight mainly at 6 h in rats that received the higher dose of LOBE \n\n(1.5 mg/kg, s.c.) (Fig. 1A). The weight loss was accompanied by a significant reduction \n\nin water intake between 6 and 48 h and by an increase in urinary output at 6 and 12 h for \n\nboth tested doses (Fig. 1B). The polyuria was maximal at 6 h, when urinary output \n\nincreased from 0.58 \u00b1 0.08 mL/2h in PBS-treated animals to 1.80 \u00b1 0.16 mL/2 h (p &lt;\n\n0.05) in rats injected with LOBE (1.5 mg/kg, s.c.). At the same time, animals that \n\nreceived a dose of 1.0 mg/kg had a urinary output significantly lower (0.9 \u00b1 0.2 mL/2h, \n\np &lt;0.05) compared to those treated with 1.5 mg/kg (Fig. 1C).       \n\n Important glomerular and tubular functions related to control of fluid filtration, \n\nwater and electrolyte balance were severely impaired. Despite the polyuria, L. obliqua-\n\ninduced AKI is associated with a marked reduction in the glomerular filtration rate \n\n(GFR). In the first 24 h of envenomation, a rapid decrease of GFR was observed in \n\nanimals treated with both doses of LOBE. At 48 h envenomed rats (injected with 1.5 \n\nmg/kg of LOBE) presented values of GFR 16 times lower than controls at the same \n\ntime. This remarkable effect of the venom on GFR was observed for as long as 96 hours \n\n(Fig. 1D). Similarly, the kidney's ability to concentrate urine (a primordial tubular \n\nfunction) was also impaired, since the density and osmolality of urine had a reduction in \n\nvalues between 2 and 48 h (Fig. 1E an F). The decrease in urinary osmolality was \n\naccompanied by a significant increase in the plasma osmolality observed mainly in rats \n\ninjected with the higher dose of LOBE (Fig. 1G). Consistent with these results the \n\nosmolar clearance (Cosm) was lower in envenomed animals, while the free water \n\nclearance (CH2O) increased, which imply that the kidney is producing dilute urine \n\nthrough the excretion of solute-free water (Fig. 1H and I). As expected, with the loss of \n\nability to retain water, the fractional excretion of water (FEH2O) increased from 0.33 \u00b1 \n\n0.03 % in PBS-treated animals to 29.1 \u00b1 4.9 % (p &lt;0.05) in rats injected with LOBE \n\n(1.5 mg/kg, s.c.) at 48 h (Fig. 1J). Likewise, tubular ability to conserve and maintain the \n\nelectrolytic balance was lost throughout the envenoming period. The fractional \n\nexcretion of sodium and potassium (FENa+ and FEK+) was high between 24 and 48 h, \n\nindicating a marked impairment in the tubular reabsorption of filtered Na\n+\n and K\n\n+\n (Fig. \n\n1K and L). At 96 h most of the renal function parameters (excepting GFR) tends to \n\nreturn to normal levels (similar from that obtained to non-envenomed rats).   \n\n     \n\n \n\n \n\n\n\nResultados \n\n126 \n\n \n\n3.2 Proteinuria \n\n Most of envenomed animals produced dark-brown-colored urine in the period of \n\n6 to 12 h, indicating the occurrence of hematuria and/or hemoglobinuria. The presence \n\nof intact and fragmented erythrocytes, epithelial cells and leukocytes were observed in \n\nthe urinary sediment by light microscopy (not shown). Consistent with these \n\nobservations, L. obliqua venom induced massive acute proteinuria, which was maximal \n\nat 6 and 12 h post-venom injection (Fig. 2A). As expected, the group treated with 1.5 \n\nmg/kg of LOBE had more severe proteinuria compared to animals treated with 1.0 \n\nmg/kg, but for both groups, urinary protein excretion decreased progressively between \n\n12 and 48 h, reaching levels similar to controls at 96 h. Analysis of urine by SDS-PAGE \n\nrevealed the presence of several proteins with molecular weights ranging from 10 to 75 \n\nkDa (Fig. 2B). A greater variety of bands were evident mainly at 6 and 12 h after \n\nenvenomation, confirming this time interval as crucial to the development of glomerular \n\ninjury. The two most prominent bands (observed around of 70 and 15 kDa) have \n\nmolecular weights that match to serum albumin (68 kDa) and subunits of hemoglobin \n\n(16 kDa). The presence of venom excreted in urine was verified by western-blot. As \n\nshown in Fig. 2C, we detected at least 5 bands in urine from venom-treated rats at 6 and \n\n12 h, which specifically react with antibodies raised against L. obliqua toxic proteins. \n\nThese bands have molecular weights around of 70-60, 50, 37, 25 and 20 kDa (arrows in \n\nFig. 2C) and were not recognized in urine from non-envenomed animals (controls). \n\nSeveral toxins in this range of molecular weights have already been identified through \n\ntranscriptomic and proteomic analysis of LOBE. Some of them include lectins and c-\n\ntype lectin-like proteins (70-60 kDa), serine-proteinases (50 kDa), cysteine-proteinases \n\n(37 kDa) and lipocalins (25-20 kDa) (Ricci-Silva et al., 2008; Veiga et al., 2005).  \n\n    \n\n3.3 Renal histopathological alterations \n\n Light microscopy of kidney biopsies from PBS-injected rats revealed a normal \n\nrenal parenchyma (Fig. 3A). In contrast, envenomed animals showed progressive \n\ndegenerative lesions compatible with acute tubular necrosis (ATN) (Fig. 3B\u2013H). \n\nIncreased acidophilia and dilation of renal tubules were observed between 6 and 48 h \n\nafter venom administration (Fig. 3C-F). Loss of proximal brush border, cytoplasm \n\nvacuolation, and in some tubules, degeneration and desquamation of necrotic cells \n\noccurred between 12 and 48 h (Fig. 3D-F). The nuclei of the various proximal tubular \n\ncells at 24 and 48 h often showed pyknosis with clumping of chromatin material (Fig. \n\n\n\nResultados \n\n127 \n\n \n\n3E and F). In several tubules at 48 h, the renal epithelium was completely necrotic \n\nwhereas the basement membrane was either intact or disrupted by tubular necrosis (Fig. \n\n3F). Consistent with the histological signs of tubular injury, ?-GT urinary activity ? \n\nwhich is considered an efficient biomarker for early diagnosis of ATN (Guder and Ross, \n\n1984) ? increased in a dose- and time-dependent manner up to 48 h. At 96 h, ?-GT \n\nactivity decreased, but remained significantly high in animals treated with 1.5 mg/kg of \n\nLOBE. Histologically, the signs of lesions were much less marked and the proximal and \n\npost-proximal tubular epithelia assumed a normal appearance at 96 h (Fig. 3G and H).  \n\n Besides the evidence of degenerative lesions, proximal and distal tubules also \n\nhad swollen lumens. Hyaline and hematic casts and cellular debris were found within \n\ntubules, obstructing their lumens (Figs. 3C-F and 4). Hyaline casts (predominantly \n\nformed by a protein-rich material) were more prevalent at 6 and 12 h (Figs. 3C-D and \n\n4A), while hematic casts (predominantly formed by fragmented or intact erythrocytes) \n\nand cellular debris have appeared commonly at 12, 24 and 48 h (Figs. 3D-F and 4A-B).  \n\n An intense inflammatory response characterized by edema, cellular infiltration \n\nand fibrosis was observed mainly at 48 h and 96 h (Figs. 3F and 5). Inflammatory cell \n\ninfiltrate and edema were detected at 48 h in regions of extensive necrosis (Fig. 3F) and \n\nwithin glomeruli (Fig. 5C). At 96 h, despite signs of tubular regeneration, the \n\ninflammatory infiltrate increased significantly, probably to help in tissue repair (Fig. \n\n5B). Light microscopy of sections stained with picrosirius revealed extensive \n\nperitubular collagen deposition at 96 h after administration of L. obliqua venom (Fig. \n\n5E) compared to PBS-treated rats (Fig. 5D), indicating fibrosis. Foci of interglomerular \n\ncollagen deposition were also observed in the renal cortex at the same time (Fig. 5F). \n\n \n\n3.4 Glomerular morphometric alterations and renal tissue factor activity \n\n Glomerular alterations in envenomed animals were associated with lobulation of \n\nthe capillary tufts, dilation of glomeruli, deposition of a hyaline material inside the \n\nBowman's space and distention of Bowman's space (Figs. 3D, 6A and 7B). Nodules \n\nthat formed a dense, strongly-stained mesangial matrix, evidenced by the presence of a \n\nPAS positive stain in the capillary tufts was also observed between 2 and 12 h post-\n\nvenom (Fig. 6A). Consistent with histological observations, computer-assisted \n\nmorphometric analysis has indicated a significant increase in glomerular area at all-time \n\nintervals examined. There was also an increase in the areas of glomerular tuft and \n\nBowman's space, which confirms that the capillaries and Bowman's space are dilated \n\n\n\nResultados \n\n128 \n\n \n\n(Fig. 6B). The enlargement of Bowman's space observed at 12 h possibly is related to \n\nthe presence of a hyaline material (rich in plasma proteins) found in several glomeruli at \n\nthis time (details in Figs 3D and 7B).    \n\n Since intra-glomerular fibrin deposition can impair renal function and L. obliqua \n\nvenom is able to activate the coagulation system both in vitro and in vivo (Berger et al., \n\n2010), we decide to measure the levels of renal tissue factor (TF) activity during \n\nenvenomation. TF is a transmembrane enzyme activator that triggers the coagulation \n\ncascade, generating activated factor X and fibrin. As showed in Fig. 6C, renal TF \n\nactivity increased rapidly from the first 2 h, reaching levels 2 times higher than control \n\nvalues at 6 hours. At 12 and 24 h post-venom injection this level remained significantly \n\nhigh, but decreased progressively thereafter (Fig. 6C). Interestingly, the rise in renal TF \n\nactivity was coincident with the presence of PAS positive deposits (which stain \n\nspecifically glycoproteins) within the capillary tufts at 2-12 h (Fig. 6A). \n\n \n\n3.5 Hemodynamics and renal vascular permeability  \n\n Mean arterial blood pressure was lower in animals that received LOBE \n\ncompared to basal levels in controls (Table 1). Sustained hypotension was detected \n\nbetween 24 and 96 h in rats treated with the both doses of venom. The maximum \n\ndecrease occurred at 24 h. In contrast, the heart rate increased significantly at 12 and 96 \n\nh in animals injected with 1 mg/kg of LOBE and at 48 h in animals injected with 1.5 \n\nmg/kg. Hypotension was accompanied by an increase in renal vascular permeability \n\n(Fig. 7). Kidney blood vessels were hyperemic and signs of plasma leakage, migration \n\nof inflammatory cells and interstitial edema were also evident after 12 h of venom \n\nadministration (Fig. 7A). As mentioned above, several glomeruli at 12 h have their \n\nBowman's space filled with a protein-rich material that had extravasated from \n\nglomerular capillaries (Fig. 7B). Confirming these observations, a marked increase of \n\nvascular permeability in the kidney, as measured by the extravasation of Evans blue \n\ndye, was detected at 12 and 24 h after LOBE injection (1.5 mg/kg, s.c) (Fig. 7C). \n\n \n\n3.6 Immunohistochemical detection of venom in the renal tissue \n\n Venom distribution and its binding to renal structures was investigated by \n\nsubmitting kidney biopsies from venom-treated and control rats to \n\nimmunohistochemistry using anti-LOBE IgG that reacts specifically with venom toxins \n\n(Fig. 8). Positive immunohistochemical reaction was found in cortical and medullar \n\n\n\nResultados \n\n129 \n\n \n\nregions of kidneys from rats injected with 1.5 mg/kg of LOBE (Fig. 8D and C). Venom \n\nwas detected in glomerular capillaries, Bowman\u2019s capsule, proximal and distal tubules \n\nand in intra-tubular casts. Staining for venom was intense in tubular brush border at 2 \n\nand 6 h and was also present in cells of tubules in degeneration at 48 h (Fig. 8B-D). \n\nGenerally, tubules stained more than glomeruli. There was no immunoreactivity for \n\nvenom in the renal structures of PBS-treated rats (controls) (Fig. 8A). The highest levels \n\nof venom (estimated by the area of positive immunohistochemical reaction) were \n\ndetected in the renal tissue at 2 h (Fig. 8F). After that, venom immunoreactivity \n\ndecreased progressively until 96 h when the staining was weak (Fig. 8E and F). L. \n\nobliqua toxins were also detected in other kidney structures such as in perivascular \n\nconnective tissue of blood vessels, endothelium and smooth muscle of arteries and veins \n\n(Fig. 9A and B). \n\n \n\n3.7 Kidney proteins differentially expressed during envenomation \n\n To gain further mechanistic insight which drive venom-induced kidney disease, \n\nwe applied a semi-quantitative discovery based shotgun proteomic approach to identify \n\nthe proteins differentially expressed in the kidney of envenomed animals. For this \n\npurpose, the proteomic data was acquired by tandem mass spectrometry with \n\nsubsequent quantification, analysis of differential protein expression, validation, and \n\nfunctional annotations in order to identify the involved molecular pathways. The \n\nproteins identified consist of two classes: (1) those that were differentially expressed \n\nand met our significance criteria and (2) proteins that were uniquely identified in \n\nkidneys of rats injected with PBS or LOBE (1.5 mg/kg) after 24h. Figure 10A \n\nrepresents differentially expressed and unique proteins via a Venn diagram. Overlaps \n\nbetween PBS- and LOBE-treated animals represent significant differentially expressed \n\nproteins and non-overlapping portions of the diagram represent unique protein \n\nidentifications. A total of 779 proteins were identified. Twenty-four proteins were \n\nexclusively identified in envenomed animals; 169 were exclusively identified in control \n\nrats and 586 were common proteins in both treatments. Among these 586 proteins, 138 \n\n(23.5 %) were identified as being differentially expressed. \n\n Ingenuity Pathway Analysis was used for functional annotations and revealed \n\nseveral key protein categories and pathways significantly enriched in the differentially \n\nexpressed proteins. Thus, the sets of proteins were assigned to either biologic function \n\nin disease or canonical signaling pathways. Through these analyses it was evident that \n\n\n\nResultados \n\n130 \n\n \n\nthe set of proteins identified in control kidneys displayed healthy biological functions \n\nsuch amino acid metabolism and small-molecule biochemistry associated with normal \n\nrenal metabolic pathways (Fig. 10B). On the other hand, protein expression shifts \n\ntoward \"cellular distress\" functions in the kidney of envenomed rats (Fig. 10C). In this \n\ncase, the expression profiles were considerably enriched for proteins that belong to \n\nacute phase inflammatory response signaling, LXR/RXR activation (involved in retinoic \n\nacid-mediated gene activation triggered by inflammatory stimulus), oxidative stress \n\nresponse pathways such as that mediated by the nuclear erythroid-related factor 2 \n\n(NRF2) and coagulation and complement systems (involved in thrombosis, fibrosis, \n\ninflammation and vascular alterations) (Fig. 10C).  \n\n Accordingly to our functional and histopathological results, several novel \n\nproteins related to renal disease were identified in the kidney of LOBE-treated animals. \n\nProteins associated with tubular and glomerular injury, necrosis, inflammation and \n\nfibrosis were up-regulated or unique in envenomed rats (Fig. 10D). Some of these \n\nmolecules, mainly those that were related to renal disease or identified in canonical \n\npathways, are listed in Table 2. A complete list with differentially expressed and unique \n\nproteins of envenomed and control animals are shown in supplemental Table 1. It is \n\nworth mentioning, that proteins functionally linked to tissue injury (markers of necrosis \n\nand/or apoptosis), osmotic and oxidative stress, electrolytic imbalance, acute phase \n\ninflammatory response, fibrosis and thrombosis were expressed in the kidneys of \n\nLOBE-treated rats (Table 2). Proteins of the kallikrein-kinin and complement systems \n\nwhich are related to hypotension and control of vascular permeability were also found \n\nto be up-regulated in envenomed animals (Table 2). Our proteomic data also confirm \n\nthat an important mechanism of Lonomia-induced AKI is mediated by hemoglobin and \n\nthe release of its degradation products: free heme and iron. In fact, hemoglobin, \n\nhemopexin and ferritin were up-regulated and the expression of heme oxygenase-1 was \n\nuniquely induced in the kidneys of envenomed rats (Table 2). As a result of heme and \n\niron release, several antioxidant enzymes were found to be up-regulated, indicating the \n\ngeneration of reactive oxygen species (Table 2).  \n\n \n\n4. Discussion \n\n AKI is frequently described and is life threatening in several cases of snake and \n\narthropod envenomation (Sitprija, 2006; Berger et al., 2012). Particularly in Lonomia \n\nobliqua envenomation, AKI is the main cause of death and its mechanisms are \n\n\n\nResultados \n\n131 \n\n \n\ncompletely unknown until now. In this work we use an in vivo experimental model to \n\ncharacterize the L. obliqua-induced AKI. According to our results, the \n\npathophysiological mechanism seems to be complex and multifactorial involving four \n\nmain issues: (1) vascular abnormalities; (2) tubular and glomerular alterations; (3) renal \n\ninflammation and (4) a direct venom cytotoxic activity.   \n\n \n\n4.1 Vascular abnormalities \n\n Rats injected with L. obliqua venom presented important hemodynamic \n\nalterations characterized by systemic hypotension and increased heart rate. The time of \n\nmaximal decrease in blood pressure was coincident with the reduction of GFR and the \n\nimpairment of renal function. In addition, an increase of renal vascular permeability and \n\nedema was also observed at the same period of envenomation. These findings are \n\nimportant because systemic vasodilation is associated with the decrease in GFR and can \n\nlead to renal hypoperfusion and ischemia in different pathological conditions (Schrier et \n\nal., 2004). Specifically in this type of envenomation, one mechanism that could \n\ncontribute to vasodilation is the activation of kallikrein-kinin system (KKS). It is known \n\nthat L. obliqua venom has toxins (kallikrein activators and kininogenases) able to \n\nactivate plasma pre-kallikrein and directly release bradykinin (BK) from low molecular \n\nweight kininogen (LMWK) (Pinto et al., 2010; Bohrer et al., 2007). Interestingly, our \n\nresults indicated that the expression of LMWK (the main substrate of tissue kallikrein \n\nand venom kininogenases) is up-regulated in the kidneys of envenomed animals, which \n\nmay favor the generation of BK. The immediate consequence of intravascular activation \n\nof KKS is a fall in systemic blood pressure and in peripheral tissues is edema and \n\nerythema formation (Bohrer et al., 2007). The participation of BK was already \n\nconfirmed, since the hypotensive and edematogenic responses elicited by LOBE were \n\ninhibited by HOE-140, a B2 receptor antagonist (Bohrer et al., 2007). In agreement with \n\nthese experimental observations, hypotension and reduced plasma levels of pre-\n\nkallikrein are common features observed in patients (Zannin et al., 2003), which support \n\nthe evidence that KKS is activated during envenomation and is clinically relevant. \n\nMoreover, the data presented here also suggest that KKS activation may be involved in \n\nvenom-induced AKI.  \n\n \n\n \n\n \n\n\n\nResultados \n\n132 \n\n \n\n4.2 Tubular and glomerular alterations  \n\n Despite the scarce clinical case-reports, the main pathological finding obtained \n\nfrom kidney biopsies is acute tubular necrosis (ATN). Experimental animals also \n\nshowed histological alterations compatible with ATN such as loss of proximal brush \n\nborder, cytoplasm vacuolation, pyknotic nuclei, degeneration and desquamation of \n\nnecrotic cells. These necrotic cells exfoliating into the lumen due to either cell death or \n\ndefective cell-to-cell or cell-to-basement membrane adhesion, can obstruct the flow of \n\nfiltrated fluid and give rise to a back pressure limiting glomerular filtration (Trof et al., \n\n2006). Accordingly, in this work, markers of ATN were detected in urine (urinary ?-\n\nGT) and several proteins related to tubule injury were found to be up-regulated (Orm-1, \n\nYBX1, Alb, CK-B, FABP3 and NHE-RF1) or uniquely expressed (NGAL) in the \n\nkidneys of envenomed rats. Proteins linked to apoptosis (CytC, S100-A8 and MFP-1) \n\nwere also up-regulated. The occurrence of glomerular dysfunction was evident, because \n\nenvenomed rats presented massive proteinuria, serum Alb had a 2.1-fold increase in the \n\nkidneys and a band corresponding to the molecular weight of Alb was detected in urine. \n\nIn addition, our results confirm that hematuria and hemoglobinuria are predominant \n\ncharacteristics of L. obliqua-induced AKI. Indeed, the venom has strong in vitro and in \n\nvivo hemolytic activity and a phospholipase A2 responsible for this effect was already \n\nisolated (Seibert et al., 2006; Seibert et al., 2010). Intact erythrocytes were found within \n\nthe tubules forming intra-tubular casts and, as a result of intravascular hemolysis, \n\ndifferent Hb subunits were detected in urine and kidneys. It is known that the formation \n\nof Hb deposits may be toxic to renal tubules due to heme cytotoxicity (Zager, 1996). \n\nOnce reabsorbed by the proximal tubular cells the heme porphyrin ring is rapidly \n\ncatabolized by Hmox-1 yielding equimolar amounts of free iron, biliverdin and carbon \n\nmonoxide (Camara and Soares, 2005). Free iron then up-regulates intracellular ferritin \n\nexpression, a key defense mechanism against iron-induced tissue damage. However, in \n\nthe presence of large amounts of Hb the levels of released iron also increase, saturating \n\nthe binding capacity of ferritin. Thus, the iron not removed by ferritin binding is able to \n\nreadily accept and donate electrons and greatly facilitates free radical production (Zager, \n\n1996; Khan, 2009; Zager et al., 2012). As proteins related to canonical pathways of \n\noxidative stress were identified exclusively in the kidneys of LOBE-treated rats, we \n\nbelieve that heme cytotoxicity plays a significant role in L. obliqua-induced AKI. \n\nConsistent with this, several anti-oxidant enzymes (Prdx-5, Prdx-2, GST, DJ-1 and \n\nSOD) and proteins associated with heme and iron metabolism (Hmox-1, ferritin, Hpx \n\n\n\nResultados \n\n133 \n\n \n\nand Cygb) were up-regulated or uniquely expressed during envenomation, suggesting \n\nthat heme is effectively metabolized, generating free radicals and inducing oxidative \n\ndamage to proteins, lipids and DNA. In fact, in previous experiments we demonstrated \n\nthat LOBE induces kidney DNA damage leading to double-strand breaks and formation \n\nof oxidized purines and pyrimidines (Berger et al., 2013). Probably this is associated \n\nwith the increased expression of Rad50, a double-strand break repair protein, detected in \n\nthe present work.        \n\n As a consequence of ATN, the excretion of Na\n+\n and K\n\n+\n increased significantly \n\nduring envenomation. Injured proximal tubule cells have alterations in the actin and \n\nmicrotubule cytoskeletal networks that lead to a redistribution of Na\n+\n/K\n\n+\n ATPase from \n\nthe basolateral to the apical membrane, contributing to a decrease in Na\n+\n transport and \n\nreabsorption (Thadhani et al., 1996). It was reported that FENa+ and FEK+ also increase \n\nin envenomation caused by Bothrops snakes (Boer-Lima et al., 1999; Linardi et al., \n\n2011). Despite the redistribution of Na\n+\n/K\n\n+\n ATPase to the apical membrane, Linardi et \n\nal. (2011) reported an increase in expression and activity of Na\n+\n/K\n\n+\n ATPase during \n\nenvenomation by Bothrops alternatus and suggest that it is a protective mechanism \n\ntriggered in response to natriuresis with the aim to preserve renal function during acute \n\ndamage. In agreement with this observation, we found an increase in expression of type-\n\n3 Na\n+\n/H\n\n+\n exchanger regulatory cofactor, which is important in Na\n\n+\n and HCO\n\n-\n3 \n\nreabsorption in proximal tubule cells (Trof et al., 2006). Likewise Na\n+\n/K\n\n+\n, water \n\nexcretion increased significantly and envenomed animals had polyuria. Several \n\nparameters measured, such as urinary density and osmolality, Cosm, CH2O and FEH2O, \n\nindicate that kidneys from envenomed rats are producing dilute urine through the \n\nexcretion of solute-free water. Possibly, the presence of intratubular Na\n+\n not reabsorbed \n\nby proximal tubule cells may contribute to the increased water excretion and both, Na\n+\n \n\nand water rejection, may also be associated with the fall in blood pressure.    \n\n Regarding the glomerular dysfunctions, a valuable hypothesis that should be \n\nconsidered is the deposition of fibrin clots in glomerular capillaries. Indeed, the most \n\npotent activity of LOBE in vitro is the procoagulant activity (Donato et al., 1998; Veiga \n\net al., 2003). In vivo, LOBE also causes activation of coagulation and fibrinolysis \n\nleading to a consumptive coagulopathy characteristic of this type of envenomation. Two \n\nenzymes responsible for the venom procoagulant activity, activators of prothrombin and \n\nfactor X, have already been isolated (Alvarez-Flores et al., 2006; Reis et al., 2006). \n\nBesides the direct effect on coagulation factors, LOBE is also able to induce a \n\n\n\nResultados \n\n134 \n\n \n\nprocoagulant profile in endothelial cells in culture through an up-regulation of TF \n\nexpression (Pinto et al., 2008). Confirming these results obtained in endothelial cells, \n\nenvenomed kidneys showed an increase in TF procoagulant activity. In addition, the \n\nexpression of known markers of disseminated intravascular coagulation and thrombosis \n\n(serpin 1 alpha-1-antiproteinase, PAI-1 and HC-2) increased in the kidneys of venom-\n\ntreated rats. The gamma and beta chains of fibrinogen were detected solely in \n\nenvenomed kidneys, which are probably related to the PAS positive stain observed in \n\nglomeruli and is suggestive of fibrin formation.   \n\n \n\n4.3 Renal Inflammation \n\n Intense inflammatory response is a common feature in L. obliqua envenomation. \n\nPain and edema are the most characteristic initial symptoms observed at the local site of \n\ncontact (Zannin et al., 2003). Usually signs of systemic inflammation with neutrophilic \n\nleukocytosis, cell infiltrate and edema have also been described in lungs, kidney and \n\nheart of experimental animals (Berger et al., 2013). The inflammatory response is \n\naccompanied by the production of several cytokines (TNF, IL-1? IL-8, IL-6, CCL2 and \n\nCXCL1), vasoactive mediators (BK, histamine, prostaglandins and nitric oxide), \n\nadhesion molecules (E-selectin, VCAM-1 and ICAM-3) and an increase in leukocyte \n\nrolling and adhesion to the endothelium (Alvarez-Flores et al., 2006; Bohrer et al., \n\n2007; Pinto et al., 2008; Berger et al., 2010; Nascimento-Silva et al., 2012). \n\nSpecifically in the kidney, it was observed an up-regulation of several proteins related to \n\nacute phase inflammatory signaling, nephritis, inflammatory cell infiltration, increase in \n\nvascular permeability, glomerular dilation, distention of Bowman's space and interstitial \n\nedema. Kidney sections stained with picrosirius revealed extensive collagen deposition \n\nin cortical periglomerular and peritubular regions and proteins involved with fibrosis, \n\nsuch as Cygb, PAI-1, complement C3 and complement factor D were identified. \n\nEnhanced deposition of extracellular matrix (ECM) proteins in renal tissue has been \n\nobserved in response to a variety of stimuli, including TGF-?, TNF-?, IL-1, several \n\nadhesion molecules and chemoattractants. These stimuli can also increase the levels of \n\ntissue inhibitors of matrix metalloproteinases, thereby attenuating ECM turnover, and \n\nthus, favoring the deposition of collagen and other matrix proteins (Eddy, 1996; \n\nPawluczyk and Harris, 1998).  \n\nBesides fibrosis, activated complement components (C3 and factor D) may also \n\ncontribute to the alterations in vascular permeability and acts as a chemoattractant for \n\n\n\nResultados \n\n135 \n\n \n\nneutrophils (Turnberg et al., 2006). Moreover, complement activation by albumin is a \n\npowerful underlying mechanism of tubular and interstitial injury via cytotoxic, \n\nproinflammatory, and fibrogenic effects, which often occur in renal diseases where \n\nproteinuria is present (Portella et al., 2013). In an experiment conducted in proximal \n\ntubular cells incubated with serum proteins, in vitro complement activation was \n\nobserved, which could be associated with changes in the cytoskeleton, production of \n\nsuperoxide anion, hydrogen peroxide, and proinflammatory cytokines, such as IL-6 and \n\nTNF-? (Abbate et al., 2006). \n\n \n\n4.4 Direct venom cytotoxic activity \n\nAs the kidneys are highly vascularized organs, they are particularly susceptible \n\nto direct venom toxicity (Sitprija, 2006). Renal epithelial cells in culture and isolated \n\nperfused kidneys have been used to characterize the direct cytotoxic effects of different \n\nvenoms including bee, snake and spider venoms. The most common isolated toxins, \n\nwhich are nephrotoxic, belong to the classes of metalloproteinases, serine-proteinases, \n\nC-type lectins, phospholipases A2, sphingomyelinases D and L-amino acid oxidases \n\n(Berger et al., 2012). In the case of L. obliqua some toxins belonging to these classes \n\nhave already been isolated (Pinto et al., 2010); however, their effects on renal cells are \n\nunknown. Our results provide some evidence that the whole venom probably has a \n\ndirect nephrotoxic effect, since immunohistochemical staining confirmed the presence \n\nof venom in renal tissue, with stronger staining in the initial 6 h after venom \n\nadministration followed by a progressive decrease thereafter. The venom was rapidly \n\nexcreted in urine, because at least 5 bands which specifically react with antibodies \n\nraised against L. obliqua toxins were detected in urine. Interestingly, the positive \n\nimmunohistochemical reaction for venom in different kidney structures agreed with the \n\nmorphological and histological damage caused by the venom in these anatomical \n\nregions and indicated that there was a close correlation between the sites of venom \n\nlocalization and subsequent tissue injury. Previous studies are consistent with our \n\nobservations. Using immunochemical and radio-labeling methods to analyze venom \n\nbiodistribution in rats, the highest quantities of LOBE were detected in kidneys, blood \n\nand urine (Rocha-Campos et al., 2001; Da Silva et al., 2004).       \n\n \n\n \n\n \n\n\n\nResultados \n\n136 \n\n \n\n5. Conclusion \n\n In this work a rat experimental model was used to study the progression of renal \n\ndisease during Lonomia obliqua envenomation. According to our results, the \n\npathophysiological mechanism involved in L. obliqua-induced AKI seems to be \n\nmultifactorial where events such as systemic hypotension and fibrin deposition \n\ncontribute to renal hypoperfusion, tubular necrosis and the sudden loss of basic renal \n\nfunctions, including filtration and excretion capacities, urinary concentration and \n\nmaintenance of body fluid homeostasis. In addition, when compared to control rats, the \n\nkidneys from envenomed animals showed to be increasingly enriched for stress-related \n\nproteins, which are commonly associated to inflammation, tissue injury, heme-induced \n\noxidative stress, coagulation and complement systems activation. Finally, the \n\nlocalization of the venom in renal tissue agreed with morphological and functional \n\nalterations, suggesting a close correlation between venom tissue levels and renal \n\ndamage. \n\n \n\n6. Acknowledgments \n\n This work was supported by funding and fellowships from the Brazilian \n\nAgencies: Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior, Minist\u00e9rio \n\nda Educa\u00e7\u00e3o, Brazil (CAPES-MEC) - Edital Toxinologia (Processo: \n\n23038.006277/2011-85) and Conselho Nacional de Desenvolvimento Cient\u00edfico e \n\nTecnol\u00f3gico, Minist\u00e9rio da Ci\u00eancia e Tecnologia, Brazil (CNPq-MCT). This work was \n\nalso supported by NIH grant P41 GM103533 (to JRY).  We thank Dr Jeffrey N. Savas\n \n\nfor his advice on the mass spectrometric analysis and for a critical reading of the \n\nmanuscript. \n\n \n\n7. Conflict of interest statement \n\n The authors declare that there are no conflicts of interest. \n\n \n\n8. References \n\nAbbate, M.; Zoja, C.; Remuzzi, G., 2006. How does proteinuria cause progressive renal \n\n damage? J Am Soc Nephrol 17, 2974\u20132984. \n\nAlvarez-Flores, M.P., Fritzen, M., Reis, C.V., Chudzinski-Tavassi, A.M., 2006. Losac, \n\n a factor X activator from Lonomia obliqua bristle extract: its role in the \n\n pathophysiological mechanisms and cell survival. Biochem Biophys Res \n\n Commun 343, 1216-1223. \n\n\n\nResultados \n\n137 \n\n \n\nAmbatipudi, K.S., Lu, B., Hagen, F.K., Melvin, J.E., Yates, J.R., 2009. Quantitative \n\n analysis of age specific variation in the abundance of human female parotid \n\n salivary proteins. J Proteome Res 8, 5093-5102. \n\nBasnakian, A.G., Kaushal, G.P., Shah, S.V., 2002. Apoptotic pathways of oxidative \n\n damage to renal tubular epithelial cells. Antioxid Redox Signal 4 (6), 915-924. \n\nBerger, M., Reck J, Jr., Terra, R.M., Pinto, A.F., Termignoni, C., Guimar\u00e3es, J.A., \n\n 2010. Lonomia obliqua caterpillar envenomation causes platelet \n\n hypoaggregation and blood  incoagulability in rats. Toxicon 55 (1), 33-44. \n\nBerger, M., Vieira, M.A.R., Guimaraes, J.A., 2012. Acute Kidney Injury Induced by \n\n Snake and Arthropod Venoms, in: Polenakovic, M. (Ed.), Renal Failure  - The \n\n Facts. ISBN: 978953-51-0630-2, InTech-Open, Rijeka, Croatia, pp. 157- 186. \n\nBerger, M., Beys-da-Silva, W., Santi, L., de Oliveira, I.M., Jorge, P.M., Henriques, \n\n J.A.P., Driemeier, D., Vieira, M.A.R., Guimar\u00e3es, J.A., 2013. Acute Lonomia \n\n obliqua caterpillar envenomation-induced physiopathological alterations in rats: \n\n Evidence of new toxic venom activities and the efficacy of serum therapy to \n\n counteract systemic tissue damage. Toxicon (in press). \n\nBern, M., Goldberg, D., McDonald, W.H., Yates, J.R. 3rd., 2004. Automatic quality \n\n assessment of peptide tandem mass spectra. Bioinformatics 20, i49-54. \n\nBoer-Lima, P.A., Gontijo, J.A., da Cruz-H\u00f6fling, M.A., 1999. Histologic and functional \n\n renal alterations caused by Bothrops moojeni snake venom in rats. Am J Trop \n\n Med Hyg 61 (5), 698-706.  \n\nBohrer, C.B., Reck Jr, J., Fernandes, D., Sordi, R., Guimar\u00e3es, J.A., Assreuy, J., \n\n Termignoni, C., 2007. Kallikrein-kinin system activation by Lonomia obliqua \n\n caterpillar bristles: involvement in edema and hypotension responses to \n\n envenomation. Toxicon 49, 663-639.  \n\nBowler, R.P., Duda, B., Chan, E.D., Enghild, J.J., Ware, L.B., Matthay, M.A., Duncan, \n\n M.W., 2004. Proteomic analysis of pulmonary edema fluid and plasma in \n\n patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 286 (6) \n\n L1095-104. \n\nBrocker, C., Lassen, N., Estey, T., Pappa, A., Cantore, M., Orlova, V.V., Chavakis, T., \n\n Kavanagh, K.L., Oppermann, U., Vasiliou, V., 2010. Aldehyde dehydrogenase \n\n 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against \n\n hyperosmotic stress. J Biol Chem 285 (24), 18452-63. \n\nBurdmann, E.A., Antunes, I., Saldanha, L.B., Abdulkader, R.C., 1996. Severe acute \n\n renal failure induced by the venom of Lonomia caterpillars. Clinical \n\n Nephrololgy 46 (5), 337-339. \n\nCaliari, M.V. Princ\u00edpios de Morfometria Digital: KS300 para iniciantes.  Ed. UFMG, \n\n 1997. 149p. \n\nCamara, N.O, Soares, M.P., 2005. Heme oxygenase-1 (HO-1), a protective gene that \n\n prevents chronic graft dysfunction. Free Radic Biol Med 38 (4), 426-435.  \n\n\n\nResultados \n\n138 \n\n \n\nCaplin, B., Wang, Z., Slaviero, A., Tomlinson, J., Dowsett, L., Delahaye, M., Salama, \n\n A.; Wheeler, D.C., Leiper, J., 2012. Alanine-glyoxylate aminotransferase-2 \n\n metabolizes endogenous methylarginines, regulates NO, and controls blood \n\n pressure. Arterioscler Thromb Vasc Biol 32(12):2892-900. \n\nCarvalho, P.C., Fischer, J.S., Chen, E.I., Yates, J.R. 3rd, Barbosa, V.C. 2008. \n\n PatternLab for proteomics: a tool for differential shotgun proteomics. BMC \n\n Bioinformatics  9, 316. \n\nCarvalho, P.C., Fischer, J.S., Xu, T., Yates, J.R. 3rd, Barbosa, V.C., 2012. PatternLab: \n\n from mass spectra to label-free differential shotgun proteomics. Curr Protoc \n\n Bioinformatics Chapter 13:Unit13.19. \n\nChandler, R.J., Zerfas, P.M., Shanske, S., Sloan, J., Hoffmann, V., DiMauro, S., \n\n Venditti, C.P, 2009. Mitochondrial dysfunction in mut methylmalonic acidemia. \n\n FASEB J 23 (4), 1252-1261. \n\nChang, S.H., Phelps, P.C., Berezesky, I.K., Ebersberger, M.L. Jr, Trump, B.F., 2000. \n\n Studies on the mechanisms and kinetics of apoptosis induced by microinjection \n\n of cytochrome c in rat kidney tubule epithelial cells (NRK-52E). Am J Pathol \n\n 156 (2), 637-649. \n\nChen, G., Paka, L., Kako, Y., Singhal, P., Duan, W., Pillarisetti, S., 2001. A protective \n\n role for kidney apolipoprotein E: Regulation of mesangial cell proliferation and \n\n matrix expansion. J Biol Chem 276, 49142\u201349147. \n\nChinnaiyan, A.M., Huber-Lang, M., Kumar-Sinha, C., Barrette, T.R., Shankar-Sinha, \n\n S., Sarma, V.J., Padgaonkar, V.A., Ward, P.A., 2001. Molecular signatures of \n\n sepsis: multiorgan gene expression profiles of systemic inflammation. Am J \n\n Pathol 159 (4), 1199-1209. \n\nDa Silva, G.H., Panunto, P.C., Hyslop, S., Da Cruz-H\u00f6fling, M.A., 2004. \n\n Immunochemical detection of Lonomia obliqua caterpillar venom in rats. \n\n Microsc Res Tech 65, 276-281. \n\nDevarajan, P., Krawczeski, C.D., Nguyen, M.T., Kathman, T., Wang, Z., Parikh, C.R., \n\n 2010. Proteomic identification of early biomarkers of acute kidney injury after \n\n cardiac surgery in children. Am J Kidney Dis 56 (4), 632-642. \n\nDias da Silva, W., Campos, C.M., Gon\u00e7alves, L.R., Sousa-e-Silva, M.C., Higashi, H.G., \n\n Yamagushi, I.K., Kelen, E.M., 1996. Development of an antivenom against \n\n toxins of Lonomia obliqua caterpillars. Toxicon 34, 1045-1049. \n\nDonato, J.L., Moreno, R.A., Hyslop, S., Duarte, A., Antunes, E., Le Bonniec, B.F., \n\n Rendu, F., de Nucci, G., 1998. Lonomia obliqua Caterpillar Spicules Trigger \n\n Human Blood Coagulation via Activation of Factor X and Prothrombin. \n\n Thromb Haemost 79, 539\u2013542. \n\nDuarte, A.C., Caovilla, J.J., Lorini, J.D., Mantovani, G., Sumida, J., Manfre, P.C., \n\n Silveira, R.C., de Moura, S.P., 1990. Insufici\u00eancia renal aguda por acidentes \n\n com lagartas. J Bras Nefrol 12, 184-187. \n\n\n\nResultados \n\n139 \n\n \n\nDuarte, A.C., Crusius, P.S., Pires, C.A.L., 1994. Insufici\u00eancia renal aguda nos acidentes \n\n com lonomia obliqua. Nefrol Lat Americana 1 (1), 38\u201340. \n\nEng, J.K., Mccormack, A.L., Yates, J.R., 1994. An approach to correlate tandem mass-\n\nspectral data of peptides with amino-acid-sequences in a protein database. J Am \n\nSoc Mass Spectrom 5 (11), 976-989. \n\nEddy, A.A., 1996. Molecular insights into renal interstitial fibrosis. J. Am. Soc. \n\n Nephrol 7, 2495\u20132508. \n\nEddy, A.A., 2004. Proteinuria and interstitial injury. Nephrol Dial Transplant 2004 \n\n 19 (2), 277-281. \n\nFan, H.W., Cardoso, J.L., Olmos, R.D., Almeida, F.J., Viana, R.P., Martinez, A.P., \n\n 1998. Hemorrhagic syndrome and acute renal failure in a pregnant woman after \n\n contact with Lonomia caterpillars: a case report. Rev Inst  Med Trop S\u00e3o Paulo \n\n 40 (2), 119-120. \n\nFeng, M.G., Navar, L.G., 2010. Afferent arteriolar vasodilator effect of adenosine \n\n predominantly involves adenosine A2B receptor activation. Am J Physiol \n\n Renal  Physiol 299 (2), F310-5. \n\nGamborgi, G.P., Metcalf, E.B., Barros, E.J.G., 2006. Acute renal failure provoked by \n\n toxin from caterpillars of the species Lonomia obliqua. Toxicon 47, 68-74.  \n\nGodoy, J.R., Oesteritz, S., Hanschmann, E.M., Ockenga, W., Ackermann, W., Lillig, \n\n C.H., 2011. Segment-specific overexpression of redoxins after renal ischemia \n\n and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3, and \n\n peroxiredoxin 6. Free Radic Biol Med. 51 (2), 552-561. \n\nGuder, W.G., Ross, B.D., 1984. Enzyme distribution along the nephron. Kidney Int \n\n 26,101\u2013111. \n\nKhan, F.Y., 2009. Rhabdomyolysis: a review of the literature. Netherland Journal of \n\n Medicine 67 (9), 272-283. \n\nLaemmli, U. K., 1970. Cleavage of structural proteins during the assembly of the head \n\n of  bacteriophage  T4. Nature 227, 680-685. \n\nLarsen, R., Gozzelino, R., Jeney, V., Tokaji, L., Bozza, F.A., Japiass\u00fa, A.M., \n\n Bonaparte, D., Cavalcante, M.M., Chora, A., Ferreira, A., Marguti, I., Cardoso, \n\n S., Sep\u00falveda, N., Smith, A., Soares, M.P., 2010. A central role for free heme in \n\n the pathogenesis of severe sepsis. Sci Transl Med 29 2 (51) 51ra71. \n\nLinardi, A., Rocha e Silva, T.A., Miyabara, E.H., Franco-Penteado, C.F., Cardoso, \n\n K.C., Boer, P.A., Moriscot, A.S., Gontijo, J.A., Joazeiro, P.P., Collares-Buzato, \n\n C.B., Hyslop, S., 2011. Histological and functional renal alterations caused by \n\n Bothrops alternatus snake venom: expression and activity of Na+/K+-ATPase. \n\n Biochimica et Biophysica Acta 1810 (9), 895-906.  \n\nMcDonald, W.H., Tabb, D.L., Sadygov, R.G., MacCoss, M.J., Venable, J., Graumann, \n\n J., Johnson,  J.R., Cociorva, D., Yates, J.R., 2004. MS1, MS2, and SQT-three \n\n\n\nResultados \n\n140 \n\n \n\n unified, compact, and easily parsed file formats for the storage of shotgun \n\n proteomic spectra and identifications. Rapid Commun Mass Spectrom  18 \n\n (18), 2162\u20132168. \n\nMorrissey, J.H., 1995. Tissue factor modulation of factor VIIa activity: use in \n\n measuring trace levels of factor VIIa in plasma. Thromb Haemost 74 (1), 185-\n\n 188. \n\nMimura, I., Nangaku, M., Nishi, H., Inagi, R., Tanaka, T., Fujita, T., 2010. Cytoglobin, \n\n a novel globin, plays an antifibrotic role in the kidney. Am J Physiol Renal \n\n Physiol. 299 (5), F1120-1133. \n\nNascimento-Silva, V., Rodrigues da Silva, G., Moraes, J.A., Cyrino, F.Z., Seabra, S.H., \n\n Bouskela, E., Almeida Guimar\u00e3es, J., Barja-Fidalgo, C., 2012. A pro-\n\n inflammatory profile  of endothelial cell in Lonomia obliqua envenomation. \n\n Toxicon 60 (1), 50-60.  \n\nNishi, H., Inagi, R., Kawada, N., Yoshizato, K., Mimura, I., Fujita, T., Nangaku, M., \n\n 2011. Cytoglobin, a novel member of the globin family, protects kidney \n\n fibroblasts against oxidative stress under ischemic conditions. Am J Pathol \n\n 178 (1), 128-139. \n\nPawluczyk, I.Z.A.; Harris, K.P.G., 1998. Cytokine interactions promote synergistic \n\n fibronectin accumulation by mesangial cells. Kidney Int. 54, 62\u201370. \n\nPeng, J., Elias, J.E., Thoreen, C.C., Licklider, L.J., Gygi, S.P., 2003. Evaluation of \n\n multidimensional chromatography coupled with tandem mass spectrometry \n\n (LC/LC-MS/MS) for large-scale protein analysis. The yeast proteome. J. \n\n Proteome Res. 2, 43\u201350 \n\nPinho, F.M., Zanetta, D.M., Burdmann, E.A., 2005. Acute renal failure after \n\n Crotalus durissus snakebite: a prospective survey on 100 patients. Kidney \n\n International. 67 (2), 659-667. \n\nPinto, A.F.M., Silva, K.R.L.M., Guimaraes, J.A., 2006. Proteases from Lonomia \n\n obliqua venomous secretions: comparison of procoagulant, fibrin(ogen)olytic \n\n and amidolytic activities. Toxicon 47, 113-121. \n\nPinto, A.F.M., Dragulev, B., Guimar\u00e3es, J.A., Fox, J.W., 2008. Novel perspectives in \n\n the pathogenesis of Lonomia obliqua caterpillar envenomation based on \n\n assessment of host response by gene expression analysis.  Toxicon 51, 1119-\n\n 1128. \n\nPinto, A.F.M., Berger, M., Reck-Jr, J., Terra, R.M., Guimar\u00e3es, J.A., 2010. Lonomia \n\n obliqua venom: In vivo effects and molecular aspects associated with the \n\n hemorrhagic syndrome. Toxicon 56 (7), 1103-1112. \n\nPortella, V.G., Silva-Filho, J.L., Landgraf, S.S., de Rico, T.B., Vieira, M.A., Takiya, \n\n C.M., Souza, M.C., Henriques, M.G., Canetti, C., Pinheiro, A.A., Benjamim, \n\n C.F., Caruso-Neves, C., 2013. Sepsis-surviving mice are more susceptible to a \n\n secondary kidney insult. Crit Care Med. 41 (4), 1056-1068.  \n\n\n\nResultados \n\n141 \n\n \n\nPompermayer, K., Souza, D.G., Lara, G.G., Silveira, K.D., Cassali, G.D., Andrade, \n\n A.A., Bonjardim, C.A., Passaglio, K.T., Assreuy, J., Cunha, F.Q., Vieira, M.A., \n\n Teixeira, M.M., 2005. The ATP-sensitive potassium channel blocker \n\n glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney Int \n\n 67(5), 1785-1796. \n\nReis, C.V., Andrade, S.A., Ramos, O.H., Ramos, C.R., Ho, P.L., Batista, I.F., \n\n Chudzinski-Tavassi, A.M., 2006. Lopap, a prothrombin activator from Lonomia \n\n obliqua belonging to the lipocalin family: recombinant production, biochemical \n\n characterization and structure-function insights. Biochem. J. 398 (2), 295-302. \n\nRevelo, M.P., Federspiel, C., Helderman, H., Fogo, A.B., 2005. Chronic allograft \n\n nephropathy: Expression and localization of PAI-1 and PPAR-gamma. Nephrol \n\n Dial Transplant 20, 2812\u20132819. \n\nRicci-Silva, M.E., Valente, R.H., Le\u00f3n, I.R., Tambourgi, D.V., Ramos, O.H., Perales, \n\n J., Chudzinski-Tavassi, A.M., 2008. Immunochemical and proteomic \n\n technologies as tools for unravelling toxins involved in envenoming by \n\n accidental contact with Lonomia obliqua caterpillars. Toxicon, 51, 1017-1028. \n\nRocha-Campos, A.C., Gon\u00e7alves, L.R., Higasshi, H.G., Yamagushi, I.K., Fernandes, I., \n\n Oliveira, J.E., Ribela, M.T., Sousa-e-Silva, M.C., Dias da Silva, W., 2001. \n\n Specific heterologous F(ab\u2019)2 antibodies revert blood incoagulability resulting \n\n from envenoming by Lonomia obliqua caterpillars. Am. J. Trop. Med. Hyg. 64, \n\n 283\u2013289. \n\nRusso, L.M., Sandoval, R.M., McKee, M., Osicka, T.M., Collins, A.B., Brown, D., \n\n Molitoris, B.A., Comper, W.D., 2007. The normal kidney filters nephrotic levels \n\n of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic \n\n states. Kidney Int 71(6) 504-513. \n\nSafadi, F.F., Thornton, P., Magiera, H., Hollis, B.W., Gentile, M., Haddad, J.G., \n\n Liebhaber, S.A., Cooke, N.E., 1999. Osteopathy and resistance to vitamin D \n\n toxicity in mice null for vitamin D binding protein. J Clin Invest 103(2), 239-\n\n 251. \n\nSchrier, R.W., Wang, W., Poole, B., Mitra, A., 2004. Acute renal failure: definitions, \n\n diagnosis, pathogenesis, and therapy. J Clin Invest 114 (1), 5-14.  \n\nSeibert, C.S., Oliveira, M.R.L., Gon\u00e7alves, L.R.C., Santoro, M.L., Sano-Martins, I.S., \n\n 2004. Intravascular hemolysis induced by Lonomia obliqua caterpillar bristle \n\n extract: an experimental model of envenomation in rats. Toxicon 44, 793-799.  \n\nSeibert, C.S., Tanaka-Azevedo, A.M., Santoro, M.L., Mackessy, S.P., Torquato, R.J.S., \n\n Lebrun, I., Tanaka, A.S., Sano-Martins, I.S., 2006. Purification of a \n\n phospholipase A2 from Lonomia obliqua caterpillar bristle extract. Biochem. \n\n Biophys. Res. Commun. 342,1027-1033. \n\nShashidharamurthy, R., Mahadeswaraswamy, Y.H., Ragupathi, L., Vishwanath, B.S., \n\n Kemparaju, K., 2010. Systemic pathological effects induced by cobra (Naja \n\n naja) venom from geographically distinct origins of Indian peninsula. Exp \n\n Toxicol Pathol. 62 (6), 587-592. \n\n\n\nResultados \n\n142 \n\n \n\nSitprija, V., 2006. Snakebite nephropathy. Nephrology (Carlton) 11(5), 442-448. \n\nSon, D., Kojima, I., Inagi, R., Matsumoto, M., Fujita, T., Nangaku, M, 2008. Chronic \n\n hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: a proteomic \n\n analysis. Am J Physiol Renal Physiol 294 (1), F62-72. \n\nStefanska, B., Huang, J., Bhattacharyya, B., Suderman, M., Hallett, M., Han, Z.G., \n\n Szyf, M., 2011. Definition of the landscape of promoter DNA hypomethylation \n\n in liver cancer. Cancer Res 71(17), 5891-903. \n\nTabb, D.L., McDonald, W.H., Yates, J.R. 3rd, 2002. DTASelect and Contrast: tools \n\n for assembling and comparing protein identifications from shotgun \n\n proteomics. J Proteome Res 1, 21\u201326. \n\nTakatsuka, H., Nakajima, T., Nomura, K., Wakae, T., Toda, A., Itoi, H., Okada, M., \n\n Misawa, M., Hara, H., 2006. Heparin cofactor II as a predictor of thrombotic \n\n microangiopathy after bone marrow transplantation. Hematology 11 (2),  101-\n\n 103.  \n\nThadhani, R., Pascual, M., Bonventre, J.V., 1996. Acute renal failure. N Engl J Med \n\n 334 (22), 1448-1460. \n\nThukral, S.K., Nordone, P.J., Hu, R., Sullivan, L., Galambos, E., Fitzpatrick, V.D., \n\n Healy, L., Bass, M.B., Cosenza, M.E., Afshari, C.A., 2005. Prediction of \n\n nephrotoxicant action and identification of candidate toxicity-related \n\n biomarkers. Toxicol Pathol 33 (3), 343-355. \n\nTofovic, S.P., Kusaka, H., Li, P., Jackson, E.K., 1998. Effects of adenosine deaminase \n\n inhibition on blood pressure in old spontaneously hypertensive rats. Clin Exp \n\n Hypertens 20 (3),329-44. \n\nTogawa, A., Miyoshi, J., Ishizaki, H., Tanaka, M., Takakura, A., Nishioka, H., Yoshida, \n\n H., Doi, T., Mizoguchi, A., Matsuura, N., Niho, Y., Nishimune, Y., Nishikawa, \n\n S.I., Takai, Y., Progressive impairment of kidneys and reproductive organs in \n\n mice lacking Rho GDIalpha. Oncogene 18 (39), 5373-5380. \n\nTrof, R.J., Di Maggio, F., Leemreis, J., Groeneveld, A.B., 2006. Biomarkers of acute \n\n renal injury and renal failure. Shock 26 (3), 245-53. \n\nTurnberg, D., Lewis, M., Moss, J., Xu, Y., Botto, M., Cook, H.T., 2006. Complement \n\n activation contributes to both glomerular and tubulointerstitial damage in \n\n adriamycin nephropathy in mice. J Immunol 177, 4094\u20134102. \n\nVeiga, A.B.G., Blochtein, B., Guimar\u00e3es, J.A., 2001. Structures involved production, \n\n secretion and injection of the venom produced by the caterpillar Lonomia \n\n obliqua (Lepidoptera, saturniidae). Toxicon 39, 1343-1351. \n\nVeiga, A.B.G., Pinto, A.F.M., Guimar\u00e3es, J.A., 2003. Fibrinogenolytic and \n\n procoagulant  activities in the hemorrhagic syndrome caused by Lonomia \n\n obliqua caterpillars.  Thrombosis Research 111(1-2), 95-101. \n\n\n\nResultados \n\n143 \n\n \n\nVeiga, A.B.G., Ribeiro, J.M., Guimar\u00e3es, J.A., Francischetti, I.M., 2005. A catalog for \n\n the transcripts from the venomous structures of the caterpillar Lonomia obliqua: \n\n identification of the proteins potentially involved in the coagulation disorder and \n\n hemorrhagic syndrome. Gene 355, 11-27. \n\nWarrell, D.A., 2010. Snake bite. Lancet. 375 (9708), 77-88. \n\nWashburn, M.P., Wolters, D., Yates, J.R. 3rd, 2001. Large-scale analysis of the yeast \n\n proteome by multidimensional protein identification technology. Nature \n\n Biotechnology 19, 242\u2013247. \n\nWilliams, D., Guti\u00e9rrez, J.M., Harrison, R., Warrell, D.A., White, J., Winkel, K.D., \n\n Gopalakrishnakone, P., 2010. Global Snake Bite Initiative Working Group; \n\n International Society on Toxinology. The Global Snake Bite Initiative: an \n\n antidote for snake bite. Lancet 375, (9708), 89-91. \n\nXu, T., Venable, J.D., Park, S.K., Cociorva, D., Lu, B., 2006. ProLuCID, a fast and \n\n sensitive tandem mass spectra-based protein identification program. Mol Cell \n\n Proteomics 5, S174. \n\nZager, R.A., 1996. Rhabdomyolysis and myohemoglobinuric acute renal failure. \n\n Kidney International. 49 (2), 314-326. \n\nZager, R.A., Johnson, A.C., Becker, K., 2012. Renal cortical hemopexin accumulation \n\n in response to acute kidney injury. Am J Physiol Renal Physiol 303 (10), \n\n F1460-472. \n\nZannin, M., Louren\u00e7o, D.M., Motta, G., Costa, L.R.D., Grando, M., Gamborgi, G.P., \n\n Noguti, M.A., Chudzinski-Tavassi, A.M., 2003. Blood coagulation and \n\n fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by \n\n accidental contact with Lonomia obliqua caterpillar in Santa Catarina, Southern \n\n Brazil. Thromb. Haemost. 89, 355\u2013364.  \n\n \n\nFigure captions \n\n \n\n \n\nFigure 1. Functional parameters during L. obliqua-induced AKI. Rats were injected \n\nsubcutaneously with PBS (controls - CTRL) or LOBE (1.5 or 1.0 mg/kg). After \n\ndifferent times post administration the following parameters were determined: (A) Body \n\nweight, (B) water intake, (C) urine outoput, (D) glomerular filtrattion rate (GFR), (E) \n\nurinary density, (F) urine osmolality (urine osm), (G) plasma osmolality (plasma osm), \n\n(H) osmolar clearance (Cosm), (I) water free clearance (CH2O), (J) fractional water \n\nexcretion (FEH2O), (K) fractional sodium excretion (FENa\n+\n) and (L) fractional potassium \n\nexcretion (FEK\n+\n). Data are presented as means \u00b1 SE (n=6/group). Significant \n\ndifferences: *p &lt;0.05 vs. CTRL and \n\u00a7\np &lt;0.05 vs. LOBE (1.0 mg/kg, s.c). \n\n \n\n\n\nResultados \n\n144 \n\n \n\nFigure 2. Proteinuria. (A) Rats were injected subcutaneously with PBS (controls - \n\nCTRL) or LOBE (1.5 or 1.0 mg/kg). After different times post administration the \n\nprotein levels in urine were measured. Data are presented as means \u00b1 SE (n=6/group). \n\nStatistical differences of *p &lt;0.05 vs. CTRL and \n\u00a7\np &lt;0.05 vs. LOBE (1.0 mg/kg, s.c) \n\nwere considered significant. (B) Representative urine samples from CTRL and rats \n\ntreated with LOBE (1.5 mg/kg, s.c.) were analyzed by SDS-PAGE (8-20 %) under \n\nreducing conditions. (C) Toxins excreted in urine were detected by western-blot. \n\nSamples of urine from CTRL and rats treated with LOBE (1.5 mg/kg, s.c.) at 6 and 12 h \n\npost-venom injection were separated by SDS-PAGE and different toxins were detected \n\nby immunoreaction with polyclonal antibodies against LOBE. Toxins present in crude \n\nbristle extract are also showed (LOBE). The arrows indicate bands detected in urine \n\nsamples at 6 and 12 h of envenomation. Molecular weight (MW) standards were shown \n\non the left of figure B and C.  \n\n \n\nFigure 3. L. obliqua envenomation induces acute tubular necrosis. Representative \n\nkidney sections from control (CTRL) or envenomed animals (injected with 1.5 mg/kg, \n\ns.c.) are presented (A-G). Note the normal morphology of kidney from CTRL animal \n\n(A) in comparison to the progressive degenerative lesions of venom-treated rats (B-G). \n\nIncreased acidophilia, dilation of renal tubules, loss of proximal brush border, \n\ncytoplasm vacuolation, nuclear pyknosis and desquamation of necrotic cells can be \n\nobserved (D-F). Hyaline (arrowheads in C, D and G) and hematic (arrows in D) casts \n\nare also present inside renal tubules. Arrowheads in E indicate necrotic cells. Asterisks \n\nin D and F indicate the presence of a hyaline material within the Bowman's space and \n\nan inflammatory cell infiltrate and edema, respectively. All sections were stained with \n\nH&amp;E. Magnification: 10 X. (H) Levels of urinary ?-glutamyl transferase (?-GT) activity \n\nwere measured in rats injected with PBS or LOBE (1.5 or 1.0 mg/kg) at different times \n\npost-administration. Data are presented as means \u00b1 SE (n=6/group). Statistical \n\ndifferences of *p &lt;0.05 vs. CTRL and \n\u00a7\np &lt;0.05 vs. LOBE (1.0 mg/kg, s.c) were \n\nconsidered significant. \n\n \n\nFigure 4. L. obliqua envenomation induces renal tubular obstruction. \n\nRepresentative kidney sections from animals injected with LOBE (1.5 mg/kg, s.c.) \n\nshowing details of tubular obstruction by hyaline and hematic casts and cellular debris \n\nat 12 h (A) and 24 h (B) post-venom injection. Hyaline casts (black arrowheads) are \n\n\n\nResultados \n\n145 \n\n \n\nformed by a protein-rich material (predominantly serum albumin and hemoglobin), \n\nwhile hematic casts (black arrows) are formed by fragmented or intact erythrocytes. \n\nDue to tubular necrosis, the basement membrane in some tubules is disrupted, resulting \n\nin detachment of necrotic cells into the lumen (white arrowheads).  All sections were \n\nstained with H&amp;E. Magnification: 4 X (panel A) and 20 X (panel B).     \n\n \n\nFigure 5. L. obliqua envenomation induces renal inflammation and fibrosis. Light \n\nmicrographs showing a marked inflammatory cell infiltrate (arrowheads) in the tubulo-\n\ninterstitial region at 96 h (B) and glomerulus at 48 h (C) after LOBE injection (1.5 \n\nmg/kg, s.c.). There were no signs of inflammation in control (CTRL) animals (A). It \n\nwas also observed an extensive peritubular (E) and interglomerular (F) collagen \n\ndeposition at 96 h (regions stained in red), indicating fibrosis. Arrowheads in these \n\npanels indicate inflammatory infiltrate. There were no signs of fibrosis in CTRL rats \n\n(D). Stain: H&amp;E (panels A-C) and picrosirius (panels D-F). Magnification: 10 X (panel \n\nA, B, D and E), 20 X (panel F) and 40 X (panel C). \n\n \n\nFigure 6. Glomerular alterations. A. Light micrographs showing a time dependent \n\nincrease in the deposition of a PAS positive material in glomerular capillaries of LOBE-\n\ninjected animals (1.5 mg/kg, s.c.) in comparison to controls. Also note the increase in \n\nglomerular size. All sections were stained with PAS. Magnification: 40 X. B. Thirty \n\nglomeruli from each animal injected with the dose of 1.5 mg/kg were used to quantify \n\nthe mean area of glomerulus, glomerular tuft and Bowman's space of animals treated \n\nwith the dose of 1.5 mg/kg. Data are presented as means \u00b1 SE (n=6/group). Statistical \n\ndifferences of *p &lt;0.05 in comparison to the respective control (C) were considered \n\nsignificant. C. Renal tissue factor activity was measured in control (C) and envenomed \n\n(1.5 mg/kg, s.c.) animals  by generation of factor Xa (FXa). Data are presented as means \n\n\u00b1 SE (n=6/group). Statistical differences of *p &lt;0.05 were considered significant in \n\ncomparison to the respective control. \n\n \n\nFigure 7. Renal vascular permeability. Representative micrographs of a kidney blood \n\nvessel (A) and glomerulus (B) from animals injected with LOBE (1.5 mg/kg, s.c.) after \n\n12 h of envenomation. Note the vascular leakage and edema (asterisks) and migration of \n\ninflammatory cells to damaged tissue (arrowheads). Also, the presence of a hyaline \n\nmaterial inside the Bowman's space (asterisk in B) was associated with the increase in \n\n\n\nResultados \n\n146 \n\n \n\nglomerular area observed at this time. All sections were stained with H&amp;E. \n\nMagnification: 10 X (panel A) and 40 X (panel B). C. Evaluation of changes in renal \n\nvascular permeability were assessed by Evans blue dye extravasation. Results are \n\nexpressed as ?g Evans blue dye per 100 mg of renal tissue from control (CTRL) and \n\nLOBE-treated (1.5 mg/kg, s.c.) rats at 12 and 24 h post-venom administration.  Data are \n\npresented as means \u00b1 SE (n=6/group). Statistical comparisons are indicated.  \n\n \n\nFigure 8. Immunohistochemical detection of L. obliqua venom in renal tissue. \n\nPositive immunohistochemical reaction was found in cortical and medullar regions of \n\nkidneys from rats injected with 1.5 mg/kg of LOBE (B-E). Venom was detected in \n\nglomerular capillaries (arrows in B), Bowman\u2019s capsule (arrow in the inset B), tubular \n\nbrush border (arrows in the inset C), in intra-tubular casts (arrowheads in C) and also \n\nwas present in cells of tubules in degeneration (arrowheads in the insets C and D). After \n\n96 h the immunoreactivity for venom was weak and mainly localized in tubules (arrows \n\nin E). There was no immunoreactivity in the renal structures of control (CTRL) rats (A). \n\nMagnification: 10 X (panels A-E) and 40 X (insets in B-D) F. The amounts of venom \n\ndetected in renal tissue was estimated by the area of positive immunohistochemical \n\nreaction. Thirty sections per rat were analyzed as described in material and methods. \n\nData are presented as means \u00b1 SE (n=6/group). \n\n \n\nFigure 9. Immunohistochemical detection of L. obliqua venom in renal vascular \n\ntissue.    Positive immunohistochemical reaction was detected in renal arteries (A) and \n\nveins (B) of rats injected with LOBE (1.5 mg/kg, s.c.) at 6 h of envenomation. Note the \n\npresence of venom in perivascular connective tissue (arrows) and endothelium and \n\nsmooth muscle cells (arrowheads). Magnification: 10 X (panel B) and 40 X (panel A). \n\n \n\nFigure 10. Kidney proteins differentially expressed during L. obliqua \n\nenvenomation. Unique or differentially expressed kidney proteins from control and \n\nenvenomed (1.5 mg/kg, s.c.) animals were identified at 24 h post-venom injection by \n\nproteomic analysis. Exclusive and common proteins in each condition, as well as the \n\ntotal number of proteins identified are showed via a Venn diagram (A). Top canonical \n\npathways of differentially expressed and unique proteins identified in control (CTRL) \n\n(B) and LOBE-treated (C) kidneys are shown. Those proteins functionally related to \n\nrenal disease were also categorized accordingly to their roles in different types of renal \n\n\n\nResultados \n\n147 \n\n \n\npathologies (D). Each functional annotation is assigned to a significance score \n\nrepresented as P value (Fisher exact test) determining the probability that the \n\nassociation between the proteins in the data set and the canonical pathway or function in \n\ndisease is explained by chance alone. The number of identified proteins (NIP) that \n\nbelong to a particular canonical pathway or play a role in renal pathology is shown. \n\n \n\nTables \n\n \n\nTable 1. Hemodynamic parameters. \n\nMAP: Mean arterial pressure, HR: heart rate. Data are presented as means \u00b1 SE \n\n(n=6/group). Statistical differences of *p &lt;0.05 vs. CTRL and \n\u00a7\np &lt;0.05 vs. LOBE (1.0 \n\nmg/kg, s.c) were considered significant. \n\n \n\nTable 2. Unique and differentially expressed proteins identified in the kidneys of \n\nrats envenomed by L. obliqua.   \n\nProteins functionally related to renal disease were selected and their specific role in \n\nrenal pathology was reviewed based on literature data. Complete proteome analysis was \n\nincluded in supplemental table 1. \n\na\nAcession number in UniProtKB/Swiss-Prot data base. \n\nb\nLog(2) ratio change. \n\nc\nSpec count G-test p-value (proteins were considered differentially expressed with p &lt;\n\n0.1.). \n\n \n\nSupplemental Table 1. Proteins identified in kidney proteome. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\nResultados \n\n \n\n148 \n\n \n\nFigure 1 \n\n \n\n \n\n\n\nResultados \n\n \n\n149 \n\n \n\nFigure 2 \n\n \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n150 \n\n \n\nFigure 3 \n\n \n\n \n \n\n \n\n \n\n\n\nResultados \n\n151 \n\n \n\nFigure 4 \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n152 \n\n \n\nFigure 5 \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\nResultados \n\n \n\n153 \n\n \n\nFigure 6 \n\n \n\n \n\n\n\n \n\nResultados \n\n154 \n\n \n\nFigure 7 \n\n \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n \n\n155 \n\n \n\nFigure 8 \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n156 \n\n \n\nFigure 9 \n\n \n\n \n \n\n\n\n \n\nResultados \n\n \n\n157 \n\n \n\nFigure 10 \n\n \n\n \n\n\n\n \n\nResultados \n\n \n\n158 \n\n \n\nTable 1 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n  Time after envenomation (h) \n\nParameter Group 0 2 6 12 24 48 96 \n\nMAP (mmHg) CTRL 94.6\u00b12.2 107.5\u00b11.5 100.2\u00b13.4 96.3\u00b11.2 115\u00b112.2 111.4\u00b11.1 118\u00b112.6 \n\n LOBE (1.0 mg/kg, s.c.) 103\u00b13.8 92.8\u00b12.6 104.3\u00b12.7 84.5\u00b13.6 88\u00b13.1* 91.6\u00b11.5* 91.7\u00b13.5* \n\n LOBE (1.5 mg/kg, s.c.) 104\u00b12.3 124.8\u00b18.6\u00a7 112.7\u00b14.8 95.1\u00b12.9 74.9\u00b11.5*\u00a7 81.5\u00b11.1* 95.1\u00b11.4* \n\nHR (Beats/min) CTRL 366\u00b15.4 391\u00b11.8 391\u00b15.8 403\u00b12.1 401\u00b14.1 362\u00b111.3 376\u00b18.7 \n\n LOBE (1.0 mg/kg, s.c.) 383\u00b13.7 402\u00b116.1 409\u00b113.1 449\u00b16.9* 398\u00b111.4 381\u00b18.5 443\u00b18.5* \n\n LOBE (1.5 mg/kg, s.c.) 355\u00b17.2 390\u00b114.3 391\u00b15.4 393\u00b110.2\u00a7 427\u00b16.6\u00a7 424\u00b15.7*\u00a7 369\u00b13.3\u00a7 \n\n\n\n \n\nResultados \n\n \n\n159 \n\n \n\nTable 2 \n\n \n\nAcession \n\nnumber\na\n \n\nProtein description Fold \n\nchange\nb\n \n\np-value\nc\n Biological Function and/or Participation in Disease Reference \n\nUp-\n\nregulated \n\n     \n\nP24090 Alpha-2-HS-\n\nglycoprotein \n\n6.034 0.004 Cysteine-type endopeptidase inhibitor activity/Acute-phase response/ Regulation \n\nof inflammatory response/Up-regulation of Ahsg2 is associated with inflammation \n\nand tissue edema. \n\nBowler et al., 2004 \n\nP02764 Alpha-1-acid \nglycoprotein (Orm1) \n\n5.093 0.001 Acute-phase inflammatory response to antigenic stimulus/ Up-regulated in \nresponse to LPS/ Orm1 is considered an early and accurate biomarker of AKI. \n\nDevarajan et al., 2010 \n\nP11517  Hemoglobin subunit \n\nbeta-2 (HbB) \n\n4.395 0.001 Oxygen transport/Up-regulation of Hb is nephrotoxic and associated with kidney \n\ninjury in several diseases including sepsis, type 2 diabetes and Crotalus \n\nenvenomation. \n\nZager, 1996; Pinho et \n\nal., 2005;  Larsen et al., \n\n2010 \n\nQ76MJ6 YBX1 3.37 0.04 DNA-binding/Upregulation of Ybx1 mRNA in kidney is associated with proximal \n\ntubular injury in male rat. \n\nThukral et al., 2005 \n\nQ6LE95 Low molecular weight \n\nkininogen (LMWK) \n\n3.282 0.001 Acute-phase inflammatory response/ Precursor of the active peptide bradykinin \n\n(BK)/Related to vasodilation, hypotension and increase of vascular \n\npermeability/Participates of the contact-phase reactions of blood coagulation and \n\nkallikrein-kinin system/ L. obliqua venom is able to release BK from LMWK.   \n\nBohrer et al., 2007; \n\nPinto et al., 2010 \n\nQ921A4 Cytoglobin (Cygb) 3.003 0.015 Heme and iron binding/Up-regulated in conditions of oxidative stress/Plays a role \nin the development of  renal fibrosis/ Overexpression of Cygb improved \nhistological renal injury, preserved renal function, and ameliorated fibrosis. \n\nMimura et al., 2010; \nNishi et al., 2011 \n\nQ9R063 Peroxiredoxin-5, \n\nmitochondrial (Prdx-5) \n\n2.796 0.001 Involved in redox regulation of the cell/ Eliminating peroxides generated during \n\nmetabolism/ Play a major role in the cellular response to oxidative stress/ Up-\n\nregulated in conditions of renal ischemia-reperfusion injury and hypoxia. \n\nGodoy et al., 2011 \n\nP70388 DNA repair protein \n\n(Rad50) \n\n2.713 0.061 DNA repair/Plays a central role in double-strand break repair/Up-regulation of \n\nRad50 mRNA is associated with hepatocellular carcinoma. \n\nStefanska et al., 2011;  \n\nP02793 Ferritin light chain 1 2.563 0.001 Ferric iron binding/Iron homeostasis and metabolism.  Zager, 1996; Zager et \n\nal., 2012 \n\nP08932  T-kininogen 2 (isoform \n\n2 of LMWK) \n\n2.128 0.001 Acute-phase inflammatory response/ Precursor of the active peptide bradykinin \n\n(BK)/Related to vasodilation, hypotension and increase of vascular \npermeability/Participates of the contact-phase reactions of blood coagulation and \n\nkallikrein-kinin system/ L. obliqua venom is able to release BK from LMWK.     \n\nBohrer et al., 2007; \n\nPinto et al., 2010 \n\nP02770 Serum  Albumin (Alb) 2.096 0.018 The main protein of plasma/ Involved in molecular transport/Regulation of the \n\ncolloidal osmotic pressure of blood/Up-regulation of serum albumin mRNA and \n\nThukral et al., 2005 \n\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0004869\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0006953\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0050727\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0050727\nhttps://reports.ingenuity.com/rs/nodeview/nodeview.jsp?analysisid=-1&amp;did=ING:1cwmk&amp;sname=findings\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0008199\nhttps://reports.ingenuity.com/rs/nodeview/nodeview.jsp?analysisid=-1&amp;did=ING:1cwmk&amp;sname=findings\n\n\n \n\nResultados \n\n160 \n\n \n\nalbuminuria is associated with proximal tubular and glomerular injury and \ninterstitial nephritis in male rat.  \n\nP09006 Serine protease \n\ninhibitor A3N \n\n1.891 0.001 Acute-phase inflammatory response/ Induced by IL-1, IL-6 and  interferon-?/ Up-\n\nregulated during sepsis.  \n\nChinnaiyan et al., 2001 \n\nP31977 Ezrin 1.706 0.032 Involved in connections of major cytoskeletal structures to the plasma membrane \n\nof glomerular epithelium cells (podocytes)/  \n\nThukral et al., 2005; \n\nTrof et al., 2006 \n\nP35704 Peroxiredoxin-2 (Prdx-\n\n2) \n\n1.691 0.015 Involved in redox regulation of the cell/ Eliminating peroxides generated during \n\nmetabolism/ Play a major role in the cellular response to oxidative stress/ Up-\n\nregulated in conditions of renal ischemia-reperfusion injury and hypoxia. \n\nGodoy et al., 2011 \n\nQ6P9V2 Ferritin, heavy \n\npolypeptide 1 \n\n1.543 0.012 Stores iron/ Important for iron homeostasis. Zager, 1996; Zager et \n\nal., 2012 \n\nP14942 Glutathione S-\ntransferase alpha-4 \n\n(GST) \n\n1.516 0.032 \n \n\nAntioxidant enzyme/ Conjugation of reduced glutathione to a wide number of \nexogenous and endogenous hydrophobic electrophiles/It is a marker of proximal \n\ntubular injury.  \n\nThukral et al., 2005; \nTrof et al., 2006 \n\nP01946 Hemoglobin subunit \n\nalpha-1/2 (HbA) \n\n1.495 0.001 \n\n \n\nOxygen transport/Up-regulation of Hb is nephrotoxic and associated with kidney \n\ninjury in several diseases including sepsis, type 2 diabetes and Crotalus \n\nenvenomation. \n\nLarsen et al., 2010; \n\nPinho et al., 2005; \n\nZager, 1996 \n\nB1H216 Hemoglobin alpha, \n\nadult chain 2 (HbB) \n\n1.495 0.001 Oxygen transport/Up-regulation of Hb is nephrotoxic and associated with kidney \n\ninjury in several diseases including sepsis, type 2 diabetes and Crotalus \n\nenvenomation. \n\nLarsen et al., 2010; \n\nPinho et al., 2005; \n\nZager, 1996 \n\nP07335  Creatine kinase B-type \n\n(CK-B) \n\n1.452 0.012 Creatine kinase isoenzymes play a central role in energy transduction in tissues. In \n\nthe kidney localized primarily in the outer medulla in the thick ascending limb and \n\ndistal convoluted tubule/ Marker of acute tubular injury. \n\nShashidharamurthy et \n\nal., 2010 \n\nP01026  Complement C3 \n(Neutrophil \n\nchemotactic factor-1) \n\n1.319 0.044 Plays a central role in the activation of the complement system/ Its processing by \nC3 convertase is the central reaction in both classical and alternative complement \n\npathways/ It is a mediator of local inflammatory process/ It induces the \n\ncontraction of smooth muscle/ Increases vascular permeability/ Causes histamine \n\nrelease from mast cells and basophilic leukocytes/ Acts as a chemoattractant for \n\nneutrophils/ Complement activation increases tubulo-interstitial fibrosis of the \n\nkidney. \n\nTurnberg et al., 2006 \n\nP07483 Fatty Acid Binding \n\nProtein 3 (FABP3) \n\n1.286 0.001 FABP3 are thought to play a role in the intracellular transport of long-chain fatty \n\nacids and their acyl-CoA esters/ Upregulation of FABP3 mRNA in kidney is \n\nassociated with proximal tubular injury in male rat. \n\nThukral et al., 2005 \n\nQ9JJ19 Na\n+\n/H\n\n+\n exchange \n\nregulatory cofactor \nNHE-RF1 \n\n1.196 0.053 \n\n \n\nSodium transporter localized in apical membrane of proximal tubular \n\ncells/Important in renal sodium transport and phosphate absorption/ It is a marker \nof tubular injury. \n\nTrof et al., 2006 \n\nhttps://reports.ingenuity.com/rs/nodeview/nodeview.jsp?analysisid=-1&amp;did=ING:1cwmk&amp;sname=findings\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0003096\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0097291\n\n\n \n\nResultados \n\n161 \n\n \n\nP17475 Serpin 1 Alpha-1-\nantiproteinase \n\n1.175 0.071 Acute-phase inflammatory response/ Response to hypoxia/ Inhibitor of serine \nproteases/ Has affinity for plasmin and thrombin/Serpine1 is involved in damage \n\nof tubulointerstitium and is up-regulated in cases of disseminated intravascular \n\ncoagulation (DIC). \n\nEddy, 2004 \n\nP32038 Complement factor D \n\n(C3 convertase \n\nactivator) \n\n1.144 0.017 Plays a central role in the activation of the complement system/ Factor D cleaves \n\nfactor B when the latter is complexed with factor C3b, activating the C3bbb \n\ncomplex, which then becomes the C3 convertase of the alternate pathway. Its \n\nfunction is homologous to that of C1s in the classical pathway/ Complement \n\nactivation increases tubulo-interstitial fibrosis in the kidney. \n\nTurnberg et al., 2006 \n\nP04276 Vitamin D-binding \n\nprotein (DBP) \n\n1.088 0.011 It carries the vitamin D sterols and prevents polymerization of actin by binding its \n\nmonomers. DBP associates with membrane-bound immunoglobulin on the surface \n\nof B-lymphocytes and with IgG Fc receptor on the membranes of T-\nlymphocytes/DBP knockout mice displayed decreased damage in renal cortex.  \n\nSafadi et al., 1999 \n\nO88767 Protein DJ-1 1.07 0.001 Protects cells against oxidative stress and cell death/ Eliminates hydrogen \n\nperoxide/ May act as an atypical peroxiredoxin-like peroxidase that scavenges \n\nhydrogen peroxide.  \n\nGodoy et al., 2011 \n\nP04041 Glutathione peroxidase \n\n1 \n\n1.059 0.096 Antioxidant enzyme/ Protects the hemoglobin in erythrocytes from oxidative \n\nbreakdown \n\nZager, 1996; Basnakian \n\net al., 2002; Khan, 2009 \n\nP62898 Cytochrome c, somatic \n\n(CytC) \n\n1.003 0.004 Electron carrier protein/ Plays a role in apoptosis/ Suppression of the anti-\n\napoptotic members or activation of the pro-apoptotic members of the Bcl-2 family \n\nleads to altered mitochondrial membrane permeability resulting in release of \n\ncytochrome c into the cytosol/ Increases apoptosis in kidney tubule epithelial \n\ncells.  \n\nChang et al., 2000 \n\nP20059 Hemopexin (Hpx) 0.951 0.065 Participate in heme metabolism/ Binds and neutralizes pro-oxidant free \nheme/Potentially impacts heme-iron-mediated tubular injury. \n\nZager et al., 2012 \n\nP07632 Superoxide dismutase \n\n[cu-zn] (SOD) \n\n0.606 0.001 Antioxidant enzyme/ Destroys radicals which are normally produced within the \n\ncells and which are toxic to biological systems \n\nZager, 1996; Basnakian \n\net al., 2002; Khan, 2009 \n\nDown-\n\nregulated \n\n     \n\nQ63213 Alpha-2u globulin 5.33 0.001 Associated with proximal tubule necrosis and protein droplet accumulation in \n\nmale rats/ It is down-regulated in chronic hypoxia in the kidney. \n\nSon et al., 2008 \n\nP97615 Thioredoxin, \n\nmitochondrial \n\n4.301 0.008 Has an anti-apoptotic function/ Plays an important role in the regulation of \n\nmitochondrial membrane potential/ Response to hypoxia/ Response to oxidative \nstress. \n\nGodoy et al., 2011 \n\nQ03626 Murinoglobulin-1 3.268 0.045 Peptidase inhibitor activity/ Acute-phase inflammatory response/ It is down-\n\nregulated by up to 70% during acute inflammation or tumor development. \n\nThukral et al., 2005 \n\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0006953\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0001666\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0001666\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0006979\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0006979\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0030414\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0006953\n\n\n \n\nResultados \n\n162 \n\n \n\nQ64565 Alanine--glyoxylate \naminotransferase 2, \n\nmitochondrial \n\n3.112 0.08 \n \n\nEnzyme responsible by the metabolism of dimethylarginine (ADMA)/ ADMA is a \npotent inhibitor of nitric-oxide (NO) synthase/ This activity provides mechanism \n\nthrough which the kidney regulates blood pressure/ Its inhibition decreases the \n\nproduction of NO. \n\nCaplin et al., 2012 \n\nD3ZKG1 Methylmalonyl-CoA \n\nmutase, mitochondrial \n\n(Mut) \n\n2.55 0.05 Involved in the degradation of several amino acids, odd-chain fatty acids and \n\ncholesterol via propionyl-CoA to the tricarboxylic acid cycle/ Knockout mouse \n\nfor Mut gene displayed increased tubulointerstitial nephritis. \n\nChandler et al., 2009 \n\nQ62980 Heparin sulfate \n\nproteoglycan 2 \n\n(HSPG2) \n\n2.391 0.001 Cell adhesion protein/ Increase glomerular and mesangial kidney proliferation/ \n\nPositive regulation of endothelial cell proliferation/ Response to hypoxia. \n\nChen et al., 2001 \n\nP11232 Thioredoxin 2.191 0.009 Participates in various redox reactions through the reversible oxidation of its \n\nactive center/ Cell redox homeostasis. \n\nGodoy et al., 2011 \n\nQ920P6 Adenosine deaminase 2.139 0.019 Catalyzes the hydrolytic deamination of adenosine/ Its inhibition leads to \n\naccumulation of adenosine, which has a potent afferent arteriolar vasodilator \n\neffect through A2B receptors located in glomerular vessels/  Adenosine also has a \n\nplatelet aggregation inhibitory activity.  \n\nFeng and Navar, \n\n2010/Tofovic et al., \n\n1998/ \n\nQ64057 Alpha-aminoadipic \n\nsemialdehyde \n\ndehydrogenase \n\n(ALDH) \n\n2.083 0.05 Multifunctional enzyme mediating important protective effects/ Protects against \n\nhyperosmotic stress/ Protects cells from oxidative stress by metabolizing a \n\nnumber of lipid peroxidation-derived aldehydes. \n\nBrocker et al., 2010 \n\nP98158 Low-density \n\nlipoprotein receptor-\n\nrelated protein 2 (Lrp2) \n\n1.786 0.03 Acts together with cubilin to mediate HDL endocytosis/Downregulation of Lrp2 \n\n protein in apical pole from kidney proximal tubule is associated with nephrosis \n\nin male rat. \n\nRusso et al., 2007 \n\nQ5XI73 Rho GDP dissociation \ninhibitor alpha \n\n(ARHGDIA) \n\n0.522 0.005 Regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the \ndissociation of GDP from them, and the subsequent binding of GTP to \n\nthem/Knockout mouse for ARHGDIA displayed increased tubulointerstitial \n\nnephritis and degeneration of renal tubular epithelial cells. \n\nTogawa et al., 1999 \n\nUnique \n\nproteins \n\n     \n\nP30152 Neutrophil gelatinase-\n\nassociated lipocalin \n\n(NGAL) \n\n- - Iron-trafficking protein involved in multiple processes such as apoptosis, innate \n\nimmunity and renal development/ Involved in apoptosis due to interleukin-3 (IL3) \n\ndeprivation/ It is a marker and predictor of renal injury/ Up-regulation of NGAL is \n\nassociated with ischemic acute kidney injury. \n\nTrof et al., 2006 \n\nP06762 Heme oxygenase 1 \n\n(HO-1) \n\n- - Heme oxygenase cleaves the heme ring to form biliverdin. Biliverdin is \n\nsubsequently converted to bilirubin by biliverdin reductase.  \n\nCamara and Soares, \n\n2005; Zager, 1996 \n\nP01048 Rat T-kininogen 1 - - Acute-phase inflammatory response/ Precursor of the active peptide bradykinin Bohrer et al., 2007; \n\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0001938\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0001666\nhttp://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0045454\nhttps://reports.ingenuity.com/rs/nodeview/nodeview.jsp?analysisid=-1&amp;did=ING:268k&amp;sname=findings\n\n\n \n\nResultados \n\n163 \n\n \n\n(Isoform 1 of LMWK) (BK)/Related to vasodilation, hypotension and increase of vascular \npermeability/Participates of the contact-phase reactions of blood coagulation and \n\nkallikrein-kinin system/ L. obliqua venom is able to release BK from LMWK.   \n\nPinto et al., 2010 \n\nP14480-1 Isoform 1 of \n\nFibrinogen beta chain \n\n(FbB) \n\n- - Precursor of fibrin clots/ Polymerize into fibrin and acting as a cofactor in platelet \n\naggregation/ Conversion of fibrinogen to fibrin is triggered by thrombin/ Up-\n\nregulation of Fb mRNA in kidney is associated with proximal tubular injury and \n\nintra-glomerular fibrin deposition.  \n\nThukral et al., 2005 \n\nP20961 Plasminogen activator \n\ninhibitor 1 (PAI-1) \n\n- - Serine protease inhibitor. This inhibitor acts as 'bait' for tissue plasminogen \n\nactivator, urokinase, protein C and matriptase-3/It's the major control point in the \n\nregulation of fibrinolysis/Up-regulation of PAI-1 is associated with renal \n\nthrombosis and fibrosis in cases of chronic allograft nephropathy.  \n\nRevelo et al., 2005 \n\nP50115 Protein S100-A8 - - Calcium- and zinc-binding protein/ Plays a prominent role in the regulation of \ninflammatory processes and immune response/  Its proinflammatory activity \nincludes recruitment of leukocytes, promotion of cytokine and chemokine \n\nproduction, and regulation of leukocyte adhesion and migration. Can induce cell \n\ndeath via autophagy and apoptosis and this occurs through the cross-talk of \n\nmitochondria and lysosomes via reactive oxygen species (ROS). \n\nBasnakian et al., 2002 \n\nP02680-1 Gamma-B of \n\nFibrinogen gamma \n\nchain (FbG) \n\n- - Precursor of fibrin clots/ Polymerize into fibrin and acting as a cofactor in platelet \n\naggregation/ Conversion of fibrinogen to fibrin is triggered by thrombin/ Up-\n\nregulation of Fb mRNA in kidney is associated with proximal tubular injury and \n\nintra-glomerular fibrin deposition.  \n\nThukral et al., 2005 \n\nQ64268 Heparin cofactor 2 \n\n(HC-2) \n\n- - Thrombin inhibitor/ It is activated by the glycosaminoglycans, heparin or \n\ndermatan sulfate. In the presence of the latter, HC-II becomes the predominant \n\nthrombin inhibitor in place of antithrombin III (AT)/ HC-II -levels increase in \nthrombosis and intravascular disseminated coagulation (DIC).  \n\nTakatsuka et al., 2006 \n\nP84817 Mitochondrial fission 1 \n\nprotein (MFP-1) \n\n- - Promotes the fragmentation of the mitochondrial network and its perinuclear \n\nclustering/ Can induce cytochrome c release from the mitochondrion to the \n\ncytosol, ultimately leading to apoptosis. Also mediates peroxisomal fission. \n\nBasnakian et al., 2002 \n\n \n\n\n\nResultados \n\n \n\n164 \n\n \n\nSupplemental Table 1. \n\n \n\n \n\nOBS: A tabela suplementar deste artigo \u00e9 apenas complementar \u00e0 Tabela 2 e est\u00e1 \n\ninclu\u00edda em arquivo (.xls) enviado separadamente via e-mail devido ao grande volume \n\nde dados contidos. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n165 \n\n \n\n3.5 Cap\u00edtulo V \n\n \n\nPharmacological blockade of the kinin B1 receptor or kallikrein inhibition reduces \n\nthe renal damage in a model of acute kidney injury induced by Lonomia obliqua \n\nvenom \n\n \n\n Neste cap\u00edtulo final, uma abordagem farmacol\u00f3gica foi utilizada para explorar o \n\npapel do sistema calicre\u00edna-cininas (SCC) na insufici\u00eancia renal aguda induzida pelo \n\nveneno da taturana em ratos. \n\n \n\nOs principais resultados obtidos foram: \n\n \n\n? O SCC est\u00e1 ativado no rim durante o envenenamento. H\u00e1 um aumento na \n\nexpress\u00e3o g\u00eanica dos receptores B1 e B2 (B1R e B2R) de bradicinina, \n\ndiminui\u00e7\u00e3o na express\u00e3o da enzima conversora de angiotensina (ECA), aumento \n\nda atividade da calicre\u00edna renal e plasm\u00e1tica e aumento na produ\u00e7\u00e3o de \u00f3xido \n\nn\u00edtrico no rim; \n\n? A ativa\u00e7\u00e3o de calicre\u00edna e o aumento na express\u00e3o de B1R indicam que o SCC \n\ntem papel fundamental para o desenvolvimento das les\u00f5es renais. O tratamento \n\npr\u00e9vio com antagonistas de B1R ou a inibi\u00e7\u00e3o de calicre\u00edna previne as principais \n\naltera\u00e7\u00f5es de fun\u00e7\u00e3o renal, incluindo a queda acentuada do ritmo de filtra\u00e7\u00e3o \n\nglomerular, aumento de creatinina plasm\u00e1tica e protein\u00faria. O pr\u00e9-tratamento \n\ncom antagonistas de B2R n\u00e3o apresenta qualquer efeito; \n\n? O antagonismo de B1R ou inibi\u00e7\u00e3o de calicre\u00edna protege contra as altera\u00e7\u00f5es \n\ntubulares degenerativas, inflama\u00e7\u00e3o e obstru\u00e7\u00e3o tubular. O antagonismo de B2R \n\nn\u00e3o apresenta efeito; \n\n? O antagonismo de B1R ou inibi\u00e7\u00e3o de calicre\u00edna previne o desenvolvimento da \n\ncoagulopatia de consumo, j\u00e1 o antagonismo de B2R n\u00e3o apresenta o mesmo \n\nefeito.  \n\n \n\n O manuscrito a seguir ser\u00e1 submetido para publica\u00e7\u00e3o em peri\u00f3dico cient\u00edfico \n\ninternacional. \n\n \n\n\n\nResultados \n\n166 \n\n \n\nPharmacological blockade of the kinin B1 receptor or kallikrein inhibition reduces \n\nrenal damage in a model of Lonomia obliqua venom-induced acute kidney injury \n\n \n\nMarkus Berger\n1\n, Walter Orlando Beys-da-Silva\n\n2\n, Luc\u00e9lia Santi\n\n2\n, Fabiana Alves\n\n3\n, Almir \n\nde Sousa Martins\n3\n, David Driemeier\n\n4\n, Maria Aparecida Ribeiro Vieira\n\n5\n &amp; Jorge \n\nAlmeida Guimar\u00e3es\n1*. \n\n1. Laborat\u00f3rio de Bioqu\u00edmica Farmacol\u00f3gica, Centro de Biotecnologia, Universidade \n\nFederal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. \n\n2. Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, \n\nUnited States. \n\n3. Laborat\u00f3rio de Biologia Molecular, Departamento de Fisiologia e Biof\u00edsica, Instituto \n\nde Ci\u00eancias Biol\u00f3gicas, Universidade Federal de Minas Gerais (UFMG), Belo \n\nHorizonte, MG, Brazil.  \n\n4. Departamento de Patologia Cl\u00ednica Veterin\u00e1ria, Faculdade de Medicina Veterin\u00e1ria, \n\nUniversidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. \n\n5. Laborat\u00f3rio de Fisiologia Renal, Departamento de Fisiologia e Biof\u00edsica, Instituto de \n\nCi\u00eancias Biol\u00f3gicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, \n\nMG, Brazil. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n? \nCorresponding author: Prof. Jorge Almeida Guimar\u00e3es, Laborat\u00f3rio de Bioqu\u00edmica \n\nFarmacol\u00f3gica, Centro de Biotecnologia (UFRGS). Av. Bento Gon\u00e7alves, 9500, Cep \n\n91501-970, Porto Alegre, RS, Brasil. Tel.: +55 51 33086068. Fax +55 51 33087309. E-\n\nmail: guimar@cbiot.ufrgs.br \n\nmailto:guimar@cbiot.ufrgs.br\n\n\nResultados \n\n167 \n\n \n\nAbstract \n\n \n\nLonomia obliqua venom is highly nephrotoxic, and acute kidney injury (AKI) is the \n\nmain cause of death among envenomed victims. We have previously demonstrated that \n\nthe pathophysiological mechanism underlying L. obliqua-induced AKI seems to be \n\nmultifactorial and involves renal hypoperfusion, inflammation, tubular necrosis and the \n\nsudden loss of glomerular filtration and tubular reabsorption capacities. In the present \n\nstudy, we aimed to investigate the contribution of kallikrein-kinin system (KKS) \n\ncomponents to the hemodynamic instability, inflammation and consequent renal \n\nfunctional impairment. To this end, rats were treated with either the bradykinin receptor \n\nB1 (B1R) antagonists DALBK and R-715, the B2 receptor (B2R) antagonist HOE-140, or \n\na kallikrein inhibitor (aprotinin) 30 min prior to the subcutaneous injection of L. obliqua \n\nvenom (1.5 mg/kg). After 24 h of envenomation, plasma, urine and kidney samples \n\nwere collected to analyze renal function, morphological alterations and the expression \n\nof KKS components. The activity of renal tissue kallikrein and the expression of the \n\nB1R and B2R increased during envenomation, indicating that the KKS was indeed \n\nactivated. Both B1R antagonism and kallikrein inhibition prevented glomerular injury \n\nand reductions in the rate of glomerular filtration, and restored fluid homeostasis and \n\ntubular water retention ability. The main mechanism underlying these beneficial effects \n\nwas associated with decreased renal inflammation and reduced levels of renal pro-\n\ninflammatory cytokines and tubular degeneration. In addition, B1R antagonists and \n\naprotinin also ameliorated venom-induced blood incoagulability and hemorrhagic \n\nsyndrome, an outcome that is commonly observed during L. obliqua envenomation. In \n\ncontrast, rats pretreated with the B2R antagonist, HOE-140, did not display such \n\nbeneficial effects. Thus, these data indicate that blocking kallikrein or B1R activity may \n\nbe therapeutic alternatives that could be used to control the progression of L. obliqua \n\nvenom-induced AKI.    \n\n \n\n \n\n \n\n \n\n \n\nKeywords: Venom, Lonomia, renal, acute kidney injury, nephrotoxicity, kallikrein-kinin \n\nsystem, and bradykinin. \n\n\n\nResultados \n\n168 \n\n \n\n1. Introduction \n\n \n\n Envenomation resulting from contact with Lonomia obliqua caterpillars has been \n\nrecognized as a neglected public health issue that mainly occurs in impoverished \n\ncommunities in the rural areas of the southern regions of Brazil. Envenomed victims \n\ndisplay systemic hemorrhage secondary to intravascular disseminated coagulation (For \n\nreview see Veiga et al., 2009; Pinto et al., 2010). Frequently, the clinical profile evolves \n\nto acute kidney injury (AKI), which is the main cause of death following this type of \n\nenvenomation (Gamborgi et al., 2006; Berger et al., 2012). In experimental models, L. \n\nobliqua venom induces the sudden loss of basic renal functions, including filtration and \n\nexcretion capacities, urinary concentration and the maintenance of body fluid \n\nhomeostasis. In addition to the direct cytotoxic effects of venom toxins, renal \n\nhypoperfusion also appears to be an important underlying mechanism, because signs of \n\nglomerular fibrin deposition and hemodynamic instability (systemic hypotension and \n\nincreased renal vascular permeability) have been detected in rats injected with L. \n\nobliqua venom (Berger et al., unpublished data). In fact, the coagulation, complement \n\nand kallikrein-kinin systems are known to be activated during envenomation (Zannin et \n\nal., 2003; Bohrer et al., 2007).   \n\n The kallikrein-kinin system (KKS) is composed of potent vasoactive and \n\nproinflammatory molecules that are involved in the control of blood pressure, vascular \n\npermeability, smooth muscle contraction or relaxation, and pain. Kinins are generated \n\nby the proteolytic cleavage of kininogens by tissue or plasma kallikreins. Once released, \n\nkinins exert the majority of their biological effects by activating two types of kinin \n\nreceptors: the bradykinin B1 receptor (B1R) and the bradykinin B2 receptor (B2R). The \n\nB2R is constitutively expressed in most tissues, and displays a higher affinity for \n\nbradykinin (BK) and Lys-BK peptides. In contrast, the B1R displays high affinities for \n\nthe kinin metabolites des-Arg\n9\n-BK and Lys-des-Arg\n\n9\n-BK. The B1R is not expressed \n\nunder normal conditions, but is induced following inflammatory, infectious or traumatic \n\nstimuli (Regoli and Barab\u00e9, 1980, Calixto et al., 2004; Campos et al., 2006; Kayashima \n\net al., 2012). Both the B1R and B2R are G protein-coupled, seven transmembrane \n\ndomain receptors. Stimulation of the latter elevates intracellular Ca\n+2\n\n concentrations and \n\nphospholipase A2 activity, leading to the release of various mediators, including nitric \n\noxide (NO), prostaglandins, arachidonic acids and other inflammatory agents (Kakoki \n\nand Smithies, 2009). Notably, the B1R and B2R are involved in several inflammation-\n\n\n\nResultados \n\n169 \n\n \n\nrelated processes, such as atherosclerosis, airway inflammation, diabetic neuropathy, \n\ninflammatory bowel diseases, neuropathic pain, and cerebral infarction (Couture et al., \n\n2001; Souza et al., 2004; Hara et al., 2008; Quint\u00e3o et al., 2008; Austinat et al., 2009; \n\nDuchene and Ahluwalia, 2009; Kakoki et al., 2010). In renal diseases specifically, B1R \n\ndeletion or antagonism has been associated with renoprotection against ischemia-\n\nreperfusion-induced injury, glomerulonephritis and renal inflammation and fibrosis \n\n(Wang et al., 2008; Klein et al., 2009; Klein et al., 2010). In contrast, mice lacking the \n\nB2R displayed enhanced diabetic nephropathy (Kakoki et al., 2004).      \n\n The KKS is involved in the edematogenic and hypotensive responses elicited by \n\nL. obliqua venom. L. obliqua venom induces the release of kinins from low-molecular \n\nweight kininogen (LMWK), and both edematogenic and hypotensive responses are \n\nreduced following kallikrein inhibition and B2R antagonism (Bohrer et al., 2007). \n\nMoreover, envenomed patients presented low levels of plasma prekallikrein, indicating \n\nthat kallikrein had been activated and released into the blood circulation (Zannin et al., \n\n2003). Taken together, these data led us to hypothesize that the generation of kallikrein \n\nand BK during envenomation may be involved in L. obliqua-induced hemodynamic \n\ninstability, inflammation and the consequent renal functional impairment. \n\n In the present study, we used different pharmacological treatments to study the \n\nroles of kallikrein and the kinin receptors, B1R and B2R, in an experimental model of L. \n\nobliqua-induced AKI. The results indicated that both kallikrein inhibition and B1R \n\nantagonism were able to prevent venom-induced blood incoagulability and restore renal \n\nfunction by reducing tubular necrosis and tissue inflammation. In summary, these data \n\nindicate that blocking kallikrein activity or the B1R may be therapeutic alternatives that \n\ncould be used to control the progression of the renal pathology that is observed \n\nfollowing L. obliqua envenomation.   \n\n \n\n2. Materials and Methods \n\n \n\n2.1 Drugs and reagents \n\n [Leu\n8\n]-des-Arg\n\n9\n-BK (DALBK), R-715 (AcLys[D-?Nal\n\n7\n,Ile\n\n8\n]des-Arg\n\n9\n-BK), \n\nHOE-140 (D-Arg\n0\n-[Hyp\n\n3\n,Thi\n\n5\n, D-Tic\n\n7\n, Oic\n\n8\n]-BK, Icatibant), vanadium (III) chloride \n\n(VCl3), sulfanilamide (SULF), N-(1-naphthyl)ethylenediamine dihydrochloride (NEDD) \n\nand the purified coagulation factors (VII, IX and X) were purchased from Sigma-\n\nAldrich (Saint Louis, MO, USA). Aprotinin (Trasylol\n\u00ae\n) was obtained from Bayer do \n\n\n\nResultados \n\n170 \n\n \n\nBrasil S.A. (S\u00e3o Paulo, Brazil). The chromogenic substrates for factor Xa (S2222, Bz-\n\nIle-Glu-Gly-Arg-p-nitroanilide), plasma kallikrein (S2302, H-D-Pro-Phe-Arg-p-\n\nnitroanilide) and tissue kallikrein (S2366, H-D-Val-Leu-Arg-p-nitroanilide) were \n\nobtained from Chromogenix (Milan, Italy). Ketamine and xylazine were obtained from \n\nSyntec (S\u00e3o Paulo, Brazil).  \n\n \n\n  2.2 Venom \n\n L. obliqua caterpillars were kindly provided by the Centro de Informa\u00e7\u00f5es \n\nToxicol\u00f3gicas (CIT), Porto Alegre, Rio Grande do Sul, Brazil. The specimens used in \n\nthe present study were collected in the cities of Bom Princ\u00edpio and Progresso, both of \n\nwhich are located at Rio Grande do Sul, Brazil. L. obliqua venom was obtained by \n\ncutting bristles at the base of each scoli and macerating them in cold phosphate-buffered \n\nsaline (PBS), pH = 7.4, as previously described (Veiga et al., 2005; Pinto et al., 2006; \n\nBerger et al., 2010). The venom obtained following this procedure was designated as \n\nLonomia obliqua Bristle Extract (LOBE). The protein concentrations of the LOBE \n\nsamples were determined using a BCA assay kit (Pierce, Rockford, USA), and the \n\naliquots were stored at -80 \u00b0C prior to use.  \n\n \n\n2.3 Animals \n\n Adult male Wistar rats, weighing 250-300 g, were supplied by the central animal \n\nfacility of our institution. The animals were housed under standard conditions within a \n\ntemperature controlled room (22-23 \u00baC, on a 12 h light/dark cycle, with the lights on at \n\n7:00 am), and had free access to water and food. All of the procedures involving \n\nanimals were carried out in accordance with the Guiding Principles for the Use of \n\nAnimals in Toxicology (International Society of Toxicology, \n\nhttp://www.toxicology.org) and the Brazilian College of Animal Experimentation \n\n(COBEA). The experimental protocol was approved by the ethical committee on \n\nresearch animal care of the Federal University of Rio Grande do Sul, Brazil (register \n\nnumber 2008177/2009) and by the Institute's Animal Ethics Committee of the Federal \n\nUniversity of Minas Gerais, Brazil (protocol 177/2008).  \n\n \n\n \n\n \n\n \n\nhttp://www.toxicology.org/\n\n\nResultados \n\n171 \n\n \n\n2.4 Experimental design \n\n \n\n2.4.1 Venom induced-acute kidney injury (AKI) \n\n The time course of alterations in KKS components during L. obliqua induced-\n\nAKI was examined using an in vivo experimental model of envenomation. The animals \n\nwere divided into one of two groups: A control group (CTRL), which contained animals \n\n(n = 6 per sampling time) that were injected subcutaneously (sc) with 100 \u00b5L of a sterile \n\nPBS solution, and an experimental group (LOBE), which contained animals (n = 6 per \n\nsampling time) that were injected sc with a solution containing 1.5 mg of the LOBE per \n\nkg of body weight in a final volume of 100 \u00b5L. The animals were then distributed \n\nindividually in metabolic cages, which allowed for quantitative urine collections and \n\nmeasurements of water intake. At several time points post-venom injection (12, 24, 48 \n\nand 96 h), blood, urine and kidney samples were obtained for biochemical, \n\nhistopathological, and renal tissue factor activity and gene expression analyses. The \n\nvenom dose and times post-envenomation were selected based on the results of previous \n\nexperiments that were conducted using rats as an animal model (Berger et al., \n\nunpublished data) to reproduce the kidney damage and consumption coagulopathy that \n\nhas been observed in humans (Dias da Silva et al., 1996; Rocha-Campos et al., 2001; \n\nGamborgi et al., 2006; Berger et al., 2010).  \n\n \n\n2.4.2 Pharmacological treatments \n\n Different pharmacological treatments were tested to determine the roles of the \n\nBK receptors and kallikrein. The animals were divided into six groups (n = 6/group): (i) \n\nControl group (CTRL), in which the animals were treated intraperitoneally (ip) with 250 \n\n?L of a sterile PBS solution 30 min prior to the sc injection of 100 ?L of a sterile PBS \n\nsolution; (ii) LOBE + PBS, in which the animals were treated with 250 ?L of PBS (ip) \n\n30 min prior to the injection of the LOBE (1.5 mg/kg, sc); (iii) LOBE + HOE-140, in \n\nwhich the animals were treated with the B2R antagonist, HOE-140 (250 ?g/kg, ip, \n\ndiluted in 250 ?L of PBS), 30 min prior to the injection of the LOBE (1.5 mg/kg, sc); \n\n(iv) LOBE + DALBK, in which the animals were treated with the B1R antagonist, \n\nDALBK (1.0 mg/kg, ip, diluted in 250 ?L of PBS), 30 min prior to the injection of the \n\nLOBE (1.5 mg/kg, sc); (v) LOBE + R-715, in which the animals were treated with the \n\nB1R antagonist, R-715 (1.0 mg/kg, ip, diluted in 250 ?L of PBS), 30 min prior to the \n\ninjection of the LOBE (1.5 mg/kg, sc); and (vi) LOBE + APROTININ, in which the \n\n\n\nResultados \n\n172 \n\n \n\nanimals were treated with the kallikrein inhibitor, aprotinin (5.6 mg/kg, iv, \n\ncorresponding to 40,000 kallikrein inhibitory units/kg, diluted in sterile saline), 30 min \n\nprior to the injection of the LOBE (1.5 mg/kg, sc). Additional groups were treated only \n\nwith the drugs (using the same doses) to exclude their own direct effects on renal \n\nfunction parameters. Immediately after the treatments, the animals were distributed \n\nindividually in metabolic cages. At 24 h post-venom injection, blood, urine and kidney \n\nsamples were obtained for biochemical, histopathological, renal tissue factor activity \n\nand gene expression analyses. All of the drug doses were selected based on previously \n\npublished data (Day et al., 2006; Bohrer et al., 2007; Austinat et al., 2009; Raslan et al., \n\n2010; Viana et al., 2010)  \n\n \n\n2.5 Blood, urine and kidney samples \n\n Blood samples were obtained by cardiac puncture in rats that had been \n\nanesthetized with ketamine (75 mg/kg) and xylazine (10 mg/kg) and anticoagulated \n\nwith 1:10 (v/v) 3.8 % trisodium citrate. Plasma was obtained by centrifugation at 1500 x \n\ng for 10 min and stored at \u2013 80 \u00baC prior to the biochemical determinations. Urine \n\nsamples were collected directly from the metabolic cages and centrifuged at 2500 x g \n\nfor 5 min. The supernatants were stored under the same conditions used for the plasma \n\nsamples. After blood collection, the hearts were perfused through the left ventricle with \n\na PBS solution, and a circulatory circuit was opened by an incision in the right atrium to \n\nensure the elimination of intravascular blood. Immediately after perfusion, the kidneys \n\nwere quickly removed. One of the kidneys was fixed for histological analysis, and the \n\nother was frozen in liquid nitrogen and stored at \u2013 80 \u00baC prior to the measurements of \n\ntissue factor and kallikrein activities, nitrate/nitrite levels and the gene expression \n\nprofile. For the measurements of tissue factor and kallikrein activities and nitrate/nitrite \n\nlevels, a portion of the kidney was homogenized in a cold PBS solut ion containing 1 % \n\nTriton X-100 and centrifuged at 9500 x g for 15 min. The supernatants were \n\nimmediately used in the assays. \n\n \n\n2.6 Analyses of renal function \n\n The levels of creatinine, urinary ?-glutamyl transferase (?-GT) activity and \n\nurinary proteins were used for renal function assessments. Urine and plasma creatinine, \n\nurinary ?-GT activity and proteinuria were determined spectrophotometrically (SP-220 \n\nBioSpectro Spectrophotometer, Paran\u00e1, Brazil) using commercially available kits \n\n\n\nResultados \n\n173 \n\n \n\n(BioClin/Quibasa, Belo Horizonte, Brazil). The glomerular filtration rate (GFR), \n\nexpressed as mL/min/100 g of body weight, was estimated by the creatinine clearance \n\n(Ccr) using the standard formula: Ccr = Ucr.V/Pcr, where Ucr is the urinary creatinine \n\nconcentration, V is the urinary output and Pcr is the plasma creatinine concentration. \n\nWater fractional excretion (FEH2O), expressed as a %, was determined using the \n\nequation: FEH2O = V/GFR.100. Hydric balance (HB), expressed as a %, represents the \n\nrelationship between water consumption (WC) and urinary output (V). It was calculated \n\nas: HB = V/WC.100.   \n\n \n\n2.7 Gene expression analyses \n\n Renal mRNA levels of angiotensin converting enzyme (ACE), angiotensin \n\nconverting enzyme 2 (ACE2), angiotensin II receptor (AT1R), angiotensin (1-7) \n\nreceptor (MAS), the bradykinin B1 receptor (B1R), the bradykinin B2 receptor (B2R) \n\nand glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were estimated using \n\nquantitative real-time PCR (qRT-PCR). First, total RNA was extracted from the kidneys \n\nusing the TRIzol\n\u00ae\n (Invitrogen, Carlsbad, CA, USA) reagent, according to the \n\nmanufacturer\u2019s recommended protocol. Reverse transcription was performed using 1 ?g \n\nof total pure RNA, 200 units of reverse transcriptase, 100 mM DTT (dithiothreitol) (1.0 \n\n?L), 5\u00d7 reverse transcription buffer (2.5 ?L), 10 mM dNTPs (1.8 ?L), 10,000 units of \n\nRNAsin (0.2 ?L) and 50 ng/ml of oligo(dT) (1.0 ?L). The temperature profile for this \n\nreaction was: 25 \n?\nC for 5 min, 37 \n\n?\nC for 60 min, 70 \n\n?\nC for 5 min and 4 \n\n?\nC for 5 min. The \n\nresultant cDNA was used for real-time PCR, as described below. Specific primers were \n\ndesigned using Primer Express software and were synthesized by Applied Biosystems \n\n(California, USA). The primers were as follows (forward and reverse, respectively): \n\nB1R, 5'-AACATCGGGAACCGTTTCAAC-3' and 5'-CACCCGGCAGAGGTCAGTT-\n\n3'; B2R, 5'-TTCCGAAAGAAGTCCCGAGA-3' and 5'-GCCTCCCTTCCGGCATATT-\n\n3'; AT1R, 5'-TCTCAGCATCGATCGCTACCT-3' and 5'-\n\nAGGCGAGACTTCATTGGGTG-3'; MAS, 5'-TGACCATTGAACAGATTGCCA-3' \n\nand 5'-TGTAGTTTGTGACGGCTGGTG-3'; ACE, 5'-\n\nCTTCACTGACCAAAAGCTGCG-3' and 5'-CCTAGGGTCTGTACGGATCCG-3'; \n\nACE2, 5'-GTGGAGGTGGATGGTCTTTCA-3' and 5'-\n\nTTGGTCCACTGTTCTCTGGGA-3'; and GAPDH, 5'-\n\nATGTTCCAGTATGACTCCACTCACG-3' and 5'- \n\nGAAGACACCAGTAGACTCCACGACA-3'. The AT1 receptor primer set detected \n\n\n\nResultados \n\n174 \n\n \n\nboth the AT1a and AT1b receptor subtypes. Real-time PCR was carried out using an \n\nABI PRISM 7000 Sequence Detection System (Applied Biosystems, California, USA) \n\nwith SYBR Green PCR Master Mix (Applied Biosystems, California, USA). The \n\nrelative levels of gene expression were determined using the comparative threshold \n\ncycle method, as outlined in the manufacturer's instructions, in which the data for each \n\nsample were normalized to GAPDH expression. \n\n \n\n2.8 Renal tissue factor activities \n\n Renal tissue factor (TF) was measured indirectly based on its ability to form a \n\ncomplex with factor VIIa (TF/FVIIa) and activate factors IX and X (Morrissey, 1995). \n\nBriefly, the kidneys were collected as described above, homogenized in a cold PBS \n\nsolution containing 1 % Triton X-100 and centrifuged at 9500 x g for 15 min. \n\nSupernatant samples (10 \u00b5g of protein) were incubated with a concentrated mixture of \n\nthe FVII+FIX+FX complex (15 \u00b5g total) in 20 mM Tris-HCl, pH 7.4, containing 10 \n\nmM CaCl2 for 10 min at 37 \u00b0C. Activated factor Xa (FXa) that was produced during the \n\nreaction was detected by the addition of a specific chromogenic substrate (0.2 mM \n\nS2222). The kinetics of p-nitroaniline release were monitored at 405 nm for 30 min in a \n\nfinal volume of 100 \u00b5L using a microplate reader spectrophotometer (SpectraMAX, \n\nMolecular Devices Co., Sunnyvale, USA). Each sample was measured in triplicate, and \n\nthe results were expressed as \u00b5mol of FXa generated per min per mg of kidney tissue. \n\n \n\n2.9 Plasma prekallikrein and renal kallikrein activities \n\n To measure plasma prekallikrein, plasma samples (5 ?L) were previously \n\nincubated with 20 mM Tris-HCl, pH 7.4, containing 100 ?M elagic acid, phospholipids, \n\n0.005 % bovine albumin and 10 mM CaCl2 for 10 min at 37 \u00b0C. Activated kallikrein \n\nthat was produced during the reaction was detected by the addition of 0.2 mM S2302, a \n\nspecific chromogenic substrate for plasma kallikrein. To measure renal kallikrein, \n\nkidney extracts were prepared as described above, diluted (1:2) and incubated (15 ?L) \n\nin 20 mM Tris-HCl, pH 7.4, for 10 min at 37\u00b0C. Kallikrein activity was detected by the \n\naddition of 0.2 mM S2366, a specific chromogenic substrate for tissue kallikrein. In \n\nboth cases, the kinetics of p-nitroaniline release were monitored at 405 nm for 30 min in \n\na final volume of 100 \u00b5L using a microplate reader spectrophotometer (SpectraMAX, \n\n\n\nResultados \n\n175 \n\n \n\nMolecular Devices Co., Sunnyvale, USA). Each sample was measured in triplicate, and \n\nthe results were expressed as \u00b5mol of p-nitroaniline released per min per mg of protein. \n\n \n\n2.10 Nitric oxide determinations \n\n The total plasmatic and kidney levels of nitrate and nitrite were determined as an \n\nindication of nitric oxide (NO) production, as described previously (Miranda et al., \n\n2001). Briefly, plasma or kidney samples were deproteinized by the addition of 1:1 \n\n(v/v) ethanol and incubated overnight at 4\n \n\u00b0C. After centrifugation at 1500 X g for 10 \n\nmin, the supernatants (100 ?L) were mixed with 8 mg/mL of VCl3 (100 ?L) in 96 well \n\nmicroplates. The Griess reagent (100 ?L of 2 % SULF + 0.1 % NEED) was \n\nimmediately added to the wells, and the absorbance was then read at 540 nm after 30 \n\nmin of incubation at room temperature. The sample values were compared with the \n\nabsorbance of a standard curve of sodium nitrate (1 \u2013 200 ?M). \n\n \n\n2.11 Histology  \n\n For the renal histopathology analyses, the kidneys were collected, as described \n\npreviously, sectioned sagitally, and fixed in 10 % buffered formaldehyde, pH 7.2. After \n\nprocessing in alcohol and xylol, the organs were embedded in paraffin, and 4 ?m thick \n\nsections were obtained and stained with hematoxylin and eosin (H&amp;E). Thirty high-\n\npower fields (40 X) of the renal cortex were randomly selected for each section, and the \n\npresence of the following alterations was observed: Intratubular casts, tubular \n\ndegeneration and cellular inflammatory infiltrate. A semi-quantitative score (ranging \n\nfrom 0 to 3) was attributed to each of these alterations as follows: a score of zero was \n\nattributed to normal regions, a score of 1 was attributed to changes affecting less than 30 \n\n% of the region under examination, a score of 2 was attributed to changes affecting 30 \n\nto 60 % of the region, and a score of 3 was attributed to changes affecting greater than \n\n60 % of the region. All scoring was performed in a blinded manner. \n\n \n\n2.12 Assessments of renal vascular permeability and pro-inflammatory cytokine levels \n\n The index of vascular permeability was assessed by the extravasation of Evans \n\nblue dye into the kidneys, as described previously (Pompermayer et al., 2005). Rats \n\nwere pretreated with either the B1R antagonist (R-715) or the kallikrein inhibitor \n\n(aprotinin) according to the previously outlined protocol. The rats then received Evans \n\n\n\nResultados \n\n176 \n\n \n\nblue dye (30 mg/kg) intravenously (1 mL/kg) via the caudal vein 10 min prior to LOBE \n\n(1.5 mg/kg, sc) or PBS (100 \u00b5L, sc) injection. After 24 h, the animals were anesthetized \n\nand perfused through the left ventricle with a PBS solution to remove the intravascular \n\nEvans Blue. Then, the kidneys were quickly removed, weighed and allowed to dry for \n\n24 h at 40 \u00b0C. The dry weights were determined and Evans blue dye was extracted in \n\n2.5 mL of 1 % formamide (48 h at 40 \u00b0C). The absorbance of the extracted solution was \n\nmeasured in triplicate using a microplate reader spectrophotometer (SpectraMAX, \n\nMolecular Devices Co., Sunnyvale, USA), and the amounts of Evans blue dye were \n\ncalculated based on a standard curve that was generated with known concentrations of \n\nEvans Blue. The results are presented as the amount of Evans blue dye extravasated \n\n(?g) per 100 mg of kidney tissue. The levels of pro-inflammatory cytokines (interleukin \n\n[IL] 1-? and tumor necrosis factor [TNF]-?) were determined in the kidney supernatants \n\n(homogenized as described in subsection 2.5) using enzyme-linked immunosorbent \n\nassay (ELISA) kits from R&amp;D Systems (Minneapolis, MN, USA), according to the \n\nmanufacturer's recommendations. \n\n \n\n2.13 Statistical analyses \n\n The data are presented as the means \u00b1 SE, and significant differences were \n\nanalyzed using one-way ANOVA followed by an unpaired t-test with a Bonferroni \n\ncorrection for multiple comparisons. P-values of 0.05 were considered to be significant. \n\nStatistical analyses were performed using GraphPad Prism (GraphPad Software Inc., \n\nSan Diego, CA, USA). \n\n \n\n3. Results \n\n \n\n3.1 B1R and B2R expression and kallikrein activity are increased in the kidneys during \n\nL. obliqua-induced AKI \n\n The results of a previous study indicated that the subcutaneous injection of L. \n\nobliqua venom (1.5 mg/kg) in rats causes a sudden loss of glomerular filtration \n\ncapacity, a decrease in tubular hydro-electrolytic transport and tubular necrosis. These \n\nalterations peaked between 12 and 48 h. In the present study, we observed that \n\nalterations in renal function are also associated with the up-regulation of the expression \n\nof the BK receptors, B1R and B2R (Figs. 1A and B). B1R expression was up-regulated \n\nin the kidneys throughout the period of envenomation (12-96 h), with a maximal \n\n\n\nResultados \n\n177 \n\n \n\nincrease of 2.1-fold observed 12 and 48 h post-venom injection (Fig. 1A). B2R \n\nexpression in the kidneys was up-regulated between 24-96 h, with a maximal increase \n\nof 2.3-fold observed 48 h post-venom (Fig. 1B). The renal expression of ACE, which is \n\na kininase that is responsible for BK inactivation and the generation of the \n\nvasoconstrictor peptide angiotensin II (Ang II), was down-regulated 12 and 24 h after \n\nenvenomation (Fig. 1C). The decrease in renal ACE expression was accompanied by \n\nthe simultaneous down-regulation of the AT1R, the Ang II receptor (Fig. 1D). At 48 and \n\n96 h post-envenomation, ACE expression had significantly increased in the kidneys of \n\nenvenomed animals, but AT1R expression remained unchanged (Figs. 1C and D). The \n\nmRNA levels of renal MAS, which is the receptor for the vasodilator peptide \n\nangiotensin 1-7 (Ang-(1-7)), had increased by 3.2- and 3.4-fold at 48 and 96 h, \n\nrespectively (Fig. 1E). Despite the up-regulation of MAS expression, the mRNA levels \n\nof ACE2, which is the main enzyme responsible for the conversion of Ang II into Ang-\n\n(1\u20137), had only increased slightly, and this increase did not reach statistical significance \n\n(Fig. 1F). The ratio of the expression of the MAS/AT1R receptors increased at all of the \n\ntime points evaluated, indicating that renal MAS expression predominated during \n\nenvenomation (Fig. 1G). However, the B2R/B1R ratio decreased at 12 h, indicating that \n\nB1R expression predominated at this time point. The B2R/B1R ratio increased between \n\n24 and 96 h, indicating that B2R expression predominated at these time points (Fig. \n\n1H).  \n\n Along with the up-regulation of the BK receptors, plasma prekallikrein activity \n\ndecreased in envenomed animals, suggesting that active kallikrein is generated \n\nsystemically during envenomation (Table 1). Consistent with this observation, renal \n\nkallikrein activity significantly increased between 24 and 96 h post-venom injection. \n\nIncreases of 3.1-, 2.3- and 2.6-fold in renal tissue kallikrein activities were observed at \n\n24, 48 and 96 h, respectively, indicating that the KKS is activated in the kidneys of \n\nenvenomed rats (Table 1). Likewise, as a consequence of kallikrein activation and BK \n\nformation, nitrate/nitrite levels (which are indicative of nitric oxide production) \n\nincreased in the plasma and kidneys of envenomed animals, mainly between 12 and 24 \n\nh. \n\n \n\n \n\n \n\n\n\nResultados \n\n178 \n\n \n\n3.2 Kinin B1 receptor blockade or kallikrein inhibition ameliorates renal function \n\nduring L. obliqua envenomation  \n\n Because the KKS appeared to be activated during experimental envenomation, \n\nwe decided to investigate whether the pharmacological blockade of kinin receptors and \n\nkallikrein inhibition could be beneficial during L. obliqua-induced AKI. As shown in \n\nFig. 2, both B1R antagonism and systemic kallikrein inhibition prevented venom-\n\ninduced alterations in renal function. After 24 h of envenomation, significant polyuria \n\nwas induced (Fig. 2A), which was accompanied by increases in the hydric balance (the \n\nratio of urine output/water consumption) (Fig. 2B), plasma creatinine (Fig. 2C), the \n\nfractional excretion of water (FEH2O) (Fig. 2E), urinary protein excretion (Fig. 2F), and \n\na marked reduction in the glomerular filtration rate (GFR) (Fig. 2D). Pretreatment with \n\nboth B1R antagonists, DALBK and R-715, completely prevented these alterations. B1R \n\nantagonism restored fluid homeostasis and the tubular ability to retain water, as \n\nreflected by the fact that urinary output, hydric balance and FEH2O returned to the levels \n\nobserved in the PBS-treated animals (Figs. 2A, B and E). DALBK and R-715 \n\npretreatment also restored filtration capacity and protected the animals from venom-\n\ninduced glomerular injury, as indicated by the levels of GFR, plasma creatinine and \n\nurinary protein, which had returned to the levels observed in the control animals (Figs. \n\n2C, D and F). All of these functional parameters also returned to normal (values similar \n\nto those observed in the controls) when aprotinin, a kallikrein inhibitor, was \n\nadministered to the envenomed animals. In contrast, renal protection under B2R \n\nantagonism was not observed, as evidenced by the fact that pretreatment with HOE-140, \n\na B2R antagonist, failed to prevent renal dysfunction (Figs. 2A-F). It is worth \n\nmentioning that isolated treatment with each of the drugs (administered at the doses \n\ntested above) did not alter renal function in non-envenomed rats (data not shown).    \n\n As expected, aprotinin pretreatment protected envenomed animals from plasma \n\nprekallikrein activation and, consequently, the levels of kallikrein in the renal tissue \n\nwere only slightly increased. These increases were not significant in comparison to \n\nPBS-treated rats (Table 2). Nitric oxide production was inhibited by pretreatment with \n\nboth B1R (DALBK and R-715) and B2R (HOE-140) antagonists and aprotinin. Plasma \n\nand renal nitrate/nitrite levels were significantly reduced in envenomed animals that \n\nwere treated with BK antagonists or aprotinin in comparison to those in the LOBE+PBS \n\ngroup (Table 2). \n\n \n\n\n\nResultados \n\n179 \n\n \n\n3.3 Kinin B1 receptor blockade and kallikrein inhibition ameliorate renal \n\nhistopathological alterations and inflammation during L. obliqua envenomation  \n\n We next investigated whether BK antagonists or aprotinin pretreatment would \n\nbe effective in preventing the development of kidney lesions during L. obliqua-induced \n\nAKI. Along with the progressive decline in renal function, LOBE injection also induced \n\nprogressive degenerative lesions that were compatible with acute tubular necrosis \n\n(ATN) (Fig. 3). Increased acidophilia, loss of the proximal brush border, inflammatory \n\ninfiltration, edema, cytoplasmic vacuolation, degeneration and desquamation of necrotic \n\ncells forming intratubular casts were common alterations that were observed in \n\nenvenomed animals (LOBE+PBS group) (Figs. 3A and B). In general, pretreatment \n\nwith DALBK, R-715 and aprotinin prevented the occurrence of these morphological \n\nalterations, despite the presence of intratubular casts in some of the tubules of the rats \n\nthat had been pretreated with DALBK and aprotinin (Fig. 3A). Nevertheless, the \n\nhistopathological scores for intratubular casts, tubular degeneration and renal \n\ninflammation were ameliorated following B1R blockade or systemic kallikrein \n\ninhibition. Similar effects were not observed following B2R antagonism (Fig. 3B). \n\nFurther confirming these histological observations, DALBK, R-715 and aprotinin \n\nreduced ?-GT urinary activity, which is considered to be an efficient biomarker for ATN \n\n(Guder and Ross, 1984). However, ?-GT activity remained high in envenomed animals \n\nthat had been pretreated with HOE-140 (Fig. 3C). The main mechanism involved in the \n\nbeneficial effects of B1R blockade or kallikrein inhibition appeared to be the \n\nsuppression of renal inflammation, because pretreatment with R-715 or aprotinin \n\nreduced renal vascular extravasation (Fig. 3D) and the production of the pro-\n\ninflammatory cytokines, tumor necrosis factor-? (TNF-?) (Fig. 3E) and interleukin 1-? \n\n(IL-1?) (Fig. 3F). \n\n \n\n3.4 Kinin B1 receptor blockade and kallikrein inhibition ameliorate L. obliqua \n\nenvenomation-induced hemostatic abnormalities \n\n L. obliqua envenomation is known to induce blood incoagulability and thus, \n\nhemorrhagic syndrome, which is characterized by coagulation and fibrinolysis \n\nactivation with the secondary consumption of coagulation factors, including fibrinogen \n\n(Zannin et al., 2003; Berger et al., 2010). In the present study, our results indicated that \n\nenvenomed animals that had been injected with the B2R antagonist displayed a \n\nprolonged activated partial thromboplastin time (aPTT), while those that had been \n\n\n\nResultados \n\n180 \n\n \n\npretreated with the B1R antagonists or aprotinin displayed aPTT values that were similar \n\nto non-envenomed animals, indicating that blood clotting remained normal in these rats \n\n(Fig. 4A). Despite the normal coagulation time, fibrinogen levels were significantly \n\nreduced in envenomed animals that received the B1R antagonists or aprotinin, although \n\npartial recovery occurred in these groups (Fig. 4B). Aprotinin was also the only \n\ntreatment that was able to protect against the increases in renal tissue factor activity \n\n(Fig. 4C). \n\n \n\n4. Discussion \n\n Collectively, our results indicate that the renal KKS is activated during L. \n\nobliqua-induced AKI and that blockade of the B1R or kallikrein inhibition can reduce \n\nthe development of tubular injury and renal inflammation and improve not only renal \n\nfunction but also hemostatic abnormalities. Although AKI is a common consequence of \n\naccidental contact with L. obliqua caterpillars, the present study was the first to \n\ndemonstrate both the importance of the KKS in venom-induced pathology and that the \n\nspecific inhibition of the KKS may be a promising therapeutic option. To date, animal-\n\nderived antivenoms have provided the only effective treatments for envenomation cases \n\n(Bon, 1996). Several laboratories throughout the continents manufacture antivenoms \n\n(Guti\u00e9rrez et al., 2010), which consist of whole IgG molecules or products of their \n\nenzymatic digestion, such as bivalent F(ab')2 or monovalent Fab (Lalloo and Theakston, \n\n2003; Theakston et al., 2003; Guti\u00e9rrez and Le\u00f3n, 2009). Despite its efficacy, \n\nantivenom therapy has been associated with several problems, including the high cost of \n\nproduction; failures in the distribution of antivenom ampoules to localized, but distant, \n\nareas that have a high incidence of accidents and/or the low-income agrarian regions in \n\nwhich they are most needed; inadequate storage and transportation of antivenoms; and \n\nthe lack of trained health workers who know how to use these products and conduct the \n\nappropriate clinical management of medical emergencies (Guti\u00e9rrez et al., 2010). \n\nAnother serious problem is the adverse effects caused by antivenom therapy, including \n\npotentially life-threatening systemic disturbances, such as anaphylactic reactions, which \n\noccur quite frequently (Fan et al., 1999). The beneficial effects observed following \n\ntreatment with the B1R antagonists in the present study are of particular interest for this \n\nreason. Due to the inducible nature of the B1R at the site of tissue injury, it has been \n\nsuggested that blocking the proinflammatory B1R may lack significant adverse effects. \n\nThis hypothesis has drawn attention to the B1R as a new therapeutic target for the \n\n\n\nResultados \n\n181 \n\n \n\ntreatment of different pathologies, such as airway inflammation, diabetic neuropathy, \n\nbrain ischemia, arthritis and neuropathic pain (Campos et al., 2006). \n\n Previous data indicated that L. obliqua venom possesses kininogenase activity, \n\nbeing able to release BK from low molecular weight kininogen and activate plasma \n\nkallikrein in vitro (Bohrer et al., 2007). Kallikrein is also believed to be activated in \n\nvivo, because prekallikrein levels were decreased in the plasma of human victims \n\n(Zannin et al., 2003) and in experimental animals, and renal tissue kallikrein activity \n\nwas increased in envenomed rats (as observed in the present study). In addition, the \n\nexpression of kininogen increased in the kidneys during envenomation (Berger et al., \n\nunpublished data). Taken together, these results are in agreement with the hypothesis \n\nthat BK is generated during envenomation and are also in accordance with the up-\n\nregulation of renal B1R and B2R that was observed in the present study. The renal \n\npathophysiological effects produced by locally generated BK can also be enhanced, \n\nbecause ACE expression was down-regulated during the first 24 h, and the \n\nvasoconstrictor axis of the renin-angiotensin system (formed by ACE/Ang II/ AT1R) \n\n(Bader et al., 2012) seems to be suppressed during envenomation. In fact, the \n\nexpression of the AT1R, which is the receptor for the vasoconstrictor peptide Ang II, \n\ndecreased during the first 24 h and remained unchanged between 48 and 96 h. In \n\ncontrast, the vasodilator counter-regulatory axis, which consists of ACE2/Ang-(1-\n\n7)/MAS (Passos-Silva et al., 2013), seems to be up-regulated during envenomation. \n\nDespite ACE2 expression only being slightly increased, MAS expression and the \n\nMAS/AT1R ratio increased significantly, suggesting that a vasodilatory profile \n\npredominated. The B1R and B2R also have dual effects on kidney hemodynamics. While \n\nBK mediates a vasorelaxant effect through the B2R, its metabolite, des-Arg\n9\n-BK, \n\ninduces a renal vasoconstrictor response through the B1R (Guimar\u00e3es et al., 1986; \n\nVieira et al., 1994). The imbalance observed in the present study between renal \n\nB2R/B1R expression may be involved in renal hemodynamic alterations, mainly in the \n\ndecrease of GFR. \n\n Previous studies have demonstrated that KKS components are modulated in a \n\nsimilar fashion in different models of renal injury. BK receptors are induced during \n\nrenal ischemia-reperfusion-induced injury, glomerulonephritis and obstructive \n\nnephropathy (Wang et al., 2008; Klein et al., 2009; Klein et al., 2010). In general, these \n\nmodels demonstrated that animals treated with B1R antagonists or B1R knockout are \n\nprotected from kidney damage. The protection observed following B1R deletion or \n\n\n\nResultados \n\n182 \n\n \n\nantagonism was associated with the increased expression of anti-inflammatory \n\nmolecules and the down-regulation of pro-inflammatory cytokines and pro-fibrotic \n\nmolecules (Wang et al., 2008; 2009; Klein et al., 2009). Interestingly, neither B2R \n\ndeletion nor antagonism have been shown to be beneficial during renal ischemia-\n\nreperfusion-induced injury (Wang et al., 2008). Similar results were obtained by Raslan \n\net al. (2010), who observed reduced blood-brain barrier leakage and inflammation in \n\nmice lacking the B1R that had been subjected to cerebral ischemia, while animals \n\nlacking the B2R displayed no significant alterations in lesion formation or the \n\ndevelopment of brain edema. The data obtained in the present study lead us to believe \n\nthat a similar mechanism occurred in L. obliqua-induced AKI, because significant \n\nimprovements in glomerular function, tubular handling of water and renal \n\nhemodynamics were observed only under B1R, and not B2R, antagonism. Indeed, both \n\nDALBK and R-715 restored the levels of plasma creatinine, GFR, tubular water \n\nreabsorption, water imbalance, polyuria and proteinuria in envenomed animals. In \n\naddition, treatment with B1R antagonists also improved histopathological changes, \n\npreventing tubular necrosis, the formation of intratubular casts, renal inflammation, \n\nvascular leakage and edema. The inhibition of pro-inflammatory signaling mediated by \n\nTNF-? and IL-1? seems to be critical for these beneficial effects, because B1R blockade \n\nreduced the renal levels of these cytokines. A similar beneficial effect was observed in \n\nenvenomed animals treated with the kallikrein inhibitor, aprotinin, confirming that the \n\nproduction of BK through kallikrein activation plays a central role in the renal injury \n\nelicited by this venom. The indirect activation of the KKS appears to be an essential \n\nmechanism by which L. obliqua venom leads to AKI. In other words, despite the \n\npresence of several toxins that are potentially cytotoxic (Veiga et al., 2005; Ricci-Silva \n\net al., 2008), a direct cytotoxic effect of the venom on renal cells makes a minor \n\ncontribution, because blocking BK generation or even B1R activation is enough to \n\nprevent the progression of renal disease. \n\n The mechanisms involved in B1R up-regulation during venom-induced AKI \n\nremain unknown, although evidence provided by other studies has indicated that B1R \n\ninduction is controlled by many pro-inflammatory cytokines and growth factors, \n\nincluding IL-1?, TNF-?, and interferon gamma, as well as epidermal growth factor \n\n(Calixto et al., 2004; Rocha et al., 2005; Klein et al., 2010). Clear evidence now exists \n\nindicating that the induction of the B1R by many of these factors involves the activation \n\nof the transcription factor NF-?B, and, conversely, that B1R stimulation activates NF-\n\n\n\nResultados \n\n183 \n\n \n\n?B (Medeiros et al., 2001; 2004; Calixto et al., 2004). An intense inflammatory \n\nresponse is a common feature of L. obliqua envenomation. Systemically, the venom \n\ninduces neutrophilic leukocytosis, while in the kidneys, the occurrence of cellular \n\ninflammatory infiltrate, edema, increases in vascular permeability and the up-regulation \n\nof several proteins associated with the acute phase of inflammatory signaling and \n\nnephritis have been described (Berger et al., unpublished data). In vitro, when incubated \n\nwith human fibroblasts or endothelial cells in culture, L. obliqua venom induces the \n\nproduction of several cytokines, including TNF-? and IL-1?, and also activates NF-?B \n\nand increases the expression of inflammatory inducible enzymes, such as COX-2, \n\niNOS, and HO-1 (Pinto et al., 2008; Nascimento-Silva et al., 2012). In the present \n\nstudy, we also observed high levels of TNF-? and IL-1? in the kidneys of envenomed \n\nanimals. Therefore, we propose that pro-inflammatory stimuli are the main factors \n\nunderlying B1R induction during envenomation. Moreover, once activated, the B1R \n\nstimulates the release of more TNF-? and IL-1?, amplifying the inflammatory response \n\nand leading to leukocyte accumulation and the production of prostaglandins, reactive \n\noxygen species and nitric oxide (NO) (Kayashima et al., 2012). As demonstrated \n\npreviously, the intravascular NO levels increased during experimental envenomation in \n\nrats. NO production is associated with venom-induced platelet hypoaggregation, as \n\nevidenced by the fact that L-NAME restores platelet aggregation ability (Berger et al., \n\n2010). In the present study, plasma NO levels also increased, along with the levels in \n\nthe kidneys, and both B1R and B2R antagonism blocked NO production. However, \n\ndespite the evident participation of NO in platelet aggregation disturbances, it seems \n\nthat NO plays a minor role in kidney injury. B2R antagonism inhibits NO production, \n\nbut does not prevent renal functional and morphological alterations.   \n\n In addition to renal alterations, L. obliqua envenomation is also characterized by \n\nseveral hemostatic disturbances. Both human patients and experimental animals \n\ndisplayed signs of consumption coagulopathy with blood incoagulability, prolonged \n\ncoagulation times, low fibrinogen levels and platelet hypoaggregation (Zannin et al., \n\n2003; Berger et al., 2010). The venom contains specific toxins that are able to directly \n\nactivate blood and fibrinolytic cascades, which ultimately contribute to fibrinogen \n\nconsumption and blood incoagulability (Reis et al., 2001; Pinto et al., 2004). \n\nSurprisingly, in addition to preventing renal alterations, B1R antagonism was also \n\nbeneficial to blood incoagulability, because animals pretreated with DALBK or R-715 \n\nhad similar coagulation times to those in controls that received only PBS. However, \n\n\n\nResultados \n\n184 \n\n \n\nwhen fibrinogen consumption was analyzed, we observed only partial protection during \n\nB1R antagonism, while the procoagulant activity of renal tissue factor decreased \n\nslightly. The mechanism involved in the beneficial effects of B1R blockade remains \n\nunknown and requires further investigation. However, because systemic inflammation \n\nleads to coagulation activation (Esmon, 2004), we speculate that inhibiting the pro-\n\ninflammatory signaling triggered by B1R activation may not completely prevent \n\nfibrinogen consumption, but it may maintain a basal level of circulating fibrinogen, \n\nwhich may be sufficient to avoid blood incoagulability and the consequent delay in \n\ncoagulation time. Aprotinin pretreatment was also able to efficiently prevent \n\ncoagulation disturbances. In this case, the beneficial effect was expected because \n\nactivated kallikrein is known to trigger the intrinsic coagulation pathway by directly \n\nactivating factor XII (Shariat-Madar et al., 2002; Renn\u00e9, 2012). Thus, by inhibiting \n\nkallikrein during envenomation, it is possible to counteract the progression of renal \n\ninjury and consumption coagulopathy.   \n\n Taken together, the results of the present study revealed that B1R blockade or \n\nkallikrein inhibition improves renal function during L. obliqua-induced AKI by \n\nreducing tubular necrosis, renal inflammation, and the production of pro-inflammatory \n\ncytokines, and ameliorates the coagulopathy commonly observed during this type of \n\nenvenomation. Thus, the present study provides consistent evidence linking KKS \n\nactivation to L. obliqua-induced AKI, and indicates that the inhibition of KKS \n\ncomponents (mainly kallikrein inhibition or B1R antagonism) may be a therapeutic \n\nalternative that can be used to control the progression of renal injury during such \n\nenvenomation. \n\n \n\n5. Acknowledgments \n\n This work was supported by funding and fellowships from the following \n\nBrazilian Agencies: the Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior, \n\nMinist\u00e9rio da Educa\u00e7\u00e3o, Brazil (CAPES-MEC) - Edital Toxinologia (Processo: \n\n23038.006277/2011-85) and the Conselho Nacional de Desenvolvimento Cient\u00edfico e \n\nTecnol\u00f3gico, Minist\u00e9rio da Ci\u00eancia e Tecnologia, Brazil (CNPq-MCT).  \n\n \n\n6. Conflict of interest statement \n\nThe authors declare that no conflicts of interest exist. \n\n \n\n\n\nResultados \n\n185 \n\n \n\n7. References \n\nAustinat, M., Braeuninger, S., Pesquero, J.B., Brede, M., Bader, M., Stoll, G., Renn\u00e9, \n\n T., Kleinschnitz, C., 2009. Blockade of bradykinin receptor B1 but not \n\n bradykinin receptor B2 provides protection from cerebral infarction and brain \n\n edema. Stroke 40 (1), 285-293. \n\nBader, M., Santos, R.A., Unger, T., Steckelings, U.M., 2012. New therapeutic pathways \n\n in the RAS. J Renin Angiotensin Aldosterone Syst. 13(4), 505-508. \n\nBerger, M., Reck J, Jr., Terra, R.M., Pinto, A.F., Termignoni, C., Guimar\u00e3es, J.A., \n\n 2010. Lonomia obliqua caterpillar envenomation causes platelet \n\n hypoaggregation and blood  incoagulability in rats. Toxicon 55 (1), 33-44. \n\nBerger, M., Vieira, M.A.R., Guimaraes, J.A., 2012. Acute Kidney Injury Induced by \n\n Snake and Arthropod Venoms. In: Polenakovic, M. (Ed.), Renal Failure  - The \n\n Facts. ISBN: 978953-51-0630-2, InTech-Open, Rijeka, Croatia, pp. 157- 186. \n\nBohrer, C.B., Reck Jr, J., Fernandes, D., Sordi, R., Guimar\u00e3es, J.A., Assreuy, J., \n\n Termignoni, C., 2007. Kallikrein-kinin system activation by Lonomia obliqua \n\n caterpillar bristles: involvement in edema and hypotension responses to \n\n envenomation. Toxicon 49, 663-639.  \n\nBon, C., 1996. Serum therapy was discovered 100 years ago. In: Bon, C., Goyffon, M. \n\n (Eds.). Envenomings and Their Treatments. Fondation Marcel M\u00e9rieux, \n\n Lyon, pp. 3\u20139. \n\nCalixto, J.B., Medeiros, R., Fernandes, E.S., Ferreira, J., Cabrini, D.A., Campos, M.M., \n\n 2004. Kinin B1 receptors: key G-protein-coupled receptors and their role in \n\n inflammatory and painful processes. Br J Pharmacol. 143, 7, 803-818. \n\nCampos, M.M., Leal, P.C., Yunes, R.A., Calixto, J.B., 2006. Non-peptide antagonists \n\n for kinin B1  receptors: New insights into their therapeutic potential for the \n\n management of inflammation and pain. Trends Pharmacol Sci. 27, 646\u201365. \n\nCouture, R., Harrisson, M., Vianna, R.M., Cloutier, E.F., 2001. Kinin receptors  in pain \n\n and inflammation. Eur J Pharmacol. 429 (1-3), 161-176. \n\nDay, J.R., Haskard, D.O., Taylor, K.M., Landis, R.C, 2006. Effect of aprotinin and \n\n recombinant  variants on platelet protease-activated receptor 1 activation. Ann \n\n Thorac Surg. 81(2), 619-624. \n\nDias da Silva, W., Campos, C.M., Gon\u00e7alves, L.R., Sousa-e-Silva, M.C., Higashi, H.G., \n\n Yamagushi, I.K., Kelen, E.M., 1996. Development of an antivenom against \n\n toxins of Lonomia obliqua caterpillars. Toxicon 34, 1045-1049. \n\nDuchene, J., Ahluwalia A., 2009. The kinin B(1) receptor and inflammation: New \n\n therapeutic target for cardiovascular disease. Curr Opin Pharmacol. 9, 125\u2013\n\n 131. \n\nEsmon, C.T., 2004. The impact of the inflammatory response on coagulation. \n\n Thromb Res. 114(5-6), 321-327. \n\n\n\nResultados \n\n186 \n\n \n\nFan, H.W., Marcopito, L.F., Cardoso, J.L., Fran\u00e7a, F.O., Malaque, C.M., Ferrari, R.A., \n\n Theakston, R.D., Warrell, D.A., 1999. Sequential randomised and double \n\n blind trial of promethazine prophylaxis against early anaphylactic reactions to \n\n antivenom for Bothrops snakebites. British Medical Journal 318, 1451\u20131453. \n\nGamborgi, G.P., Metcalf, E.B., Barros, E.J.G., 2006. Acute renal failure provoked by \n\n toxin from caterpillars of the species Lonomia obliqua. Toxicon 47, 68-74. \n\nGuder, W.G., Ross, B.D., 1984. Enzyme distribution along the nephron. Kidney Int. \n\n 26,101\u2013111. \n\nGuimar\u00e3es, J.A., Vieira, M.A., Camargo, M.J., Maack, T., 1986. Renal vasoconstrictive \n\n effect of kinins mediated by B1-kinin receptors. Eur J Pharmacol. 4, 130 (3), \n\n 177-85. \n\nGuti\u00e9rrez, J.M., Le\u00f3n, G., 2009. Snake antivenoms. Technological, clinical and public \n\n health issues. In: de Lima, M.E., Pimenta, A.M.C., Martin-Euclairte, M.F., \n\n Zingali, R.B., Rochat, H. (Eds.), Animal Toxins: State of the Art. Perspectives \n\n in Health and Biotechnology. Editora UFMG, Belo Horizonte, pp. 393\u2013421. \n\nGuti\u00e9rrez, J.M., Williams, D., Fan, H.W., Warrell, D.A., 2010. Snakebite \n\n envenoming from a global perspective: Towards an integrated approach. \n\n Toxicon 56 (7), 1223-35. \n\nHara, D.B., Leite, D.F., Fernandes, E.S., Passos, G.F., Guimaraes, A.O., Pesquero, J.B., \n\n Campos, M.M., Calixto, J.B., 2008. The relevance of kinin B1 receptor \n\n upregulation in a mouse model of colitis. Br J Pharmacol. 154, 1276\u20131286. \n\nKayashima, Y., Smithies, O., Kakoki, M., 2012. The kallikrein-kinin system and \n\n oxidative stress. Curr Opin Nephrol Hypertens. 21 (1), 92-96. \n\nKakoki, M., Smithies O., 2009. The kallikrein-kinin system in health and in diseases of \n\n the kidney. Kidney Int. 75 (10), 1019-1030. \n\nKakoki, M., Sullivan, K.A., Backus, C., Hayes, J.M., Oh, S.S., Hua, K., Gasim, A.M., \n\n Tomita, H.,  Grant, R., Nossov, S.B., Kim, H.S., Jennette, J.C., Feldman, E.L., \n\n Smithies, O., 2010. Lack of  both bradykinin B1 and B2 receptors enhances \n\n nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc \n\n Natl Acad Sci USA. 107 (22), 10190-5. \n\nKakoki, M., Takahashi, N., Jennette, J.C., Smithies, O., 2004. Diabetic nephropathy is \n\n markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad \n\n Sci USA. 101 (36), 13302-5. \n\nKlein, J., Gonzalez, J., Duchene, J., Esposito, L., Prad\u00e8re, J.P., Neau, E., Delage, C., \n\n Calise, D., Ahluwalia, A., Carayon, P., Pesquero, J.B., Bader, M., Schanstra, \n\n J.P., Bascands, J.L., 2009. Delayed blockade of the kinin B1 receptor reduces \n\n renal inflammation and fibrosis in obstructive nephropathy. FASEB J. 23 (1), \n\n 134-142. \n\n\n\nResultados \n\n187 \n\n \n\nKlein, J., Gonzalez, J., Decramer, S., Bandin, F., Neau, E., Salant, D.J., Heeringa, P., \n\n Pesquero, J.B., Schanstra, J.P., Bascands, J.L., 2010. Blockade of the kinin B1 \n\n receptor ameloriates glomerulonephritis. J Am Soc Nephrol. 21 (7), 1157-64. \n\nLalloo, D.G., Theakston, R.D.G., 2003. Snake antivenoms. J. Toxicol. Clin. Toxicol. \n\n 41, 317\u2013327. \n\nMedeiros, R., Cabrini, D.A., Calixto, J.B., 2001. The in vivo and ex vivo roles of \n\n cyclooxygenase-2, nuclear factor-kB and protein kinases pathways in the up-\n\n regulation of B1 receptor mediated contraction of the rabbit aorta. Regul. \n\n Pept. 97, 121\u2013130. \n\nMedeiros, R., Cabrini, D.A., Ferreira, J., Fernandes, E.S., Mori, M.A., Pesquero, J.B., \n\n Bader, M., Avellar, M.C., Campos, M.M., Calixto, J.B., 2004. Bradykinin B1 \n\n receptor expression induced by tissue damage in the rat portal vein. A critical \n\n role for mitogen-activated protein kinase and nuclear factor-kB signaling \n\n pathways. Circ Res. 94, 1375\u20131382. \n\nMiranda, K.M., Espey, M.G., Wink, D.A., 2001. A Rapid, Simple Spectrophotometric \n\n method for Simultaneous Detection of Nitrate and Nitrite. Nitric oxide 5, 62-71. \n\nMorrissey, J.H., 1995. Tissue factor modulation of factor VIIa activity: use in \n\n measuring trace levels of factor VIIa in plasma. Thromb Haemost. 74 (1), 185-\n\n 188. \n\nNascimento-Silva, V., Rodrigues da Silva, G., Moraes, J.A., Cyrino, F.Z., Seabra, S.H., \n\n Bouskela, E., Almeida Guimar\u00e3es, J., Barja-Fidalgo, C., 2012. A pro-\n\n inflammatory profile  of endothelial cell in Lonomia obliqua envenomation. \n\n Toxicon 60 (1), 50-60.  \n\nPassos-Silva, D.G., Verano-Braga, T., Santos, R.A., 2013. Angiotensin-(1-7): beyond \n\n the cardio-renal actions. Clin Sci (Lond). 124 (7), 443-456. \n\nPinto, A.F., Dobrovolski, R., Veiga, A.B., Guimar\u00e3es, J.A., 2004. Lonofibrase, a \n\n novel alpha-fibrinogenase from Lonomia obliqua caterpillars. Thromb Res. 113 \n\n (2), 147-154. \n\nPinto, A.F.M., Silva, K.R.L.M., Guimaraes, J.A., 2006. Proteases from Lonomia \n\n obliqua venomous secretions: comparison of procoagulant, fibrin(ogen)olytic \n\n and amidolytic activities. Toxicon 47, 113-121. \n\nPinto, A.F.M., Dragulev, B., Guimar\u00e3es, J.A., Fox, J.W., 2008. Novel perspectives in \n\n the pathogenesis of Lonomia obliqua caterpillar envenomation based on \n\n assessment of host response by gene expression analysis.  Toxicon 51, 1119-\n\n 1128. \n\nPinto, A.F.M., Berger, M., Reck-Jr, J., Terra, R.M., Guimar\u00e3es, J.A., 2010. Lonomia \n\n obliqua venom: In vivo effects and molecular aspects associated with the \n\n hemorrhagic syndrome. Toxicon 56 (7), 1103-1112. \n\nPompermayer, K., Souza, D.G., Lara, G.G., Silveira, K.D., Cassali, G.D., Andrade, \n\n A.A., Bonjardim, C.A., Passaglio, K.T., Assreuy, J., Cunha, F.Q., Vieira, M.A., \n\n\n\nResultados \n\n188 \n\n \n\n Teixeira, M.M., 2005. The ATP-sensitive potassium channel blocker \n\n glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney Int \n\n 67(5), 1785-1796. \n\nQuintao, N.L., Passos, G.F., Medeiros, R., Paszcuk, A.F., Motta, F.L., Pesquero, J.B., \n\n Campos, M.M., Calixto, J.B., 2008. Neuropathic pain-like behavior after \n\n brachial plexus avulsion in mice: The relevance of kinin B1 and B2 receptors. J \n\n Neurosci. 28, 2856\u2013 2863. \n\nRaslan, F., Schwarz, T., Meuth, S.G., Austinat, M., Bader, M., Renn\u00e9, T., Roosen, K., \n\n Stoll, G., Sir\u00e9n, A.L., Kleinschnitz, C., 2010. Inhibition of bradykinin receptor \n\n B1 protects mice from focal brain injury by reducing blood-brain barrier leakage \n\n and inflammation. J Cereb Blood Flow Metab. 30 (8), 1477-86. \n\nReis, C.V., Farsky, S.H.P., Fernandes, B.L., Santoro, M.L., Oliva, M.L.V., Mariano, \n\n M., Chudzinski-Tavassi, A.M., 2001. In vivo characterization of lopap, a \n\n prothrombin activator serine protease from the Lonomia obliqua caterpillar \n\n venom. Thromb Res. 102 (5), 437\u2013443. \n\nRegoli, D., Barab\u00e9, J., 1980. Pharmacology of bradykinin and related kinins. \n\n Pharmacol Rev. 32 (1), 1-46. \n\nRenn\u00e9, T., 2012. The procoagulant and proinflammatory plasma contact system. Semin \n\n Immunopathol. 34 (1), 31-41. \n\nRicci-Silva, M.E., Valente, R.H., Le\u00f3n, I.R., Tambourgi, D.V., Ramos, O.H., Perales, \n\n J., Chudzinski-Tavassi, A.M., 2008. Immunochemical and proteomic \n\n technologies as tools for unravelling toxins involved in envenoming by \n\n accidental contact with Lonomia obliqua caterpillars. Toxicon, 51, 1017-1028. \n\nRocha, A.C., Fernandes, E.S., Passos, G.F., Calixto, J.B., Campos, M.M., 2005. \n\n Assessment of TNFalpha contribution to the functional up-regulation of kinin \n\n B(1) receptors in the mouse paw after treatment with LPS. Int \n\n Immunopharmacol. 5 (11), 1593-600. \n\nRocha-Campos, A.C., Gon\u00e7alves, L.R., Higasshi, H.G., Yamagushi, I.K., Fernandes, I., \n\n Oliveira, J.E., Ribela, M.T., Sousa-e-Silva, M.C., Dias da Silva, W., 2001. \n\n Specific heterologous F(ab\u2019)2 antibodies revert blood incoagulability resulting \n\n from envenoming by Lonomia obliqua caterpillars. Am. J. Trop. Med. Hyg. 64, \n\n 283\u2013289. \n\nShariat-Madar, Z., Mahdi, F., Schmaier, A.H., 2002. Assembly and activation of the \n\n plasma kallikrein/kinin system: a new interpretation. Int. Immunopharmacol. \n\n 2 (13-14), 1841-1849.  \n\nSouza, D.G., Lomez, E.S., Pinho, V., Pesquero, J.B., Bader, M., Pesquero, J.L., \n\n Teixeira, M.M., 2004. Role of bradykinin B2 and B1 receptors in the local, \n\n remote, and systemic inflammatory responses that follow intestinal ischemia and \n\n reperfusion injury. J. Immunol. 172(4), 2542-8. \n\nTheakston, R.D.G., Warrell, D.A., Griffiths, E., 2003. Report of a WHO workshop on \n\n the standardization and control of antivenoms. Toxicon 41, 541\u2013557. \n\n\n\nResultados \n\n189 \n\n \n\nVeiga, A.B.G., Berger, M., Guimar\u00e3es, J.A., 2009. Lonomia obliqua venom: pharmaco-\n\n toxicological effects and biotechnological perspectives. In: de Lima, M.E., \n\n Pimenta, A.M.C., Martin-Euclairte, M.F., Zingali, R.B., Rochat, H. (Eds.), \n\n Animal Toxins: State of the Art. Perspectives in Health and Biotechnology. \n\n Editora UFMG, Belo Horizonte, pp. 371\u2013390. \n\nVeiga, A.B.G., Ribeiro, J.M., Guimar\u00e3es, J.A., Francischetti, I.M., 2005. A catalog for \n\n the transcripts from the venomous structures of the caterpillar Lonomia obliqua: \n\n identification of the proteins potentially involved in the coagulation disorder and \n\n hemorrhagic syndrome. Gene 355, 11-27. \n\nVieira, M.A., Moreira, M.F., Maack, T., Guimar\u00e3es, J.A., 1994. Conversion of T-kinin \n\n to bradykinin by the rat kidney. Biochem Pharmacol. 29, 47 (9), 1693-9. \n\nViana, A.F., Maciel, I.S., Dornelles, F.N., Figueiredo, C.P., Siqueira, J.M., Campos, \n\n M.M., Calixto, J.B., 2010. Kinin B1 receptors mediate depression-like behavior \n\n response in stressed  mice treated with systemic E.coli lipopolysaccharide. J \n\n Neuroinflammation. 31 (7), 98. \n\nWang, P.H., Campanholle, G., Cenedeze, M.A., Feitoza, C.Q., Gon\u00e7alves, G.M., \n\n Landgraf, R.G., Jancar, S., Pesquero, J.B., Pacheco-Silva, A., C\u00e2mara, N.O., \n\n 2008.  Bradykinin B1 receptor antagonism is beneficial in renal ischemia-\n\n reperfusion injury. PLoS One 25, 3(8), e3050. \n\nWang, P.H., Cenedeze, M.A., Campanholle, G., Malheiros, D.M., Torres, H.A., \n\n Pesquero, J.B., Pacheco-Silva, A., C\u00e2mara, N.O., 2009. Deletion of bradykinin \n\n B1 receptor reduces renal fibrosis. Int Immunopharmacol. 9 (6), 653-7. \n\nZannin, M., Louren\u00e7o, D.M., Motta, G., Costa, L.R.D., Grando, M., Gamborgi, G.P., \n\n Noguti, M.A., Chudzinski-Tavassi, A.M., 2003. Blood coagulation and \n\n fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by \n\n accidental contact with Lonomia obliqua caterpillar in Santa Catarina, Southern \n\n Brazil. Thromb Haemost. 89, 355\u2013364.  \n\n \n\n \n\nFigure Legends \n\n \n\nFigure 1: Expression of components of the renal kallikrein-kinin system during L. \n\nobliqua envenomation.  Renal mRNA levels of B1R (A), B2R (B), ACE (C), AT1R (D), \n\nMAS (E), ACE2 (F), the MAS/AT1R ratio (G) and the B2R/B1R ratio (H) were \n\ndetermined using quantitative real-time PCR in control (CTRL) and envenomed animals \n\nat different time points post-venom injection (LOBE, 1.5 mg/kg, sc). The data are \n\npresented as the means \u00b1 SE (n=6/group). Significant differences of *p &lt;0.05 were \n\nconsidered to be significant in comparison to the respective control. \n\n \n\n\n\nResultados \n\n190 \n\n \n\nFigure 2: Pharmacological blockade of the B1R or kallikrein inhibition improves \n\nrenal function in L. obliqua-envenomed rats. Rats were pretreated with antagonists of \n\neither the B1R (DALBK and R-715) or the B2R (HOE-140) or the kallikrein inhibitor \n\n(aprotinin) 30 min prior to L. obliqua venom injection (LOBE, 1.5 mg/kg, sc). After 24 \n\nh of envenomation, plasma and urine samples were collected, and the following \n\nparameters were determined: (A) Urine output, (B) hydric balance, (C) plasma \n\ncreatinine, (D) glomerular filtration rate (GFR), (E) fractional water excretion (FEH2O) \n\nand (F) urinary protein levels. The data are presented as the means \u00b1 SE (n=6/group). \n\nSignificant differences are indicated as follows: *p &lt;0.05 vs. PBS, \n\u00a7\np &lt;0.05 vs. LOBE \n\n+ PBS and \n\u2021\np &lt;0.05 vs. LOBE + HOE-140. \n\n \n\nFigure 3: Pharmacological blockade of the B1R or kallikrein inhibition ameliorates \n\ntubular injury and renal inflammation in L. obliqua-envenomed rats. A. \n\nRepresentative kidney sections from the control animals (pretreated with PBS) and \n\nenvenomed rats that had been pretreated with antagonists of either the B1R (DALBK \n\nand R-715) or the B2R (HOE-140) or the kallikrein inhibitor (aprotinin) 30 min prior to \n\nL. obliqua venom injection (LOBE, 1.5 mg/kg, sc). Morphological alterations were \n\nanalyzed 24 h post-venom injection. All of the sections were stained with H&amp;E. \n\nMagnification: 10 X. B. The kidney sections from the different groups were analyzed, \n\nand a semi-quantitative score was attributed according to the presence of intratubular \n\ncasts, tubular degeneration and renal inflammation. C. Levels of urinary ?-glutamyl \n\ntransferase (?-GT) activity were also measured in the different groups as biochemical \n\nmarkers of tubular injury. D. Changes in renal vascular permeability were assessed \n\nusing Evans blue dye extravasation in the control animals (pretreated with PBS) and \n\nenvenomed rats that had been pretreated with either the B1R antagonist (R-715) or the \n\nkallikrein inhibitor (aprotinin). The results are expressed as ?g of Evans blue dye per \n\n100 mg of renal tissue. E and F. The renal levels of TNF-? and IL-1? were also \n\nmeasured in these animals using an enzyme-linked immunosorbent assay (ELISA). The \n\nresults are expressed as pg per 100 mg of renal tissue. All of the data are presented as \n\nthe means \u00b1 SE (n=6/group). In B and C, significant differences of *p &lt;0.05 vs. PBS, \n\n\u00a7\np &lt;0.05 vs. LOBE + PBS and \n\n\u2021\np &lt;0.05 vs. LOBE + HOE-140 were considered to be \n\nsignificant. In D-F, differences of *p &lt;0.05 vs. PBS, \n\u00a7\np &lt;0.05 vs. LOBE + PBS and \n\n\u2021\np \n\n&lt;0.05 vs. LOBE + R-715 were considered to be significant. \n\n \n\n\n\nResultados \n\n191 \n\n \n\nFigure 4: Pharmacological blockade of the B1R or kallikrein inhibition prevents L. \n\nobliqua venom-induced coagulation disturbances. Rats were pretreated with \n\nantagonists of either the B1R (DALBK and R-715) or the B2R (HOE-140) or the \n\nkallikrein inhibitor (aprotinin) 30 min prior to L. obliqua venom injection (LOBE, 1.5 \n\nmg/kg, sc). After 24 h of envenomation, the activated partial thromboplastin time (A) \n\nand fibrinogen levels (B) in the plasma were measured, and factor Xa (FXa) generation \n\nwas measured in kidney extracts to determine renal tissue factor activity (C). The data \n\nare presented as the means \u00b1 SE (n=6/group). Significant differences of *p &lt;0.05 vs. \n\nPBS, \n\u00a7\np &lt;0.05 vs. LOBE + PBS, \n\n\u2021\np &lt;0.05 vs. LOBE + HOE-140 and \n\n\u2020\np &lt;0.05 vs. \n\nLOBE + DALBK were considered to be significant. \n\n \n\nTables \n\n \n\nTable 1: Kallikrein and nitrate/nitrite levels in the plasma and kidneys of control \n\n(CTRL) and envenomed rats (LOBE, 1.5 mg/kg, sc) at different time points post-L. \n\nobliqua venom injection. \n\nSignificant differences of *p &lt;0.05 vs. CTRL were considered to be significant. \n\n \n\nTable 2: Kallikrein and nitrate/nitrite levels in the plasma and kidneys of control \n\nand envenomed rats pretreated with bradykinin antagonists or the kallikrein \n\ninhibitor.  \nRats were pretreated with antagonists of either the B1R (DALBK and R-715) or the B2R \n\n(HOE-140) or the kallikrein inhibitor (aprotinin) 30 min prior to L. obliqua venom \n\ninjection (LOBE, 1.5 mg/kg, sc). After 24 h of envenomation, the levels of plasma \n\nprekallikrein, renal tissue kallikrein and plasma and kidney nitrate/nitrite levels were \n\ndetermined. The data are presented as the means \u00b1 SE (n=6/group). Significant \n\ndifferences of *p &lt;0.05 vs. PBS, \n\u00a7\np &lt;0.05 vs. LOBE + PBS, \n\n\u2021\np &lt;0.05 vs. LOBE + \n\nHOE-140 and \n\u2020\np &lt;0.05 vs. LOBE + DALBK were considered to be significant. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n192 \n\n \n\nFigure 1 \n\n \n\n \n\n  \n\n\n\nResultados \n\n193 \n\n \n\nFigure 2 \n\n \n\n \n\n \n  \n\n\n\nResultados \n\n194 \n\n \n\nFigure 3 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nResultados \n\n195 \n\n \n\nFigure 4 \n\n \n\n \n\n\n\n \n\nResultados \n\n \n\n196 \n\n \n\nTable 1 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n  Time after envenomation (h) \n\n CTRL 12 24 48 96 \n\nPlasma prekallikrein (\u00b5mol/min/mg) 2.10\u00b10.2 0.78\u00b10.09* 1.04\u00b10.08* 1.01\u00b10.1* 1.36\u00b10.07 \n\nRenal tissue kallikrein (\u00b5mol/min/mg) 0.31\u00b10.03 0.41\u00b10.03 0.97\u00b10.1* 0.73\u00b10.06* 0.80\u00b10.05* \n\nPlasma nitrate/nitrite (\u00b5M) 22.9\u00b12.5 50.9\u00b15.0* 44.7\u00b15.4* 26.9\u00b17.4 19.1\u00b15.4 \n\nRenal nitrate/nitrite (\u00b5M) 71.8\u00b16.1 135.9\u00b13.4* 117.5\u00b15.7* 106.4\u00b15.9* 87.3\u00b110 \n\n\n\n \n\nResultados \n\n \n\n197 \n\n \n\nTable 2 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n  Experimental Groups  \n\n PBS LOBE+PBS LOBE+HOE-140 LOBE+DALBK LOBE+R-715 LOBE+APROTININ \n\nPlasma prekallikrein \n\n(\u00b5mol/min/mg) \n\n2.70\u00b10.1 1.2\u00b10.1* 1.4\u00b10.13* 1.9\u00b10.1\u00a7 1.9\u00b10.1\u00a7 2.8\u00b10.4\u00a7\u2021\u2020 \n\nRenal tissue kallikrein \n\n(\u00b5mol/min/mg) \n\n0.28\u00b10.03 0.84\u00b10.09* 0.92\u00b10.2* 0.98\u00b10.1* 0.91\u00b10.1* 0.57\u00b10.03 \n\nPlasma nitrate/nitrite (\u00b5M) 17.5\u00b12.6 33.5\u00b15.4* 21.1\u00b13.3 13.4\u00b10.9\u00a7 14.3\u00b10.6\u00a7 7.5\u00b10.8\u00a7 \n\nRenal nitrate/nitrite (\u00b5M) 54.6\u00b15.4 85.3\u00b16.9* 34.1\u00b15.7\u00a7 55.4\u00b12.6\u00a7 68.1\u00b13.1\u2021 49.4\u00b15.1\u00a7 \n\n\n\n \n\n198 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n 44..  DDIISSCCUUSSSS\u00c3\u00c3OO \n\n \n\n \n\n \n\n\n\nDiscuss\u00e3o \n\n \n\n199 \n\n \n\n4. DISCUSS\u00c3O \n\n \n\n A patologia desencadeada pelos envenenamentos com animais pe\u00e7onhentos \u00e9 \n\ncomplexa e decorrente n\u00e3o s\u00f3 da a\u00e7\u00e3o direta das diferentes toxinas presentes nos \n\nvenenos em tecidos ou sistemas espec\u00edficos, mas tamb\u00e9m \u00e9 resultado da resposta do \n\norganismo \u00e0 les\u00e3o provocada por essas toxinas. Neste trabalho, demonstramos que o \n\nveneno da taturana Lonomia obliqua, reconhecidamente de efeito hemorr\u00e1gico devido \u00e0 \n\npresen\u00e7a de toxinas pr\u00f3- e anticoagulantes, \u00e9 capaz de induzir, al\u00e9m das altera\u00e7\u00f5es na \n\nhemostasia, uma s\u00edndrome de toxicidade sist\u00eamica onde h\u00e1 les\u00e3o de m\u00faltiplos \u00f3rg\u00e3os. \n\nDentre estes \u00f3rg\u00e3os, o rim \u00e9 um dos mais afetados, tendo, ademais, import\u00e2ncia cl\u00ednica \n\nsignificativa considerando os casos de v\u00edtimas envenenadas. Devido \u00e0 incid\u00eancia e \n\naumento da mortalidade associado ao desenvolvimento de les\u00e3o renal ap\u00f3s o contato \n\ncom a taturana, empenhamos esfor\u00e7os na investiga\u00e7\u00e3o da patog\u00eanese dessa doen\u00e7a em \n\num modelo experimental in vivo em ratos. Os dados obtidos apontam para um \n\nmecanismo multifatorial onde a hem\u00f3lise, a ativa\u00e7\u00e3o do sistema calicre\u00edna-cininas \n\n(SCC) e altera\u00e7\u00f5es vasculares mostraram ser componentes fundamentais no \n\ndesenvolvimento da insufici\u00eancia renal aguda (IRA) induzida pelo veneno de L. \n\nobliqua. De acordo com os resultados apresentados nos cap\u00edtulos anteriores, a Figura 9 \n\nmostra as poss\u00edveis vias envolvidas no desenvolvimento da les\u00e3o renal. A seguir, uma \n\nbreve discuss\u00e3o integrativa acerca dos mecanismos da IRA neste tipo de \n\nenvenenamento \u00e9 apresentada.  \n\n \n\nHem\u00f3lise. Hem\u00f3lise intensa ou rabdomi\u00f3lise podem estar associadas ao \n\ndesenvolvimento de IRA principalmente devido \u00e0 nefrotoxicidade do heme liberado a \n\npartir da hemoglobina (Hb) ou mioglobina (Mb) (ZAGER, 1996; SITPRIJA, 2006). O \n\nheme \u00e9 uma mol\u00e9cula altamente citot\u00f3xica, proinflamat\u00f3ria e prooxidante que est\u00e1 \n\nenvolvida em uma s\u00e9rie de patologias incluindo sepse, mal\u00e1ria, les\u00f5es isqu\u00eamicas, \n\nhemorragia pulmonar e cerebral e anemia falciforme (FERREIRA et al., 2008; TRACZ \n\net al., 2007; PAMPLONA et al., 2007; LARA et al., 2009; LARSEN et al., 2010; \n\nSIM\u00d5ES et al., 2013). Em condi\u00e7\u00f5es normais, a Hb ou Mb livre na circula\u00e7\u00e3o \u00e9 \n\nremovida pela liga\u00e7\u00e3o \u00e0 haptoglobina (Hpt) e o heme pela liga\u00e7\u00e3o \u00e0 hemopexina (Hpx). \n\nA forma\u00e7\u00e3o dos complexos Hb-Hpt ou Mb-Hpt e heme-Hpx neutralizam os efeitos \n\nprooxidantes e proinflamat\u00f3rios do heme e, dessa forma, s\u00e3o direcionados para as \n\n\n\nDiscuss\u00e3o \n\n200 \n\n \n\nc\u00e9lulas do f\u00edgado, ligam-se a receptores espec\u00edficos e s\u00e3o reutilizados para a s\u00edntese de \n\nnovas mol\u00e9culas de Hb e Mb para os eritr\u00f3citos e c\u00e9lulas musculares, respectivamente \n\n(ZAGER et al., 2012). Entretanto, em condi\u00e7\u00f5es onde h\u00e1 hem\u00f3lise ou rabdomi\u00f3lise \n\nintensa, tanto a Hpt quanto a Hpx s\u00e3o consumidas, sua quantidade diminui no plasma e \n\nh\u00e1 um ac\u00famulo de Hb ou Mb e heme livres na circula\u00e7\u00e3o. Durante o envenenamento por \n\nL. obliqua, ocorre libera\u00e7\u00e3o de Hb a partir dos eritr\u00f3citos devido ao efeito hemol\u00edtico do \n\nveneno in vitro e in vivo (SEIBERT et al., 2004; 2006). A libera\u00e7\u00e3o de Mb tamb\u00e9m \n\npode ocorrer, pois o veneno tem atividade miot\u00f3xica e cardiot\u00f3xica, apesar de n\u00e3o \n\ninduzir rabdomi\u00f3lise intensa como observado em outros envenenamentos como por \n\nCrotalus sp., por exemplo, que se caracterizam por fraqueza muscular generalizada. \n\nComo mostrado nesta tese, quantidades significativas de Hb acumulam-se no plasma \n\ndos ratos envenenados, h\u00e1 redu\u00e7\u00e3o do n\u00famero de eritr\u00f3citos e Hpt circulantes, presen\u00e7a \n\nde eritr\u00f3citos fragmentados no esfrega\u00e7o sangu\u00edneo, aumento dos reticul\u00f3citos, \n\neritrofagocitose e deposi\u00e7\u00e3o de hemosiderina no ba\u00e7o, ac\u00famulo de eritr\u00f3citos e Hb nos \n\nt\u00fabulos renais, hemat\u00faria e hemoglobin\u00faria. Especificamente no rim, a express\u00e3o da \n\nheme-oxigenase 1 (HO-1), Hpx e ferritina aumentam, indicando que o metabolismo do \n\nheme est\u00e1 ativado durante o envenenamento. Uma vez reabsorvido pelas c\u00e9lulas \n\ntubulares, o heme \u00e9 catabolizado pelo sistema da HO-1, gerando quantidades \n\nequimolares de biliverdina, mon\u00f3xido de carbono (CO) e ferro livre (CAMARA &amp; \n\nSOARES, 2005; LARSEN et al., 2010). A biliverdina ainda \u00e9 convertida em bilirrubina \n\npela biliverdina redutase e o ferro livre, por ser um potente agente prooxidante, \u00e9 \n\nneutralizado formando um complexo com a ferritina (KUMAR &amp; \n\nBANDYOPADHYAY, 2005). Na presen\u00e7a de pequenas quantidades de heme, esse \n\nsistema da HO-1 \u00e9 efetivo em proteger as c\u00e9lulas tubulares. No entanto, como \u00e9 grande \n\no ac\u00famulo de Hb e eritr\u00f3citos nos t\u00fabulos durante o envenenamento, possivelmente o \n\nsistema da HO-1 esteja saturado. Com isso, os n\u00edveis de bilirrubina aumentam no \n\nplasma e o ferro livre n\u00e3o complexado \u00e0 ferritina gera esp\u00e9cies reativas de oxig\u00eanio \n\n(EROs) respons\u00e1veis por les\u00e3o tissular (ZAGER, 1996). De fato, em nossos \n\nexperimentos, observamos que a express\u00e3o de v\u00e1rias enzimas antioxidantes aumentam \n\nno rim juntamente com as atividades de super\u00f3xido dismutase, catalase e peroxidase \n\n(dados n\u00e3o mostrados) que tamb\u00e9m aumentam no rim de animais envenenados, \n\nindicando a produ\u00e7\u00e3o de EROs. O aumento na gera\u00e7\u00e3o de EROs ainda pode estar \n\ncorrelacionado com diferentes eventos observados ao longo do envenenamento, tais \n\ncomo (i) as quebras duplas detectadas no DNA de c\u00e9lulas renais de animais \n\n\n\nDiscuss\u00e3o \n\n201 \n\n \n\nenvenenados que, pelos nossos resultados, parecem ser efetivamente mediadas por \n\nEROs; (ii) o aumento na express\u00e3o de enzimas de reparo de DNA; e (iii) a presen\u00e7a de \n\numa s\u00e9rie de marcadores de les\u00e3o tecidual incluindo marcadores de necrose e apoptose \n\nque foram detectados nos rins (Figura 9). Al\u00e9m disso, j\u00e1 foi demonstrado que o heme \n\nlivre, mesmo antes de ser metabolizado pelo sistema da HO-1, tamb\u00e9m pode mediar a \n\nprodu\u00e7\u00e3o de EROs via NADPH-oxidase e induzir a express\u00e3o de citocinas \n\nproinflamat\u00f3rias (IL-1?, IL-6 e TNF-?) pela ativa\u00e7\u00e3o do fator de transcri\u00e7\u00e3o NF-?B \n\n(GRA\u00c7A-SOUZA et al., 2002; ARRUDA et al., 2004; SIM\u00d5ES et al., 2013).  \n\n \n\nAtiva\u00e7\u00e3o do sistema calicre\u00edna-cininas. O veneno de L. obliqua \u00e9 capaz de ativar a pr\u00e9-\n\ncalicre\u00edna no plasma e liberar BK diretamente a partir do LMWK. Portanto, a BK pode \n\nser gerada durante o envenenamento por atividade direta de uma cininogenase do \n\nveneno sobre o LMWK ou pela a\u00e7\u00e3o da calicre\u00edna ativada sobre o HMWK (BOHRER \n\net al., 2007) (Figura 9). A BK assim gerada e tamb\u00e9m seus metab\u00f3litos ativos, \n\nrespondem por uma s\u00e9rie de efeitos observados no envenenamento, incluindo edema, \n\ninflama\u00e7\u00e3o, dor e hipotens\u00e3o (DE CASTRO BASTOS et al., 2004; BOHRER et al., \n\n2007). Os resultados aqui apresentados acrescentam que essa ativa\u00e7\u00e3o do SCC tamb\u00e9m \n\n\u00e9 de fundamental import\u00e2ncia para o desenvolvimento da IRA durante o \n\nenvenenamento. A express\u00e3o dos genes codificadores de ambos os receptores de BK \n\n(B1R e B2R) est\u00e1 aumentada no rim. Verificamos, todavia, que somente o antagonismo \n\nde B1R ou a inibi\u00e7\u00e3o de calicre\u00edna s\u00e3o capazes de prevenir as altera\u00e7\u00f5es funcionais e \n\nmorfol\u00f3gicas renais e o desequil\u00edbrio hidroeletrol\u00edtico causado pelo envenenamento. O \n\ntratamento pr\u00e9vio com antagonistas de B2R n\u00e3o \u00e9 capaz de proteger contra os efeitos \n\nnefrot\u00f3xicos do veneno. Ou seja, tanto a ativa\u00e7\u00e3o de calicre\u00edna quanto do B1R s\u00e3o \n\nessenciais para os efeitos delet\u00e9rios do veneno sobre o rim. Resultados semelhantes \n\nforam descritos em outros modelos de IRA incluindo nefropatia diab\u00e9tica, les\u00e3o renal \n\npor isquemia-reperfus\u00e3o, glomerulonefrite e fibrose renal (KAKOKI et al., 2004; \n\nWANG et al., 2008; KLEIN et al., 2009; KLEIN et al., 2010). Especificamente em \n\nmodelo de isquemia-reperfus\u00e3o renal, animais nocautes para B1R apresentam menores \n\nn\u00edveis de creatinina plasm\u00e1tica, melhora da les\u00e3o tubular e inflama\u00e7\u00e3o, aumento na \n\nexpress\u00e3o de citocinas anti-inflamat\u00f3rias, como IL-4 e IL-10, e redu\u00e7\u00e3o na express\u00e3o de \n\ncitocinas pr\u00f3-inflamat\u00f3rias, como IL-1? e TNF-? (WANG et al., 2006; 2008). Em \n\nmodelos de glomerulonefrite, fibrose renal e mesmo em bi\u00f3psias de pacientes com \n\nglomerulonefrite o B1R tem sua express\u00e3o aumentada e o bloqueio deste receptor \n\n\n\nDiscuss\u00e3o \n\n202 \n\n \n\nassocia-se a uma redu\u00e7\u00e3o na express\u00e3o de citocinas profibr\u00f3ticas, como o TGF-? e \n\nCTGF, e quimiocinas respons\u00e1veis pelo recrutamento de macr\u00f3fagos/mon\u00f3citos, como \n\na MCP-1 e MCP-3 (KLEIN et al., 2009; WANG et al., 2009; KLEIN et al., 2010). \n\nPortanto, a aus\u00eancia ou o bloqueio do B1R parece estar relacionado diretamente a uma \n\ndiminui\u00e7\u00e3o do processo inflamat\u00f3rio no rim. Nos animais envenenados a melhora na \n\nfun\u00e7\u00e3o renal provavelmente tamb\u00e9m esteja relacionada a uma redu\u00e7\u00e3o da inflama\u00e7\u00e3o, j\u00e1 \n\nque o bloqueio de B1R reduz o ac\u00famulo de c\u00e9lulas inflamat\u00f3rias, edema, \n\nextravasamento vascular e a express\u00e3o de IL-1? e TNF-? no rim. De fato, estudos \n\nrelacionados com B1R demonstraram que sua express\u00e3o apresenta importante fun\u00e7\u00e3o, \n\nprincipalmente na manuten\u00e7\u00e3o da inflama\u00e7\u00e3o (CALIXTO et al., 2004; MARCEAU E \n\nREGOLI, 2004), e os efeitos proinflamat\u00f3rios dos B1R incluem dor, edema e aumento \n\ndo tr\u00e2nsito de leuc\u00f3citos para as regi\u00f5es inflamadas (COUTURE et al., 2001). Citocinas \n\nproinflamat\u00f3rias e a ativa\u00e7\u00e3o de componentes da fam\u00edlia MAPK est\u00e3o envolvidos na \n\nregula\u00e7\u00e3o e indu\u00e7\u00e3o de express\u00e3o do gene que codifica para o B1R. A regi\u00e3o promotora \n\ndo gene codificador de B1R tem s\u00edtios de liga\u00e7\u00e3o para o fator transcricional NF-?B, o \n\nqual parece ser essencial para o controle da transcri\u00e7\u00e3o deste gene ap\u00f3s a exposi\u00e7\u00e3o a \n\nagentes inflamat\u00f3rios como, por exemplo, IL-1?, TNF-? e LPS (MEDEIROS et al., \n\n2004). Dessa forma, uma vez ativado, o B1R induz a transloca\u00e7\u00e3o de NF-?B para o \n\nn\u00facleo, o qual ser\u00e1 respons\u00e1vel pelo aumento n\u00e3o s\u00f3 da express\u00e3o do pr\u00f3prio gene de \n\nB1R, mas tamb\u00e9m de uma s\u00e9rie de citocinas, quimiocinas e prostaglandinas que, em \n\n\u00faltima inst\u00e2ncia mediar\u00e3o a migra\u00e7\u00e3o de c\u00e9lulas inflamat\u00f3rias para o tecido lesado, a \n\nforma\u00e7\u00e3o de edema, dor e produ\u00e7\u00e3o de EROs (PASSOS et al., 2004; KAYASHIMA et \n\nal., 2012) (Figura 9).  \n\n De forma interessante, tanto o bloqueio farmacol\u00f3gico do B1R quanto a inibi\u00e7\u00e3o \n\nsist\u00eamica de calicre\u00edna tamb\u00e9m protegeram os animais das altera\u00e7\u00f5es de coagula\u00e7\u00e3o \n\nsangu\u00ednea que s\u00e3o comuns no envenenamento por L. obliqua. No caso da inibi\u00e7\u00e3o de \n\ncalicre\u00edna, este efeito ben\u00e9fico pode ser explicado pelo fato de que a calicre\u00edna ativa na \n\ncircula\u00e7\u00e3o, al\u00e9m de gerar BK, pode tamb\u00e9m disparar a coagula\u00e7\u00e3o pela ativa\u00e7\u00e3o de fator \n\nXII (SHARIAT-MADAR et al., 2002) (Figura 9). Entretanto, a ativa\u00e7\u00e3o do B1R n\u00e3o \n\ntem aparentemente qualquer rela\u00e7\u00e3o direta conhecida com a coagula\u00e7\u00e3o. Uma hip\u00f3tese \n\nplaus\u00edvel \u00e9 que a produ\u00e7\u00e3o de citocinas proinflamat\u00f3rias mediadas pelo B1R possam \n\nativar a coagula\u00e7\u00e3o e/ou inibir os mecanismos anticoagulantes end\u00f3genos que limitam a \n\nresposta protromb\u00f3tica, j\u00e1 que inflama\u00e7\u00e3o e coagula\u00e7\u00e3o s\u00e3o processos intimamente \n\nrelacionados (MASSBERG et al., 2010; RENN\u00c9, 2012). Por exemplo, a produ\u00e7\u00e3o de \n\n\n\nDiscuss\u00e3o \n\n203 \n\n \n\nTNF-? estimulada por LPS induz um perfil protromb\u00f3tico, pois aumenta a express\u00e3o de \n\nfator tecidual e ao mesmo tempo inibe a via da prote\u00edna C e trombomodulina, que s\u00e3o \n\nimportantes anticoagulantes end\u00f3genos (ESMON, 2004). Al\u00e9m disso, o est\u00edmulo \n\ninflamat\u00f3rio resulta na ativa\u00e7\u00e3o do sistema complemento e eleva os n\u00edveis do inibidor \n\ndo ativador de plasminog\u00eanio (PAI-1), portanto diminuindo a fibrin\u00f3lise e axacerbando \n\na coagula\u00e7\u00e3o e a coagulopatia de consumo (ESMON, 2004; SCHOUTEN et al., 2008). \n\nDe acordo com esta hip\u00f3tese, de fato encontramos, al\u00e9m da resposta inflamat\u00f3ria \n\nintensa, n\u00edveis aumentados de PAI-1 e dos componentes C3 e D do complemento e, \n\ntamb\u00e9m, uma atividade aumentada de fator tissular nos rins de animais envenenados.  \n\n \n\nAltera\u00e7\u00f5es vasculares. O processo de ultrafiltra\u00e7\u00e3o do plasma nos glom\u00e9rulos \n\ncaracteriza-se basicamente pela passagem seletiva de \u00e1gua, eletr\u00f3litos e pequenas \n\nmol\u00e9culas para o espa\u00e7o de Bowman, enquanto os elementos figurados do sangue e as \n\nprote\u00ednas dissolvidas no plasma ficam retidos. A energia para esse processo prov\u00e9m \n\nessencialmente do trabalho card\u00edaco e depende da press\u00e3o arterial sist\u00eamica e da press\u00e3o \n\nna microvasculatura renal (ZATZ, 2000). Dessa forma, a varia\u00e7\u00e3o da press\u00e3o \n\nhidrost\u00e1tica nos capilares glomerulares interfere no ritmo que acontece o processo de \n\nfiltra\u00e7\u00e3o. Nos capilares glomerulares, a press\u00e3o hidrost\u00e1tica \u00e9 regulada pela varia\u00e7\u00e3o do \n\ndi\u00e2metro das arter\u00edolas aferente e eferente e, portanto, pela resist\u00eancia oferecida por \n\nesses vasos. Quando a resist\u00eancia da arter\u00edola aferente decresce (por vasodilata\u00e7\u00e3o), a \n\npress\u00e3o hidrost\u00e1tica dentro do capilar glomerular (PCG) aumenta, pois uma maior fra\u00e7\u00e3o \n\nda press\u00e3o arterial renal \u00e9 transmitida ao capilar glomerular. O aumento da PCG eleva o \n\nritmo de filtra\u00e7\u00e3o glomerular (RFG). J\u00e1 quando a resist\u00eancia na arter\u00edola aferente \n\naumenta (por vasoconstri\u00e7\u00e3o), a PCG diminui e o RFG tamb\u00e9m se reduz. Na arter\u00edola \n\neferente, quando a resist\u00eancia \u00e9 diminu\u00edda, como quando relaxada, acontece diminui\u00e7\u00e3o \n\nda PCG e do RFG. Por outro lado, quando h\u00e1 constri\u00e7\u00e3o na arter\u00edola eferente, observa-se \n\num aumento da PCG e do RFG (ZATZ, 2000). Em situa\u00e7\u00f5es normais, existe um processo \n\nde autorregula\u00e7\u00e3o do RFG que o mant\u00e9m em valores relativamente est\u00e1veis mesmo que \n\nocorram flutua\u00e7\u00f5es na press\u00e3o arterial (CUPPLES and BRAAM, 2007). No entanto, \n\nquando h\u00e1 vasodilata\u00e7\u00e3o sist\u00eamica ou hemorragia, a press\u00e3o arterial pode cair bastante e \n\nficar fora dos limiares da autorregula\u00e7\u00e3o. Nesse caso normalmente ocorre uma \n\nvasoconstri\u00e7\u00e3o na arter\u00edola aferente, como parte da tentativa do organismo de denfender \n\na sua volemia, e, consequentemente, redu\u00e7\u00e3o da PCG e do RFG (ZATZ, 2000; \n\nSCHRIER et al., 2004). A principal evid\u00eancia de que um mecanismo semelhante tenha \n\n\n\nDiscuss\u00e3o \n\n204 \n\n \n\nparte na queda acentuada do RFG observada nos animais envenenados, al\u00e9m, \n\nobviamente, da hemorragia, \u00e9 a hipotens\u00e3o (Figura 9). Ap\u00f3s a inje\u00e7\u00e3o do veneno, h\u00e1 \n\numa queda progressiva da press\u00e3o arterial nas primeiras 12 h e os animais permanecem \n\nhipotensos entre 24 e 96 h, per\u00edodo em que tamb\u00e9m \u00e9 observada a maior queda no RFG. \n\nApesar da diminui\u00e7\u00e3o acentuada do RFG, o desbalan\u00e7o h\u00eddrico com o aumento \n\nconcomitante da fra\u00e7\u00e3o de excre\u00e7\u00e3o de \u00e1gua e eletr\u00f3litos tamb\u00e9m observado nos animais \n\nenvenenados pode, pelo menos em parte, contribuir para a queda de press\u00e3o arterial \n\n(Figura 9). Estes resultados indicam que os n\u00e9frons deixaram de desempenhar \n\nadequadamente suas fun\u00e7\u00f5es: n\u00e3o est\u00e3o \u00e1vidos por s\u00f3dio, n\u00e3o parecem estar secretando \n\npot\u00e1ssio em quantidade significativa, nem est\u00e3o empenhados em concentrar a urina para \n\nreter \u00e1gua. Em outras palavras, n\u00e3o parece estar havendo um processamento da pequena \n\nquantidade de filtrado glomerular que ainda se forma. Assim, como a capacidade de \n\nreabsor\u00e7\u00e3o tubular est\u00e1 diminu\u00edda boa parte do filtrado formado \u00e9 eliminado e ocorre \n\npoli\u00faria mesmo com o RFG baixo. Na pr\u00e1tica cl\u00ednica, esse tipo de quadro \u00e9 conhecido \n\ncomo IRA n\u00e3o-olig\u00farica (ou IRA poli\u00farica) e, apesar do evidente comprometimento \n\nrenal em tal situa\u00e7\u00e3o, ainda assim \u00e9 considerada de bom progn\u00f3stico se comparada \u00e0 \n\nIRA olig\u00farica ou an\u00farica (ZATZ et al., 2000). A diferen\u00e7a b\u00e1sica est\u00e1 no grau de les\u00e3o \n\ntubular a que cada condi\u00e7\u00e3o est\u00e1 associada. Na IRA olig\u00farica a extens\u00e3o da necrose \n\ntubular \u00e9 grande, de forma que em v\u00e1rios pontos do rim as c\u00e9lulas tubulares aparecem \n\nnecrosadas ou ausentes, restando aos t\u00fabulos, em certos segmentos, apenas a membrana \n\nbasal. Isso permite o vazamento puro e simples do filtrado de volta ao interst\u00edcio. Ou \n\nseja, o filtrado n\u00e3o \u00e9 reabsorvido e nem eliminado corretamente. J\u00e1 na IRA n\u00e3o-\n\nolig\u00farica, a extens\u00e3o da necrose tubular \u00e9 menor e regi\u00f5es necrosadas contrastam com \n\noutras menos comprometidas (geralmente na \u00e1rea medular). O resultado \u00e9 que, apesar \n\nda incapacidade de reabsor\u00e7\u00e3o de \u00e1gua e eletr\u00f3litos, o filtrado permanece no interior dos \n\nt\u00fabulos e \u00e9 eliminado. Assim, o d\u00e9bito urin\u00e1rio se mant\u00e9m (ou at\u00e9 mesmo aumenta), \n\nproduzindo uma urina completamente dilu\u00edda (THADHANI et al., 1996; SCHRIER et \n\nal., 2004).    \n\n Tanto a ativa\u00e7\u00e3o da coagula\u00e7\u00e3o quanto do SCC tamb\u00e9m podem interferir na \n\nhemodin\u00e2mica glomerular e contribuir para a redu\u00e7\u00e3o do RFG (Figura 9). Independente \n\nda PCG, se h\u00e1 les\u00e3o endotelial e deposi\u00e7\u00e3o de fibrina no capilar, o fluxo sangu\u00edneo pode \n\nsofrer uma redu\u00e7\u00e3o e, como o processo de filtra\u00e7\u00e3o tamb\u00e9m \u00e9 diretamente proporcional \n\nao fluxo, o RFG cai. J\u00e1 as cininas geradas pela ativa\u00e7\u00e3o do SCC alteram \n\nsignificativamente a resist\u00eancia vascular renal. Em rim isolado de rato perfundido com \n\n\n\nDiscuss\u00e3o \n\n205 \n\n \n\nBK ou lys-BK observa-se um efeito bif\u00e1sico de vasodilata\u00e7\u00e3o e vasoconstri\u00e7\u00e3o. Em uma \n\nprimeira fase, ocorre vasodilata\u00e7\u00e3o mediada pela liga\u00e7\u00e3o da BK ou Lys-BK ao B2R e \n\ndependente da produ\u00e7\u00e3o de prostaglandinas. Na segunda fase, ocorre vasoconstri\u00e7\u00e3o \n\nmediada pela liga\u00e7\u00e3o de des-Arg\n9\n-BK ou Lys-des-Arg\n\n9\n-BK (geradas a partir de BK ou \n\nLys-BK) ao B1R e totalmente independente da produ\u00e7\u00e3o de prostaglandinas \n\n(GUIMAR\u00c3ES et al., 1986a,b; VIEIRA et al., 1994; REN et al., 2002). In vivo durante \n\no envenenamento \u00e9 dif\u00edcil prever qual desses efeitos \u00e9 predominante e, portanto, \n\nrealmente interfere no RFG. O fato \u00e9 que a express\u00e3o de ambos os receptores de BK \n\naumenta ao longo do envenenamento (Figura 9), mas somente o bloqueio do B1R \u00e9 \n\ncapaz de prevenir a queda do RFG. Talvez o bloqueio do B1R favore\u00e7a o efeito \n\nvasodilatador mediado pelo B2R no rim, diminua a resist\u00eancia vascular e facilite o \n\nprocesso de filtra\u00e7\u00e3o. \u00c9 poss\u00edvel que investiga\u00e7\u00f5es futuras e o uso de outras \n\nmetodologias como o rim isolado, por exemplo, auxiliem a esclarecer a real influ\u00eancia \n\ndos receptores de BK nas altera\u00e7\u00f5es hemodin\u00e2micas renais induzidas pelo veneno. \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nDiscuss\u00e3o \n\n206 \n\n \n\n \n\nFigura 9. Poss\u00edveis mecanismos envolvidos na insufici\u00eancia renal aguda (IRA) induzida pelo veneno \n\nda taturana Lonomia obliqua. Coletivamente os resultados obtidos indicam que o mecanismo da IRA \u00e9 \n\ncomplexo, multifatorial e provavelmente envolve vias correlacionadas. S\u00e3o elas: (i) Hem\u00f3lise \n\nintravascular e a toxicidade derivada da libera\u00e7\u00e3o do heme; (ii) Ativa\u00e7\u00e3o do sistema calicre\u00edna-cininas e \n\nefeito proinflamat\u00f3rio mediado pelo B1R  e (iii) Altera\u00e7\u00f5es vasculares que contribuem para a diminui\u00e7\u00e3o \n\ndo RFG e hipoperfus\u00e3o renal, incluindo a ativa\u00e7\u00e3o da coagula\u00e7\u00e3o, deposi\u00e7\u00e3o de fibrina nos capilares \n\nglomerulares, aumento na fra\u00e7\u00e3o de excre\u00e7\u00e3o de eletr\u00f3litos e \u00e1gua e hipotens\u00e3o. Hb: hemoglobina; Mb: \n\nmioglobina; Hpt: haptoglobina; Hpx: hemopexina; RBC: contagem de eritr\u00f3citos; Hct: hemat\u00f3crito; RFG: \n\nritmo de filtra\u00e7\u00e3o glomerular; TF: fator tecidual; Pthr: protrombina; Thr: trombina; FBG: fibrinog\u00eanio; \n\nTNF-?: fator de necrose tumoral-?; IL-1?: interleucina-1?; HO-1: heme-oxigenase-1; EROs: esp\u00e9cies \n\nreativas de oxig\u00eanio; LMWK: cininog\u00eanio de baixo peso molecular; HMWK: cininog\u00eanio de alto peso \n\nmolecular; BK: bradicinina; DABK: des-Arg\n9\n-BK; B1R: receptor B1 de bradicinina; B2R: receptor B2 de \n\nbradicinina; Prdx: peroxirredoxina; SOD: super\u00f3xido dismutase; GST: glutationa s-transferase; DJ-1: \n\nprote\u00edna anti-oxidante (tipo-peroxirredoxina); RAD-50: prote\u00edna de reparo de DNA; CK-B: creatina \n\nkinase-B; CK: creatina kinase; CK-MB: creatina kinase-MB; Orm-1: ?-1-glicoprote\u00edna \u00e1cida; YBX-1: \n\nmarcador de dano tubular; FABP3: prote\u00edna ligante de \u00e1cidos graxos (marcador de necrose tubular \n\naguda); NGAL: lipocalina associada \u00e0 gelatinase de neutr\u00f3filos (marcador de necrose tubular aguda); \n\nCytC: citocromo C; MFP-1: prote\u00edna de fiss\u00e3o mitocondrial (marcador de apoptose); S100-A8: prote\u00edna \n\nenvolvida em processos de apoptose. Setas pretas: denotam ativa\u00e7\u00e3o, libera\u00e7\u00e3o ou causa. Setas vermelhas: \n\ndenotam aumento. Setas verdes: denotam efeitos diretos de toxinas do veneno.\n\n\n\n \n\n207 \n\n \n\n \n\n    \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n CCOONNCCLLUUSS\u00c3\u00c3OO \n \n\n \n\n \n\n\n\nConclus\u00e3o \n\n208 \n\n \n\nCONCLUS\u00c3O \n\n \n\n A partir dos resultados expostos nesta tese, as seguintes conclus\u00f5es podem ser \n\nformuladas:  \n\n \n\n? O veneno da taturana Lonomia obliqua induz, al\u00e9m da s\u00edndrome hemorr\u00e1gica \n\ncaracter\u00edstica, importantes altera\u00e7\u00f5es bioqu\u00edmicas, hematol\u00f3gicas e \n\nhistopatol\u00f3gicas, indicando que ocorre les\u00e3o de m\u00faltiplos \u00f3rg\u00e3os ao longo do \n\nenvenenamento. Essas les\u00f5es parecem estar relacionadas principalmente \u00e0 \n\ncoagulopatia de consumo e aos efeitos hemol\u00edtico, proinflamat\u00f3rio, nefrot\u00f3xico, \n\nmiot\u00f3xico, cardiot\u00f3xico e genot\u00f3xico do veneno. O dano genot\u00f3xico em \n\nparticular parece ser mediado pela produ\u00e7\u00e3o de esp\u00e9cies reativas de oxig\u00eanio ; \n\n \n\n? O soro antilon\u00f4mico \u00e9 capaz de neutralizar os efeitos t\u00f3xicos sist\u00eamicos do \n\nveneno apenas se administrado no in\u00edcio do envenenamento (nas primeiras 2 h). \n\nSe administrado ap\u00f3s 6 h de envenenamento, o soro \u00e9 ineficaz em neutralizar o \n\ndano renal, card\u00edaco e o efeito hemol\u00edtico, apesar de reverter a coagulopatia de \n\nconsumo;  \n\n \n\n? Especificamente no rim, as altera\u00e7\u00f5es morfol\u00f3gicas s\u00e3o compat\u00edveis com \n\nnecrose tubular aguda. H\u00e1 obstru\u00e7\u00e3o tubular e o desenvolvimento da les\u00e3o renal \n\ninduzida pelo envenenamento est\u00e1 relacionada com altera\u00e7\u00f5es hemodin\u00e2micas \n\nincluindo hipotens\u00e3o sist\u00eamica, aumento do d\u00e9bito card\u00edaco, aumento da \n\npermeabilidade vascular renal, redu\u00e7\u00e3o do ritmo de filtra\u00e7\u00e3o glomerular e \n\naltera\u00e7\u00f5es tubulares como redu\u00e7\u00e3o da capacidade de reabsor\u00e7\u00e3o de \u00e1gua e \n\neletr\u00f3litos; \n\n \n\n? Marcadores de les\u00e3o tubular s\u00e3o encontrados nos rins e urina dos animais \n\nenvenenados. A express\u00e3o de prote\u00ednas associadas com inflama\u00e7\u00e3o, dano \n\noxidativo, reparo de DNA, metabolismo e detoxifica\u00e7\u00e3o de hemoglobina, heme \n\ne ferro est\u00e3o aumentadas no rim de animais envenenados. Marcadores que \n\nindicam ativa\u00e7\u00e3o da coagula\u00e7\u00e3o, complemento e do sistema calicre\u00edna-cininas \n\ntamb\u00e9m est\u00e3o presentes no rim de ratos envenenados; \n\n\n\nConclus\u00e3o \n\n209 \n\n \n\n? Toxinas do veneno s\u00e3o detectadas no rim, endot\u00e9lio, tecido conjuntivo \n\nperivascular e urina. \n\n \n\n? A ativa\u00e7\u00e3o do sistema calicre\u00edna-cininas parece ter um papel fundamental para o \n\ndesenvolvimento da insufici\u00eancia renal aguda no envenenamento por L. obliqua; \n\n \n\n? O bloqueio da atividade da calicre\u00edna ou do receptor B1 de bradicinina \u00e9 capaz \n\nde previnir a maioria das altera\u00e7\u00f5es morfol\u00f3gicas e funcionais renais e o \n\ndesenvolvimento da coagulopatia de consumo, constituindo-se, portanto, em \n\numa alternativa terap\u00eautica para o tratamento do envenenamento;  \n\n \n\n? O efeito protetor do antagonismo do receptor B1 de bradicinina ou a inibi\u00e7\u00e3o \n\nsist\u00eamica de calicre\u00edna possivelmente est\u00e1 associado a uma diminui\u00e7\u00e3o do \n\nprocesso inflamat\u00f3rio no rim e a redu\u00e7\u00e3o da libera\u00e7\u00e3o de citocinas \n\nproinflamat\u00f3rias como TNF-? e IL-1?.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n  \n\n \u2020 \n \n\n   \n\n \n\n \n\n\n\nRefer\u00eancias \n\n210 \n\n \n\nREFER\u00caNCIAS \n\nABDULKADER, R.C.; BARBARO, K.C.; BARROS, E.J. &amp; BURDMANN, E.A. \n\n Nephrotoxicity of insect and spider venoms in Latin America. Semin \n\n Nephrol, v. 28, n. 4, p. 373-82, 2008. \n\nABELLA, H. B.; MARQUES, M. G. B.; SILVA, K. R. L. M.; ROSSONI, M. G.; \n\n TORRES, J. B. Acidentes com lagartas do g\u00eanero Lonomia registrados no \n\n Centro de Informa\u00e7\u00e3o Toxicol\u00f3gica do Rio Grande do Sul no per\u00edodo de 1997 a \n\n 2005. In: NICOLELLA, A. (org.). Toxicovigil\u00e2ncia \u2013 toxicologia cl\u00ednica: \n\n dados e indicadores selecionados. Rio Grande do Sul, 2005, p. 29-34, Porto \n\n Alegre, Secretaria da Sa\u00fade. Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em \n\n Sa\u00fade. Centro de Informa\u00e7\u00e3o Toxicol\u00f3gica, 2006. \n\nALVAREZ-FLORES, M.P.; FRITZEN, M.; REIS, C.V.; CHUDZINSKI-TAVASSI, \n\n A.M. Losac, a factor X activator from Lonomia obliqua bristle extract: its role in \n\n the pathophysiological mechanisms and cell survival. Biochem Biophys Res \n\n Commun, v. 343, p. 1216-1223, 2006. \n\nALVING, B.M.; HOJIMA, Y.; PISANO, J.J.; MASON, B.L.; BUCKINGHAN, R.E.; \n\n MOZEN, M.M.; FINLAYSON, J.S. Hypotension associated with prekallikrein \n\n activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med, v. \n\n 299, p. 66-70, 1978. \n\nAROCHA-PI\u00d1ANGO, C.L. Fibrin\u00f3lisis producida por contacto con orugas: comunicaci\u00f3n \n\n preliminar. Acta Cient Venez, v. 18, p. 136-139, 1967. \n\nAROCHA-PI\u00d1ANGO, C.L.; BOSCH, N.B.; TORRES, A.; GOLDSTEIN, C.; NOUEL, A.; \n\n ARG\u00dcELLO, A.; CARVAJAL, Z.; GUERRERO, B.; OJEDA, A.; RODRIGUEZ, \n\n A.; RODRIGUEZ, S. Six new cases of a caterpillar induced bleeding syndrome. \n\n Thromb Haemost, v. 67, p. 402-407, 1992. \n\nAROCHA-PI\u00d1ANGO, C.L.; GUERRERO, B. Hemorrhagic syndrome induced by \n\n caterpilars. Clinical and experimental studies. Invest Clin, v. 44, p. 155-163, 2003. \n\nARRUDA, M.A.; ROSSI, A.G.; DE FREITAS, M.S.; BARJA-FIDALGO, C.; GRA\u00c7A-\n\n SOUZA, A.V. Heme inhibits human neutrophil apoptosis: Involvement of \n\n phosphoinositide 3-kinase, MAPK, and NF- B. J Immunol, v. 173, n. 3, p. 2023\u2013\n 2030, 2004. \n\nBARRAVIERA, B. O interior do estado de S\u00e3o Paulo na hist\u00f3ria dos animais pe\u00e7onhetos. \n\n In: BARRAVIERA, B. (ed.). Venenos. Aspectos cl\u00ednicos e terap\u00eauticos dos \n\n acidentes por animais pe\u00e7onhentos, p. 3-6, S\u00e3o Paulo, EPUB, 1999. \n\nBERGER, M.; RECK J, JR.; TERRA, R.M.; PINTO, A.F.; TERMIGNONI, C.; \n\n GUIMAR\u00c3ES, J.A. Lonomia obliqua caterpillar envenomation causes platelet \n\n hypoaggregation and blood  incoagulability in rats. Toxicon, v. 55, n. 1, p. 33-\n\n 44, 2010a. \n\nBERGER, M.; RECK J, JR.; TERRA, R.M.; BEYS DA SILVA, W.O.; SANTI, L.; \n\n PINTO, A.F.; VAINSTEIN, M.H.; TERMIGNONI, C.; GUIMAR\u00c3ES, J.A., \n\n Lonomia obliqua venomous secretion induces human platelet adhesion and \n\n aggregation. J Thromb Thrombolysis, v. 30, n. 3, p. 300-310, 2010b. \n\nBERGER, M.; VIEIRA, M.A.R.; GUIMARAES, J.A. Acute Kidney Injury Induced by \n\n Snake and Arthropod Venoms. In: POLENAKOVIC, M. (Ed.), Renal Failure -  \n\n\n\nRefer\u00eancias \n\n211 \n\n \n\nThe Facts, p. 157-186, ISBN: 978953-51-0630-2, Rijeka, Cro\u00e1cia, Editora: \n\n InTech-Open, 2012. \n\nBHOOLA, K.D.; FIGUEROA, C.D.; WORTHY, K. Bioregulation of kinins: \n\n kallikreins, kininogens and kininases. Pharmacol. Rev., v. 44, n. 1, p. 1-80, \n\n 1992. \n\nBOHRER, C.B.; RECK JUNIOR, J.; FERNANDES, D.; SORDI, R.; GUIMARAES, \n\n J.A.; ASSREUY, J.; TERMIGNONI, C. Kallikrein-kinin system activation by \n\n Lonomia obliqua caterpillar bristles: involvement in edema and hypotension \n\n responses to envenomation. Toxicon, v. 49, n. 5, p. 663-669, 2007. \n\nBOLETIM ELETR\u00d4NICO EPIDEMIOL\u00d3GICO, 2010. Secretaria de Vigil\u00e2ncia em \n\n Sa\u00fade/Minist\u00e9rio da Sa\u00fade (SVS/MS), Brasil. Dispon\u00edvel em: \n\n www.portal.saude.gov.br/portal/arquivos/pdf/ano10_n02_sit_epidemiol_zoonos\n\n es_br.pdf  \n\nBORGES, D.R.; LIM\u00c3OS, E.A.; PRADO, J.L.; CAMARGO, A.C. Catabolism of \n\n vasoactive polypeptides by perfused rat liver. Naunyn Schmiedebergs Arch \n\n Pharmacol, v. 295, n. 1, p. 33-40, 1976.  \n\nBURDMANN, E.A.; ANTUNES, I.; SALDANHA, L.B.; ABDULKADER, R.C.M.R. \n\n Severe acute renal failure induced by the venom of Lonomia caterpillars. Clin \n\n Nephrol,  v. 46, p. 337-339, 1996. \n\nCALIXTO, J.B.; CABRINI, D.A.; FERREIRA, J.; CAMPOS, MM. Kinins in pain and \n\n inflammation. Pain, v. 87, n. 1, p. 1-5, 2000. \n\nCALIXTO, J.B.; MEDEIROS, R.; FERNANDES, E.S.; FERREIRA, J.; CABRINI, \n\n D.A.; CAMPOS, M.M. Kinin B1 receptors: key G-protein-coupled receptors and \n\n their role in inflammatory and painful processes. Br J Pharmacol, v. 143, n. 7, \n\n p. 803-18, 2004. \n\nCAMARA, N.O; SOARES, M.P. Heme oxygenase-1 (HO-1), a protective gene that \n\n prevents chronic graft dysfunction. Free Radic Biol Med, v. 38, n. 4, p. 426-\n\n 435, 2005.  \n\nCAOVILLA, J.J.; BARROS, E.J. Efficacy of two different doses of antilonomic serum \n\n in the resolution of hemorrhagic syndrome resulting from envenoming by \n\n Lonomia obliqua caterpillars: a randomized controlled trial. Toxicon, v. 43, p. \n\n 811-818, 2004. \n\nCARDOSO, A.E.C.; HADDAD, V.J. Acidentes por Lepid\u00f3pteros (larvas e adultos de \n\n mariposas): estudo dos aspectos epidemiol\u00f3gicos, cl\u00ednicos e terap\u00eauticos. An \n\n Bras Dermatol, v. 80, n. 6, p. 571-578, 2005. \n\nCHAIM, O.M.; SADE, Y.B.; DA SILVEIRA, R.B.; TOMA, L.; KALAPOTHAKIS, E.; \n\n CH\u00c1VEZ-OL\u00d3RTEGUI, C.; MANGILI, O.C.; GREMSKI, W.; VON \n\n DIETRICH, C.P.; NADER, H.B. &amp; VEIGA S.S. Brown spider dermonecrotic \n\n toxin directly induces nephrotoxicity. Toxicol Appl Pharmacol,  v. 211, n. 1, p. \n\n 64-77, 2006. \n\nCHIPPAUX, J.P. Snake-bites: appraisal of the global situation. Bull World Health \n\n Organ, v. 76, n. 5, pp. 515-24, 1998. \n\n \n\nhttp://www.portal.saude.gov.br/portal/arquivos/pdf/\n\n\nRefer\u00eancias \n\n212 \n\n \n\nCOSTA, R.M. Acidentes por Lagartas Venenosas. In: BARRAVIERA, B. (ed.) \n\n Venenos animais: uma vis\u00e3o integrada. Rio de Janeiro, Editora de Publica\u00e7\u00f5es \n\n Cient\u00edficas, p. 327-338, 1994. \n\nCOUTURE, R.; HARRISSON, M.; VIANNA, R.M.; CLOUTIER, E.F. Kinin receptors \n\n in pain and inflammation. Eur J Pharmacol, v. 429, n.1-3, p.161-76, 2001. \n\nCUPPLES, W.A.; BRAAM, B. Assessment of renal autoregulation. Am J Physiol \n\n Renal Physiol, v. 292, n. 4, p. F1105-23, 2007. \n\nCUSHMAN, D.W.; PLUSEC, J.; WILLIAMS, N.J.; WEAVER, E.R.; SABO, E.F.; \n\n KOCY, O.; CHEUNG, H.S.; ONDETTI, M.A. Inhibition of angiotensin-\n\n converting enzyme by analogs of peptides from Bothrops jararaca venom. \n\n Experientia, v. 29, p.1032-1035, 1973.  \n\nDA SILVA, P.H.; DA SILVEIRA, R.B.; APPEL, M.H.; MANGILI, O.C.; GREMSKI, \n\n W.; VEIGA, S.S. Brown spiders and loxoscelism. Toxicon, v. 44, p. 693\u2013709, \n\n 2004. \n\nDE CASTRO BASTOS, L.; VEIGA, A.B.; GUIMARAES, J.A.; TONUSSI, C.R. \n\n Nociceptive and edematogenic responses elicited by a crude bristle extract of \n\n Lonomia obliqua caterpillars. Toxicon, v. 43, p. 273-278, 2004. \n\nDEUTSCH, H.F.; DINIZ, C.R. Some proteolytic activities of snake venoms. J Biol \n\n Chem, v. 216, p. 17-26, 1955. \n\nDIAS DA SILVA, W.; CAMPOS, A.C.M.R.; GON\u00c7ALVES, L.R.C.; SOUSA E \n\n SILVA, M.C.C.; HIGAHSI, H.G.; YAMAGUSHI, I.K.; KELEN, E.M.A. \n\n Development of an antivenom against toxins of Lonomia obliqua caterpillars. \n\n Toxicon, v. 34, p. 1045-1049, 1996. \n\nDIAZ, J.H. The evolving global epidemiology, syndromic classification, management, \n\n and prevention of caterpillar envenoming. Am J Trop Med Hyg, v. 72, n. 3, p. \n\n 347-357, 2005. \n\nDONATO, J.L.; MORENO, R.A.; HYSLOP, S.; DUARTE, A.; ANTUNES, E.; LE \n\n BONNIEC, B.F.; RENDU, F.; DE NUCCI, G. Lonomia obliqua caterpillar \n\n trigger human blood coagulation via activation of factor X and prothrombin. \n\n Thromb Haemost, v. 79, p. 539-542, 1998. \n\nDUARTE, A.C.; CAOVILLA, J.; LORINI, I.; LORINI, D.; MANTOVANI, G.; \n\n SUMIDA, J.; MANFRE, P.C.; SILVEIRA, R.C.; DE MOURA, S.P. \n\n Insufici\u00eancia renal aguda por acidentes com lagartas. J Bras Nefrol, v. 12, p. \n\n 184-186, 1990. \n\nDUARTE, A.C.; WALTER, G.M.; BARROS, G.; LORINI, I. Insufici\u00eancia renal aguda \n\n nos acidentes com Lonomia obliqua. Nefrologia Latino-Americana, v. 1, n. 1, \n\n p. 38-40, 1994. \n\nDUARTE, A.C.L.; CRUSIUS, P.S.; PIRES, C.A.L.; SCHILLING, M.A.; FAN, H.W. \n\n Intracerebral haemorrhage after contact with Lonomia caterpillars. Lancet, v. \n\n 348, p. 1033, 1996. \n\nERD\u00d6S, E.G. Kininases. In: ERD\u00d6S, E.G. (ed.). Bradykinin, kallidin and kallikrein. \n\n Handbook of Experimental Pharmacology, v. 25, p. 428-488, Berlim, \n\n Springer-Verlag, 1979.  \n\n\n\nRefer\u00eancias \n\n213 \n\n \n\nESMON, C.T. The impact of the inflammatory response on coagulation. Thromb Res, \n\n v. 114, n. 5-6, p. 321-7, 2004. \n\nFAN, H.W.; CARDOSO, J.L.C. Clinical toxicology of snakebites in South America. In: \n\n MEIER, J.; WHITE, J. (eds.). Handbook of clinical toxicology of animal \n\n venoms and poisons, p. 667-688, Boca Raton: CRC, 1995. \n\nFAN, H.W.; CARDOSO, J.L.; OLMOS, R.D.; ALMEIDA, F.J.; VIANA, R.P.; \n\n MARTINEZ, A.P. Hemorrhagic syndrome and acute renal failure in a pregnant \n\n woman after contact with Lonomia caterpillars: a case report. Rev Inst Med \n\n Trop S\u00e3o Paulo, v. 40, n. 2, p. 119-20, 1998. \n\nFERREIRA, A.; BALLA, J.; JENEY, V.; BALLA, G.; SOARES, M.P. A central role \n\n for free heme in the pathogenesis of severe malaria: The missing link? J Mol \n\n Med, v. 86, p. 1097\u20131111, 2008. \n\nFERREIRA, S.H. A bradykinin potentiating factor (BPF) present in the venom of \n\n Bothrops jararaca. Brit J Pharmacol, v. 24, p. 163-169, 1965.  \n\nFERREIRA, S.H.; VANE, J.R. The detection and stimulation of bradykinin in the \n\n circulating blood. Br J Pharmacol Chem, v. 29, p. 367-377, 1987.  \n\nFRAIHA-NETO, H.; BALLARINI, A.J.; LE\u00c3O, R.N.Q.; COSTA, JR. D.; DIAS, L.B. \n\n S\u00edndrome hemorr\u00e1gica por contato com larvas de mariposa (Lepidoptera, \n\n saturniidae). Instituto Evandro Chagas, 50 anos de contribui\u00e7\u00e3o \u00e0s ci\u00eancias \n\n biol\u00f3gicas e \u00e0 medicina tropical, v. 2, p. 811-820, 1986. \n\nFRAIHA-NETO, H.; COSTA JUNIOR, D.; DE LE\u00c3O, R.N.Q. Acidentes por contato \n\n com larvas de Lonomia. In: LE\u00c3O, R.N.Q. (Ed.). Doen\u00e7as Infecciosas e \n\n Parasit\u00e1rias: Enfoque Amaz\u00f4nico, p. 800-804, Bel\u00e9m, Cejup: UEPA, Instituto \n\n Evandro Chagas, 1997. \n\nFRITZEN, M.; FLORES, M.P.A.; REIS, C.V.; CHUDZINSKI-TAVASSI, A.M. A \n\n prothrombin activator (Lopap) modulating inflammation, coagulation and cell \n\n survival mechanisms. Biochem Biophys Res Commun, v. 333, p. 517-523, \n\n 2005. \n\nGAMBORGI, G.P.; METCALF, E.B.; BARROS, E.J.G. Acute renal failure provoked \n\n by toxin from caterpillars of the species Lonomia obliqua. Toxicon v. 47, p. 68-\n\n 74, 2006. \n\nGARCIA, C.M.; DANNI-OLIVEIRA, I.M. Ocorr\u00eancia de acidentes provocados por \n\n Lonomia obliqua Walker, no Estado do Paran\u00e1, no per\u00edodo de 1989 a 2001. Rev \n\n Soc Bras Med Trop, v. 40, n. 2, p. 242-246, 2007. \n\nGON\u00c7ALVES, L.R.C.; SOUSA E SILVA, M.C.C.; TOMY, S.C.; SANO-MARTINS, \n\n I.S. Efficacy of serum therapy on the treatment of rats experimentally \n\n envenomed  by bristle extract of the caterpillar Lonomia obliqua: Comparison \n\n with epsilon- aminocaproic acid therapy. Toxicon, v. 50, n. 3, p. 349-356, \n\n 2007. \n\nGOUVEIA, A.I.C.B.; SILVEIRA, R.B.; NADER, H.B.; DIETRICH, C.P.; GREMSKI, \n\n W.; VEIGA, S.S. Identification and partial caracterization of hyaluronidases in \n\n Lonomia obliqua venom. Toxicon, v. 45, p. 403-410, 2005. \n\n\n\nRefer\u00eancias \n\n214 \n\n \n\nGRA\u00c7A-SOUZA, A.V.; ARRUDA, M.A.B.; DE FREITAS, M.S.; BARJA-FIDALGO, \n\n C.; OLIVEIRA, P.L. Neutrophil activation by heme: implications for \n\n inflammatory processes. Blood, v. 99, n. 11, p. 4160\u20134165, 2002. \n\nGRISOTTO, L.S.; MENDES, G.E.; CASTRO, I.; BAPTISTA, M.A.; ALVES, V.A.; \n\n YU, L.; BURDMANN, E.A. Mechanisms of bee venom-induced acute renal \n\n failure. Toxicon, v. 48, n. 1, p. 44-54, 2006. \n\nGUIMAR\u00c3ES, J.A.; BORGES, D.R.; PRADO, E.S.; PRADO, J.L. Kinin-converting \n\n aminopeptidase from human serum. Biochem Pharmacol, v. 22, p. 3157-3172, \n\n 1973.  \n\nGUIMAR\u00c3ES, J.A.; PIERCE, J.V.; HIAL, V.; PISANO, J.J. Methyonyl-lysil-bradykinin: \n\n the kinin released by pepsin from human kininogens. Adv Exp Med Biol, v. 70, p. \n 265-269, 1976.  \n\nGUIMAR\u00c3ES, J.A.; VIEIRA, M.A.; CAMARGO, M.J.; MAACK, T. Renal \n\n vasoconstrictive effect of kinins mediated by B1-kinin receptors. Eur J \n\n Pharmacol, v. 130, n. 3, p. 177-85, 1986a. \n\nGUIMAR\u00c3ES, J.A.; VIEIRA, M.A.; EICH, E.; MAACK, T. Effects of kinins on the \n\n isolated perfused rat kidney and evidence for the presence of renal B1 receptors. \n\n Adv Exp Med Biol, v. 198, p. 559-62, 1986b. \n\nGUIMAR\u00c3ES, J.A. Toxinas: Envenenamento por animais pe\u00e7onhentos. Situa\u00e7\u00e3o no \n\n Brasil, In: DE SOUZA, W. (Ed). Doen\u00e7as Negligenciadas. Academia Brasileira \n\n de Ci\u00eancias \u2013 Ci\u00eancia e Tecnologia para o Desenvolvimento \u2013 Estudos \n\n Estrat\u00e9gicos, Rio de Janeiro, Brazil, p. 34 -38, 2011. \n\nGUTI\u00c9RREZ, J.M.; THEAKSTON, R.D.; WARRELL, D.A. Confronting the neglected \n\n problem of snake bite envenoming: the need for a global partnership. PLoS \n\n Medicine, v. 3, n. 6, p. e150, 2006. \n\nGUTI\u00c9RREZ, J.M.; WARRELL, D.A.; WILLIAMS, D.J.; JENSEN, S.; BROWN, N.; \n\n CALVETE, J.J.; HARRISON, R.A.; Global Snakebite Initiative. The Need for \n\n Full Integration of Snakebite Envenoming within a Global Strategy to Combat \n\n the Neglected Tropical Diseases: The Way Forward. PLoS Negl Trop Dis, v. \n\n 13, n. 7, pp. e2162, 2013. \n\nHAMBERG, U.; ROCHA E SILVA, M. On the release of bradykinin by trypsin and \n\n snake venoms. Arch Int Pharmacodyn Ther, v. 110, p. 222-238, 1957.  \n\nKAKOKI, M.; TAKAHASHI, N.; JENNETTE, J.C.; SMITHIES, O. Diabetic \n\n nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. \n\n Proc Natl Acad Sci USA, v. 101, n. 36, p. 13302-5, 2004. \n\nKASTURIRATNE, A.; WICKREMASINGHE, A.R.; DE SILVA, N.; \n\n GUNAWARDENA, N.K.; PATHMESWARAN, A.; PREMARATNA, R.; \n\n SAVIOLI, L.; LALLOO, D.G.; DE SILVA, H.J. The global burden of snakebite: \n\n a literature analysis and modelling based on regional estimates of envenoming \n\n and deaths. PLoS Medicine, v. 5, n. 11, p. e218, 2008. \n\nKAYASHIMA, Y.; SMITHIES, O.; KAKOKI, M. The kallikrein-kinin system and \n\n oxidative stress. Curr Opin Nephrol Hypertens, v. 21, n. 1, p. 92-6, 2012. \n\n\n\nRefer\u00eancias \n\n215 \n\n \n\nKELEN, E.M.A.; PICARELLI, Z.P.; DUARTE, A.C. Hemorrhagic syndrome induced \n\n by contact with caterpillars of the genus Lonomia (Saturniidae, Hemileucinae). \n\n J Toxicol - Toxin Reviews, v. 14, p. 283-308, 1995. \n\nKINI, R.M. Excitement ahead: structure, function and mechanism of snake venom \n\n phospholipase A2 enzymes. Toxicon, v. 42, p. 827-840, 2003. \n\nKLEIN, J.; GONZALEZ, J.; DUCHENE, J.; ESPOSITO, L.; PRAD\u00c8RE, J.P.; NEAU, \n\n E.; DELAGE, C.; CALISE, D.; AHLUWALIA, A.; CARAYON, P.; \n\n PESQUERO, J.B.; BADER, M.; SCHANSTRA, J.P.; BASCANDS, J.L. \n\n Delayed blockade of the kinin B1 receptor reduces renal inflammation and \n\n fibrosis in obstructive nephropathy. FASEB J, v. 23, n. 1, p. 134-42, 2009. \n\nKLEIN, J.; GONZALEZ, J.; DECRAMER, S.; BANDIN, F.; NEAU, E.; SALANT, \n\n D.J.; HEERINGA, P.; PESQUERO, J.B.; SCHANSTRA, J.P.; BASCANDS, \n\n J.L. Blockade of the kinin B1 receptor ameloriates glomerulonephritis. J Am \n\n Soc Nephrol, n. 21, v. 7, p. 1157-64, 2010. \n\nKOWACS, P.A.; CARDOSO, J.; ENTRES, M.; NOVAK, E.M.; WERNECK, L.C. \n\n Fatal intracerebral hemorrhage secondary to lonomia obliqua caterpillar \n\n envenoming, a case report. Arq Neuro-Psiquiatr, v. 64, n. 4, p.1030-1032, \n\n 2006. \n\nKUDO, K.; TU, A.T. Characterization of hyaluronidase isolated from Agkistrodon \n\n contortrix contortrix (Southern Copperhead) venom. Arch Biochem Biophys, v. \n\n 15, p. 154\u2013162, 2001. \n\nKUMAR, S.; BANDYOPADHYAY, U. Free heme toxicity and its detoxification \n\n systems in human. Toxicol Lett, v. 157, n. 3, p. 175-88, 2005. \n\nLARA, F.A.; KAHN, S.A.; DA FONSECA, A.C.; BAHIA, C.P.; PINHO, J.P.; \n\n GRACA-SOUZA, A.V.; HOUZEL, J.C.; DE OLIVEIRA, P.L.; MOURA-\n\n NETO, V.; OLIVEIRA, M.F. On the fate of extracellular hemoglobin and heme \n\n in brain. J Cereb Blood Flow Metab., v. 29, n. 6, p. 1109-20, 2009. \n\nLARSEN, R.; GOZZELINO, R.; JENEY, V.; TOKAJI, L.; BOZZA, F.A.; JAPIASS\u00da, \n\n A.M.; BONAPARTE, D.; CAVALCANTE, M.M.; CHORA, A.; FERREIRA, \n\n A.; MARGUTI, I.; CARDOSO,  S.; SEP\u00daLVEDA, N.; SMITH, A.; \n\n SOARES, M.P. A central role for free heme in the pathogenesis of severe sepsis. \n\n Sci Transl Med, v. 2, n. 51, p. 51ra71, 2010. \n\nLORINI, L.M. Aspectos biol\u00f3gicos e morfol\u00f3gicos de Lonomia obliqua WALKER, \n\n 1855 (Lepid\u00f3ptera: Saturniidae), em laborat\u00f3rio. Disserta\u00e7\u00e3o de Mestrado. \n\n Porto Alegre, Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul \u2013 Instituto \n\n de Bioci\u00eancias, 1997. \n\nLORINI, L.M.; CORSEUIL, E. Aspectos Morfol\u00f3gicos de Lonomia obliqua Walker \n\n (Lepidoptera: Saturniidae). Neotrop Entomol, v. 30, p. 373-378, 2001. \n\nMALAQUE, C.M.S.; ANDRADE, L.; MADALOSSO, G.; TOMY, S.; TAVARES, \n\n F.L.; SEGURO, A.C. Short report: a case of hemolysis resulting from contact \n\n with a Lonomia caterpillar in southern Brazil. Am J Trop  Med Hyg, v. 74, n. 5, \n\n p. 807-809, 2006. \n\nMARCEAU, F.; REGOLI, D. Bradykinin receptor ligands: therapeutic perspectives. \n\n Nat Rev Drug Discov, v.3, n.10, p.845-52, 2004. \n\n\n\nRefer\u00eancias \n\n216 \n\n \n\nMARKOVI-HOUSLEY, Z.; MIGLIERINI, G.; SOLDATOVA, L.; RIZKALLAH, P.J.; \n\n M\u00dcLLER, U.; SCHIRMER, T. Crystal structure of Hyaluronidase, a major \n\n allergen of bee venom. Structure, v. 8, p. 1025\u20131035, 2000. \n\nMASSBERG, S.; GRAHL, L.; VON BRUEHL, M.L.; MANUKYAN, D.; PFEILER, \n\n S.; GOOSMANN, C.; BRINKMANN, V.; LORENZ, M.; BIDZHEKOV, K.; \n\n KHANDAGALE, A.B.; KONRAD, I.; KENNERKNECHT, E.; REGES, K.; \n\n HOLDENRIEDER, S.; BRAUN, S.; REINHARDT, C.; SPANNAGL, M.; \n\n PREISSNER, K.T.; ENGELMANN B. Reciprocal coupling of coagulation and \n\n innate immunity via neutrophil serine proteases. Nat Med, v. 16, n. 8, p. 887-\n\n 96, 2010. \n\nMINIST\u00c9RIO DA SA\u00daDE. Acidentes por Lepid\u00f3pteros. In: Manual de diagn\u00f3stico e \n\n tratamento de acidentes por animais pe\u00e7onhentos. Bras\u00edlia, Funda\u00e7\u00e3o \n\n Nacional de Sa\u00fade/Coordena\u00e7\u00e3o de Controle de Zoonoses e Animais \n\n Pe\u00e7onhentos, p. 75-84, 1998. \n\nMINIST\u00c9RIO DA SA\u00daDE. Acidentes por animais pe\u00e7onhentos. In: Guia de \n\n Vigil\u00e2ncia Epidemiol\u00f3gica. Bras\u00edlia, Secretaria de Vigil\u00e2ncia em Sa\u00fade e \n\n Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica, p. 102-125, 2005.  \n\nMEDEIROS, R.; CABRINI, D.A.; CALIXTO, J.B. The in vivo and ex vivo roles of \n\n cyclooxygenase-2, nuclear factor-?B and protein kinases pathways in the up-\n\n regulation of B1 receptor mediated contraction of the rabbit aorta. Regul Pept, \n\n v. 97, p. 121\u2013130, 2001. \n\nMEDEIROS, R.; CABRINI, D.A.; FERREIRA, J.; FERNANDES, E.S.; MORI, M.A.; \n\n PESQUERO, J.B.; BADER, M.; AVELLAR, M.C.; CAMPOS, M.M.; \n\n CALIXTO, J.B. Bradykinin B1 receptor expression induced by tissue damage in \n\n the rat portal vein. A critical role for mitogen-activated protein kinase and \n\n nuclear factor-?B signaling pathways. Circ Res, v. 94, p. 1375\u20131382, 2004. \n\nMORAES, R.H.P. Identifica\u00e7\u00e3o dos inimigos naturais de Lonomia obliqua Walker, \n\n 1855 (Lepidoptera, Saturniidae) e poss\u00edveis fatores determinantes do aumento da \n\n sua popula\u00e7\u00e3o. Disserta\u00e7\u00e3o. Escola Superior de Agricultura, Universidade de \n\n S\u00e3o Paulo, S\u00e3o Paulo, 2002. \n\nMOVAT, H.Z. The plasma kallikrein-kinin system and its interrelationship with other \n\n components of blood. In: Erd\u00f6s, E. G. (ed.). Bradykinin, kallidin and kallikrein. \n\n Handbook of Experimental Pharmacology, v. 25, p. 1-89. Berlim, Springer-\n\n Verlag, 1979.  \n\nNASCIMENTO-SILVA, V.; RODRIGUES DA SILVA, G.; MORAES, J.A.; CYRINO, \n\n F.Z.; SEABRA, S.H.; BOUSKELA, E.; GUIMAR\u00c3ES, J.A.; BARJA-\n\n FIDALGO, C. A pro-inflammatory profile of endothelial cell in Lonomia \n\n obliqua envenomation. Toxicon, v. 60, n. 1, p. 50-60, 2012.  \n\nNICOLELLA, A.; FERREIRA, M.E.; SPALDING-LESSA, C.A. Relat\u00f3rios anuais de \n\n atendimento do Centro de Informa\u00e7\u00f5es Toxicol\u00f3gicas do Rio Grande do \n\n Sul. Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade, Secretaria Estadual \n\n da Sa\u00fade do Rio Grande do Sul, Porto Alegre, RS. Anos de 2006-2012. \n\n Dispon\u00edvel em: http://www.cit.rs.gov.br. \n\nOKAMOTO, H.; GREENBAUM, L. M. Isolation and structure of T-kinin. Biochem \n\n Biophys Res Commun, v. 112, n. 2, p. 701-708, 1983.  \n\n\n\nRefer\u00eancias \n\n217 \n\n \n\nONDETTI, M.A.; WILLIAMS, N.J.; SABO, E.F.; PLUSEC, J.; WEAVER, E.R.; \n\n KOCY, O. Angiotensin-converting enzyme inhibitors from the venom of \n\n Bothrops jararaca. Isolation, elucidation of structure and synthesis. \n\n Biochemistry, v. 10, p. 4033-4039, 1971. \n\nPAMPLONA, A.; FERREIRA, A.; BALLA, J.; JENEY, V.; BALLA, G.; EPIPHANIO, \n\n S.; CHORA, A.; RODRIGUES, C.D.; GREGOIRE, I.P.; CUNHA-\n\n RODRIGUES, M.; PORTUGAL, S.; SOARES, M.P.; MOTA, M.M. Heme \n\n oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental \n\n cerebral malaria. Nat Med, v. 13, p. 703\u2013710, 2007. \n\nPASSOS, G.F.; FERNANDES, E.S.; CAMPOS, M.M.; ARAUJO, J.G.; PESQUERO, \n\n J.L.; SOUZA, G.E.; AVELLAR, M.C.; TEIXEIRA, M.M.; CALIXTO, J.B. \n\n Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of \n\n proinflammatory cytokines and neutrophil influx. J Immunol, v. 172, n. 3, p. \n\n 1839-47, 2004. \n\nPESQUERO, J.B.; PESQUERO, J.L.; OLIVEIRA, S.M.; ROSCHER, A.A.; \n\n METZGER, R.; GANTEN, D.; BADER, M. Molecular cloning &amp; functional \n\n characterization of a mouse bradykinin B1 receptor gene. Biochem Biophys Res \n\n Commun, v. 220, n. 1, p. 219-225, 1996. \n\nPIERCE, J.V.; GUIMAR\u00c3ES, J.A. Further characterization of highly purified human \n\n plasma kininogens. In: The kallikrein-kinin system in health and disease. \n\n Fogarty International Center Proceedings n\no\n 27; PISANO, J. J.; AUSTEN, K. F., \n\n eds. p. 127-127, 1976. Washington, DC. US-Government Printing Office. \n\nPINHO, F.M.; ZANETTA, D.M. &amp; BURDMANN, E.A. Acute renal failure after \n\n Crotalus durissus snakebite: a prospective survey on 100 patients. Kidney \n\n Int, v. 67, n. 2, p. 659-67, 2005. \n\nPINHO, F.M.; YU, L.; BURDMANN, E.A. Snakebite-induced acute kidney injury in \n\n Latin America. Semin Nephrol, v. 28, n. 4, p. 354-62, 2008. \n\nPINTO, A.F.M.; DOBROVOLSKI, R.; VEIGA, A.B.G.; GUIMAR\u00c3ES, J.A. \n\n Lonofibrase, a novel ?-fibrinogenase from Lonomia obliqua caterpillars. \n\n Thromb Res, v. 113, p. 147\u2013154, 2004. \n\nPINTO, A.F.M.; SILVA, K.R.L.M.; GUIMARAES, J.A. Proteases from Lonomia \n\n obliqua venomous secretions: comparison of procoagulant, fibrin(ogen)olytic \n\n and amidolytic activities. Toxicon, v. 47, p. 113-121, 2006. \n\nPINTO, A.F.M.; DRAGULEV, B.; GUIMAR\u00c3ES, J.A.; FOX, J.W. Novel perspectives \n\n on the pathogenesis of Lonomia obliqua caterpillar envenomation based on \n\n assessment of host response by gene expression analysis. Toxicon, v. 51, p. \n\n 1119-1128, 2008. \n\nPINTO, A.F.M; BERGER, M.; RECK-JR, J.; TERRA, R.M.; GUIMAR\u00c3ES, J.A. \n\n Lonomia obliqua venom: In vivo effects and molecular aspects associated with \n\n the hemorrhagic syndrome. Toxicon, v. 56, n. 7, p. 1103-12, 2010. \n\nREIS, C.V.; PORTARO, F.C.V.; ANDRADE, S.A.; FRITZEN, M.; FERNANDEZ, \n\n B.L.; SAMPAIO, C.A.M.; CAMARGO, A.C.M.; CHUDZINSKI-TAVASSI, \n\n A.M. A Prothrombin Activator Serine Protease from the Lonomia obliqua \n\n Caterpillar Venom (Lopap) Biochemical Characterization. Thromb Res, v. \n\n 102, p. 427-436, 2001a. \n\n\n\nRefer\u00eancias \n\n218 \n\n \n\nREIS, C.V.; FARSKY, S.H.P.; FERNANDES, B.L.; SANTORO, M.L.; OLIVA, \n\n M.L.V.; MARIANO, M.; CHUDZINSKI-TAVASSI, A.M. In vivo \n\n characterization of lopap, a prothrombin activator serine protease from the \n\n Lonomia obliqua Caterpillar Venom. Thromb Res, v. 102, n. 5, p. 437\u2013443, \n\n 2001b. \n\nREIS, C.V.; ANDRADE, S.A.; RAMOS, O.H.; RAMOS, C.R.; HO, P.L.; BATISTA, \n\n I.F.; CHUDZINSKI-TAVASSI, A.M. Lopap, a prothrombin activator from \n\n Lonomia obliqua belonging to the lipocalin family: recombinant production, \n\n biochemical characterization and structure-function insights. Biochem J, v. 398, \n\n p. 295-302, 2006. \n\nREGOLI, D.; BARAB\u00c9, J. Pharmacology of bradykinin and related kinins. Pharmacol \n\n Rev, v. 32, n. 1, p. 1-46, 1980.  \n\nREN, Y; GARVIN, J.; CARRETERO, O.A. Mechanism involved in bradykinin-\n\n induced efferent arteriole dilation. Kidney Int, v. 62, n. 2, p. 544-9, 2000. \n\nRENN\u00c9 T. The procoagulant and proinflammatory plasma contact system. Semin \n\n Immunopathol, v. 34, n. 1, p. 31-41, 2012. \n\nRICCI-SILVA, M.E.; VALENTE, R.H.; LE\u00d3N, I.R.; TAMBOURGI, D.V.; RAMOS, \n\n O.H.; PERALES, J.; CHUDZINSKI-TAVASSI, A.M. Immunochemical and \n\n proteomic technologies as tools for unravelling toxins involved in envenoming \n\n by accidental contact with Lonomia obliqua caterpillars. Toxicon, v. 51, n. 6, p. \n\n 1017-28, 2008. \n\nROCHA-CAMPOS, A.C.; GON\u00c7ALVES, L.R.; HIGASSHI, H.G.; YAMAGUSHI, \n\n I.K.; FERNANDES, I.; OLIVEIRA, J.E.; RIBELA, M.T.; SOUSA-E-SILVA, \n\n M.C.; DIAS DA SILVA, W. Specific heterologous F(ab\u2019)2 antibodies revert \n\n blood incoagulability resulting from envenoming by Lonomia obliqua \n\n caterpillars. Am J Trop Med Hyg, v. 64, n. 5\u20136, p. 283\u2013289, 2001. \n\nROCHA E SILVA, M.; BERALDO, W. T.; ROSENFELD, G. Bradykinin, a \n\n hypotensive and smooth muscle stimulating factor released from plasma \n\n globulin by snake venoms and by trypsin. Am J Physiol, v. 156, p. 261-273, \n\n 1949.  \n\nRODRIGUES-SGRIGNOLLI, L.; FLORIDO-MENDES, G.E.; CARLOS, C.P.; \n\n BURDMANN, E.A. Acute kidney injury caused by Bothrops snake venom. \n\n Nephron Clin Pract, v. 119, n. 2, p. c131-7, 2011. \n\nROTBERG, A., 1971. Lepidopterism in Brazil. In: B\u00fccherl, W., Buckley, E.E. \n\n Venomous Animals and their Venoms, vol. 3. New York, Academic Press. p. \n\n 157-168. \n\nSAMPAIO, S.V.; ARANTES, E.C.; PRADO, W.A.; RICCIOPPO NETO, F.; GIGLIO, \n\n J.R. Further characterization of toxins T1IV (TsTX-III) and T2IV from Tityus \n\n serrulatus scorpion venom. Toxicon, v. 26, p. 663\u2013672, 1991. \n\nSCHMAIER, A. H.; ROJKJAER, R.; SHARIAT-MADAR, Z. Activation of the plasma \n\n kallikrein/kinin system on cells: a revised hypothesis. Thromb Haemost, v. \n\n 82, n. 2, p. 226-233, 1999.  \n\nSCHOUTEN, M.; WIERSINGA, W.J.; LEVI, M.; VAN DER POLL, T. Inflammation, \n\n endothelium, and coagulation in sepsis. J Leukoc Biol, v. 83, n. 3, p. 536-45, \n\n 2008. \n\n\n\nRefer\u00eancias \n\n219 \n\n \n\nSCHRIER, R.W.; WANG, W.; POOLE, B.; MITRA, A. Acute renal failure: definitions, \n\n diagnosis, pathogenesis, and therapy. J Clin Invest, v. 114, n. 1, p. 5-14, 2004.  \n\nSEIBERT, C.S.; SHINOHARA, E.M.G.; SANO-MARTINS, I.S. In vitro hemolytic \n\n activity of Lonomia obliqua caterpillar bristle extract on human and Wistar rat \n\n erythrocytes. Toxicon, v. 41, p. 831-839, 2003. \n\nSEIBERT, C.S.; OLIVEIRA, M.R.L.; GON\u00c7ALVES, L.R.C.; SANTORO, M.L.; \n\n SANO-MARTINS, I.S. Intravascular hemolysis induced by Lonomia obliqua \n\n caterpillar bristle extract: an experimental model of envenomation in rats. \n\n Toxicon, v. 44, p. 793-799, 2004. \n\nSEIBERT, C.S.; TANAKA-AZEVEDO, A.M.; SANTORO, M.L.; MACKESSY, S.P.; \n\n TORQUATO, R.J.S.; LEBRUN, I.; TANAKA, A.S.; SANO-MARTINS, I.S. \n\n Purification of a phospholipase A2 from Lonomia obliqua caterpillar bristle \n\n extract. Biochem Biophys Res Commun, v. 342, p. 1027-1033, 2006. \n\nSHARIAT-MADAR, Z.; MAHDI, F.; SCHMAIER, A.H. Assembly and activation of \n\n the plasma kallikrein/kinin system: a new interpretation. Int \n\n Immunopharmacol, v. 2, n. 13-14, p. 1841-1849, 2002.  \n\nSIM\u00d5ES, R.L.; ARRUDA, M.A.; CANETTI, C.; SEREZANI, C.H.; FIERRO, I.M.; \n\n BARJA-FIDALGO, C. Proinflammatory responses of heme in alveolar \n\n macrophages: repercussion in lung hemorrhagic episodes. Mediators Inflamm \n\n DOI: 10.1155/2013/946878, in press, 2013. \n\nSITPRIJA, V. Snakebite nephropathy. Nephrology (Carlton), v. 11, n. 5, p. 442-448, \n\n 2006. \n\nTHADHANI, R.; PASCUAL, M.; BONVENTRE, J.V. Acute renal failure. N Engl J \n\n Med, v. 334, n. 22, p. 1448-1460, 1996. \n\nTRACZ, M.J; JUNCOS, J.P.; CROATT, A.J.; ACKERMAN, A.W.; GRANDE, J.P.; \n\n KNUTSON, K.L.; KANE, G.C.; TERZIC, A.; GRIFFIN, M.D.; NATH, K.A. \n\n Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates \n\n systemic inflammatory responses to renal ischemia. Kidney Int, v. 72, p. 1073\u2013\n\n 1080, 2007. \n\nVEIGA, A.B.G.; BLOCHTEIN, B.; GUIMAR\u00c3ES, J.A. Structures involved in \n\n production, secretion and injection of the venom produced by the caterpillar \n\n Lonomia obliqua (Lepidoptera, Saturniidae). Toxicon, v. 39, p. 1343-1351, \n\n 2001. \n\nVEIGA, A.B.G.; PINTO, A.F.M.; GUIMAR\u00c3ES, J.A. Fibrinogenolytic and \n\n procoagulant activities in the hemorrhagic syndrome caused by Lonomia obliqua \n\n caterpillars. Thromb Res, v. 111, p. 95-101, 2003. \n\nVEIGA, A.B.G.; RIBEIRO, J.M.C.; GUIMAR\u00c3ES, J.A.; FRANCISCHETTI, I.M.B. A \n\n catalog for the transcripts from the venomous structures of the caterpillar \n\n Lonomia obliqua: identification of the proteins potentially involved in the \n\n coagulation disorder and hemorrhagic syndrome. Gene, v. 355, p. 11-27, 2005. \n\nVEIGA, A.B.G.; BERGER, M.; GUIMAR\u00c3ES, J.A. Lonomia obliqua venom: \n\n pharmaco-toxicological effects and biotechnological perspectives. In: DE LIMA, \n\n M.E.; PIMENTA, A.M.C.; MARTIN-EAUCLAIRE, M.F. ; ZINGALI, R.B. ; \n\n ROCHAT, H. (eds.). Animal Toxins: The State of the Art. Perspectives on \n\n Health and Biotechnology, p. 371-390, Belo Horizonte: Editora UFMG, 2009. \n\n\n\nRefer\u00eancias \n\n220 \n\n \n\nVIEIRA, M.A.; MOREIRA, M.F.; MAACK, T.; GUIMAR\u00c3ES, J.A. Conversion of T-\n\n kinin to bradykinin by the rat kidney. Biochem Pharmacol, v. 47, n. 9, p. 1693-\n\n 9, 1994. \n\nWALTER, G.M. Acidentes com Lonomia: Tratamento com soro antilon\u00f4mico e \n\n insufici\u00eancia renal aguda. Disserta\u00e7\u00e3o de Mestrado. Porto Alegre, Universidade \n\n Federal do Rio Grande do Sul \u2013 Faculdade de Medicina, 1999. \n\nWANG, P.H.; CENEDEZE, M.A.; PESQUERO, J.B.; PACHECO-SILVA, A.; \n\n C\u00c2MARA, N.O. Influence of bradykinin B1 and B2 receptors in the immune \n\n response triggered by renal ischemia-reperfusion injury. Int \n\n Immunopharmacol, v. 6, n. 13-14, p. 1960-5, 2006.  \n\nWANG, P.H.; CAMPANHOLLE, G.; CENEDEZE, M.A.; FEITOZA, C.Q.; \n\n GON\u00c7ALVES, G.M.; LANDGRAF, R.G.; JANCAR, S.; PESQUERO, J.B.; \n\n PACHECO-SILVA, A.; C\u00c2MARA, N.O. Bradykinin B1 receptor antagonism is \n\n beneficial in renal ischemia-reperfusion injury. PLoS One, v. 25, n. 8, p. e3050, \n\n 2008. \n\nWANG, P.H.; CENEDEZE, M.A.; CAMPANHOLLE, G.; MALHEIROS, D.M.; \n\n TORRES, H.A.; PESQUERO, J.B.; PACHECO-SILVA, A.; C\u00c2MARA, N.O. \n\n Deletion of bradykinin B1 receptor reduces renal fibrosis. Int \n\n Immunopharmacol, v. 9, n. 6, p. 653-7, 2009. \n\nWILLIAMS, D.; GUTI\u00c9RREZ, J.M.; HARRISON, R.; WARRELL, D.A.; WHITE, J.; \n\n WINKEL, K.D.; GOPALAKRISHNAKONE, P; Global Snake Bite Initiative \n\n Working Group; International Society on Toxinology. The Global Snake Bite \n\n Initiative: an antidote for snake bite. Lancet, v. 375, n. 9708, p. 89-91, 2010. \n\nZAGER, R.A. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney \n\n Int, v. 49, n. 2, p. 314-326, 1996. \n\nZAGER, R.A.; JOHNSON, A.C.; BECKER, K. Renal cortical hemopexin accumulation \n\n in response to acute kidney injury. Am J Physiol Renal Physiol, v. 303, n. 10, \n\n p. F1460-472, 2012. \n\nZANNIN, M. Avalia\u00e7\u00e3o dos par\u00e2metros de coagula\u00e7\u00e3o e fibrin\u00f3lise no plasma de \n\n pacientes acidentados por contato com lagartas da esp\u00e9cie Lonomia obliqua. \n\n Tese de Doutorado. S\u00e3o Paulo, Universidade Federal de S\u00e3o Paulo \u2013 Escola \n\n Paulista de Medicina, 2002. \n\nZANNIN, M.; LOUREN\u00c7O, D.M.; MOTTA, G.; COSTA, L.R.D.; GRANDO, M.; \n\n GAMBORGI, G.P.; NOGUTI, M.A.; CHUDZINSKI-TAVASSI, A.M. Blood \n\n coagulation and fibrinolytic factors in 105 patients with hemorrhagic syndrome \n\n caused by accidental contact with Lonomia obliqua caterpillar in Santa Catarina, \n\n Southern Brazil. Thromb Haemost, v. 89, p. 355\u2013364, 2003. \n\nZATZ, R.; BARROS-HELOU, C.M.; SEGURO, A.C.; BURDMANN, E.; YU, L.,  \n\n Insufici\u00eancia renal aguda. In: ZATZ, Z. (Ed.), Fisiopatologia Renal. S\u00e9rie: \n\n Fisiopatologia Cl\u00ednica, pp. 261-282, S\u00e3o Paulo, Brasil, Atheneu, 2000. \n\nZATZ, R. Dist\u00farbios da filtra\u00e7\u00e3o glomerular. In: ZATZ, Z. (Ed.), Fisiopatologia \n\n Renal. S\u00e9rie: Fisiopatologia Cl\u00ednica, pp. 1-20, S\u00e3o Paulo, Brasil, Atheneu, 2000. \n\n \n\n \n\n\n\nAnexos \n\n221 \n\n \n\nANEXOS \n\n \n\n Abaixo ser\u00e3o apresentados outros resultados obtidos ao longo do per\u00edodo do \n\ndoutoramento. Vale lembrar que todos esses resultados est\u00e3o publicados ou aceitos para \n\npublica\u00e7\u00e3o em peri\u00f3dicos internacionais indexados e com \u00edndice de impacto conhecido \n\ne fazem parte de linhas de pesquisas tamb\u00e9m desenvolvidas no laborat\u00f3rio de \n\nBioqu\u00edmica Farmacol\u00f3gica do Centro de Biotecnologia da UFRGS.  \n\n \n\nS\u00e3o eles: \n\n \n\n? Susceptibility of Loxosceles sp. to the arthropod pathogenic fungus \n\nMetarhizium anisopliae: potential biocontrol of the brown spider. A aranha-\n\nmarrom (Loxosceles spp.) \u00e9 um animal venenoso capaz de causar les\u00f5es \n\ndermonecr\u00f3ticas extensas que podem evoluir para um quadro de envenenamento \n\nsist\u00eamico potencialmente fatal. No Brasil existem diferentes esp\u00e9cies e algumas \n\n\u00e1reas (inclusive \u00e1reas urbanas e regi\u00f5es metropolitanas) s\u00e3o infestadas por essas \n\naranhas, o que faz com que o n\u00famero de acidentes seja muito elevado. Neste \n\ntrabalho mostramos uma forma alternativa e eficaz de controle biol\u00f3gico desses \n\nanimais utilizando o fungo entomopatog\u00eanico Metarhizium anisopliae. Artigo \n\npublicado no Transactions of the Royal Society of Tropical Medicine and \n\nHygiene 2013; 107: 59-61.  \n\n \n\n? Antithrombotic effect of chikusetsusaponin IVa isolated from Ilex \n\nparaguariensis (Mat\u00e9). Em trabalhos anteriores nosso grupo demonstrou pela \n\nprimeira vez que a glicirrizina (GL), uma saponina triterp\u00eanica conhecida \n\nprincipalmente por suas propriedades anti-inflamat\u00f3rias, tamb\u00e9m possui \n\natividade anti-tromb\u00f3tica. A GL \u00e9 capaz de ligar-se ao exos\u00edtio-1 da trombina, \n\ninibindo a sua atividade e, portanto, a forma\u00e7\u00e3o de trombos, tanto in vitro, \n\nquanto em modelos animais. Neste trabalho, isolamos e identificamos outra \n\nsaponina triterp\u00eanica, a chikusetsusaponin IVa, obtida dos frutos da erva-mate \n\n(Ilex paraguariensis). A chikusetsusaponin IVa \u00e9 um inibidor de trombina, liga-\n\nse ao exos\u00edtio-1, mas tamb\u00e9m, diferente da GL, \u00e9 capaz de modular o s\u00edtio ativo \n\n\n\nAnexos \n\n222 \n\n \n\n? da enzima. Tamb\u00e9m inibe agrega\u00e7\u00e3o plaquet\u00e1ria e apresenta atividade anti-\n\ntromb\u00f3tica in vitro e in vivo. Artigo publicado no Journal of Medicinal Food \n\n2012, 15 (12): 1073-1080.  \n\n \n\n? Improving the thrombin inhibitory activity of Glycyrrhizin, a triterpenic \n\nsaponin, through a molecular simplification of the carbohydrate moiety. \n\nNeste trabalho aliamos t\u00e9cnicas de modelagem molecular, din\u00e2mica molecular e \n\ns\u00edntese org\u00e2nica para obter derivados sint\u00e9ticos da GL com maior atividade \n\ninibit\u00f3ria frente \u00e0 trombina. Entre os diferentes derivados obtidos, um \u00e9ster-\n\nft\u00e1lico da GL apresentou atividade inibit\u00f3ria superior ao do composto original e \n\nseu arcabou\u00e7o estrutural ser\u00e1 utilizado para o desenho de uma nova classe de \n\ncompostos anti-tromb\u00f3ticos e para testes em modelos animais de trombose. \n\nArtigo aceito para publica\u00e7\u00e3o no Chemical Biology &amp; Drug Design (in \n\npress). DOI: 10.1111/cbdd.12204. \n\n \n\n Esses trabalhos s\u00e3o apresentados na \u00edntegra nas pr\u00f3ximas p\u00e1ginas. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nSusceptibility of Loxosceles sp. to the arthropod pathogenic fungus\nMetarhizium anisopliae: potential biocontrol of the brown spider\n\nWalter O. Beys-da-Silva*, Luce?lia Santi, Markus Berger, Jorge A. Guimara?es, Augusto Schrank\nand Marilene H. Vainstein\n\nCentro de Biotecnologia, Universidade Federal do Rio Grande do Sul, PO Box 15005, 91501-970, Porto Alegre, RS, Brazil\n\n*Corresponding author: Tel: +55 51 3308 6062; Fax: +55 51 3308 7309; E-mail: walterbeys@yahoo.com.br\n\nReceived 1 March 2012; revised 13 August 2012; accepted 13 August 2012\n\nBackground: Loxosceles genus (brown spider) is an important pest with great impact on public health. Thus,\nmore effective strategies for spider control are necessary.\n\nMethods: Three isolates of Metarhizium anisopliae fungus were tested for the control of Loxosceles sp.\n\nResults: Metarhizium anisopliae isolate E6 was highly virulent to the Loxosceles sp. spider, causing 100% mor-\ntality at 109 conidia/ml after 12 days and 9 days for juvenile and adult spiders, respectively.\n\nConclusions: This is the first report of the pathogenicity of M. anisopliae against a venomous arthropod. This\nfungus could offer an interesting alternative to reduce loxoscelism in future biocontrol strategies.\n\nKeywords: Loxosceles sp., Loxoscelism, Biological control, Metarhizium anisopliae\n\nIntroduction\nBites of brown spiders (Loxosceles spp.) cause a severe clinical\nprofile associated with dermonecrotic lesions and systemic man-\nifestations that may be intense and occasionally fatal.1 These\nspiders have a worldwide distribution, and accidents have been\ndescribed mainly in developing countries. Some urban regions\naround the world, such as the metropolitan area of Curitiba\ncity, Brazil, have thousands of cases of loxoscelism (accidents\ncaused by spiders of the genus Loxosceles) reported per year,\nand it is an important health problem with great economic\nimpact on the public health system.1 Population control strat-\negies for these and other spiders are unspecific and are mostly\nbased on the use of insecticides. In this scenario, re-infestation\nis a continuous problem and the toxic side effects of indiscrimin-\nate use of insecticides for humans have to be considered. Thus,\nalternative strategies that are more effective to control brown\nspider populations and the consequent occurrences of loxosce-\nlism have recently gained considerable importance.\n\nThe fungus Metarhizium anisopliae, a biocontrol agent that is\nan arthropod pathogen but is not infectious to humans, has been\napplied safely for several decades in the control of agricultural\npests and other arthropods of medical relevance.2 \u2013 4 In this\nwork, the susceptibility of the brown spider (Loxosceles sp.) to\nM. anisopliae is presented.\n\nMaterials and methods\nMetarhizium anisopliae isolate E6 (from the hemipteran insect Deois\nflavopicta, Esp??rito Santo, Brazil, 1981), isolate Nordeste (from the\n\nhemipteran insect Mahanarva posticata, Pernambuco, Brazil,\n1969) and isolate AL (from M. posticata, Alagoas state, Brazil,\n1995) were maintained in the laboratory (Universidade Federal do\nRio Grande do Sul, Porto Alegre, RS, Brazil). Conidia production and\nconidial suspensions were performed as described previously.5\n\nLoxosceles sp. spiders were collected on different days (during\nDecember 2010 \u2013 March 2011) from a highly infested and inhab-\nited house in the city of Viama?o, RS, Brazil, with the owner\u2019s author-\nisation and only for the bioassays. Spiders were exposed before\nassay to dead ants (Atta sp.) as a food source and were maintained\nfor ?20 days at 28 8C for observation of their health condition.\nSpiders were maintained individually in 50 ml plastic tubes\ncovered with screen tissues with free access to sterile water\nthrough wet cotton flakes at the bottom of tubes before the bio-\nassay procedure.\n\nFor bioassays, 10 adult and 10 juvenile Loxosceles sp. individuals\nwere used per treatment. Metarhizium anisopliae conidial suspen-\nsion (2 ml) was applied through sprinkling to cover the total body\nof the spider (at three concentrations of 107, 108 or 109 conidia/\nml). Following fungal inoculation, the spiders were individually\nplaced in tubes covered with screen tissues at 28 8C and .90% rela-\ntive humidity in a biochemical oxygen demand incubator. Controls\nconsisted of Loxosceles sp. spiders treated with sterile distilled\nwater instead of the conidial suspension. Experiments were\ncarried out in three replicates and spiders were observed daily to\ndetermine survival. Bioassays were evaluated for 25 days. Statistical\nanalysis, including analysis of Probit for dependent results, was con-\nducted to obtain the lethal concentration (LC50 and LC90) and lethal\ntime (LT50 and LT90) for 50% and 90% of the spiders, respectively,\nusing SPSS 13.0 for Windows (SPSS Inc., Chicago, IL, USA).\n\n# Royal Society of Tropical Medicine and Hygiene 2012. All rights reserved. For Permissions, please email: journals.permissions@oup.com\n\nS\nH\n\nO\nR\n\nT\nC\n\nO\nM\n\nM\nU\n\nN\nIC\n\nA\nT\n\nIO\nN\n\nTrans R Soc Trop Med Hyg 2013; 107: 59 \u2013 61\ndoi:10.1093/trstmh/trs006\n\n59\n\n by guest on D\necem\n\nber 13, 2012\nhttp://trstm\n\nh.oxfordjournals.org/\nD\n\now\nnloaded from\n\n \n\n223\n\nhttp://trstmh.oxfordjournals.org/\n\n\nResults\nComparing three M. anisopliae isolates (E6, Nordeste and AL), it\nwas observed that isolate E6 caused 100% mortality following ap-\nplication of 109 conidia/ml after 12 days and 9 days of treatment\nfor juvenile and adult spiders, respectively, being considered highly\nvirulent to Loxosceles sp. (Table 1). Isolate Nordeste showed lower\nvirulence (100% mortality in 19 days for juveniles and 13 days for\nadults at 109 conidia/ml), whilst isolate AL was not virulent at all\nconcentrations tested. For all isolates tested, a concentration of\n107 conidia/ml caused a low mortality rate (Table 1). Interestingly,\nthe most effective isolate (E6) also caused 100% mortality for\nadult spiders at a concentration of 108 conidia/ml (15 days). In\nall experiments, the survival rate in the brown spider control\ngroup was 100%. All dead spiders infected with M. anisopliae\ndeveloped intense surface mycosis (Supplementary Figure 1). No\nfungal growth was observed in the control spiders.\n\nAdults were more susceptible to fungal infection compared\nwith juvenile spiders, as evidenced by the LT50 and LT90 values.\nIn some cases, especially for isolate AL, mortality values were\n,50% at the end of experiment; thus, LT50 and LT90 values could\nnot be calculated. LC50 values on day 25 post treatment for the\nmost infective M. anisopliae isolate (E6) were 4.9\u00d7107 and 8.9\u00d7\n106 conidia/ml for juvenile and adult spiders, respectively (Table 1).\n\nDiscussion\nTo our knowledge, this is the first study evaluating the effect of a\nfungus to control a venomous spider of medical relevance. We\nhave shown in vitro that the fungus M. anisopliae can be used\nto control juvenile and adult Loxosceles sp. spiders, especially\nfungal isolate E6. Biocontrol strategies with M. anisopliae are con-\nsidered of low impact in nature because this fungus is specific to\nits arthropod target host.4 Moreover, use of biocontrol agents\ndecreases the application of chemical pesticides, which greatly\nimpact on the environment, humans and animals.\n\nMetarhizium anisopliae appears to be a promising alternative\nto unspecific chemical insecticides in use owing to its verified ef-\nficacy in Loxosceles sp. infection and control. The potential use of\nthis fungus might be its application inside homes in specific sites\nassociated with the brown spider\u2019s lifestyle, such as basements,\ngarages, behind and under furniture, and baseboards. It could\nalso be a good alternative for highly infested areas in abandoned\nconstructions, wastelands, warehouses, deposits and sheds.\nMetarhizium anisopliae can be applied directly in the field or at\nspecific sites through pulverisation. Another way to apply the\nfungus in biocontrol in domestic areas might be the use of dry\nconidia associated with any kind of spider attractant, allowing\ncontact of conidia onto the spider\u2019s body, like a spider trap.\n\nDevelopment of specific strategies based on the use of M. ani-\nsopliae conidia and treatment of highly infested sites by Loxos-\nceles sp. with a conidial suspension could be an alternative for\nspider population control, consequently reducing loxoscelism in\nBrazil and other countries.\n\nSupplementary data\nSupplementary data are available at Transactions Online (http://\ntrstmh.oxfordjournals.org/).\n\nTa\nb\n\nle\n1\n\n.\nC\n\nu\nm\n\nu\nla\n\nti\nve\n\nm\no\n\nrt\na\n\nlit\ny,\n\na\nn\n\nd\nle\n\nth\na\n\nl\nti\n\nm\ne\n\ns\n(L\n\nT\n5\n\n0\n/9\n\n0\n)\n\na\nn\n\nd\nle\n\nth\na\n\nl\nco\n\nn\nce\n\nn\ntr\n\na\nti\n\no\nn\n\ns\n(L\n\nC\n5\n\n0\n/9\n\n0\n)\n\nin\nd\n\na\nys\n\nfo\nllo\n\nw\nin\n\ng\nim\n\nm\ne\n\nrs\nio\n\nn\no\n\nf\nju\n\nve\nn\n\nile\na\n\nn\nd\n\na\nd\n\nu\nlt\n\nLo\nxo\n\nsc\ne\n\nle\ns\n\nsp\n.\n\nis\no\n\nla\nte\n\ns\nin\n\na\nn\n\na\nq\n\nu\ne\n\no\nu\n\ns\nsu\n\nsp\ne\n\nn\nsi\n\no\nn\n\no\nf\n\nM\ne\n\nta\nrh\n\niz\niu\n\nm\na\n\nn\nis\n\no\np\n\nlia\ne\n\nco\nn\n\nid\nia\n\nIs\no\n\nla\nte\n\nC\no\n\nn\nce\n\nn\ntr\n\na\nti\n\no\nn\n\n(c\no\n\nn\nid\n\nia\n/m\n\nl)\nC\n\nu\nm\n\nu\nla\n\nti\nve\n\nm\no\n\nrt\na\n\nlit\ny\n\n(%\n)a\n\nLT\n5\n\n0\n(9\n\n5\n%\n\nC\nI)\n\n(d\na\n\nys\n)\n\nLT\n9\n\n0\n(9\n\n5\n%\n\nC\nI)\n\n(d\na\n\nys\n)\n\nLC\n5\n\n0\n(9\n\n5\n%\n\nC\nI)\n\n(c\no\n\nn\nid\n\nia\n/m\n\nl)\na\n\nLC\n9\n\n0\n(9\n\n5\n%\n\nC\nI)\n\n(c\no\n\nn\nid\n\nia\n/m\n\nl)\na\n\nJu\nve\n\nn\nile\n\nA\nd\n\nu\nlt\n\nJu\nve\n\nn\nile\n\nA\nd\n\nu\nlt\n\nJu\nve\n\nn\nile\n\nA\nd\n\nu\nlt\n\nJu\nve\n\nn\nile\n\nA\nd\n\nu\nlt\n\nJu\nve\n\nn\nile\n\nA\nd\n\nu\nlt\n\nE\n6\n\n1\n0\n\n7\n2\n\n0\n.3\n+\n\n9\n.5\n\n8\n0\n\n.7\n+\n\n8\n.1\n\nN\nD\n\n1\n6\n\n.9\n(1\n\n6\n.3\n\n\u2013\n1\n\n7\n.5\n\n)\nN\n\nD\n2\n\n5\n.0\n\n(2\n3\n\n.9\n\u2013\n\n2\n6\n\n.3\n)\n\n4\n.9\n\u00d7\n\n1\n0\n\n7\n\n(4\n.3\n\u00d7\n\n1\n0\n\n7\n\u2013\n\n5\n.6\n\u00d7\n\n1\n0\n\n7\n)\n\n8\n.9\n\u00d7\n\n1\n0\n\n6\n\n(8\n.2\n\u00d7\n\n1\n0\n\n6\n\u2013\n\n9\n.4\n\u00d7\n\n1\n0\n\n6\n)\n\n1\n.2\n\u00d7\n\n1\n0\n\n8\n\n(1\n.1\n\u00d7\n\n1\n0\n\n8\n\u2013\n\n1\n.4\n\u00d7\n\n1\n0\n\n8\n)\n\n2\n.0\n\u00d7\n\n1\n0\n\n7\n\n(1\n.5\n\u00d7\n\n1\n0\n\n7\n\u2013\n\n2\n.3\n\u00d7\n\n1\n0\n\n7\n)\n\n1\n0\n\n8\n8\n\n0\n.1\n+\n\n7\n.4\n\n1\n0\n\n0\n+\n\n1\n.5\n\n1\n6\n\n.4\n(1\n\n5\n.5\n\n\u2013\n1\n\n7\n.5\n\n)\n9\n\n.9\n(9\n\n.4\n\u2013\n\n1\n0\n\n.4\n)\n\n2\n5\n\n.7\n(2\n\n4\n.9\n\n\u2013\n2\n\n6\n.1\n\n)\n1\n\n3\n.3\n\n(1\n2\n\n.6\n\u2013\n\n1\n4\n\n.2\n)\n\n1\n0\n\n9\n1\n\n0\n0\n\n1\n0\n\n0\n8\n\n.3\n(8\n\n.0\n\u2013\n\n8\n.6\n\n)\n6\n\n.4\n(6\n\n.1\n\u2013\n\n6\n.7\n\n)\n1\n\n0\n.2\n\n(9\n.8\n\n\u2013\n1\n\n0\n.7\n\n)\n8\n\n.1\n(7\n\n.7\n\u2013\n\n8\n.6\n\n)\n\nN\no\n\nrd\ne\n\nst\ne\n\n1\n0\n\n7\n1\n\n5\n.6\n+\n\n7\n.4\n\n2\n0\n\n.6\n+\n\n9\n.2\n\nN\nD\n\nN\nD\n\nN\nD\n\nN\nD\n\n6\n.3\n\u00d7\n\n1\n0\n\n7\n\n(5\n.6\n\u00d7\n\n1\n0\n\n7\n\u2013\n\n6\n.8\n\u00d7\n\n1\n0\n\n7\n)\n\n2\n.4\n\u00d7\n\n1\n0\n\n7\n\n(2\n.1\n\u00d7\n\n1\n0\n\n7\n\u2013\n\n2\n.7\n\u00d7\n\n1\n0\n\n7\n)\n\n1\n.6\n\u00d7\n\n1\n0\n\n8\n\n(1\n.3\n\u00d7\n\n1\n0\n\n8\n\u2013\n\n2\n.3\n\u00d7\n\n1\n0\n\n8\n)\n\n4\n.5\n\u00d7\n\n1\n0\n\n7\n\n(4\n.1\n\u00d7\n\n1\n0\n\n7\n\u2013\n\n4\n.9\n\u00d7\n\n1\n0\n\n7\n)\n\n1\n0\n\n8\n6\n\n5\n.6\n+\n\n1\n0\n\n.1\n1\n\n0\n0\n+\n\n2\n.4\n\n1\n9\n\n.8\n(1\n\n9\n.5\n\n\u2013\n2\n\n0\n.1\n\n)\n1\n\n7\n.8\n\n(1\n7\n\n.6\n\u2013\n\n1\n8\n\n.0\n)\n\n2\n5\n\n.9\n(2\n\n5\n.3\n\n\u2013\n2\n\n6\n.5\n\n)\n2\n\n1\n.7\n\n(2\n1\n\n.4\n\u2013\n\n2\n2\n\n.0\n)\n\n1\n0\n\n9\n1\n\n0\n0\n+\n\n2\n.1\n\n1\n0\n\n0\n1\n\n2\n.9\n\n(1\n1\n\n.7\n\u2013\n\n1\n3\n\n.2\n)\n\n9\n.7\n\n(8\n.6\n\n\u2013\n1\n\n0\n.8\n\n)\n1\n\n6\n.6\n\n(1\n6\n\n.3\n\u2013\n\n1\n7\n\n.0\n)\n\n1\n1\n\n.5\n(1\n\n0\n.3\n\n\u2013\n1\n\n2\n.7\n\n)\n\nA\nL\n\n1\n0\n\n7\n1\n\n5\n.3\n+\n\n6\n.6\n\n1\n0\n\n.6\n+\n\n1\n.8\n\nN\nD\n\nN\nD\n\nN\nD\n\nN\nD\n\n.\n5\n\u00d7\n\n1\n0\n\n9\n7\n\n.2\n\u00d7\n\n1\n0\n\n7\n\n(7\n.0\n\u00d7\n\n1\n0\n\n7\n\u2013\n\n7\n.6\n\u00d7\n\n1\n0\n\n7\n)\n\n.\n5\n\u00d7\n\n1\n0\n\n9\n2\n\u00d7\n\n1\n0\n\n9\n\n(1\n.8\n\u00d7\n\n1\n0\n\n9\n\u2013\n\n2\n.4\n\u00d7\n\n1\n0\n\n9\n)\n\n1\n0\n\n8\n3\n\n5\n.6\n+\n\n8\n.8\n\n5\n0\n\n.3\n+\n\n1\n2\n\n.5\nN\n\nD\n2\n\n4\n.5\n\n(2\n4\n\n.2\n\u2013\n\n2\n4\n\n.9\n)\n\nN\nD\n\n2\n5\n\n.5\n(2\n\n4\n.9\n\n\u2013\n2\n\n6\n.2\n\n)\n1\n\n0\n9\n\n4\n5\n\n.9\n+\n\n1\n1\n\n.6\n7\n\n0\n.6\n+\n\n1\n5\n\n.3\nN\n\nD\n1\n\n9\n.4\n\n(1\n8\n\n.1\n\u2013\n\n2\n0\n\n.8\n)\n\nN\nD\n\n2\n4\n\n.5\n(2\n\n4\n.2\n\n\u2013\n2\n\n4\n.9\n\n)\n\nN\nD\n\n:\nn\n\no\nt\n\nd\ne\n\nte\nrm\n\nin\ne\n\nd\n(m\n\no\nrt\n\na\nlit\n\ny\n,\n\n5\n0\n\n%\n).\n\na\n2\n\n5\nd\n\na\nys\n\na\nft\n\ne\nr\n\ntr\ne\n\na\ntm\n\ne\nn\n\nt.\n\nW. O. Beys-da-Silva et al.\n\n60\n\n by guest on D\necem\n\nber 13, 2012\nhttp://trstm\n\nh.oxfordjournals.org/\nD\n\now\nnloaded from\n\n \n\n224\n\nhttp://trstmh.oxfordjournals.org/lookup/suppl/doi:10.1093/trstmh/trs006/-/DC1\nhttp://trstmh.oxfordjournals.org/lookup/suppl/doi:10.1093/trstmh/trs006/-/DC1\nhttp://trstmh.oxfordjournals.org/\nhttp://trstmh.oxfordjournals.org/\nhttp://trstmh.oxfordjournals.org/\nhttp://trstmh.oxfordjournals.org/\n\n\nAuthors\u2019 contributions: WOBS and LS designed the study; WOBS, LS and\nMB performed the tests and analysed the data; WOBS, LS, JAG, AS and\nMHV interpreted the results and drafted and revised the manuscript. All\nauthors read and approved the final manuscript. WOBS is guarantor of\nthe paper.\n\nAcknowledgements: The authors are very grateful to Msc Ka?tia Moura\n[Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre,\nBrazil] for technical support and to Dr Antonio FM Pinto (UFRGS) for\nreading the manuscript.\n\nFunding: This work was supported by Coordenac?a?o de Aperfeic?oamento\nde Pessoal de N??vel Superior (CAPES) [grant no. 23038006269/2011-39]\nand Conselho Nacional de Desenvolvimento Cient??fico e Tecnolo?gico\n(CNPq) [grant no. 481162/2010-0].\n\nCompeting interests: None declared.\n\nEthical approval: Not required.\n\nReferences\n1 Silva PH, Silveira RB, Appel MH et al. Brown spiders and loxoscelism.\n\nToxicon 2004;44:693 \u2013 709.\n\n2 Beys da Silva WO, Santi L, Schrank A, Vainstein MH. Metarhizium\nanisopliae lipolytic activity plays a pivotal role in Rhipicephalus\n(Boophilus) microplus infection. Fungal Biol 2010;114:10 \u2013 5.\n\n3 Rocha LFN, Luz C. Activity of Metarhizium spp. and Isaria spp. from the\ncentral Brazilian Cerrado against Triatoma infestans nymphs. Trans R\nSoc Trop Med Hyg 2011;105:417 \u2013 9.\n\n4 Beys-da-Silva WO, Santi L, Vainstein MH, Schrank A. Biocontrol of the\ncattle tick Rhipicephalus (Boophilus) microplus by the acaricidal\nfungus Metarhizium anisopliae. In: Woldemeskel M (editor). Ticks:\nDisease, Management and Control. Hauppauge, NY: Nova Science\nPublishers Inc., 2012; 217 \u2013 46.\n\n5 Santi L, Silva LAD, Beys-da-Silva WO et al. Virulence of the\nentomopathogenic fungus Metarhizium anisopliae using soybean\noil formulation for control of the cotton stainer bug, Dysdercus\nperuvianus. World J Microbiol Biotechnol 2011;27:2297 \u2013 303.\n\nTransactions of the Royal Society of Tropical Medicine and Hygiene\n\n61\n\n by guest on D\necem\n\nber 13, 2012\nhttp://trstm\n\nh.oxfordjournals.org/\nD\n\now\nnloaded from\n\n \n\n225\n\nhttp://trstmh.oxfordjournals.org/\n\n\nAntithrombotic Effect of Chikusetsusaponin IVa\nIsolated from Ilex paraguariensis ( Mate?)\n\nTabitha Dahmer,\n1,* Markus Berger,\n\n2,* Adriana Gregory Barlette,\n1\n\nJose? Reck Jr.,\n2\n\nJe?ferson Segalin,\n2\n\nSimone Verza,\n1\n\nGeorge Gonza?lez Ortega,\n1\n\nSimone Cristina Baggio Gnoatto,\n1\n\nJorge Almeida Guimara?es,\n2\n\nHugo Verli,\n1,2\n\nand Grace Gosmann\n1\n\n1Faculty of Pharmacy and 2Center of Biotechnology, Federal University of Rio Grande do Sul, Porto Alegre,\nRio Grande do Sul, Brazil.\n\nABSTRACT The triterpene chikusetsusaponin IVa was isolated from the fruit of Ilex paraguariensis. Using biochemical\n\nand pharmacological methods, we demonstrated that chikusetsusaponin IVa (1) prolongs the recalcification time, prothrombin\n\ntime, activated partial thromboplastin time, and thrombin time of normal human plasma in a dose-dependent manner, (2)\n\ninhibits the amidolytic activity of thrombin and factor Xa upon synthetic substrates S2238 and S2222, (3) inhibits thrombin-\n\ninduced fibrinogen clotting (50% inhibition concentration, 199.4 \u2013 9.1 lM), and (4) inhibits thrombin- and collagen-induced\nplatelet aggregation. The results also indicate that chikusetsusaponin IVa preferentially inhibits thrombin in a competitive\n\nmanner (Ki = 219.6 lM). Furthermore, when administered intravenously to rats, chikusetsusaponin IVa inhibited thrombus\nformation in a stasis model of venous thrombosis, although it did not induce a significant bleeding effect. Chikusetsusaponin\n\nIVa also prolonged the ex vivo activated partial thromboplastin time. Altogether, these data suggest that chikusetsusaponin IVa\n\nexerts antithrombotic effects, including minor hemorrhagic events. This appears to be important for the development of new\n\ntherapeutic agents.\n\nKEY WORDS: ? chikusetsusaponin ? hemostasis ? Ilex paraguariensis ? platelet aggregation ? thrombosis ? thrombin\n\nINTRODUCTION\n\nThrombosis and cardiovascular diseases are themajor causes of morbidity and mortality in the Western\nworld and frequently involve a prothrombotic state such as\nmyocardial infarction, stroke, and atherosclerosis.1 Antic-\noagulant and antithrombotic agents, such as heparin, vitamin\nK antagonists, and acetylsalicylic acid, are currently used to\ntreat and prevent these thromboembolic events.2 Consider-\ning the high incidence of side effects (e.g., gastrointestinal\nbleeding and thrombocytopenia), important efforts have\nbeen made to find new antithrombotic substances.2\u20135\n\nIn the context of hemostasis, glycyrrhizin [3-O-(2-O-b-\nd-glucopyranuronosyl-a-d-glucopyranuronosyl)-18b-gly-\ncyrrhetinic acid (GL)] (Fig. 1), a triterpenoid saponin\nobtained from the roots of Glycyrrhiza glabra, presented\nanticoagulant and antithrombotic effects. GL prolonged the\nin vitro coagulation time and inhibited the thrombin-induced\n\nclotting of plasma and fibrinogen.6 In addition, the GL an-\ntithrombotic effect was also observed in animal models of\nthrombosis.7\n\nIlex paraguariensis, a South American tree of the Aqui-\nfoliaceae family, is rich in saponins (approximately 10%).8\n\nDried leaves and twigs from this tree are used to prepare a\ntea known as mate? that is commonly consumed in Brazil,\nUruguay, Paraguay, and Argentina. The saponins isolated\nfrom its leaves are glycosides derived mainly from ursolic\nand oleanolic acids.8 Other triterpenoid glycosides were\nisolated from the fruits of I. paraguariensis.9 Pentacyclic\ntriterpenoids such as ursolic and oleanolic acids and their\nderivatives possess pharmacological properties, such as\nanti-human immunodeficiency virus, hepatoprotective, anti-\ninflammatory, antimalarial, antiglycation, and cytotoxic ef-\nfects,10\u201312 suggesting their potential use for the design of\nnew bioactive compounds. In this sense, the triterpenoid\nchikusetsusaponins (identified by numbers I\u2013IV) possess\nseveral pharmacological activities such as anti-inflamma-\ntory,13 antiviral,14 fibrinolytic,15 and anticancer16\u201318 prop-\nerties. In particular, chikusetsusaponin IVa has also been\nisolated from other species of Ilex, such as Ilex dumosa,19\n\nIlex pubescens,13 and Ilex rotunda.20\n\nIn the present study, we describe the in vitro and in vivo\nanticoagulant and antiplatelet activity of chikusetsusaponin\nIVa (Fig. 1).\n\n*The first two authors contributed equally to this work.\n\nManuscript received 12 December 2011. Revision accepted 8 July 2012.\n\nAddress correspondence to: Grace Gosmann, Faculdade de Farma?cia, Universidade\nFederal do Rio Grande do Sul, Avenue Ipiranga, 2752, Porto Alegre, RS, 90610-000,\nBrazil, E-mail: grace.gosmann@ufrgs.br or Dr. Hugo Verli, Laborato?rio de Bioinfor-\nma?tica Estrutural, Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul,\nAvenue Bento Gonc?alves, 9500, P.O. Box 15005, 91501-970, Porto Alegre, RS, Brazil,\nE-mail: hverli@cbiot.ufrgs.br\n\nJOURNAL OF MEDICINAL FOOD\nJ Med Food 15 (12) 2012, 1073\u20131080\n# Mary Ann Liebert, Inc., and Korean Society of Food Science and Nutrition\nDOI: 10.1089/jmf.2011.0320\n\n1073\n226\n\n\n\nMATERIALS AND METHODS\n\nDrugs and reagents\n\nBovine fibrinogen, human factor Xa, bovine type I col-\nlagen, ADP, and GL were purchased from Sigma-Aldrich\n(St. Louis, MO, USA). Arachidonic acid was purchased\nfrom Chrono-Log Co. (Havertown, PA, USA). Human a-\nthrombin was purified from plasma of healthy volunteer\ndonors according to the precedure of Ngai and Chang.21\n\nSynthetic substrates for thrombin (S2238 [H-d-Phe-\nPip-Arg-p-nitroanilide]) and factor Xa (S2222 [Benzyl-\nIle-Glu-Gly-Arg-p-nitroanilide]) were purchased from\nChromogenix ( Milan, Italy). Anasedan? (xylazine) and\nDopalen? (ketamine) were purchased from Crista?lia Pro-\ndutos Qu??micos Farmace?uticos (Sa?o Paulo, Brazil). Calcium\nthromboplastin was purchased from Wiener Lab (Rosario,\nArgentina).\n\nApparatus\n\nMass spectrometry experiments were carried out using a\nMicromass/Waters ( Milford, MA, USA) quadrupole-time\nof flight mass spectrometer microequipped with a nano-\nelectrospray ionization source. Data were analyzed with the\nWaters MassLynx software. 1H and 13C nuclear magnetic\nresonance were recorded on a Varian (Palo Alto, CA, USA)\nInova spectrometer (300 MHz) in CD3OD. The spectro-\nphotometer used was a SpectraMax ( Molecular Devices\nCo., Sunnyvale, CA, USA), equipped with temperature\ncontrol and shaking systems.\n\nIsolation and structural elucidation of saponin\n\nFruits of I. paraguariensis A. St. Hil. were harvested in a\ncultivated area in Rio Grande do Sul, Brazil. A voucher\nspecimen was deposited at the Herbarium of the Federal\nUniversity of Rio Grande do Sul, Porto Alegre, RS, Brazil,\nas voucher number ICN/UFRGS (163413). The hydro-\nethanolic extract was prepared using 10 g of dried and\npowdered fruits in 40% ethanol by maceration (1:10,\nplant:solvent). After evaporation of the solvent, the extract\nwas subjected to chromatography on a silica gel column\n( Merck, Darmstadt, Germany) using gradient mixtures of\nchloroform:ethanol:water. Fractions were collected and\npooled according to thin-layer chromatography (silica gel\nGF254; chloroform:ethanol:water, 40:40:5 by volume). Then\n\npooled fractions were subjected to further purification,\nseparately, using Lichroprep? ( Merck; particle size,\n40\u201363 lm) and gradient mixtures of water:ethanol as eluate.\nPure saponin was obtained (90 mg), corresponding to 2% of\nthe dried ethanolic extract.\n\nChikusetsusaponin IVa\n\nThe identification of saponin in its native form was\nmostly deduced from a combination of mass spectrometry\nand nuclear magnetic resonance spectroscopy. This combi-\nnation allowed the identification of an already known sa-\nponin named chikusetsusaponin IVa, previously isolated by\nus from leaves of I. dumosa.19 It was obtained as an amor-\nphous powder; its main peak in the mass spectrum was m/z\n817.4354 Da, corresponding to the chemical species\n[(C42H66O14) Na]\n\n+ (expected m/z, 817.4350 Da), together\nwith the peak m/z 833.4175 Da [(C42H66O14) K]\n\n+ (Fig. 2).\n1H and 13C nuclear magnetic resonance (300 MHz, CD3OD)\ndata were similar to those previously described.19\n\nEffects of chikusetsusaponin IVa on hemostatic system:\nin vitro studies\n\nCoagulation assays. The anticoagulant activity of chi-\nkusetsusaponin IVa (0\u20132000 lM) was verified by the de-\ntermination of the following coagulation parameters in\nplasma: recalcification time (RT), activated partial throm-\nboplastin time (aPTT), prothrombin time (PT), and throm-\nbin time (TT). Anticoagulant experiments were performed\nusing commercial kits following the manufacturer\u2019s in-\nstructions (Wiener Lab). Human venous blood was collected\nfrom healthy volunteer donors in 1:10 (vol/vol) 3.8% tri-\nsodium citrate and centrifuged at 1500 g for 10 min to obtain\nplasma. Assays were conducted using a 96-well microplate\nSpectraMax as described.22 Results are expressed as the\ncoagulation time (in seconds) and represent the mean \u2013 SEM\nvalues of three independent experiments performed in\nquadruplicates.\n\nAmidolytic assay. Saponin (0\u20132650 lM) was incubated\nwith thrombin (2 lg/mL) or factor Xa (3.4 lg/mL) in 20 mM\nTris-HCl (pH 7.5) for 20 min at 37?C. Enzymatic reactions\nwere started by addition of the chromogenic substrate S2238\n(0.2 mM) or S2222 (0.2 mM) in a volume of 100 lL for\nthe determination of thrombin and factor Xa activities,\n\nFIG. 1. Chemical structures of chi-\nkusetsusaponin IVa and glycyrrhizin.\nGlc, glucose; GluA, glucuronic acid.\n\n1074 DAHMER ET AL.\n\n227\n\n\n\nrespectively. The amount of p-nitroaniline produced was\nmonitored at 405 nm in intervals of 14 s for 30 min using a\nSpectraMax spectrophotometer. The initial rate of hydro-\nlysis (expressed as milli-optical density units per minute)\nwas used to calculate the percentage of thrombin inhibition.\nThese data were plotted versus the concentration of inhibi-\ntor, and a nonlinear regression analysis was performed to\ncalculate the values for concentration causing 50% inhibi-\ntion (IC50) values. For kinetic analysis, saponin (0\u2013450 lM)\nwas incubated with thrombin prior to the addition of S2238\n(50 and 100 lM). Data from the initial rate, expressed as\n(lM p-nitroaniline generated/min) - 1, was plotted versus\nthe inhibitor concentration to construct a Dixon\u2019s plot. The\ncurves were analyzed by linear regression to calculate the\ninhibition constant (Ki) value and to determine the type of\ninhibition.23 Results are presented as mean \u2013 SEM values\n(n = 3).\n\nThrombin-induced fibrinogen clotting. Chikusetsusa-\nponin IVa (0\u2013900 lM) and GL (0\u20131100 lM) were solubi-\nlized in 20 mM Tris-HCl (pH 7.5) and incubated with\nthrombin (2 lg/mL) for 10 min at 37?C. Reactions were\ninitiated by the addition of fibrinogen (2 mg/mL) in a vol-\nume of 100 lL. The kinetics of fibrin formation were mea-\nsured at 14-s intervals for 30 min at 650 nm using a\nSpectraMax spectrophotometer. The initial rate of clotting\nformation (expressed as milli-optical density per minute)\nwas used to calculate the percentage of the thrombin inhi-\nbition. These data were plotted versus the concentration of\ninhibitor, and a nonlinear regression analysis was performed\nto calculate the IC50 (mean \u2013 SEM, n = 3).\n\nPlatelet aggregation. The platelet function was mea-\nsured by the in vitro photometric method,24 using a Spec-\ntraMax spectrophotometer. Whole human blood was\ncollected from healthy volunteer donors. Washed human\nplatelets were then prepared by gel filtration in a Sepharose\n2B column.25 Platelet concentration was adjusted to 350,000\ncells/lL in a Neubauer chamber. Platelet aggregation was\nmeasured by the decreased rate in washed human platelet\noptical density in a final volume of 150 lL. The agonists\nused were as follows: ADP (10 lM), collagen (2.5 lg/mL),\narachidonic acid (10 lM), or human thrombin (3 lg/mL).\nSaponin (0\u20131000 lM) was preincubated with washed human\n\nplatelets for 20 min before the addition of agonist. The re-\nsults are expressed as the percentage area under curves\n(mean \u2013 SEM, n = 4).\n\nEffects of chikusetsusaponin IVa saponin on hemostatic\nsystem: In vivo studies\n\nAnimals. Male Wistar rats (weighing 300\u2013350 g) were\nhoused in a temperature-controlled room (21\u201325?C, in a\n12-h light/dark cycle) with free access to water and food. All\nprocedures involving animals were carried out in accor-\ndance with the guiding principles of the International So-\nciety of Toxicology and the Brazilian College of Animal\nExperimentation. The experimental protocol was approved\nby the Ethical Committee on Research Animal Care of the\nFederal University of Rio Grande do Sul, Brazil (protocol\nnumber 2008177/2009).\n\nIn vivo model of deep venous thrombosis. A rat\nthrombosis model that is a combination of stasis and hy-\npercoagulability induced by a tissue factor-rich component\nwas used according to the literature26 with minor modifi-\ncations.27 In brief, rats were anesthetized with xylazine\n(16 mg/kg, i.p.) followed by ketamine (100 mg/kg, i.p.). The\nabdomen was surgically opened, and the vena cava was\nexposed and dissected free from surrounding tissues. Sub-\nsequently, rats received the following treatments via the left\nfemoral vein (final volume of 0.7 mL): (1) saline, n = 4; (2)\nchikusetsusaponin IVa at 15 and 50 mg/kg, n = 4 per dose; or\n(3) GL at 15 and 50 mg/kg, n = 4 per dose. After 3 min,\ncalcium thromboplastin (3 mg/kg) was injected into the vena\ncava, and stasis was immediately established by the ligation\nof caudal vena cava (above the insertion point of the right\nrenal vein). The distal ligations of the vena cava, left renal\nvein, and other major tributaries were conducted 20 min\nafter thromboplastin administration. The isolated segment\nof caudal vena cava was removed, and the thrombus was\nseparated, rinsed with saline (at 37?C), dried on a filter paper\nat 60?C (1 h), and weighed. The ratio value of thrombus/rat\nweight was used for data comparison.\n\nBleeding effect. Rats were anesthetized as described\nabove, and the following treatments were administered via\nthe left femoral vein (final volume of 0.7 mL): (1) saline,\n\nFIG. 2. Mass spectrum of chikusetsusaponin IVa using a Micromass/Waters quadrupole-time of flight (TOF) mass spectrometer ( MS) equipped\nwith a nano-electrospray (ES) ionization source.\n\nANTITHROMBOTIC CHIKUSETSUSAPONIN IVA 1075\n\n228\n\n\n\nn = 4; (2) chikusetsusaponin IVa at 15 and 50 mg/kg, n = 4\nper dose; or (3) GL at 15 and 50 mg/kg, n = 4 per dose. After\n5 min, the rat\u2019s tail was cut off 3 mm from the tip and\ncarefully immersed in 40 mL of distilled water at room\ntemperature. Blood loss was evaluated 60 min later as a\nfunction of hemoglobin concentration in aqueous solution.7\n\nHemoglobin concentration was determined at 540 nm using\na standard curve made with hemoglobin. The hemoglobin\ncontent in the water of saline-treated animals was used as a\ncontrol.\n\nEx vivo determination of aPTT and hemoglo-\nbin. Animals were anesthetized as described above, and\nthe following treatments were administered via the left\nfemoral vein (final volume of 0.7 mL): (1) saline, n = 4; (2)\nchikusetsusaponin IVa at 15 and 50 mg/kg, n = 4 per dose; or\n(3) GL at 15 and 50 mg/kg, n = 4 per dose. Blood samples\nwere collected from the right femoral vein (0.3 mL in 3.8%\ntrisodium citrate, 1:10 [vol/vol]) at different times post-\ntreatment. Each blood sample was centrifuged, and plasma\nwas used to measure the aPTT as described above. To es-\ntimate the hemolytic potential of saponins, hemoglobin\ncontent was measured in plasma samples of animals treated\nwith 50 mg/kg chikusetsusaponin IVa or GL. The concen-\ntration of free plasma hemoglobin was measured with a kit\ncommercially available following the manufacturer\u2019s in-\nstructions (Labtest SA, Lagoa Santa, MG, Brazil).\n\nStatistical analysis\n\nResults are expressed as mean \u2013 SEM values, and sig-\nnificance was determined by Student\u2019s t test. When more\nthan two groups were compared, an analysis of variance was\nused followed by a Bonferroni\u2019s test to compare pairs of\nmeans. The data were considered significant with a proba-\nbility of &lt;.05.\n\nRESULTS\n\nEffects of chikusetsusaponin IVa on hemostatic system:\nin vitro studies\n\nChikusetsusaponin IVa showed anticoagulation effects by\nelongating the time for RT, aPTT, PT, and TT in a dose-\ndependent manner (Table 1). At 500 lM, a significant in-\nhibition was observed in PT and TT. At 1000 lM, the sa-\nponin caused an increase of 1.3-fold in RT, 2.3-fold in\naPTT, 1.8-fold in PT, and 1.9-fold in TT compared with\nrespective control values (Table 1). In relation to the hy-\ndrolysis of synthetic substrates, chikusetsusaponin IVa in-\nhibited, in a dose-dependent manner, the enzymes tested\n(S2238 and S2222) with IC50 values of 384.2 \u2013 44.2 lM for\nthrombin-catalyzed hydrolysis (Fig. 3A) and 1585.7 \u2013\n96.9 lM for factor Xa-catalyzed hydrolysis (Fig. 3B). En-\nzyme kinetic studies indicated that chikusetsusaponin IVa\ninhibited the thrombin catalytic hydrolysis of S2238 in\na competitive manner with a Ki value of 219.6 \u2013 32 lM\n(Fig. 3C).\n\nAs shown in Figure 4, chikusetsusaponin IVa inhibited\nthe thrombin-induced fibrinogen clotting in a dose-dependent\nmanner with an IC50 value of 199.4 \u2013 9.1 lM. This inhibitory\nactivity was similar to that obtained for GL (235.7 \u2013 1.4 lM;\nFig. 4). In relation to the platelet aggregation, the saponin\nhad no effect on ADP or on arachidonic acid-induced\naggregation (Fig. 5). However, it significantly inhibited\ncollagen- and thrombin-induced platelet aggregation in a\ndose-dependent manner. The calculated IC50 values for\ncollagen- and thrombin-induced platelet aggregation were\n482 and 190 lM, respectively.\n\nEffects of chikusetsusaponin IVa on hemostatic system:\nin vivo studies\n\nAs shown in Figure 6A, chikusetsusaponin IVa reduced\nthe size of the thrombus by 56.2% and 91.2% at doses of\n15 and 50 mg/kg, respectively. In comparison, GL was able\nto reduce the thrombus only 21.2% and 53.1% at doses of\n15 and 50 mg/kg, respectively (Fig. 6A). In addition, chi-\nkusetsusaponin IVa did not induce a significant bleeding\neffect after intravascular administration (Fig. 6B). How-\never, GL caused an increase in blood loss of approximately\n1.8-fold compared with the control at the dose of 50 mg/kg\n(Fig. 6B).\n\nThe anticoagulant effect of chikusetsusaponin IVa ob-\nserved in vitro was confirmed by the measurement of aPTT\nex vivo. Compared with the control, chikusetsusaponin IVa\nat 50 mg/kg was responsible for a significant prolongation of\naPTT at different times following intravascular adminis-\ntration (Table 2). A similar result was observed after the\ninjection of GL at 50 mg/kg (Table 2). To verify the he-\nmolytic potential of chikusetsusaponin IVa and GL, we\nmeasured the hemoglobin content in the plasma of animals\npreviously treated with saponins. No signs of hemoly-\nsis were observed in the plasma of animals treated with\n50 mg/kg GL (control, 43.21 \u2013 8.2 mg/dL; treated, 43.35 \u2013\n4.5 mg/dL) or chikusetsusaponin IVa (control, 42.11 \u2013\n5.6 mg/dL; treated, 40.75 \u2013 4.7 mg/dL).\n\nTable 1. Effects of Chikusetsusaponin IVa\n\non Blood Coagulation Parameters In Vitro\n\nSaponin\nCoagulation time (s)\n\n(lM) RT aPTT PT TT\n\n0 385.6 \u2013 9.6 55.7 \u2013 2.7 17.3 \u2013 1.6 167.5 \u2013 7.3\n500 374.6 \u2013 3.1 81.6 \u2013 2.3 25.5 \u2013 0.9* 240.7 \u2013 4.5*\n\n1000 485.7 \u2013 6.6*** 126.5 \u2013 11.4** 31.7 \u2013 2.4*** 330.1 \u2013 6.3***\n1600 555.5 \u2013 4.8*** 139.6 \u2013 3.6** 40.0 \u2013 1.5*** 412.2 \u2013 27.8***\n2000 840.6 \u2013 25.0*** 158.3 \u2013 18.6*** 53.3 \u2013 1.2*** 428.9 \u2013 1.0***\n\nAfter incubation of chikusetsusaponin IVa with human plasma, the following\n\ncoagulation parameters were determined: recalcification time (RT), activated\n\npartial thromboplastin time (aPTT), prothrombin time (PT), and thrombin time\n\n(TT). Data are mean \u2013 SEM values (in s).\n*P &lt;.05, **P &lt;.01, ***P &lt;.001, statistically significant difference compared\n\nwith coagulation time measured in the absence of saponin (control).\n\n1076 DAHMER ET AL.\n\n229\n\n\n\nDISCUSSION\n\nHerein, the anticoagulant, antiplatelet, and in vivo an-\ntithrombotic activities of chikusetsusaponin IVa were de-\nscribed for the first time. When tested in vitro,\nchikusetsusaponin IVa caused a dose-dependent prolonga-\ntion of RT, aPTT, and PT, suggesting that the major targets\nfor this compound were factors Xa, Va, and thrombin. Ad-\nditionally, chikusetsusaponin IVa was able to inhibit the TT,\nindicating thrombin as a potential target for this saponin in\nplasma. A dose-dependent inhibition of thrombin- and fac-\ntor Xa-catalyzed hydrolysis of specific synthetic substrates\n(S2238 and S2222, respectively) was observed after incu-\nbation with chikusetsusaponin IVa. This observation con-\nfirms that the main targets of this saponin are common\ncoagulation factors. Moreover, the IC50 value for factor Xa\ninhibition was four times higher than that for thrombin in-\nhibition, indicating a preference for thrombin over factor\nXa. We demonstrated that chikusetsusaponin IVa is a\ncompetitive inhibitor of thrombin, similar to other thrombin\n\nFIG. 3. Effects of chikusetsusaponin IVa on thrombin and factor\nXa amidolytic activities. Data are mean \u2013 SEM values of three\nindependent determinations. IC50, concentration causing 50% inhi-\nbition. (A, B) Effects of increasing concentrations of chikusetsusa-\nponin IVa on the activity of (A) human thrombin upon synthetic\nsubstrate S2238 and (B) human factor Xa upon synthetic substrate\nS2222. (C) Dixon\u2019s plot for the inhibitory pattern of chikusetsusa-\nponin IVa on thrombin upon S2238 hydrolysis. Saponin at different\nconcentrations was incubated with thrombin prior to the addition of\n50 lM (C) and 100 lM (-) S2238. The Ki value obtained from the\ngraph is indicated.\n\n\u2030\n\nFIG. 4. Effects of chikusetsusaponin IVa and glycyrrhizin on\nthrombin-induced fibrinogen clotting. Increasing concentrations of chi-\nkusetsusaponin IVa or glycyrrhizin were incubated with human thrombin,\nfollowed by the addition of fibrinogen. The kinetics of fibrin formation\nwere monitored at 650 nm as described in Materials and Methods. Data\nare mean \u2013 SEM values of three independent determinations.\n\nANTITHROMBOTIC CHIKUSETSUSAPONIN IVA 1077\n\n230\n\n\n\ninhibitors such as the thrombin receptor peptide or glyco-\nprotein GPIb that are known to act in the micromolar\nrange.28,29\n\nChikusetsusaponin IVa also inhibited thrombin-induced\nfibrinogen clotting activity with an IC50 that was two times\n\nlower than that for the thrombin-catalyzed hydrolysis of\nS2238. These values indicate that chikusetsusaponin IVa\nmost likely interacts with sites in the thrombin molecule\nother than the catalytic site because a more potent inhibi-\ntion was observed when the macromolecular substrate fi-\nbrinogen was used. Chikusetsusaponin IVa has an in vitro\nantiplatelet effect when induced by thrombin and collagen\nas well as an in vivo antithrombotic property. In compari-\nson with GL, chikusetsusaponin IVa had a significantly\nmore potent antithrombotic effect at the doses of 15 and\n50 mg/kg. In addition, chikusetsusaponin IVa had no\nbleeding effect, which may be considered an advantage\ncompared with known antithrombotic agents such as hir-\nudin, argatroban, heparin, or acetylsalicylic acid.30 Fur-\nthermore, intravenous injection of chikusetsusaponin IVa\n\nFIG. 6. In vivo antithrombotic and bleeding effects of chikusetsusaponin IVa and glycyrrhizin. (A) The venous thrombosis model. Saponins at the\nindicated doses were administered intravenously to rats 3 min before the induction of thrombosis by thromboplastin combined with stasis as described\nin Materials and Methods. Data are mean \u2013 SEM values of four animals. *P &lt;.05, ***P &lt;.001, statistically significant difference compared with\nanimals that received saline instead of saponins. (B) The bleeding effect. Rats were injected intravenously with different doses of chikusetsusaponin\nIVa or glycyrrhizin. Five minutes after injection, the rat\u2019s tail was cut off and carefully immersed in distilled water. Blood loss was evaluated 60 min\nlater by measuring the hemoglobin (Hb) concentration in aqueous solution. Data are mean \u2013 SEM values of four animals. Statistically significant\ndifferences (P &lt;.001) are indicated for comparison with *animals that received only saline solution and #animals that received 50 mg/kg glycyrrhizin.\n\nFIG. 5. Effects of chikusetsusaponin IVa on platelet aggregation.\nIncreasing concentrations of chikusetsusaponin IVa were incubated\nwith washed human platelets. Platelet aggregation was triggered by\nthe addition of the following agonists: thrombin (THR), collagen\n(COLL), ADP, or arachidonic acid (AA). Data are mean \u2013 SEM\nvalues of four independent determinations. **P &lt;.01, ***P &lt;.001,\nstatistically significant difference compared with platelet aggregation\nin the absence of inhibitor.\n\nTable 2. Ex Vivo Anticoagulation Effect\n\nof Chikusetsusaponin IVa\n\nTreatment,\naPTT (s)\n\ndose (mg/kg) 5 min 15 min 30 min 60 min\n\nSaline 17.2 \u2013 0.2 16.8 \u2013 0.2 16.8 \u2013 0.6 17.4 \u2013 0.6\nGlycyrrhizin\n\n15 17 \u2013 0.2 17.7 \u2013 0.4 17.2 \u2013 0.3 16.8 \u2013 0.5\n50 16.6 \u2013 0.2 19.6 \u2013 1.0 20.4 \u2013 0.7* 25 \u2013 0.3***\n\nChikusetsusaponin IVa\n15 18.6 \u2013 0.9 17.6 \u2013 0.6 19.1 \u2013 0.8 14.8 \u2013 1.1\n50 20.5 \u2013 0.3*** 24 \u2013 0.6*** 21.3 \u2013 1.4* 20.4 \u2013 0.2*\n\nEx vivo aPTT was measured in plasma of rats 5, 15, 30 and 60 min after\n\nintravenous injection of saline (control), glycyrrhizin, or chikusetsusaponin\n\nIVa. Data are mean \u2013 SEM values (in s).\n*P &lt;.05, ***P &lt;.001, statistically significant difference compared with\n\ncoagulation time of the control group.\n\n1078 DAHMER ET AL.\n\n231\n\n\n\nor GL had no toxic hemolytic effect in treated animals and\ncaused only a slight increase in ex vivo aPTT. Moreover,\nthis saponin had a significant antithrombotic activity at a\ndose of 15 mg/kg without affecting the aPTT. Recently, it\nwas reported that potent orally active factor Xa inhibitors\nsuch as darexaban and darexaban glucuronide are able to\ninhibit thrombus formation and prolong the coagulation\ntime in vivo without inducing any bleeding effect.31 It was\nreported15 that chikusetsusaponins III, IV, and V increased\nthe in vitro activity of urokinase, an important plasminogen\nactivator during fibrinolysis. Possibly, the increase in fi-\nbrinolysis induced by chikusetsusaponins contributed to\nthe antithrombotic and anticoagulant effects described in\nthis research.\n\nIn conclusion, chikusetsusaponin IVa is a new plant-\nderived antithrombotic compound that increases the coag-\nulation time and promotes antiplatelet and antithrombotic\nactivity.\n\nACKNOWLEDGMENTS\n\nWe are grateful to the Conselho Nacional de De-\nsenvolvimento Cient??fico e Tecnolo?gico, Ministe?rio de\nCie?ncia e Tecnologia and to the Coordenac?a?o de Aperfei-\nc?oamento de Pessoal de N??vel Superior, Ministe?rio da\nEducac?a?o, Bras??lia, DF, Brazil, for their financial support\nand fellowships.\n\nAUTHOR DISCLOSURE STATEMENT\n\nNo competing financial interests exist.\n\nREFERENCES\n\n1. Weitz JI, Hirsh J, Samama MM: New antithrombotic drugs:\n\nAmerican College of Chest Physicians evidence-based clinical\n\npractice guidelines (8th edition). Chest 2008;133(6 Suppl):234S\u2013\n\n256S. Erratum in Chest 2008;134:473.\n\n2. Laux V, Perzborn E, Heitmeier S, et al.: Direct inhibitors of\n\ncoagulation proteins\u2014the end of the heparin and low-molecular-\n\nweight heparin era for anticoagulant therapy? Thromb Haemost\n\n2009;102:892\u2013899.\n\n3. Toschi V, Lettino M: Inhibitors of propagation of coagulation:\n\nfactors V and X. Br J Clin Pharmacol 2011;72:563\u2013580.\n\n4. Newman DJ, Cragg GM: Natural products as sources of new\n\ndrugs over the last 25 years. J Nat Prod 2007;70:461\u2013477.\n\n5. Radnaabazar C, Park CM, Kim JH, Cha J, Song Y-S: Fibrinolytic\n\nand antiplatelet aggregation properties of a recombinant\n\nCheonggukjang kinase. J Med Food 2011;14:625\u2013629.\n\n6. Francischetti IM, Monteiro RQ, Guimara?es JA: Identification of\n\nglycyrrhizin as a thrombin inhibitor. Biochem Biophys Res\n\nCommun 1997;235:259\u2013263.\n\n7. Mendes-Silva W, Assafim M, Ruta B, Monteiro RQ, Guimara?es\n\nJA, Zingali RB: Antithrombotic effect of glycyrrhizin, a plant-\n\nderived thrombin inhibitor. Thromb Res 2003;112:93\u201398.\n\n8. Heck AI, Mejia EG: Yerba mate tea (Ilex paraguariensis): a\n\ncomprehensive review on chemistry, health implications, and\n\ntechnological considerations. J Food Sci 2007;72:138\u2013151.\n\n9. Taketa A, Breitmaier E, Schenkel E: Triterpenes and triterpe-\n\nnoidal glycosides from the fruits of Ilex paraguariensis (mate?).\n\nJ Braz Chem Soc 2004;15:205\u2013211.\n\n10. Liu J: Pharmacology of oleanolic acid and ursolic acid. J Eth-\n\nnopharmacol 1995;49:57\u201368.\n\n11. Yogeeswari P, Sriram D: Betulinic acid and its derivatives: a\n\nreview on their biological properties. Curr Med Chem 2005;12:\n\n657\u2013666.\n\n12. Gnoatto S, Susplugas S, Vechia LD, et al.: Pharmacomodulation\n\non the 3-acetylursolic acid skeleton: design, synthesis and bio-\n\nlogical evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]\n\npropyl}-3-O-acetylursolamide derivatives as antimalarial agents.\n\nBioorg Med Chem 2008;16:771\u2013782.\n\n13. Wang JR, Zhou H, Jiang ZH, Liu L: Two new triterpene saponins\n\nfrom the anti-inflammatory saponin fraction of Ilex pubescens\n\nroot. Chem Biodivers 2008;5:1369\u20131376.\n\n14. Rattanathongkom A, Lee JB, Hayashi K, Sripanidkulchai BO,\n\nKanchanapoom T, Hayashi T: Evaluation of chikusetsusaponin\n\nIVa isolated from Alternanthera philoxeroides for its potency\n\nagainst viral replication. Planta Med 2009;75:829\u2013835.\n\n15. Matsuda H, Samukawa K, Fukuda S, Shiomoto H, Tung CN,\n\nKubo M: Studies of Panax japonicus fibrinolysis. Planta Med\n\n1989;55:18\u201321.\n\n16. Yoo HH, Kwon SW, Park JH: The cytotoxic saponin from heat-\n\nprocessed Achyranthes fauriei roots. Biol Pharm Bull 2006;29:\n\n1053\u20131055.\n\n17. Hosono-Nishiyama K, Matsumoto T, Kiyohara H, Nishizawa, A,\n\nAtsumi T, Yamada H: Suppression of Fas-mediated apoptosis of\n\nkeratinocyte cells by chikusetsusaponins isolated from the roots\n\nof Panax japonicus. Planta Med 2006;72:193\u2013198.\n\n18. Liang C, Ding Y, Tung Nguyen H, et al.: Oleanane-type tri-\n\nterpenoids from Panax stipuleanatus and their anticancer activ-\n\nities. Bioorg Med Chem Lett 2010;2023:7110\u20137115.\n\n19. Pires V, Guillaume D, Gosmann G, Schenkel E: Saponin from\n\nIlex dumosa, an Erva-mate? (Ilex paraguariensis) adulterating\n\nplant. J Agric Food Chem 1997;45:1027\u20131031.\n\n20. Amimoto K, Yoshikawa K, Arihara S: Triterpenoid saponins of\n\nAquifoliaceous plants. VIII. Ilexosides XXIX\u2013XXXII from the\n\nleaves of Ilex rotunda Thunb. Chem Pharm Bull 1992;40:3138\u2013\n\n3141.\n\n21. Ngai PK, Chang JY: A novel one-step purification of human a-\nthrombin after direct activation of crude prothrombin enriched\n\nfrom plasma. Biochem J 1991;280:805\u2013808.\n\n22. Ribeiro JM, Schneider M, Guimara?es JA: Purification and\n\ncharacterization of prolixin S (nitrophorin 2), the salivary anti-\n\ncoagulant of the blood-sucking bug Rhodnius prolixus. Biochem\n\nJ 1995;308:243\u2013249.\n\n23. Dixon M: The determination of enzyme inhibitor constants.\n\nBiochem J 1953;55:170\u2013171.\n\n24. Born GV, Cross MJ: The aggregation of blood platelets. J\n\nPhysiol 1963;168:178\u2013195.\n\n25. Berger M, Reck J Jr, Terra RM, Pinto AF, Termignoni C,\n\nGuimara?es JA: Lonomia obliqua caterpillar envenomation causes\n\nplatelet hypoaggregation and blood incoagulability in rats.\n\nToxicon 2010;55:33\u201344.\n\n26. Vogel GM, Meuleman DG, Bourgondie?n FG, Hobbelen PM:\n\nComparison of two experimental thrombosis models in rats\n\neffects of four glycosaminoglycans. Thromb Res 1989;54:\n\n399\u2013410.\n\nANTITHROMBOTIC CHIKUSETSUSAPONIN IVA 1079\n\n232\n\n\n\n27. Reck J Jr, Berger M, Marks FS, et al.: Pharmacological action\n\nof tick saliva upon haemostasis and the neutralization ability of sera\n\nfrom repeatedly infested hosts. Parasitology 2009;136:1339\u20131349.\n\n28. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM: Localiza-\n\ntion and characterization of an alpha-thrombin-binding site on\n\nplatelet glycoprotein Ib alpha. J Biol Chem 1994;269:6478\u20136484.\n\n29. Bouton MC, Jandrot-Perrus M, Moog S, Cazenave JP, Guillin\n\nMC, Lanza F: Thrombin interaction with a recombinant N-\n\nterminal extracellular domain of the thrombin receptor in an\n\nacellular system. Biochem J 1995;305:635\u2013641.\n\n30. Schulman S, Spencer FA: Antithrombotic drugs in coronary ar-\n\ntery disease: risk benefit ratio and bleeding. J Thromb Haemost\n\n2010;8:641\u2013650.\n\n31. Iwatsuki Y, Sato T, Moritani Y, et al.: Biochemical and phar-\n\nmacological profile of darexaban, an oral direct factor Xa in-\n\nhibitor. Eur J Pharmacol 2011;673:49\u201355.\n\n1080 DAHMER ET AL.\n\n233\n\n\n\nImproving the Thrombin Inhibitory Activity of\nGlycyrrhizin, a Triterpenic Saponin, Through a\nMolecular Simplification of the Carbohydrate Moiety\n\nFernando T. de Paula1, Petrina Q. Frauches1,\nConrado Pedebos2, Markus Berger3, Simone C.\nB. Gnoatto4, Grace Gossmann4, Hugo Verli2,\nJorge A. Guimar~aes3 and Cedric S. Graebin1,*\n\n1\nLaborat?orio de Diversidade Molecular e Qu??mica\nMedicinal (LaDMol-QM), Departamento de Qu??mica,\nInstituto de Cie?ncias Exatas, Universidade Federal Rural\ndo Rio de Janeiro, Rodovia BR-465, Km. 7, Serop?edica,\nRJ 23897-000, Brazil\n2\nGrupo de Bioinform?atica Estrutural, Centro de\nBiotecnologia, Universidade Federal do Rio Grande do\nSul, Av. Bento Gonc?alves, 9500, Pr?edios 43431 \u2013 Setor IV\n\u2013 Campus do Vale \u2013 P.O. Box 15005, Porto Alegre, RS\n91501-970, Brazil\n3\nLaborat?orio de Bioqu??mica Farmacol?ogica, Centro de\nBiotecnologia, Universidade Federal do Rio Grande do\nSul, Av. Bento Gonc?alves, 9500, Pr?edios 43431 \u2013 Setor IV\n\u2013 Campus do Vale \u2013 P.O. Box 15005, Porto Alegre, RS\n91501\u2013970, Brazil\n4\nLaborat?orio de Fitoqu??mica, Faculdade de Farm?acia,\nUniversidade Federal do Rio Grande do Sul, Av. Ipiranga,\n2752, Porto Alegre, RS 90610\u2013000, Brazil\n*Corresponding author: Cedric S. Graebin, cedric@ufrrj.br\nor cedric@ladmolqm.com.br\n\nGlycyrrhizin, a saponin, and its aglycone glycyrrhetinic\nacid are natural products found in the Liquorice (Gly-\ncyrrhiza glabra L.) root extract. This saponin is known\nfor its in vitro and in vivo thrombin inhibitory activity.\nThe design and synthesis of five glycyrrhizin deriva-\ntives were carried out to improve the natural product\nactivity. Compound 3b, a phthalic ester derivative of\nglycyrrhizin, presented a more pronounced thrombin\ninhibition (IC50 = 114.4 ? 1.3 lM) than the saponin\n(IC50 = 235.7 ? 1.4 lM). Molecular docking simulations\nperformed to investigate the molecular interaction\nbetween compound 3b and the enzyme indicate that\nthis product is, as previously determined for glycyrrhi-\nzin, an allosteric thrombin inhibitor.\n\nKey words: glucuronic acid, glycyrrhetinic acid, glycyrrhizin,\nsaponin, thrombin\n\nAbbreviations: MD, molecular docking.\n\nReceived 10 April 2013, revised 14 June 2013 and accepted\nfor publication 12 August 2013\n\nPathologies associated with hypercoagulable states,\nincluding myocardial infarction, deep vein thrombosis and\npulmonary embolism, are one of the most important\ncauses of morbidity and mortality worldwide (1). In spite of\nthe arise of several new synthetic agents in the recent\nyears for treating such diseases, mainly direct thrombin\nand fXa inhibitors, concerns still exist for side-effects, spe-\ncially bleeding (2,3).\n\nIn the recent years, the saponin glycyrrhizin (1) was found\nto be an in vitro and in vivo thrombin inhibitor, being the\nfirst plant-derived natural product with this activity reported\nin the literature (4,5). Additionally, the in vitro assays indi-\ncate that its observed thrombin inhibitory effect is due\nto the selective inhibition of the enzyme\u2019s anion-binding\nexosite 1 (3).\n\nGlycyrrhizin (1) and its aglycone glycyrrhetinic acid (2) are\nnatural products that are abundant in the Liquorice (Glyc-\nyrrhiza glabra L.) root extract. This saponin is used world-\nwide as a natural sweetener and employed in many\nChinese, Indian and Tibetan traditional preparations. Both\ncompounds are known in the literature for its wide range\nof biological activities, and they have been employed as\nscaffolds for the semisynthesis of several derivatives with\ninteresting pharmacological proprieties (6,7). \u2018Stronger\nNeo-Minophagen C\u2019, a glycyrrhizin-containing i.v. formula-\ntion, has been used for more than 30 years in Japan for\nthe treatment of chronic hepatitis diseases (8), being also\nmarketed in China, Korea, Taiwan, Indonesia, India and\nMongolia (9).\n\nWhile synthetic derivatives of heparin analogues as fonda-\nparinux are already in therapeutic use (1), such compounds\nare difficult and expensive to obtain, which has supported\nthe simplification of the carbohydrate scaffold by other,\nnon-saccharidic structures (10). In this context, the current\nwork is focused on the structural simplification of the car-\nbohydrate moiety of 1, searching for potential new non-\nsaccharidic scaffolds with improved antithrombotic activity.\n\nMethods and Materials\n\nAssuming that the carboxylic acid groups present at the\ncarbohydrate units of 1 were crucial to the interaction with\n\n\u00aa 2013 John Wiley &amp; Sons A/S. doi: 10.1111/cbdd.12204 1\n\nChem Biol Drug Des 2013\n\nResearch Letter\n\n234\n\n\n\nthe enzyme\u2019s basic exosite, we devised a simple and\nstraightforward molecular simplification via the synthesis of\nhemi-esters employing the triterpene 2 as starting material\n(Scheme 1) and cyclic and acyclic anhydrides, leading to\nthe esters 3a (also known as carbenoxolone), 3b and the\n3-O-acetyl derivative 3c (6,7). We also employed the clas-\nsical Jones oxidation protocol (6,7) to obtain the ketone\nderivative (4). The reaction of 4 with hydroxylamine hydro-\nchloride gave its respective oxime 5 in moderate-to-good\nyields (Scheme 1). Chemical purity and properties of all\nsynthesized compounds (melting point, TLC profiles when\navailable and 1H- and 13C-NMR) were compared with pre-\nvious reports in the literature [3a and 3b (10), 3c (11), 4\n(12) and 5 (13)].\n\nResults and Discussion\n\nBecause no previous structure\u2013activity relationship was\navailable to guide compound 1 structural modifications,\nour first step was to evaluate the importance of the\n\ncarbohydrate moiety on thrombin modulation. Accordingly,\nthe saponin 1 and its aglycone 2 were tested in the thrombin-\ninduced fibrinogen clotting assay. While 1 presented an\nIC50 = 235.7 ? 1.4 lM, compound 2 was found to be\ninactive on thrombin-induced fibrinogen clotting assay\n(Figure 1), pointing to the importance of the carbohydrate\nmoiety interactions with thrombin.\n\nAs previous works from our group described the binding\nof 1 to thrombin exosite 1, known for its basic properties,\nthe carbohydrate moiety was substituted by acidic, hydro-\ngen-bonding acceptor groups (Scheme 1) to evaluate (i)\nthe influence of the substituent configurational entropy and\nflexibility (3a and 3b), (ii) the role of the chemical function\nnature at C-3 upon removal of the carbohydrate residues\n(4 and 5) and (iii) the importance of the ester group at C-3\n(3a\u2013c).\n\nCompounds 4 and 5 presented IC50 values >1000 lM in the\nthrombin-induced fibrinogen clotting assay, pointing to an\nabsence of influence of the hydrogen bond characteristics\n\nA B\n\nC\n\nFigure 1: Structural and functional features of thrombin inhibition. (A) Conformational ensemble of the inhibitors at the anionic exosite 1,\nsuperimposed at every 10 ns of MD. (B) Inhibitory activity of compounds on thrombin-induced fibrinogen clotting. (C) Comparison of\nthrombin inhibitory activity using fibrinogen and the synthetic substrate S2238 (H-D-Phe-Pip-Arg-p-nitroanilide) as substrates. All inhibitors\nwere tested at 500 lM.\n\n2 Chem Biol Drug Des 2013\n\nde Paula et al.\n\n235\n\n\n\nof the group at C-3, that is, donor or acceptor. Similar\nresults were obtained for 3c, indicating that the ester\ngroup at C-3 has minor or no participation on interactions\nwith thrombin, being unable to recover the interactions lost\nfrom glycan removal.\n\nCompounds 3a and 3b, however, indicate that such carbo-\nhydrate moiety is not an absolute requirement for thrombin\nbinding and inhibition, with the phthalic ester 3b showing an\nalmost twofold increase in its activity (IC50 = 114.4\n? 1.3 lM) accompanied with a significant simplification of\nthe molecule structure (Figure 1A,B). In fact, substitution of\ncarbohydrates by aromatic rings has been described previ-\nously regarding antithrombin activation by heparin mimetics,\nbased on sulphated flavonoids (14). In spite of a great\nreduction in the number of hydrogen bond-capable groups\nfrom 1 to 3b, there is also a great reduction in configura-\ntional entropy lost upon complexation, which may explain\nsuch increase in activity. This possibility correlates with the\nlow activity of compound 3a (IC50 = 398.6 ? 6.9 lM) in\ncomparison with 3b (Figure 1B). Also, compound 3b\nshowed a more pronounced anticoagulant activity when\ntested in human plasma. In fact, compound 3b caused a\nsignificant prolongation of thrombin time compared with\nnormal plasma values (Table 1).\n\nWith the purpose of obtaining further insights into the\nreported activities, compounds 1, 2, 3a and 3b were\ndocked on thrombin exosite I, previously observed as\nthe binding site for glycyrrhizin (4). Additionally, as the\ninhibitory effect upon thrombin is expected to modulate\nthe conformation of its catalytic site, each docking com-\n\nplex was further refined through molecular docking (MD)\nsimulations to search for potential allosteric influences of the\ncompounds, in comparison with non-inhibited thrombin, as\nreported for the modulation of thrombin by sulphated\narabinans (15). A simulation of uncomplexed thrombin was\nemployed as a negative control, and in addition to the use of\nglycyrrhizin as the positive control, another anticoagulant\nsaponin, through thrombin inhibition, chikusetsusaponin IVa\n(b-D-glucopyranosiduronic acid, (3b)-28-(b-D-glucopyrano-\nsyloxy)-28-oxoolean-12-en-3-yl) (6) (16) was also simulated\nin complex to its target protein. The so-obtained data from\nthe combination of docking and MD are presented in\nFigure 1 and Table 2.\n\nTable 1: Pharmacological data on thrombin inhibition by com-\npounds 1\u20136\n\nCompound Thrombin time (s)a Thrombin IC50 (lM)\n\n1 86.3 ? 3b\n191.4 ? 40.0c\n\n235.7 ? 1.4\n\n2 NTd NAe\n\n3a 62.6 ? 2.1b\n107.0 ? 15.4c\n\n392.6 ? 6.9\n\n3b 118.3 ? 8.0b\n282.6 ? 62.2c\n\n114.4 ? 1.3\n\n3c NT 927.1 ? 1.5\n4 NT 2111.5 ? 11.2\n5 NT 1319.2 ? 3.6\n6 92.4 ? 2.7b\n\n240.7 ? 4.5c\n199.4 ? 9.1\n\nControla 45.8 ? 4.8 \u2013\n\naThrombin time (TT) was measured by the incubation of human\nplasma in the absence (control) or presence of inhibitors.\nbMeasured at 100 lM.\ncMeasured at 500 lM.\ndNT = not tested.\neNA = not active.\n\nScheme 1: Reagents and conditions: (i) anhydride (10 equiv.),\npyridine, 24\u201348 h, reflux, 30\u201390%; (ii) Jones oxidation; (iii)\nhydroxylamine hydrochloride, pyridine, reflux, 24 h, 38%.\n\nTable 2: Structural data on thrombin inhibition by compounds\n1\u20136\n\nCompound\n\nDistance between catalytic triad\nresidues (nm)a\n\nInteraction\nenergy (kJ/mol)a\n\nHis57\u2013\nAsp102b\n\nHis57\u2013\nSer195c Sum\n\n1 0.30 ? 0.03 0.55 ? 0.10 0.85 ?136 ? 46\n2 0.32 ? 0.04 0.65 ? 0.11 0.97 ?44 ? 21\n3a 0.31 ? 0.03 0.61 ? 0.11 0.92 ?120 ? 42\n3b 0.46 ? 0.15 0.83 ? 0.34 1.29 ?147 ? 61\n3c NTd NT NT NT\n4 NT NT NT NT\n5 NT NT NT NT\n6 0.33 ? 0.10 0.76 ? 0.14 1.09 ?178 ? 43\nControl\n\ne 0.29 ? 0.02 0.57 ? 0.12 0.86 \u2013\n\naAverage values measured after the first 20-ns MD simulations.\nbBetween atoms ND1 from His and OD2 from Asp.\ncBetween atoms NE2 from His and OG2 from Ser.\ndNT = not tested.\neControl: simulation of free, uncomplexed thrombin.\n\nChem Biol Drug Des 2013 3\n\nImproving the Thrombin Inhibitory Activity\n\n236\n\n\n\nThe MD simulations indicated a progressive reorientation\nof the docking-derived conformations, further exploring the\nexosite surface and refining the interactions with the pro-\ntein along the simulations (Figure 1). Regarding com-\npounds 1 and 3b, the dynamics of these products indicate\nthat the anionic exosite 1 is properly occupied, and there\nare similarities between the binding regions of both mole-\ncules. The less active compounds 2 and 3a appear to\npopulate the site in a more diffuse manner on the simula-\ntions, moving either to the northwest region of the site (2)\nor to the southern region (3a). The binding of 1 and 3b to\nthe anionic exosite 1 is important for inhibition because this\nsite is essential for fibrinogen recognition by thrombin.\nThus, MD simulations corroborate our previous results,\nwhich showed the ability of compound 1 to displace hiru-\ndin (a specific ligand of thrombin exosite 1) from its binding\nsite (4).\n\nAdditionally, MD simulations also indicated that the com-\npounds could modulate the conformation of thrombin cat-\nalytic site. As showed in Table 2, the distance between\ncatalytic triad residues had an increase after binding of\ncompounds 3b and 6 in comparison with uncomplexed\nthrombin. Interestingly, these compounds also had the\nlowest IC50 values in the thrombin-induced fibrinogen clot-\nting assay and the most potent anticoagulant activity in\nplasma. Our hypothesis is that the binding to exosite 1\ncould induce these changes in catalytic triad residues via\nallosteric modulation and thus contribute to the inhibitory\nactivity. In fact, we recently showed that compound 6 is\nalso able to inhibit the thrombin-induced hydrolysis of\nchromogenic substrate S2238 (H-D-Phe-Pip-Arg-p-nitro-\nanilide), a synthetic peptide designed specifically to the\nthrombin catalytic site (16). Unlike fibrinogen, the cleavage\nof synthetic peptide is not dependent on interaction with\nexosite 1, indicating that compound 6 can modulate the\nactive site. Similar to compound 6, compound 3b was\nalso able to inhibit hydrolysis of the synthetic peptide,\nwhile 1 was not (Figure 1C).\n\nBased on the final frame of thrombin-3b complex, the\nmain interactions are depicted in Figure 2. The carboxyl\ngroup at the aromatic ring contributes to the majority of\nthe interactions, through hydrogen bonding with Ala113\nbackbone and Lys110 side chain. Furthermore, the phenyl\nring participates in hydrophobic interactions involving\nmostly Lys81, Ile82, Lys109 and Ser83 (Figure 2). These\nfindings suggest that the dual nature of the substituent,\ncomprehending polar and apolar groups, provides multiple\npossibilities for the compound binding to the anionic exo-\nsite 1 and, most important, future insights for further com-\npound optimizations.\n\nConclusions\n\nAlthough the synthesized compounds are already known in\nthe literature, this is the first report regarding the synthesis\nof thrombin inhibitory glycyrrhizin (1) derivatives. Compound\n3b, with a simpler molecular scaffold than 1, presented a\ngreater thrombin inhibitory activity and prolonged thrombin\ntime and, unlike 1, was able to inhibit hydrolysis of the\nsynthetic peptide S2238, indicating that this ester can\nmodulate the active site. These results, along with the\ndocking and MD simulations performed, can be used for\nthe design and synthesis of new glycyrrhizin derivatives\ntowards new thrombin inhibitory compounds.\n\nAcknowledgments\n\nF. T. de Paula acknowledges funding from the Universid-\nade Federal Rural do Rio de Janeiro. Petrina Q. Frauches\nand C. S. Graebin acknowledge funding from FAPERJ\n(Fundac?~ao de Amparo ?a Pesquisa do Estado do Rio de\nJaneiro). H. Verli, C. Pedebos and M. Berger acknowledge\nfunding from CNPq (Conselho Nacional de Desenvolvi-\nmento Cient??fico e Tecnol?ogico), CAPES (Coordenac?~ao de\nAperfeic?oamento de Pessoal de N??vel Superior) and\n\nFigure 2: Schematics of thrombin interaction with compound 3b based on the combination of docking and MD simulation. In the left, a\n2D representation based on results obtained from PoseView Server, where a green line indicates hydrophobic interactions, while a dashed\nline indicates hydrogen bonds. In the right, thrombin is represented in a blue surface, while the highlighted residues (cyan) and compound\n3b (green backbone) are represented as sticks.\n\n4 Chem Biol Drug Des 2013\n\nde Paula et al.\n\n237\n\n\n\nFAPERGS (Fundac?~ao de Amparo ?a Pesquisa do Estado\ndo Rio Grande do Sul).\n\nReferences\n\n1. Melnikova I. (2009) The anticoagulants market. Nat Rev\nDrug Discov;8:353.\n\n2. Stroebeck J.E. (2012) Stroke prevention in atrial fibrilla-\ntion: managing the risks in light of new oral anticoagu-\nlants. Cardiovasc Drugs Ther;26:331\u2013338.\n\n3. Tsiridis E., Gamie Z., George M.J., Hamilton-Baille D.,\nWest R.M., Giannoudis P.V. (2011) Early postoperative\nbleeding in polytrauma patients treated with fondapari-\nnux: literature review and institutional experience. Curr\nVasc Pharmacol;9:42\u201347.\n\n4. Francischetti I.M.B., Monteiro R.Q., Guimar~aes J.A.\n(1997) Identification of glycyrrhizin as a thrombin inhibi-\ntor. Biochem Biophys Res Comm;9:259\u2013263.\n\n5. Mendes-Silva W., Assafim M., Ruta B., Monteiro R.Q.,\nGuimar~aes J.A., Zingali R.B. (2003) Antithrombotic\neffect of glycyrrhizin, a plant-derived thrombin inhibitor.\nThromb Res;112:93\u201398.\n\n6. Graebin C.S., Verli H., Guimar~aes J.A. (2010) Glycyrrhi-\nzin and glycyrrhetic acid: scaffolds to promising new\npharmacologically active compounds. J Braz Chem\nSoc;21:1595\u20131615.\n\n7. Baltina L.A. (2003) Chemical modification of glycyrrhizic\nacid as a route to new bioactive compounds for medi-\ncine. Curr Med Chem;10:155\u2013171.\n\n8. Ijeda K., Arase Y., Kobayashi M., Saitoh S., Someya\nT., Hosaka T., Sekazi H., Akuta N., Suzuki S., Suzuki\nF., Kumada H. (2006) A long-term glycyrrhizin injection\ntherapy reduces hepatocellular carcinogenesis rate in\npatients with interferon-resistant active chronic hepatitis\nC: a cohort study of 1249 patients. Dig Dis\nSci;51:603\u2013609.\n\n9. Michaelis M., Geiler J., Naczk P., Sithisarm P., Leutz\nA., Doerr H.W., Cnatl J. Jr (2011) Glycyrrhizin exerts\nantioxidative effects in H5N1 influenza A virus-infected\ncells and inhibits virus replication and pro-inflammatory\ngene expression. PLoS ONE;6:e19705.\n\n10. Huang L., Yu D., Ho P., Qian K., Lee K.-H., Chen C.\n(2008) Synthesis and proteasome inhibition of glycyrrh-\netinic acid derivatives. Bioorg Med Chem;16:6696\u2013\n6701.\n\n11. Yu D., Sakurai Y., Chen C., Chang F.-R., Kashiwada\nY., Lee K.-H. (2006) Anti-AIDS agents 69. Moronic\nacid and other triterpene derivatives as novel potent\nanti-HIV agents. J Med Chem;49:5462\u20135469.\n\n12. Chintharlapalli S., Papineni S., Jutooru I., McAlees A.,\nSafe S. (2007) glycyrrhetinic acid derivatives as peroxi-\nsome proliferator-activated receptor {gamma} agonists\nin colon cancer cells. Mol Cancer Ther;6:1588\u20131598.\n\n13. Liu D., Song D., Guo G., Wang R., Lv J., Jing Y., Zhao\nL. (2007) The synthesis of 18beta-glycyrrhetinic acid\nderivatives which have increased antiproliferative and\napoptotic effects in leukemia cells. Bioorg Med\nChem;15:5432\u20135439.\n\n14. Al-Horani R.A., Liang A., Desai U.R. (2011) Designing\nnonsaccharide, allosteric activators of antithrombin for\naccelerated inhibition of factor Xa. J Med\nChem;51:6125\u20136138.\n\n15. Fernandez P.V., Quintana I., Cerezo A.S., Caramelo\nJ.J., Pol-Fachin L., Verli H., Estevez J.M., Ciancia M.\n(2013) Anticoagulant activity of a unique sulfated pyr-\nanosic (1?3)-b-L-arabinan through direct interaction\nwith thrombin. J Biol Chem;288:223\u2013233.\n\n16. Dahmer T., Berger M., Barlette A.G., Reck J., Segalin\nJ., Verza S., Ortega G.G., Gnoatto S.C.B., Guimar~aes\nJ.A., Verli H., Gosmann G. (2012) Antithrombotic effect\nof chikusetsusaponin IVa isolated from Ilex paraguari-\nensis (Mat?e). J Med Food;15:1073\u20131080.\n\nChem Biol Drug Des 2013 5\n\nImproving the Thrombin Inhibitory Activity\n\n238\n\n\n\nCurriculum Vitae \n\n239 \n\n \n\nCurriculum vitae  \nOutubro de 2013 \n\n \n\nDADOS PESSOAIS \n\n \n\nNome:   Markus Berger Oliveira \n\nFilia\u00e7\u00e3o:  Denise Maria Morais Berger \n\nC\u00e9sar Augusto De Nardi Oliveira \n\n \n\nEndere\u00e7o profissional:  Universidade Federal do Rio Grande do Sul, Centro de Biotecnologia, \n\nLaborat\u00f3rio de Bioqu\u00edmica Farmacol\u00f3gica. \nAv. Bento Gon\u00e7alves, 9500 \u2013 Pr\u00e9dio 43431 \u2013 Laborat\u00f3rio 214 \u2013 \n\nCampus do vale, Agronomia \n\n91501970 Porto Alegre, RS \u2013 Brasil \n\nTelefone: (051) 33086062 \n\nE-mail: mberger@cbiot.ufrgs.br \n\n \n\nEndere\u00e7o residencial:  Rua Mariano de Mattos, 72, apto 302 \n\n    Menino Deus \n\n    90880-250 Porto Alegre, RS \u2013 Brasil \n\n    Telefone: (51) 32315546 \n\n \n\nT\u00cdTULOS ACAD\u00caMICOS \n\n \n\n2009 -  Doutorado em Ci\u00eancias. \n\nUniversidade Federal do Rio Grande do Sul, UFRGS, Rio Grande do Sul, Brasil. \n\nT\u00edtulo: MECANISMOS DE TOXICIDADE SIST\u00caMICA NO ENVENENAMENTO \n\nPELA TATURANA Lonomia obliqua: ALTERA\u00c7\u00d5ES FISIOPATOL\u00d3GICAS \n\nRENAIS E VASCULARES NA NEFROTOXICIDADE INDUZIDA PELO VENENO   \n\nOrientador: Dr. Jorge Almeida Guimar\u00e3es \n\nCoorientador: Dra. Maria Aparecida Ribeiro Vieira \n\nBolsista do(a): Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior, CAPES, \n\nBrasil. \n\n \n2008 - 2009 Mestrado em Biologia Celular e Molecular. \n\nUniversidade Federal do Rio Grande do Sul, UFRGS, Rio Grande do Sul, Brasil. \n\nT\u00edtulo: DIST\u00daRBIOS DE AGREGA\u00c7\u00c3O PLAQUET\u00c1RIA E COAGULA\u00c7\u00c3O \n\nSANG\u00dc\u00cdNEA NO ENVENENAMENTO PELA TATURANA Lonomia obliqua \n\nOrientador: Dr. Jorge Almeida Guimar\u00e3es \n\nBolsista do(a): Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico, \n\nCNPq, Brasil. \n\n \n\n2003-2007 Gradua\u00e7\u00e3o em Farm\u00e1cia \n\nUniversidade Federal do Rio Grande do Sul, UFRGS, Rio Grande do Sul, Brasil. \n\nT\u00edtulo: PURIFICA\u00c7\u00c3O E CARACTERIZA\u00c7\u00c3O FUNCIONAL DE UMA \n\nMETALOPROTEINASE ATIVADORA DE PROTROMBINA ISOLADA DO \nVENENO DA SERPENTE Bothrops jararaca. \n\nOrientador: Dr. Jorge Almeida Guimar\u00e3es \n\nBolsista do(a): Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico, \n\nCNPq, Brasil. \n\n \n\n1997-2000 Ensino Profissionalizante, T\u00e9cnico em Qu\u00edmica. \n\nEscola T\u00e9cnica da Universidade Federal do Rio Grande do Sul, UFRGS, Rio Grande do \n\nSul, Brasil. \n\nT\u00edtulo: ESTUDO COMPARATIVO DO PROCESSO DE ATIVA\u00c7\u00c3O DE \n\nPROTROMBINA PELO VENENO DAS SERPENTES Bothrops jararaca E \n\nOxyuranus scutellatus. \nOrientador: Dr. Jorge Almeida Guimar\u00e3es \n\nmailto:mberger@cbiot.ufrgs.br\n\n\nCurriculum Vitae \n\n240 \n\n \n\nBolsista do(a): Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico, \n\nCNPq, Brasil. \n\n \n\nPR\u00caMIOS E T\u00cdTULOS \n\n \n\n2012 Melhor poster na \u00e1rea de Fisiologia Renal. XLVII Congresso Anual da SBFis e III Encontro \n\nCient\u00edfico do Programa Multic\u00eantrico de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Fisiol\u00f3gicas, Sociedade \n\nBrasileira de Fisiologia. \n\n2006 Destaque no XVIII Sal\u00e3o de Inicia\u00e7\u00e3o Cient\u00edfica da UFRGS. Se\u00e7\u00e3o de Bioqu\u00edmica. Universidade \n\nFederal do Rio Grande do Sul. \n\n \n\nATIVIDADES CIENT\u00cdFICAS E T\u00c9CNICAS \n\n \n\nPublica\u00e7\u00f5es em peri\u00f3dicos \n\n \n\n1 BERGER, M., BEYS-DA-SILVA, W., SANTI, L., DE OLIVEIRA, I.M., JORGE, P.M., \n\n HENRIQUES, J.A.P., DRIEMEIER, D., VIEIRA, M.A.R., GUIMAR\u00c3ES, J.A. Acute Lonomia \n\n obliqua caterpillar envenomation-induced physiopathological alterations in rats: \n\n Evidence of new toxic venom activities and the efficacy of serum therapy to counteract systemic \n\n tissue damage. Toxicon (Oxford), v. 74, p. 179-192, 2013. \n\n \n\n2 BEYS DA SILVA, W.O.; SANTI, L.; BERGER, M.; GUIMARAES, J.A.; SCHRANK, \nA.; VAINSTEIN, M.H. Susceptibility of Loxosceles sp. to the arthropod pathogenic fungus \n\nMetarhizium anisopliae: potential biocontrol of the brown spider. Transactions of the Royal \n\nSociety of Tropical Medicine and Hygiene, v. 107, p. 59-61, 2013. \n\n \n\n3 DAHMER, T.*; BERGER, M.*; BARLETTE, A.G.; RECK-JUNIOR, J.; SEGALIN, J.; \n\nVERZA, S.; ORTEGA, G.G.; GNOATTO, S.C.B.; GUIMAR\u00c3ES, J.A.; VERLI, H.; \n\nGOSMANN, G. Antithrombotic Effect of Chikusetsusaponin IVa Isolated from Ilex \n\nparaguariensis (Mat\u00e9). Journal of Medicinal Food, v. 15, p. 1073-1080, 2012. * Os autores \n\ncompartilham a primeira autoria. \n\n \n\n4 BERGER, M.; RECK Jr., J.; TERRA, R.M.S.; PINTO, A.F.M.; TERMIGNONI, C; \n\nGUIMAR\u00c3ES, J.A. Lonomia obliqua caterpillar envenomation causes platelet hypoaggregation \nand blood incoagulability in rats. Toxicon, v. 55, p. 33-44, 2010. \n\n \n\n5 BERGER, M. ; RECK Jr., J.; TERRA, R.M. S. ; BEYS DA SILVA, W.O.; SANTI, L.; PINTO, \n\nA.F.M.; VAINSTEIN, M.H.; TERMIGNONI, C.; GUIMAR\u00c3ES, J.A. Lonomia obliqua \n\nvenomous secretion induces human platelet adhesion and aggregation. Journal of Thrombosis \n\nand Thrombolysis, v. 30, p. 300-310, 2010. \n\n \n\n6 PINTO, A.F.M.; BERGER, M.; RECK-JUNIOR, J.; TERRA, R.M.S.; GUIMARAES, J. A. \n\nLonomia obliqua venom: In vivo effects and molecular aspects associated with the hemorrhagic \n\nsyndrome. Toxicon (Oxford)., v.56, p.1103 - 1112, 2010. \n\n \n7 MARKS, F.S.; RECK Jr., J.; ALMEIDA, L.L.; BERGER, M.; CORR\u00caA, A.M.R.; \n\nDRIEMEIER, D.; BARCELLOS, D.E.S.; GUIMAR\u00c3ES, J.A.; TERMIGNONI, C.; CANAL, \n\nC.W. Porcine circovirus 2 (PCV2) induces a procoagulant state in naturally infected swine and in \n\ncultured endothelial cells. Veterinary Microbiology (Amsterdam), v. 141, p. 22-30, 2010. \n\n \n\n8 SANTI, L.; SILVA, W.O.B.; BERGER, M., GUIMARAES, J.A., SCHRANK, A., VAINSTEIN, \n\nM.H. Conidial surface proteins of Metarhizium anisopliae: Source of activities related with toxic \n\neffects, host penetration and pathogenesis. Toxicon (Oxford) , v.55, p.874 - 880, 2010. \n\n \n\n9 RECK Jr., J.; BERGER, M.; TERRA, R.M.S.; MARKS, F.S.; da SILVA VAZ J\u00daNIOR, I.; \n\nGUIMAR\u00c3ES, J.A.; TERMIGNONI, C. Systemic alterations of bovine hemostasis due to \n\nRhipicephalus (Boophilus) microplus infestation. Research in Veterinary Science, v. 86, p. 56-\n62, 2009.  \n\n \n\nhttp://lattes.cnpq.br/7154170979832540\nhttp://lattes.cnpq.br/7063936568198850\nhttp://lattes.cnpq.br/0134821761458628\nhttp://lattes.cnpq.br/0134821761458628\nhttp://lattes.cnpq.br/1152828531273019\n\n\nCurriculum Vitae \n\n241 \n\n \n\n10 SILVA, W.O.B.; SANTI, L.; BERGER, M.; PINTO, A.F.M.; GUIMAR\u00c3ES, J.A.; SCHRANK, \n\nA.; Vainstein, M.H. Characterization of a spore surface lipase from the biocontrol agent \n\nMetarhizium anisopliae. Process Biochemistry, v. 44, p. 829-834, 2009. \n\n \n\n11 RECK Jr., J.; BERGER, M.; MARKS, F. S.; ZINGAL, R.; CANAL, C. W.; FERREIRA, C.A.S.; \n\nGUIMAR\u00c3ES, J.A.; TERMIGNONI, C. Pharmacological action of tick saliva upon hemostasis \n\nand the neutralization ability of sera from repeated infested hosts. Parasitology (London), v. \n\n136, p. 1339-1349, 2009. \n\n \n\n12 ANDRADES, M.E.; LORENZI R.; BERGER M.; GUIMAR\u00c3ES J.A.; MOREIRA, J.C.F.; \n\nDALPIZZOL, F . Glycolaldehyde induces fibrinogen post-translational modification, delay in \nclotting and resistance to enzymatic digestion. Chemico-Biological Interactions, v. 100, p. 1-\n\n10, 2009. \n\n \n\n13 BERGER, M.; PINTO, A.F.M.; GUIMAR\u00c3ES, J.A. Purification and functional characterization \n\nof bothrojaractivase, a prothrombin-activating metalloproteinase isolated from Bothrops \n\njararaca snake venom. Toxicon, v. 51, p. 488-501, 2008. \n\n \n\n14 RICCI, C.G.; PINTO, A.F.M.; BERGER, M.; TERMIGNONI, C. A thrombin inhibitor from the \n\ngut of Boophilus microplus ticks. Experimental and applied accarology, v. 42, p. 291-300, \n\n2007. \n\n \n\nArtigos aceitos para publica\u00e7\u00e3o \n\n \n\n1 SILVA, W.O.B.; THOMPSON, C.E.; SANTI, L.; BERGER, M.; VAINSTEIN, M.H.; \n\nGUIMAR\u00c3ES, J.A.; VASCONCELOS, A.T.R. A potential source for cellulolytic enzyme \n\ndiscovery and environmental aspects revealed through metagenomics of Brazilian mangroves. \n\nAMB Express, In press, 2013. \n\n \n\n2 DE PAULA, F.T.; FRAUCHES, P.Q.; PEDEBOS, C.; BERGER, M.; GNOATTO, S.C.B.; \n\nGOSSMANN, G.; VERLI, H.; GUIMAR\u00c3ES, J.A.; GRAEBIN, C. Improving the thrombin \n\ninhibitory activity of Glycyrrhizin, a triterpenic saponin, through a molecular simplification of \n\nthe carbohydrate moiety. Chemical Biology &amp; Drug Design, In press, 2013. \n\n \n\nCap\u00edtulos de livro publicados \n\n \n\n1 BERGER, M., VIEIRA, M.A.R., GUIMARAES, J.A. Acute Kidney Injury Induced By Snake \n\nAnd Arthropod Venoms. In: Renal Failure - The Facts. Editor: Polenakovic, M. Editora: \n\nInTech open acess - ISBN 979-953-307-465-7, 2012. \n\n \n\n2 VEIGA, A.B.G.; BERGER, M.; GUIMAR\u00c3ES, J.A. Lonomia obliqua venom: pharmaco-\n\ntoxicological effects and biotechnological perspectives. In: DE LIMA, M.E.; PIMENTA, \n\nA.M.C.; MARTIN-EAUCLAIRE, M.F.; ZINGALI, R.B.; ROCHAT, H. (eds.). Animal Toxins: \n\nThe State of the Art. Perspectives on Health and Biotechnology, p. 371-390, Belo Horizonte: \n\nEditora UFMG, 2009. \n \n\nTrabalhos apresentados em Congressos e Simp\u00f3sios \n\n \n\n1 BERGER, M.; SANTI, L.; BEYS DA SILVA, W.O.; PINTO, A.F.M.; OLIVEIRA, F.M.S.; \n\nCALIARI, M.V.; GUIMAR\u00c3ES, J.A. &amp; VIEIRA, M.A.R. The physiopathological mechanisms \n\ninvolved in acute kidney injury induced by Lonomia obliqua caterpillar envenomation. In: \n\nXLVII Congresso Anual da SBFis e III Encontro Cient\u00edfico do Programa Multic\u00eantrico de \n\nP\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Fisiol\u00f3gicas, Gramado, RS, 2012. Anais, 2012. \n\n \n\n2 GRAEBIN, C.S.; PAULA, F.T.; FRAUCHES, P.Q.; PEDEBOS, C.; BERGER, M.; VERLI, H.; \n\nGUIMAR\u00c3ES, J. A. S\u00edntese e atividade inibidora de trombina de derivados da Glicirrizina e do \n\u00e1cido glicirret\u00ednico. In: 35\u00aa Reuni\u00e3o Anual da Sociedade Brasileira de Qu\u00edmica, 2012, \u00c1guas \n\nde Lind\u00f3ia, S\u00e3o Paulo-SP. Anais, 2012. \n\n \n\nhttp://lattes.cnpq.br/7154170979832540\nhttp://lattes.cnpq.br/1152828531273019\n\n\nCurriculum Vitae \n\n242 \n\n \n\n3 BERGER, M.; SILVA, W.O.B.; SANTI, L.; RECK J\u00daNIOR, J.; BANDARRA, P.M.; \n\nDRIEMEIER, D.; VAINSTEIN, M.H.; TERMIGNONI, C.; GUIMAR\u00c3ES, J.A. \n\nSystemic Biochemical, Hematological and Pathological Alterations during Lonomia obliqua \n\nExperimental Envenomation In Rats. In: XL Annual Meeting of Brazilian Biochemistry and \n\nMolecular Biology Society. Foz do Igua\u00e7u, PR, Brazil, 2011. Anais, 2011. \n\n \n\n4 BERGER, M.; RECK Jr., J.; TERRA, R. M. S. ; PINTO, A. F. M. ; TERMIGNONI, C. ; \n\nGUIMAR\u00c3ES, J.A. In vitro activity of Lonomia obliqua caterpillar venom on human platelets. \n\nIn: XVI World Congress of the International Society on Toxinology, 2009, Recife - PE - \n\nBrasil. Anais, 2009. \n\n \n5 BERGER, M.; RECK Jr., J.; TERRA, R. M. S.; PINTO, A. F. M.; TERMIGNONI, C; \n\nGUIMAR\u00c3ES, J. A. Lonomia obliqua caterpillar envenomation causes platelet hypoaggregation \n\nand blood incoagulability in rats. In: XVI World Congress of the International Society on \n\nToxinology, 2009, Recife - PE - Brasil. Anais, 2009. \n\n \n\n6 RECK Jr., J.; BERGER, M.; BANDARRA, P. M.; DRIEMEIER, D.; TERMIGNONI, C; \n\nGUIMAR\u00c3ES, J.A. Systemic pathological alterations caused by Lonomia obliqua caterpillar \n\nenvenomation in rabbits. In: XVI World Congress of the International Society on \n\nToxinology, 2009, Recife - PE - Brasil. Anais, 2009. \n\n \n\n7 RECK Jr., J.; BERGER, M.; MARKS, F.S.; CANAL, C.W.; ZINGALI, R.B.; FERREIRA, \nC.A.S.; TERMIGNONI, C.; GUIMAR\u00c3ES, J.A. Pharmacological activities of tick saliva upon \n\nhemostasis and the neutralization ability of cattle hyperimmune serum. In: XVI World \n\nCongress of the International Society on Toxinology, 2009, Recife - PE - Brasil. Anais, 2009. \n\n \n\n8 BARLETTE, A.G.; DAHMER, T.; BERGER, M.; ORTEGA, G.G.; GUIMARAES, J. A.; \n\nGOSMANN, G.; VERLI, H. In vitro Anticoagulant and Antiplatelet Activities of a Triterpenoid \n\nSaponin from Ilex paraguariensis Fruits. In: XXXVIII Reuni\u00e3o da Sociedade Brasileira de \n\nBioqu\u00edmica e Biologia Molecular - SBBq, 2009, \u00c1guas de Lind\u00f3ia \u2013 SP, Brasil. Resumos do \n\nXXXVII Encontro Anual da Sociedade Brasileira de Bioqu\u00edmica e Biologia Molecular. Anais, \n\n2009. \n\n \n\n9 RECK Jr., J.; BERGER, M.; TERRA, R.M.S.; MARKS, F.S.; da SILVA VAZ J\u00daNIOR, I.; \nGUIMAR\u00c3ES, J.A.; TERMIGNONI, C. Hemostatic disorders associated with Rhipicephalus \n\n(Boophilus) microplus infestation. In: VI International Conference on Ticks and Tick-borne \n\nPathogens (TTP-6), 2008, Buenos Aires - Argentina. Anais, 2008. \n\n \n\n10 LORENZI, R.; ANDRADES, M.E.; BERGER, M.; GUIMAR\u00c3ES J.A.; TERMIGNONI, C.; \n\nMOREIRA, J.C.F.; DAL-PIZZOL, F. Glycolaldehyde impairs coagulation and fibrinolysis. In: \n\nXXXVII Encontro Anual da Sociedade Brasileira de Bioqu\u00edmica e Biologia Molecular - \n\nSBBq, 2008, \u00c1guas de Lind\u00f3ia \u2013 SP, Brasil. Resumos do XXXVII Encontro Anual da \n\nSociedade Brasileira de Bioqu\u00edmica e Biologia Molecular. Anais, 2008. \n\n \n\n11 BERGER, M.; RECK Jr., J.; TERRA, R.M.S.; PINTO, A.F.M.; TERMIGNONI, C.; \nGUIMAR\u00c3ES, J.A. Effects of Lonomia obliqua caterpillar venom on blood platelets. In: 10th \n\nThe International Union of Biochemistry and Molecular Biology Conference, 2007, \n\nSalvador - BA - Brasil. Anais, 2007. \n\n \n\n12 RECK Jr., J.; BERGER, M.; TERRA, R.M.S.; MARKS, F.S.; GUIMAR\u00c3ES, J.A.; da SILVA \n\nVAZ J\u00daNIOR, I.; TERMIGNONI, C. Effects of the tick Rhipicephalus (Boophilus) microplus \n\ninfestation on the host hemostatic system. In: 10th The International Union of Biochemistry \n\nand Molecular Biology Conference, 2007, Salvador- BA - Brasil. Anais, 2007. \n\n \n\n13 SANTI, L.; SILVA, WOB; BERGER, M.; GUIMAR\u00c3ES, J.A.; SCHRANK, A.; VAINSTEIN, \n\nM. H. Enzymatic profile of spore surface proteins from Metarhizium anisopliae. In: XXXVI \n\nAnnual Meeting of the Brazilian Society for Biochemistry and Molecular Biology and 10th \n\nIUBMB conference: Infection diseases: biochemistry of parasites, vectors and hosts, 2007, \n\nSalvador. XXXVI Annual Meeting of the Brazilian Society for Biochemistry and Molecular \n\n\n\nCurriculum Vitae \n\n243 \n\n \n\nBiology and 10th IUBMB conference: Infection diseases: biochemistry of parasites, vectors \n\nand hosts, 2007. \n\n \n\n14 SILVA, W.O.B.; BERGER, M.; SANTI, L.; PINTO, A.F.M.; GUIMAR\u00c3ES, J.A.; SCHRANK, \n\nA.; VAINSTEIN, M.H. Purification of a spore surface lipase from Metarhizium anisopliae. In: \n\nXXXVI Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology \n\nSBBq/ 10th IUBMB conference: Infection diseases: biochemistry of parasites, vectors and \n\nhosts, 2007, Salvador. XXXVI Annual Meeting of the Brazilian Society for Biochemistry \n\nand Molecular Biology SBBq/ 10th IUBMB conference: Infection diseases: biochemistry of \n\nparasites, vectors and hosts, 2007. \n\n \n15 BERGER, M.; RECK JUNIOR, J.; TERRA, R.M.S.; PINTO, A.F.M.; TERMIGNONI, C.; \n\nGUIMARAES, J.A. Caracteriza\u00e7\u00e3o dos efeitos do veneno da taturana Lonomia obliqua sobre a \n\nreatividade plaquet\u00e1ria. In: XVIII Sal\u00e3o de Inicia\u00e7\u00e3o Cient\u00edfica, 2006, Porto Alegre. XVIII \n\nSal\u00e3o de Inicia\u00e7\u00e3o Cient\u00edfica. Porto Alegre: Editora da UFRGS, 2006. \n\n \n\n16 BERGER, M.; PINTO, A.F.M.; AMORIN, H.L.N. ; GUIMARAES, J.A. Bothrojaractivase, a \n\nprothrombin activating enzyme isolated from Bothrops jararaca snake venom. In: XXXV \n\nReuni\u00e3o da Sociedade Brasileira de Bioqu\u00edmica e Biologia Molecular - SBBq, 2006, \u00c1guas \n\nde Lind\u00f3ia. Livro de resumos da XXXV Reuni\u00e3o da Sociedade Brasileira de Bioqu\u00edmica e \n\nBiologia Molecular. \n\n \n17 RICCI, C.G.; PINTO, A. F.M.; BERGER, M.; TERMIGNONI, C. Purification of a thrombin \n\nexosite inhibitor from the cattle tick Boophilus microplus. In: XXXV Reuni\u00e3o Anual da \n\nSociedade Brasileira de Bioqu\u00edmica e Biologia Molecular - SBBq, 2006, \u00c1guas de Lind\u00f3ia-\n\nSP. XXXV Reuni\u00e3o Anual da Sociedade Brasileira de Bioqu\u00edmica e Biologia Molecular, 2006. \n\n \n\n18 BERGER, M.; PINTO, A.F.M.; AMORIN, H.L.N.; GUIMARAES, J.A. Purifica\u00e7\u00e3o e \n\ncaracteriza\u00e7\u00e3o de um ativador de protrombina presente no veneno da serpente Bothrops \n\njararaca. In: XVII Sal\u00e3o de Inicia\u00e7\u00e3o Cient\u00edfica da Universidade Federal do Rio Grande do \n\nSul/ PROPESQ - UFRGS, 2005, Porto Alegre. Livro de resumos do XVII Sal\u00e3o de Inicia\u00e7\u00e3o \n\nCient\u00edfica e XIV Feira de Inicia\u00e7\u00e3o Cient\u00edfica. Porto Alegre: Editora da UFRGS, 2005. \n\n \n\n19 BERGER, M.; PINTO, A.F.M.; AMORIN, H.L.N.; GUIMARAES, J.A. Purification and \ncharacterization of a prothrombin activator from Bothrops jararaca venom. In: XXXIV Reuni\u00e3o \n\nda Socieddade Brasileira de Bioqu\u00edmica e Biologia Molecular - SBBq, 2005, \u00c1guas de \n\nLind\u00f3ia. Livro resumos da XXIV Reuni\u00e3o da Sociedade Brasileira de Bioqu\u00edmica e Biologia \n\nMolecular. \n\n \n\n20 BERGER, M.; PINTO, A.F.M.; AMORIN, H.L.N.; GUIMARAES, J.A. Ativa\u00e7\u00e3o de \n\nprotrombina pelo veneno das serpentes Bothrops jararaca e Oxyuranus scutellatus. In: XVI \n\nSal\u00e3o de Inicia\u00e7\u00e3o Cient\u00edfica da Universidade Federal do Rio Grande do Sul/PROPESQ - \n\nUFRGS, 2004, Porto Alegre. XVI Sal\u00e3o de Inicia\u00e7\u00e3o Cient\u00edfica e XIII Feira de Inicia\u00e7\u00e3o \n\nCient\u00edfica. Porto Alegre: editora da UFRGS. \n\n \n \n\nAPRESENTA\u00c7\u00d5ES DE TRABALHOS \n\n \n\n1 BERGER, M. Envenenamento por animais pe\u00e7onhentos: aspectos fisiopatol\u00f3gicos das altera\u00e7\u00f5es \n\n renais, vasculares e de hemostasia. 2012. (Apresenta\u00e7\u00e3o de Trabalho/Confer\u00eancia ou palestra). \n\n \n\n \n\n2 BERGER, M. Aspectos patol\u00f3gicos envolvidos nas altera\u00e7\u00f5es sist\u00eamicas induzidas pelo veneno \n\n da taturana Lonomia obliqua em ratos 2011. (Apresenta\u00e7\u00e3o de Trabalho/Confer\u00eancia ou \n\n palestra). \n\n \n\n \n \n\n \n\n \n\n\n\nCurriculum Vitae \n\n244 \n\n \n\nORIENTA\u00c7\u00d5ES E SUPERVIS\u00d5ES \n\n \n\n1 DAHMER, T. Atividade anti-tromb\u00f3tica de saponinas triterp\u00eanicas e flavon\u00f3ides isolados de \n\n fontes naturais, 2008-2010. Inicia\u00e7\u00e3o Cient\u00edfica. (Graduando em Farm\u00e1cia) - Universidade \n\n Federal do Rio Grande do Sul. Bolsista PIBIC-CNPq, Conselho Nacional de Desenvolvimento \n\n Cient\u00edfico e Tecnol\u00f3gico. Orientador: BERGER, M. \n\n\n\tM Berger - Tese_Para Impress\u00e3o.pdf\n\t1-s2.0-S0041010110000279-main\n\tLonomia obliqua venom: In vivo effects and molecular aspects associated with the hemorrhagic syndrome\n\tIntroduction\n\tClinical aspects of human envenomation\n\tPharmacology and molecular aspects of experimental envenomation\n\tCoagulation and platelet aggregation disturbances\n\tIntravascular hemolysis\n\tInflammation and vascular disorders\n\tGene expression alterations induced by Lonomia obliqua envenomation\n\tLonomia obliqua transcriptome\n\n\tTreatment of Lonomia obliqua hemorrhagic syndrome\n\tFinal remarks\n\tAcknowledgements\n\tConflicts of interest\n\tReferences\n\n\n\t1-s2.0-S0041010110000279-main.pdf\n\tLonomia obliqua venom: In vivo effects and molecular aspects associated with the hemorrhagic syndrome\n\tIntroduction\n\tClinical aspects of human envenomation\n\tPharmacology and molecular aspects of experimental envenomation\n\tCoagulation and platelet aggregation disturbances\n\tIntravascular hemolysis\n\tInflammation and vascular disorders\n\tGene expression alterations induced by Lonomia obliqua envenomation\n\tLonomia obliqua transcriptome\n\n\tTreatment of Lonomia obliqua hemorrhagic syndrome\n\tFinal remarks\n\tAcknowledgements\n\tConflicts of interest\n\tReferences\n\n\n\tRenal_Failure_-_The_Facts.pdf\n\tpreface RENAL FAILURE\n\tChapter 1\tRisk Factors for Renal Failure: From Infancy to Adulthood\n\tChapter 2\tThe Pathogenesis of Acute Kidney Injury\n\tChapter 3\tOxidative and Nitrosative Stress in the Ischemic Acute Renal Failure\n\tChapter 4 Immunological and Molecular Mechanisms  Leading to Fibrosis:  Origin of Renal Myofibroblasts \n\tChapter 5\tEffects of Maternal Renal Dysfunction \non Fetal Development\n\tChapter 6\tProteomic Biomarkers \nfor the Early Detection of Acute Kidney Injury\n\tChapter 7\tSepsis and Dialysis Disequilibrium Syndrome\n\tChapter 8\tAcute Kidney Injury Following Cardiac Surgery: \nPrevention, Diagnosis, and Management\n\tChapter 9\tAcute Kidney Injury \nInduced by Snake and Arthropod Venoms\n\tChapter 10\tContrast Nephropathy: A Paradigm \nfor Cardiorenal Interactions in Clinical Practice\n\tChapter 11\tThe Outcome of HIV-Positive Patients Admitted \nto Intensive Care Units with Acute Kidney Injury\n\tChapter 12\tManagement of Heparin-Induced Thrombocytopenia \nin Uremic Patients with Hemodialysis\n\tChapter 13\tThe Psychological Impact of Hemodialysis \non Patients with Chronic Renal Failure\n\tChapter 14\tRenal Replacement Therapy in Uremic Diabetic Patients \u2013 Experience From The Republic of Macedonia"}]}}}